"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"IRCCS_BESTA",2000,122,7.05737704918033,3.5,0.581967213114754,0.426229508196721,0.581967213114754,1.84848484848485,1.3921568627451,1.48571428571429,1.42,0.229508196721311,9,56,45,10,7,0.46,0.37,0.08,0.06,72.07,1.58994520468588,NA,0.295081967213115,0.655737704918033,0.507,0.407,0.449,0.404,"FABRIZIO TAGLIAVINI;ORSO BUGIANI;ANDREA SALMAGGI;GIOVANNI BROGGI;DARIA RIVA;GIORGIO GIACCONE;LICIA GRAZZI;DOMENICO D’AMICO;ANGELO FRANZINI;GENNARO BUSSONE;MAURIZIO GELATI;DAVIDE PAREYSON;MASSIMO LEONE;ANTONIO SILVANI;GIACOMINA ROSSI;MARCO DE CURTIS;PAOLO FERROLI;A. BOIARDI;MARICA EOLI;ANGELO SGHIRLANZONI","13;12;11;8;7;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5","DARIA RIVA;GIOVANNI TRINGALI;ORSO BUGIANI;ANDREA SALMAGGI;FRANCO TARONI;MARCO DE CURTIS;GIUSEPPE LAURIA;FABRIZIO TAGLIAVINI;GIOVANNI BROGGI;ANGELO FRANZINI;DAVIDE PAREYSON;MAURIZIO GELATI;ROBERT G. BADGETT;PAOLO FERROLI;ANGELO SGHIRLANZONI;MARINA GRISOLI;GIORGIO GIACCONE;GRAZIELLA FILIPPINI;GERARDO BIELLA;M. SAVOIARDO","3.47;3;2.26;1.76;1.76;1.75;1.5;1.44;1.39;1.1;1.03;1;1;0.96;0.95;0.94;0.86;0.84;0.83;0.79","FABRIZIO TAGLIAVINI;ORSO BUGIANI;ANDREA SALMAGGI;GIOVANNI BROGGI;DARIA RIVA;GIORGIO GIACCONE;LICIA GRAZZI;DOMENICO D’AMICO;ANGELO FRANZINI;GENNARO BUSSONE;MAURIZIO GELATI;DAVIDE PAREYSON;MASSIMO LEONE;ANTONIO SILVANI;GIACOMINA ROSSI;MARCO DE CURTIS;PAOLO FERROLI;A. BOIARDI;MARICA EOLI;ANGELO SGHIRLANZONI","13;12;11;8;7;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5","DARIA RIVA;GIOVANNI TRINGALI;ORSO BUGIANI;ANDREA SALMAGGI;FRANCO TARONI;MARCO DE CURTIS;GIUSEPPE LAURIA;FABRIZIO TAGLIAVINI;GIOVANNI BROGGI;ANGELO FRANZINI;DAVIDE PAREYSON;MAURIZIO GELATI;ROBERT G. BADGETT;PAOLO FERROLI;ANGELO SGHIRLANZONI;MARINA GRISOLI;GIORGIO GIACCONE;GRAZIELLA FILIPPINI;GERARDO BIELLA;M. SAVOIARDO","3.47;3;2.26;1.76;1.76;1.75;1.5;1.44;1.39;1.1;1.03;1;1;0.96;0.95;0.94;0.86;0.84;0.83;0.79","MARINA MORA;FABRIZIO TAGLIAVINI;DARIA RIVA;ANGELO L. VESCOVI;ROSSELLA GALLI;AYAKA YAMAMOTO;CAROLYN M. SUE;EDUARDO BONILLA;EDWARD BYRNE;ICHIZO NISHINO;IKUYA NONAKA;JACK E. RIGGS;JIN FU;KURENAI TANJI;MICHIO HIRANO;NOBUYUKI MURAKAMI;SADATOMO SHIMOJO;SALVATORE DIMAURO;SARA SHANSKE;SHIN J. OH","1397;1181;1057;905;905;903;903;903;903;903;903;903;903;903;903;903;903;903;903;903","MARINA MORA;FABRIZIO TAGLIAVINI;DARIA RIVA;ORSO BUGIANI;ANGELO L. VESCOVI;ROSSELLA GALLI;GAETANO FINOCCHIARO;GIORGIO GIACCONE;ALBERTO ALBANESE;LUCIA MORANDI;MARIA GRAZIA BRUZZONE;A FLETCHER;A. RUIZ BREMÓN;ANNA LADOGANA;FRANCO CARDONE;H. BERNHEIMER;HERBERT BUDKA;INGA ZERR;J.P. BRANDEL;JEAN LAPLANCHE","1397;1181;1057;858;808;808;597;541;539;494;482;468;468;468;468;468;468;468;468;468","FABRIZIO TAGLIAVINI;ORSO BUGIANI;ANDREA SALMAGGI;DARIA RIVA;DOMENICO D’AMICO;LICIA GRAZZI;GENNARO BUSSONE;GIORGIO GIACCONE;GIOVANNI BROGGI;FRANCO TARONI;GIACOMINA ROSSI;MARINA MORA;A. BOIARDI;ANGELO FRANZINI;ANTONIO SILVANI;MARICA EOLI;MASSIMO LEONE;BARBARA GARAVAGLIA;DANIELA DI BELLA;E. CORSINI","13;12;11;7;7;7;7;7;6;5;5;5;5;5;5;5;5;4;4;4","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;PHILOSOPHY;ECONOMICS;MATHEMATICS;SOCIOLOGY;ENGINEERING;BUSINESS;HISTORY;MATERIALS SCIENCE","87;58;29;29;9;8;4;3;3;3;2;1;1;1","INTERNAL MEDICINE;NEUROSCIENCE;BIOCHEMISTRY;PATHOLOGY;PSYCHIATRY;GENETICS;SURGERY;CELL BIOLOGY;IMMUNOLOGY;PEDIATRICS;ANESTHESIA;RADIOLOGY;ENDOCRINOLOGY;ANATOMY;BIOPHYSICS;MOLECULAR BIOLOGY;ORGANIC CHEMISTRY;PHYSICAL MEDICINE AND REHABILITATION;AUDIOLOGY;PHARMACOLOGY","43;40;36;36;35;24;23;18;16;14;11;11;10;8;8;8;8;8;7;6","GENE;NEUROLOGY;DISEASE;NEUROSURGERY;CENTRAL NERVOUS SYSTEM;RECEPTOR;IN VITRO;COGNITION;MIGRAINE;APOPTOSIS;CYTOKINE;ENZYME;SPINAL CORD;INHIBITORY POSTSYNAPTIC POTENTIAL;MAGNETIC RESONANCE IMAGING;PEPTIDE;POPULATION;TRIGEMINAL NEURALGIA;ANTIBODY;CALCIUM;CYTOPLASM;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;MUSCULAR DYSTROPHY;RADIATION THERAPY;STEM CELL;STIMULATION","27;24;20;18;16;15;11;9;8;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4","NEURORADIOLOGY;MUTATION;PARKINSON'S DISEASE;PRION PROTEIN;GENOTYPE;NEUROPSYCHOLOGY;PHENOTYPE;CLUSTER HEADACHE;NEURAL STEM CELL;ALLELE;AURA;BLOOD–BRAIN BARRIER;EMBRYONIC STEM CELL;ENTORHINAL CORTEX;MICROVASCULAR DECOMPRESSION;MYELIN;PATCH CLAMP;PERIPHERAL BLOOD MONONUCLEAR CELL;PIRIFORM CORTEX;PROGRAMMED CELL DEATH;PROGRESSIVE SUPRANUCLEAR PALSY;SEROTONIN","18;10;6;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","DEEP BRAIN STIMULATION;PRNP;NEUROEPITHELIAL CELL;ADRENOLEUKODYSTROPHY;FRATAXIN;NUCLEAR PROTEIN;OLIGODENDROCYTE;PROBAND;REVERSAL POTENTIAL;SCRAPIE;SUBTHRESHOLD CONDUCTION;VERBAL FLUENCY TEST;5-HT RECEPTOR;ACHÉ;ACROMEGALY;ADULT STEM CELL;BICUCULLINE;CCL2;CD18;CD23;CD28;CILIARY NEUROTROPHIC FACTOR;CLADE;COMPOUND HETEROZYGOSITY;CORTICOBASAL DEGENERATION;CURRENT CLAMP;CYTOLYSIS;DEMENTIA WITH LEWY BODIES;ENHANCER;EOSINOPHIL PEROXIDASE;EPSTEIN–BARR VIRUS INFECTION;EXTINCTION EVENT;FAS LIGAND;FAS RECEPTOR;GDF7;GENOTYPE-PHENOTYPE DISTINCTION;GLOBUS PALLIDUS;GLYCOGEN STORAGE DISEASE TYPE II;GRANULE CELL;HAPLOTYPE;INTERLEUKIN 12;INTERLEUKIN 21;JURKAT CELLS;LEUKEMIA INHIBITORY FACTOR;LEWY BODY;LMNA;LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN 1;MEAN ARTERIAL PRESSURE;MIGRAINE WITH AURA;MISSENSE MUTATION;MONOAMINE NEUROTRANSMITTER;MONOAMINE OXIDASE A;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;MYELIN SHEATH;MYELIN-ASSOCIATED GLYCOPROTEIN;NEUROPSYCHOLOGICAL ASSESSMENT;NEUROPSYCHOLOGICAL TEST;OLFACTORY TUBERCLE;PENETRANCE;PHONOPHOBIA;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;REVERSION;SEROTONERGIC;SEROTONIN TRANSPORTER;SINGLE-NUCLEOTIDE POLYMORPHISM;SOX2;STEM CELL FACTOR;T-TYPE CALCIUM CHANNEL;TUMOR SUPPRESSOR GENE;VCAM-1;VIRAL ENCEPHALITIS;WISCONSIN CARD SORTING TEST","5;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;NEURONS;BRAIN;PRIONS;ANIMALS;PEPTIDE FRAGMENTS;ADULT;BRAIN NEOPLASMS;CREUTZFELDT-JAKOB SYNDROME;MIDDLE AGED;MUSCLE, SKELETAL;AGED;CEREBRAL CORTEX;CHILD;RATS;ADOLESCENT;MAGNETIC RESONANCE IMAGING","68;48;40;39;31;30;29;23;23;22;20;19;19;18;17;16;16;16;13;13","MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;PRION DISEASES: CAUSES AND MOLECULAR BASIS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;GLIOMAS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PATHOLOGY AND MANAGEMENT OF TRIGEMINAL NEURALGIA;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;ARCHAEOASTRONOMY AND CULTURAL LANDSCAPES;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;EPIDEMIOLOGY, CLASSIFICATION, AND CLINICAL FEATURES OF INFLAMMATORY MYOPATHIES;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;INTEGRIN SIGNALING IN INFLAMMATION AND CANCER;MECHANISMS OF ALZHEIMER'S DISEASE;OBSESSIVE-COMPULSIVE DISORDER AND RELATED CONDITIONS","10;10;5;5;5;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2","NEURORADIOLOGY;CELLULAR PRION PROTEIN;DEEP BRAIN STIMULATION;NEUROIMAGING;HEADACHE DISORDERS;CANCER THERAPY;CLUSTER HEADACHE;PRNP;RADIOTHERAPY;TRIGEMINAL NEURALGIA;BRAIN TUMOR EPIDEMIOLOGY;CEREBELLUM;ENTORHINAL CORTEX;MICROVASCULAR DECOMPRESSION;MIGRAINE;MIGRAINE PREVENTION;MUTATION;NEURODEGENERATION;NEUROEPITHELIAL CELL;NEUROGENESIS","18;7;6;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","PRION PROTEIN;CLUSTER HEADACHE;CREUTZFELDTJAKOB DISEASE;ITALIAN FAMILIES;MUSCULAR DYSTROPHY;CENTRAL NERVOUS;ENDOTHELIAL CELLS;ENTORHINAL CORTEX;MAGNETIC RESONANCE;MICROVASCULAR DECOMPRESSION;PARKINSONS DISEASE;RESONANCE IMAGING;TRIGEMINAL NEURALGIA;ANTERIOR CRANIOFACIAL;APOPTOTIC EFFECTS;BLOODY ENTERTAINMENT;BRAIN ENDOTHELIUM;BRAIN STIMULATION;CELL DEATH;CEREBRAL ENDOTHELIAL;CHEMOTHERAPEUTIC DRUGS;CHRONIC SENSORY;CNS STEM;COMBINED ANTERIOR;CRANIOFACIAL RESECTION;CRIBRIFORM PLATE;DEEP BRAIN;DEVELOPING RAT;DISEASE LINKED;EK MUTATION","5;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;LAMIN AC;EMERY-DREIFUSS MUSCULAR;MUSCULAR DYSTROPHY;GENET -CROSSREF;AUTOSOMAL DOMINANT;AL BONNE;NUCLEAR ENVELOPE;PRP RES;DYSTROPHYNAT GENET;LMNA GENE;MUSCULAR DYSTROPHYNAT;SKELETAL MUSCLE;AL STUURMAN;AMINO ACID;CLUSTER HEADACHE;DI BARLETTA;DILATED CARDIOMYOPATHY;GENE ENCODING;MOL GENET;MULTIPLE SCLEROSIS;PATIENTS AFFECTED;RAFFAELE DI;ROD DOMAIN;SMN PROTEIN;ANTIHUMAN CD;AUTOSOMAL RECESSIVE;BECANE HM;BIOL -CROSSREF","37;35;20;19;17;15;11;10;10;8;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;5;5;5;5",18,0.15,9,6,2,1,0,1,6,0,1,6,0,0,1,0,3,0,0,1,0,0,0,118,118.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,1005000,163019.13,4,24,11.3333333333333,1,11.3333333333333,122264.344262295,0.997837928433755,"ISTITUTO NEUROLOGICO CARLO BESTA;DÉLÉGATION PARIS 11;UNIVERSITY OF ANTWERP;AALBORG UNIVERSITY;AALBORG UNIVERSITY HOSPITAL;AARHUS UNIVERSITY HOSPITAL;ARISTOTLE UNIVERSITY OF THESSALONIKI;BARZILAI MEDICAL CENTER;BEAUMONT HOSPITAL;CATHOLIC UNIVERSITY OF THE SACRED HEART;CEA FONTENAY-AUX-ROSES;CHRISTIAN DOPPLER KLINIK;CLAUDE BERNARD UNIVERSITY LYON 1;COPENHAGEN UNIVERSITY HOSPITAL;ELI LILLY (UNITED KINGDOM);ERASMUS UNIVERSITY ROTTERDAM;FRIEDRICH-LOEFFLER-INSTITUT;HANNOVER MEDICAL SCHOOL;HOSPITAL DE EGAS MONIZ;HÔPITAL LARIBOISIÈRE","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","3","COALITION S;EC & ERC - EUROPEAN UNION","3;3","CSC - COST-SHARING CONTRACTS (FUNDING SCHEME);FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME);CON - COORDINATION OF RESEARCH ACTIONS (FUNDING SCHEME);FP5-IST - PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON A ""USER-FRIENDLY INFORMATION SOCIETY, 1998-2002"" (PROGRAMME)","2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3209 NEUROSCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","2;1;1;1;1","BRAIN DISORDERS;NEURODEGENERATIVE;NEUROSCIENCES;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BIOENGINEERING;BIOTECHNOLOGY;DEMENTIA;EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES","2;2;2;1;1;1;1;1;1;1;1;1","NEUROLOGICAL","2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","2;1",NA,NA,NA,NA,"A05 BIOLOGICAL SCIENCES;A06 AGRICULTURE, VETERINARY AND FOOD SCIENCE;B12 ENGINEERING","1;1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BESTA",2001,90,7.82222222222222,3.33333333333333,0.522222222222222,0.533333333333333,0.522222222222222,1.69491525423729,1.14634146341463,1.23076923076923,1.14634146341463,0.233333333333333,3,40,27,12,4,0.44,0.3,0.13,0.04,45.08,0.9865480724606,NA,0.3,0.6,0.419,0.369,0.384,0.369,"FRANCO TARONI;FABRIZIO TAGLIAVINI;GIOVANNI BROGGI;GENNARO BUSSONE;DOMENICO D’AMICO;MARCO DE CURTIS;ORSO BUGIANI;LICIA GRAZZI;MASSIMO ZEVIANI;ROBERTO SPREAFICO;CAROLINA FRASSONI;ALBERTO ALBANESE;ANDREA SALMAGGI;PEDRO PICCARDO;SILVANA FRANCESCHETTI;BERNARDINO GHETTI;SUSANNA USAI;BIANCA POLLO;MASSIMO LEONE;RITA GARBELLI","7;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;3;3;3","FRANCO TARONI;MARCO DE CURTIS;ANNA RITA GIOVAGNOLI;ALBERTO ALBANESE;GERARDO BIELLA;DOMENICO D’AMICO;GENNARO BUSSONE;GIOVANNI BROGGI;CAROLINA FRASSONI;LICIA GRAZZI;FABRIZIO TAGLIAVINI;ORSO BUGIANI;SARA BREVI;JACOPO MAGISTRETTI;ANDREA SALMAGGI;ROBERTO SPREAFICO;T. CARACENI;LAURA LIBRIZZI;SUSANNA USAI;ANGELO FRANZINI","1.71;1.58;1.48;1.34;1;0.89;0.86;0.85;0.81;0.76;0.68;0.67;0.67;0.67;0.64;0.63;0.61;0.58;0.56;0.53","FRANCO TARONI;FABRIZIO TAGLIAVINI;GIOVANNI BROGGI;GENNARO BUSSONE;DOMENICO D’AMICO;MARCO DE CURTIS;ORSO BUGIANI;LICIA GRAZZI;MASSIMO ZEVIANI;ROBERTO SPREAFICO;CAROLINA FRASSONI;ALBERTO ALBANESE;ANDREA SALMAGGI;PEDRO PICCARDO;SILVANA FRANCESCHETTI;BERNARDINO GHETTI;SUSANNA USAI;BIANCA POLLO;MASSIMO LEONE;RITA GARBELLI","7;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;3;3;3","FRANCO TARONI;MARCO DE CURTIS;ANNA RITA GIOVAGNOLI;ALBERTO ALBANESE;GERARDO BIELLA;DOMENICO D’AMICO;GENNARO BUSSONE;GIOVANNI BROGGI;CAROLINA FRASSONI;LICIA GRAZZI;FABRIZIO TAGLIAVINI;ORSO BUGIANI;SARA BREVI;JACOPO MAGISTRETTI;ANDREA SALMAGGI;ROBERTO SPREAFICO;T. CARACENI;LAURA LIBRIZZI;SUSANNA USAI;ANGELO FRANZINI","1.71;1.58;1.48;1.34;1;0.89;0.86;0.85;0.81;0.76;0.68;0.67;0.67;0.67;0.64;0.63;0.61;0.58;0.56;0.53","FABRIZIO TAGLIAVINI;BERNARDINO GHETTI;PEDRO PICCARDO;MARIO SALMONA;ALBERTO ALBANESE;ORSO BUGIANI;MASSIMO ZEVIANI;ROBERTO SPREAFICO;GIANLUIGI FORLONI;LAURA COLOMBO;LAURA GIROLA;ALESSANDRO FERRARIS;ANNA RITA BENTIVOGLIO;ENZA MARIA VALENTE;MARY B. DAVIS;NICHOLAS WOOD;VALERIA TIRANTI;GENNARO BUSSONE;FRANCO TARONI;GIOVANNI BROGGI","730;437;437;420;336;336;297;234;229;229;229;218;218;218;218;218;217;212;205;198","FABRIZIO TAGLIAVINI;ALBERTO ALBANESE;ORSO BUGIANI;MASSIMO ZEVIANI;ROBERTO SPREAFICO;VALERIA TIRANTI;GENNARO BUSSONE;GIOVANNI BROGGI;MARINA MORA;ANNA RITA GIOVAGNOLI;GIORGIO GIACCONE;DOMENICO D’AMICO;LICIA GRAZZI;SUSANNA USAI;MASSIMO LEONE;GRAZIELLA FILIPPINI;FRANCO TARONI;G. UZIEL;MARIANNA BUGIANI;MARCO DE CURTIS","730;336;336;242;234;217;212;198;198;179;179;166;166;165;161;156;150;145;145;144","FRANCO TARONI;GENNARO BUSSONE;DOMENICO D’AMICO;GIOVANNI BROGGI;FABRIZIO TAGLIAVINI;ALBERTO ALBANESE;CAROLINA FRASSONI;LICIA GRAZZI;MARCO DE CURTIS;ORSO BUGIANI;ROBERTO SPREAFICO;ANDREA SALMAGGI;MASSIMO ZEVIANI;SILVANA FRANCESCHETTI;SUSANNA USAI;ANNA RITA GIOVAGNOLI;F. GIROTTI;PAOLA SOLIVERI;S. GENITRINI;ANGELO FRANZINI","7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;PHILOSOPHY;SOCIOLOGY;MATHEMATICS;POLITICAL SCIENCE","67;51;22;13;9;2;2;2;2;2;1;1","INTERNAL MEDICINE;NEUROSCIENCE;PATHOLOGY;GENETICS;BIOCHEMISTRY;PSYCHIATRY;SURGERY;ENDOCRINOLOGY;MOLECULAR BIOLOGY;IMMUNOLOGY;CELL BIOLOGY;PHARMACOLOGY;ANESTHESIA;ORGANIC CHEMISTRY;PHYSICAL THERAPY;BIOPHYSICS;ANATOMY;AUDIOLOGY;PEDIATRICS;PHYSICAL MEDICINE AND REHABILITATION;RADIOLOGY","38;29;24;23;22;22;18;12;11;10;9;9;8;7;7;6;5;4;4;4;4","GENE;DISEASE;RECEPTOR;EPILEPSY;CENTRAL NERVOUS SYSTEM;MIGRAINE;NEUROLOGY;STIMULATION;AMYLOID (MYCOLOGY);ANTIBODY;HIPPOCAMPUS;IMMUNOHISTOCHEMISTRY;ATROPHY;CELL;DYSTONIA;ELECTROPHYSIOLOGY;MITOCHONDRION;PEPTIDE;ABNORMALITY;CALCIUM;CANCER;CHEMOTHERAPY;COGNITION;DEPOLARIZATION;DOPAMINE;ELECTROENCEPHALOGRAPHY;FIBRIL;HIPPOCAMPAL FORMATION;IN VITRO;INHIBITORY POSTSYNAPTIC POTENTIAL;LESION;MAGNETIC RESONANCE IMAGING;MYOCLONUS;NEUROSURGERY;POPULATION;RADIATION THERAPY","25;18;16;11;8;7;7;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MUTATION;PHENOTYPE;PARKINSON'S DISEASE;EXON;GENOTYPE;AGE OF ONSET;AGONIST;LOCUS (GENETICS);MYELIN;NEURORADIOLOGY;NMDA RECEPTOR;ALLELE;ALZHEIMER'S DISEASE;CYTOCHROME C OXIDASE;DEMENTIA;DOPAMINERGIC;GENE DUPLICATION;GENETIC LINKAGE;GLUTAMATE RECEPTOR;ICTAL;INTRON;LAMOTRIGINE;MONOCLONAL ANTIBODY;PARKINSONISM;PATCH CLAMP;PIRIFORM CORTEX;TEMPORAL LOBE;TRIPTANS","12;9;7;6;6;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","GENETIC HETEROGENEITY;MISSENSE MUTATION;HAPLOTYPE;LEVODOPA;PERIPHERAL MYELIN PROTEIN 22;AMPA RECEPTOR;DEEP BRAIN STIMULATION;LEIGH DISEASE;PROBAND;SUMATRIPTAN;AMYLOID PRECURSOR PROTEIN;APOMORPHINE;COMPOUND HETEROZYGOSITY;GENE MUTATION;MITOCHONDRIAL MYOPATHY;PENETRANCE;5-HT RECEPTOR;ACROMEGALY;ACUTE MIGRAINE;ANDROGEN RECEPTOR;BICUCULLINE;BRADYCARDIA;BRAIN-DERIVED NEUROTROPHIC FACTOR;CARNITINE O-PALMITOYLTRANSFERASE;CATENIN;CEREBRAL AMYLOID ANGIOPATHY;CYPROHEPTADINE;CYSTATIN;DEBULKING;DOPAMINE AGONIST;DYSKINESIA;EXCITOTOXICITY;EXPLICIT MEMORY;FAS LIGAND;FERROPORTIN;FLUORESCENCE IN SITU HYBRIDIZATION;FRATAXIN;FRONTOTEMPORAL DEMENTIA;GENE MAPPING;GENETICALLY MODIFIED MOUSE;GLUCURONIDATION;HETEROPLASMY;HIPPOCAMPAL SCLEROSIS;IMMUNOPEROXIDASE;IN SITU HYBRIDIZATION;KAINIC ACID;KEARNS–SAYRE SYNDROME;LEBER'S HEREDITARY OPTIC NEUROPATHY;LIMB-GIRDLE MUSCULAR DYSTROPHY;LOW-AFFINITY NERVE GROWTH FACTOR RECEPTOR;MDX MOUSE;MEMORY SPAN;METHYSERGIDE;MITOCHONDRIAL DISEASE;MITOCHONDRIAL ENCEPHALOMYOPATHY;NORMAL PRESSURE HYDROCEPHALUS;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PARAHIPPOCAMPAL GYRUS;PARKIN;PERIRHINAL CORTEX;PIGMENTED VILLONODULAR SYNOVITIS;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;POINT MUTATION;PRESENILIN;PRNP;RADIOIMMUNOTHERAPY;SELEGILINE;SEROTONERGIC;SOD1;SUBSTANCE P;T-TYPE CALCIUM CHANNEL;TRINUCLEOTIDE REPEAT EXPANSION;TROPOMYOSIN RECEPTOR KINASE A;TROPOMYOSIN RECEPTOR KINASE B;VINCRISTINE;VINCULIN;ZYGAPOPHYSEAL JOINT","5;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;BRAIN;;ADULT;ANIMALS;EPILEPSY;ADOLESCENT;MIDDLE AGED;MUTATION;NEURONS;PEPTIDE FRAGMENTS;BRAIN NEOPLASMS;AGED;CEREBRAL CORTEX;PYRAMIDAL CELLS;ACTION POTENTIALS;ALZHEIMER DISEASE;MUSCLE, SKELETAL","58;36;33;26;20;20;18;18;17;16;16;16;16;15;13;13;13;12;12;12","MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;EPILEPSY AND SEIZURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MECHANISMS OF ALZHEIMER'S DISEASE;PRION DISEASES: CAUSES AND MOLECULAR BASIS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;GLIOMAS;NEURAL MECHANISMS OF MEMORY FORMATION AND SPATIAL NAVIGATION;PRENATAL EXPOSURE TO ANTIEPILEPTIC DRUGS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;BIOLOGICAL EFFECTS OF ELECTROMAGNETIC FIELDS;CELLULAR SENESCENCE AND AGING-RELATED DISEASES","10;7;5;5;5;4;4;4;4;3;3;3;2;2;2;2;2;1;1;1","MIGRAINE;MIGRAINE PREVENTION;AMYLOID (MYCOLOGY);DEEP BRAIN STIMULATION;NEURORADIOLOGY;ABNORMALITY;CELLULAR PRION PROTEIN;CHARCOT-MARIE-TOOTH DISEASE;GENETIC LINKAGE;LEIGH DISEASE;NEUROIMAGING;NEUROMODULATION;NEURONAL CIRCUITS;PIRIFORM CORTEX;PROBAND;RIZATRIPTAN;SINGLET OXYGEN PRODUCTION;TREATMENT;TRIPTANS;ANTIEPILEPTIC DRUGS","7;6;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2","PARKINSONS DISEASE;GUINEA PIG;LEIGH SYNDROME;UPPER LIMB;ALZHEIMER DISEASE;BILATERAL SUBTHALAMIC;CORTICAL DYSPLASIA;DYSTONIA LOCUS;GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE;HIPPOCAMPAL DAMAGE;IIN VITROI;ITALIAN FAMILY;LIMB ONSET;LOCUS MAPS;PRIMARY TORSION;PRION PROTEIN;RECURRENT MALIGNANT;TORSION DYSTONIA;ACTION INDEPENDENT;ACTIVATION KINETICS;ACTIVATOR RECEPTOR;ACTIVATORUROKINASE PLASMINOGEN;ACTIVITY EVOKED;ACUTE CHALLENGE;ACUTE DOPAMINERGIC;ACUTE EFFECTS;ADHESION MOLECULES;ADHESION PHENOMENA;ADULT PATIENT;ALEXANDER DISEASE","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CROSSREF PUBMED;PUBMED SCOPUS;ALEXANDER DISEASE;GENET -CROSSREF;PUBMED GOOGLE;PRION PROTEIN;DLOUHY SR;GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE;NEUROL -CROSSREF;AL BRENNER;PRUSINER SB;EXP NEUROL;NEUROPATHOL EXP;GFAP MUTATIONS;HUM GENET;ALEXANDERS DISEASE;LEIGH SYNDROME;AUTOSOMAL DOMINANT;CHEN SG;FIBRILLARY ACIDIC;GENETIC HETEROGENEITY;GLIAL FIBRILLARY;GOLDMAN JE;GSS AV;JOHNSON AB;ACIDIC PROTEIN;BASAL GANGLIA;SURF PROTEIN;WESTERN BLOT;AMYLOID PROTEIN","157;149;39;39;39;36;35;30;29;20;20;19;19;18;17;14;14;13;13;13;13;13;13;13;13;12;12;12;12;11",14,0.16,6,4.75,0,1,0,0,6,0,0,4.75,0,1,0,0,2,0,0,0,0,0,0,55.75,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1659996,237142.29,4,7,5,1,8,181549.915690867,0.495731433735542,"ISTITUTO NEUROLOGICO CARLO BESTA;MARTIN LUTHER UNIVERSITY HALLE-WITTENBERG;UNIVERSITY OF EASTERN FINLAND;UNIVERSITY OF HELSINKI;UNIVERSITY OF TARTU;UNIVERSITY OF TURKU;UPPSALA UNIVERSITY","1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","CSC - COST-SHARING CONTRACTS (FUNDING SCHEME);FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME)","1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES","1;1;1","BRAIN DISORDERS;EPILEPSY;GENETICS;NEURODEGENERATIVE;NEUROSCIENCES","1;1;1;1;1","GENERIC HEALTH RELEVANCE;NEUROLOGICAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BESTA",2002,83,7.92771084337349,3.10843373493976,0.493975903614458,0.481927710843373,0.518072289156627,1.51764705882353,1.025,1.29032258064516,1.075,0.216867469879518,3,40,21,10,7,0.48,0.25,0.12,0.08,66.46,1.20462904974697,NA,0.313253012048193,0.686746987951807,0.458,0.324,0.391,0.324,"ROBERTO SPREAFICO;ALBERTO ALBANESE;GRAZIELLA UZIEL;ANDREA SALMAGGI;ANNA RITA BENTIVOGLIO;A. BOIARDI;MASSIMO ZEVIANI;MASSIMO LEONE;FABRIZIO TAGLIAVINI;ANTONIO SILVANI;RENATO MANTEGAZZA;GAETANO FINOCCHIARO;MARICA EOLI;GIOVANNI BROGGI;PIA BERNASCONI;MARCO DE CURTIS;ÉSPER A. CAVALHEIRO;VALERIA TIRANTI;ALESSANDRA SOLARI;NICHOLAS WOOD","7;7;6;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3","ALBERTO ALBANESE;ROBERTO SPREAFICO;LUISA CHIAPPARINI;MAURIZIO GELATI;MARCO DE CURTIS;VALERIA TIRANTI;LUCIA MORANDI;MASSIMO LEONE;GRAZIELLA UZIEL;ANDREA SALMAGGI;A. BOIARDI;ANNA RITA BENTIVOGLIO;ÉSPER A. CAVALHEIRO;ALESSANDRA SOLARI;LAURA UVA;GERARDO BIELLA;GRAZIELLA FILIPPINI;FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;ANTONIO SILVANI","1.76;1.31;1.17;1.09;1.08;0.92;0.92;0.82;0.77;0.77;0.67;0.65;0.61;0.59;0.58;0.58;0.58;0.57;0.55;0.55","ROBERTO SPREAFICO;ALBERTO ALBANESE;GRAZIELLA UZIEL;ANDREA SALMAGGI;ANNA RITA BENTIVOGLIO;A. BOIARDI;MASSIMO ZEVIANI;MASSIMO LEONE;FABRIZIO TAGLIAVINI;ANTONIO SILVANI;RENATO MANTEGAZZA;GAETANO FINOCCHIARO;MARICA EOLI;GIOVANNI BROGGI;PIA BERNASCONI;MARCO DE CURTIS;VALERIA TIRANTI;ALESSANDRA SOLARI;LUCIA MORANDI;G. AVANZINI","7;7;6;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3","ALBERTO ALBANESE;ROBERTO SPREAFICO;LUISA CHIAPPARINI;MAURIZIO GELATI;MARCO DE CURTIS;VALERIA TIRANTI;LUCIA MORANDI;MASSIMO LEONE;GRAZIELLA UZIEL;ANDREA SALMAGGI;A. BOIARDI;ANNA RITA BENTIVOGLIO;ALESSANDRA SOLARI;LAURA UVA;GERARDO BIELLA;GRAZIELLA FILIPPINI;FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;ANTONIO SILVANI;MARICA EOLI","1.76;1.31;1.17;1.09;1.08;0.92;0.92;0.82;0.77;0.77;0.67;0.65;0.59;0.58;0.58;0.58;0.57;0.55;0.55;0.55","ANDREA SALMAGGI;ALBERTO ALBANESE;ANNA RITA BENTIVOGLIO;GRANT P. CHRISTMAN;JAMI MANDELIN;JUHA PALONEVA;KARINE HOVANES;LEENA PELTONEN;LISBETH TRANEBJÆRG;MARINO MUXFELDT BIANCHIN;ROLF ADOLFSSON;ROXANA MIRANDA;THOMAS D. BIRD;TUULA MANNINEN;YRJÖ T. KONTTINEN;MASSIMO ZEVIANI;GRAZIELLA UZIEL;LUIGI ROMITO;MARIA FIORELLA CONTARINO;MASSIMO SCERRATI","747;701;679;626;626;626;626;626;626;626;626;626;626;626;626;612;554;408;408;408","ANDREA SALMAGGI;ALBERTO ALBANESE;MASSIMO ZEVIANI;GRAZIELLA UZIEL;ROBERTO SPREAFICO;ELEONORA LAMANTEA;ALESSANDRA SACCANI;RENATO MANTEGAZZA;VALERIA TIRANTI;ALESSANDRA SOLARI;PIA BERNASCONI;DARIA RIVA;ALBERTO BURLINA;CARLO DIONISI‐VICI;CRISTIANO RIZZO;DAMIANO ABENI;GAETANO SABETTA;UBALDO CARUSO;FULVIO BAGGI;LUISA CHIAPPARINI","747;701;612;554;367;338;283;283;271;262;252;236;226;226;226;226;226;226;224;222","ALBERTO ALBANESE;ROBERTO SPREAFICO;ANDREA SALMAGGI;GRAZIELLA UZIEL;A. BOIARDI;MASSIMO ZEVIANI;ANTONIO SILVANI;FABRIZIO TAGLIAVINI;MARICA EOLI;RENATO MANTEGAZZA;GAETANO FINOCCHIARO;ALESSANDRA SOLARI;LUCIA MORANDI;ANDREA RIGAMONTI;G. AVANZINI;MASSIMO LEONE;PIA BERNASCONI;VALERIA TIRANTI;GIOVANNI BROGGI;MARCO DE CURTIS","7;7;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATHEMATICS;PHYSICS;ENGINEERING;PHILOSOPHY;ART;HISTORY;MATERIALS SCIENCE","69;39;15;10;5;5;5;3;2;1;1;1","INTERNAL MEDICINE;PATHOLOGY;GENETICS;NEUROSCIENCE;PSYCHIATRY;BIOCHEMISTRY;IMMUNOLOGY;SURGERY;ENDOCRINOLOGY;PEDIATRICS;RADIOLOGY;MOLECULAR BIOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;ANATOMY;CANCER RESEARCH;ANESTHESIA;ONCOLOGY;CELL BIOLOGY;CARDIOLOGY;DEVELOPMENTAL PSYCHOLOGY;PHARMACOLOGY;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;PROGRAMMING LANGUAGE","43;28;24;18;17;15;14;11;10;10;10;9;8;7;6;6;5;5;4;3;3;3;3;3;3","DISEASE;GENE;EPILEPSY;POPULATION;CHEMOTHERAPY;NEUROLOGY;STIMULATION;HIPPOCAMPUS;MAGNETIC RESONANCE IMAGING;NEUROSURGERY;RECEPTOR;CENTRAL NERVOUS SYSTEM;COGNITION;ENZYME;IMMUNOHISTOCHEMISTRY;IN VITRO;INHIBITORY POSTSYNAPTIC POTENTIAL;MIGRAINE;NEOCORTEX;CELL CULTURE;CORTEX (ANATOMY);DNA;ELECTROPHYSIOLOGY;GLIOBLASTOMA;HIPPOCAMPAL FORMATION;IMMUNE SYSTEM;MITOCHONDRION;MULTIPLE SCLEROSIS;OCCLUSION;PARVALBUMIN;PATHOGENESIS;RATING SCALE;VIRUS","26;24;11;8;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MUTATION;PARKINSON'S DISEASE;PHENOTYPE;ALLELE;TEMPORAL LOBE;CISPLATIN;ENTORHINAL CORTEX;MITOCHONDRIAL DNA;AGE OF ONSET;EXON;NEURORADIOLOGY;POLYMERASE CHAIN REACTION;ASTROCYTE;AURA;BIPOLAR DISORDER;CALBINDIN;CHEMOKINE;CLUSTER HEADACHE;COGNITIVE IMPAIRMENT;CORTICAL DYSPLASIA;DEMENTIA;DOPAMINERGIC;GABAERGIC;GENOTYPE;GLUTAMATE DECARBOXYLASE;GLUTAMATE RECEPTOR;LOCUS (GENETICS);MENDELIAN INHERITANCE;MOVEMENT DISORDERS;PARKINSONISM;PILOCARPINE;PRION PROTEIN;PROGRAMMED CELL DEATH;RESPIRATORY CHAIN","9;7;6;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","DEEP BRAIN STIMULATION;LEIGH DISEASE;MISSENSE MUTATION;MITOCHONDRIAL MYOPATHY;CARBOPLATIN;COMPOUND HETEROZYGOSITY;DOPAMINE TRANSPORTER;GENETIC HETEROGENEITY;LEVODOPA;MANIA;MITOCHONDRIAL DISEASE;OMIM : ONLINE MENDELIAN INHERITANCE IN MAN;SELEGILINE;AUTOIMMUNE ENCEPHALITIS;BROMOCRIPTINE;CCL2;COPY-NUMBER VARIATION;CYCLIN;CYCLIN D1;DEMENTIA WITH LEWY BODIES;EXTERNAL OPHTHALMOPLEGIA;FABRY'S DISEASE;FAS LIGAND;FAS RECEPTOR;GENOTYPE-PHENOTYPE DISTINCTION;GLOBOTRIAOSYLCERAMIDE;HAPLOTYPE;HETEROPLASMY;HIPPOCAMPAL SCLEROSIS;IN SITU HYBRIDIZATION;INCREMENTAL EXERCISE;LEWY BODY;LOSS OF HETEROZYGOSITY;MAPLE SYRUP URINE DISEASE;METHYLENETETRAHYDROFOLATE REDUCTASE;METHYLMALONIC ACIDURIA;MIGRAINE WITH AURA;MUCOPOLYSACCHARIDOSIS TYPE I;MYOTONIA CONGENITA;NEUROPSYCHOLOGICAL ASSESSMENT;NEUROPSYCHOLOGICAL TEST;NUCLEAR DNA;NUCLEAR GENE;OLIVOPONTOCEREBELLAR ATROPHY;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PACED AUDITORY SERIAL ADDITION TEST;PANCREATIC ISLETS;PARKIN;PENETRANCE;PERIRHINAL CORTEX;PHARMACOGNOSY;POSITIONAL CLONING;PROBAND;RESPIRATORY EXCHANGE RATIO;SCRAPIE;SH-SY5Y;SINGLE-NUCLEOTIDE POLYMORPHISM;SUMATRIPTAN;TREM2;UREA CYCLE;VIGABATRIN","3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;EPILEPSY;BRAIN;MIDDLE AGED;ANIMALS;ADOLESCENT;AGED;MULTIPLE SCLEROSIS;;NEURONS;CHILD;MAGNETIC RESONANCE IMAGING;INFANT;ITALY;LEIGH DISEASE;ANTINEOPLASTIC AGENTS;BRAIN NEOPLASMS","59;48;39;26;25;24;23;14;13;13;13;12;12;11;11;10;10;10;9;9","MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;GLIOMAS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EPILEPSY AND SEIZURES;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PRION DISEASES: CAUSES AND MOLECULAR BASIS;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;BRAIN FLUID DYNAMICS AND WASTE CLEARANCE MECHANISMS;CEREBROSPINAL FLUID DISORDERS AND HEMATOMAS;CLASSIFICATION AND TREATMENT OF HISTIOCYTIC DISORDERS;DIAGNOSIS AND MANAGEMENT OF FETAL AND NEONATAL TUMORS;DIFFUSION MAGNETIC RESONANCE IMAGING;DISEASES RELATED TO BLOOD GROUP VARIANTS;DNA TOPOISOMERASES: STRUCTURE, FUNCTION, AND INHIBITION;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA","7;6;5;5;5;4;4;4;3;3;3;2;1;1;1;1;1;1;1;1","EPILEPSY;INBORN ERRORS OF METABOLISM;ENTORHINAL CORTEX;GLIOBLASTOMA;NEOCORTEX;CELLULAR PRION PROTEIN;DEEP BRAIN STIMULATION;DIAGNOSTIC CRITERIA;GLUTAMATE RECEPTORS;LEIGH DISEASE;NEURORADIOLOGY;PATHOGENESIS;SUBTHALAMIC NUCLEUS;BUFFY COAT;CARBOPLATIN;CLUSTER HEADACHE;COMPOUND HETEROZYGOSITY;CREATINE;ENDOVASCULAR TREATMENT;INTRACRANIAL ANEURYSMS","5;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","MULTIPLE SCLEROSIS;HUMAN BRAIN;LOBE EPILEPSY;MITOCHONDRIAL DNA;PARKINSONS DISEASE;BLOOD DONORS;BONE TUMORS;BRAIN TUMORS;CENTRAL NERVOUS;CLUSTER HEADACHE;EPILEPSY PATIENTS;GENOMIC REGIONS;GUINEA PIG;MOLECULAR ANALYSIS;MUTATIONAL SPECTRUM;NERVOUS SYSTEM;PILOCARPINE MODEL;SEQUENCES HOMOLOGOUS;SIMIAN VIRUS;SUBTHALAMIC NUCLEUS;TEMPORAL LOBE;VIRUS GENOMIC;ABNORMAL NEOCORTICAL;ABNORMAL PRION;ACTH BEI;ACTIVE PERIODS;AKUTEN EXAZERBATIONEN;ALLELIC DISORDERS;ALZHEIMER DISEASE;ALZHELMERS DISEASE","5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;AL PALONEVA;ASSOCIATION STUDIES;PHILLIPS JH;LANIER LL;PUBMED GOOGLE;BAKKER AB;GENET -CROSSREF;TYROBP DAP;AB PHILLIPS;AL BOUCHON;CANDIDATE GENES;LIPOMEMBRANOUS OSTEODYSPLASIA;POLYCYSTIC LIPOMEMBRANOUS;PRESENILE DEMENTIA;SV TAG;TAG SEQUENCES;BONE CYSTSNAT;CYSTSNAT GENET;DAP RESULT;JH PEKKARINEN;LINKAGE STUDIES;LL TIMONEN;LOSS-OF-FUNCTION MUTATIONS;SIB PAIRS;BONE CYSTS;BONE TUMORS;HUMAN GENOME;HUMAN TUMOR","32;28;17;16;15;12;10;9;9;9;8;8;8;8;8;8;8;8;7;7;7;7;7;7;7;7;6;6;6;6",15,0.18,3,2.5,0,0,0,1,4.5,1,1,2.5,0,0,2.75,0,2,0,0,2.75,0,0,0,35.5,35.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,1252953.25,128253.59,3.75,20,9.5,1,13.25,334182.564532522,0.248367236382024,"ISTITUTO NEUROLOGICO CARLO BESTA;MEDICAL RESEARCH COUNCIL;RADBOUD UNIVERSITY NIJMEGEN;TAMPERE UNIVERSITY;UNIVERSITY COLLEGE LONDON;UNIVERSITY OF CLERMONT AUVERGNE;UNIVERSITY OF GLASGOW;UNIVERSITY OF PADUA;UNIVERSITY OF ZARAGOZA;VRIJE UNIVERSITEIT AMSTERDAM;ATOMIC ENERGY AND ALTERNATIVE ENERGIES COMMISSION;AUTONOMOUS UNIVERSITY OF MADRID;AZIENDA OSPEDALIERA DI PADOVA;BISPEBJERG HOSPITAL;CARDIFF UNIVERSITY;CEA FONTENAY-AUX-ROSES;CENTRE FOR GENOMIC REGULATION;CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS;CENTRE VAL DE LOIRE;DÉLÉGATION PARIS 11","4;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","4","COALITION S;EC & ERC - EUROPEAN UNION","4;4","FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME);CSC - COST-SHARING CONTRACTS (FUNDING SCHEME);CON - COORDINATION OF RESEARCH ACTIONS (FUNDING SCHEME);THN - THEMATIC NETWORK CONTRACTS (FUNDING SCHEME)","4;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;42 HEALTH SCIENCES","3;2;1;1;1;1;1;1;1","BRAIN DISORDERS;GENETICS;NEUROSCIENCES;RARE DISEASES;CLINICAL RESEARCH;EMERGING INFECTIOUS DISEASES;HIV/AIDS;INFECTIOUS DISEASES;ORPHAN DRUG;PREVENTION;TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY (TSE)","2;2;2;2;1;1;1;1;1;1;1","NEUROLOGICAL;EAR","2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","3;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A06 AGRICULTURE, VETERINARY AND FOOD SCIENCE","2;2",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BESTA",2003,135,7.59259259259259,3.63703703703704,0.6,0.562962962962963,0.622222222222222,2.06751054852321,1.30645161290323,1.76744186046512,1.33333333333333,0.237037037037037,9,65,38,14,10,0.48,0.28,0.1,0.07,49.45,0.934324812638376,NA,0.281481481481481,0.585185185185185,0.506,0.412,0.334,0.417,"GIOVANNI BROGGI;F. CORNELIO;RENATO MANTEGAZZA;DAVIDE PAREYSON;GIUSEPPE LAURIA;G. AVANZINI;ANGELO FRANZINI;CARLO ANTOZZI;TIZIANA GRANATA;ALBERTO ALBANESE;FABRIZIO TAGLIAVINI;MICHELA MORBIN;PIA BERNASCONI;MARCO DE CURTIS;FULVIO BAGGI;PAOLO FERROLI;ROBERTO SPREAFICO;MASSIMO LEONE;PAOLO CONFALONIERI;V. SCAIOLI","10;10;9;9;8;8;7;7;7;7;6;6;6;6;6;6;6;5;5;5","ALBERTO ALBANESE;DAVIDE PAREYSON;MATILDE LEONARDI;GIOVANNI BROGGI;MARCO DE CURTIS;CARLO ANTOZZI;ANGELO FRANZINI;LUDOVICO D’INCERTI;G. AVANZINI;F. CORNELIO;PAOLO FERROLI;RENATO MANTEGAZZA;GIUSEPPE LAURIA;PAOLA SOLIVERI;F. GIROTTI;MASSIMO LEONE;A. AGOSTINO;A. AGOSTINO;DR IVANO DONES;MASSIMO ZEVIANI","3.16;2.28;2;1.92;1.9;1.76;1.36;1.27;1.26;1.21;1.19;1.18;1.14;1.1;1.1;1.04;1;1;1;0.97","GIOVANNI BROGGI;F. CORNELIO;RENATO MANTEGAZZA;DAVIDE PAREYSON;GIUSEPPE LAURIA;G. AVANZINI;ANGELO FRANZINI;CARLO ANTOZZI;TIZIANA GRANATA;ALBERTO ALBANESE;FABRIZIO TAGLIAVINI;MICHELA MORBIN;PIA BERNASCONI;MARCO DE CURTIS;FULVIO BAGGI;PAOLO FERROLI;ROBERTO SPREAFICO;MASSIMO LEONE;PAOLO CONFALONIERI;V. SCAIOLI","10;10;9;9;8;8;7;7;7;7;6;6;6;6;6;6;6;5;5;5","ALBERTO ALBANESE;DAVIDE PAREYSON;MATILDE LEONARDI;GIOVANNI BROGGI;MARCO DE CURTIS;CARLO ANTOZZI;ANGELO FRANZINI;LUDOVICO D’INCERTI;G. AVANZINI;F. CORNELIO;PAOLO FERROLI;RENATO MANTEGAZZA;GIUSEPPE LAURIA;PAOLA SOLIVERI;F. GIROTTI;MASSIMO LEONE;A. AGOSTINO;A. AGOSTINO;DR IVANO DONES;MASSIMO ZEVIANI","3.16;2.28;2;1.92;1.9;1.76;1.36;1.27;1.26;1.21;1.19;1.18;1.14;1.1;1.1;1.04;1;1;1;0.97","F. CORNELIO;LUCIA MORANDI;MAURIZIO ELIA;G. AVANZINI;TIZIANA GRANATA;FABRIZIO TAGLIAVINI;ROBERTO SPREAFICO;LAURA TASSI;MICHELA MORBIN;RENATO MANTEGAZZA;PAOLO CONFALONIERI;FRANCESCA ANDREETTA;GIUSEPPE CAPOVILLA;GIOVANNI BROGGI;ANNA RITA BENTIVOGLIO;MASSIMO LEONE;ALBERTO ALBANESE;ANGELO FRANZINI;ENRICO BERTINI;GIORGIO LO RUSSO","754;686;584;575;522;506;488;485;450;443;427;416;415;387;376;373;372;364;352;348","F. CORNELIO;LUCIA MORANDI;G. AVANZINI;TIZIANA GRANATA;FABRIZIO TAGLIAVINI;ROBERTO SPREAFICO;MICHELA MORBIN;RENATO MANTEGAZZA;PAOLO CONFALONIERI;FRANCESCA ANDREETTA;GIOVANNI BROGGI;ALBERTO ALBANESE;ANGELO FRANZINI;GIULIA MAZZOLENI;CARLO ANTOZZI;DAVIDE PAREYSON;GIUSEPPE LAURIA;PIA BERNASCONI;FULVIO BAGGI;MASSIMO LEONE","754;686;551;522;506;488;450;443;427;416;387;372;364;309;305;302;301;294;292;290","F. CORNELIO;GIOVANNI BROGGI;RENATO MANTEGAZZA;DAVIDE PAREYSON;G. AVANZINI;GIUSEPPE LAURIA;ALBERTO ALBANESE;ANGELO FRANZINI;CARLO ANTOZZI;TIZIANA GRANATA;FABRIZIO TAGLIAVINI;FULVIO BAGGI;MARCO DE CURTIS;MICHELA MORBIN;PIA BERNASCONI;PAOLO FERROLI;ROBERTO SPREAFICO;GAETANO FINOCCHIARO;LUCIA MORANDI;LUISA CHIAPPARINI","10;9;9;9;8;8;7;7;7;7;6;6;6;6;6;6;6;5;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;POLITICAL SCIENCE;ECONOMICS;PHILOSOPHY;ART;ENGINEERING;HISTORY;MATERIALS SCIENCE;MATHEMATICS","117;52;28;14;10;7;5;3;2;1;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;NEUROSCIENCE;GENETICS;SURGERY;ENDOCRINOLOGY;IMMUNOLOGY;PEDIATRICS;BIOCHEMISTRY;RADIOLOGY;ANESTHESIA;ANATOMY;CELL BIOLOGY;PHYSICAL THERAPY;GASTROENTEROLOGY;MOLECULAR BIOLOGY;PHYSICAL MEDICINE AND REHABILITATION;CANCER RESEARCH;PHARMACOLOGY","59;48;35;32;31;29;22;22;18;13;13;12;11;11;10;9;9;9;8;8","DISEASE;GENE;EPILEPSY;NEUROLOGY;MAGNETIC RESONANCE IMAGING;RECEPTOR;STIMULATION;CENTRAL NERVOUS SYSTEM;MIGRAINE;NEUROSURGERY;ALTERNATIVE MEDICINE;ATROPHY;DIABETES MELLITUS;IN VITRO;MITOCHONDRION;MYASTHENIA GRAVIS;POPULATION;ANTIBODY;CANCER;CEREBRAL CORTEX;ELECTROENCEPHALOGRAPHY;HEADACHES;IMMUNE SYSTEM;IN VIVO;INFLAMMATION;MULTIPLE SCLEROSIS;STEM CELL","34;33;21;17;11;10;10;9;8;8;7;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5","MUTATION;PARKINSON'S DISEASE;NEURORADIOLOGY;MITOCHONDRIAL DNA;PHENOTYPE;PERIPHERAL NEUROPATHY;WHITE MATTER;CLUSTER HEADACHE;CORTICAL DYSPLASIA;DEMENTIA;ENTORHINAL CORTEX;BASAL GANGLIA;BLOOD–BRAIN BARRIER;CYTOCHROME C OXIDASE;EPILEPSY SURGERY;EXON;GABAPENTIN;GENETIC ENHANCEMENT;GENOTYPE;HYPERINTENSITY;ICTAL;MOVEMENT DISORDERS;NEUROPSYCHOLOGY;PLACEBO;PROGENITOR CELL;PROGRESSIVE SUPRANUCLEAR PALSY;RELAPSING REMITTING;SEROTONIN;TEMPORAL LOBE;THYMECTOMY","12;10;8;7;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","DEEP BRAIN STIMULATION;MITOCHONDRIAL DISEASE;MISSENSE MUTATION;CORTICOBASAL DEGENERATION;LEIGH DISEASE;ACROMEGALY;ADRENOLEUKODYSTROPHY;FRONTOTEMPORAL DEMENTIA;GENETIC HETEROGENEITY;HEMIMEGALENCEPHALY;HUMAN MITOCHONDRIAL GENETICS;METHYSERGIDE;MYELIN BASIC PROTEIN;PEROXISOMAL DISORDER;ADENOSINE RECEPTOR;ADULT STEM CELL;ALTERNATIVE SPLICING;BICUCULLINE;BOVINE SPONGIFORM ENCEPHALOPATHY;CARMUSTINE;CHEMOKINE RECEPTOR;CORTICOGENESIS;CROSSOVER STUDY;DEBULKING;DEMENTIA WITH LEWY BODIES;DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;DIFFUSING CAPACITY;DIHYDROTESTOSTERONE;DISABILITY-ADJUSTED LIFE YEAR;DYSKINESIA;FLUORESCENCE IN SITU HYBRIDIZATION;FRAMESHIFT MUTATION;GENE DELIVERY;GENE MUTATION;GLOBUS PALLIDUS;GREY MATTER;HAPLOTYPE;HEMATOPOIETIC STEM CELL;HETEROPLASMY;HIPPOCAMPAL SCLEROSIS;HOMEOBOX;HUNTINGTIN;HYPERALGESIA;INTERFERON BETA-1A;KEARNS–SAYRE SYNDROME;KERATIN 7;LAFORA DISEASE;LEVODOPA;LEWY BODY;LMNA;LOSS OF HETEROZYGOSITY;LOWER URINARY TRACT SYMPTOMS;MDX MOUSE;MHC CLASS I;MHC CLASS II;MIGRAINE WITH AURA;MITOCHONDRIAL FUSION;MITOCHONDRIAL MYOPATHY;MONOAMINERGIC;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;NEUROEPITHELIAL CELL;NON-MENDELIAN INHERITANCE;NUCLEAR DNA;NUCLEAR GENE;NUCLEAR PROTEIN;OSTEOPENIA;PACHYGYRIA;PAPILLARY ADENOCARCINOMA;PARAHIPPOCAMPAL GYRUS;PENETRANCE;PERIRHINAL CORTEX;POINT MUTATION;PRNP;PROBAND;PROSTATE-SPECIFIC ANTIGEN;PULMONARY ADENOCARCINOMA;PURINE NUCLEOSIDE PHOSPHORYLASE;RADICAL POLYMERIZATION;SCRAPIE;SINGLE-STRAND CONFORMATION POLYMORPHISM;TAMOXIFEN;TAU PROTEIN;THYMIDINE KINASE;UBIQUITIN LIGASE;UTROPHIN;VASCULAR ENDOTHELIAL GROWTH FACTOR A;VASCULOGENESIS;VERBAL FLUENCY TEST;VINCRISTINE;VITRONECTIN;YEARS OF POTENTIAL LIFE LOST","6;5;4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;;BRAIN DISEASES;CEREBRAL CORTEX;ADULT;BRAIN;ANIMALS;AGED;MAGNETIC RESONANCE IMAGING;CHILD;NEURONS;ADOLESCENT;EPILEPSY;MYASTHENIA GRAVIS;MUSCLE, SKELETAL;BRAIN NEOPLASMS;CHILD, PRESCHOOL","85;47;46;36;35;33;32;30;26;23;21;21;20;20;19;18;18;16;15;13","EPILEPSY AND SEIZURES;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;PRION DISEASES: CAUSES AND MOLECULAR BASIS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;GLIOMAS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;BRAIN FLUID DYNAMICS AND WASTE CLEARANCE MECHANISMS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF RESTLESS LEGS SYNDROME;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;IMMUNOBIOLOGY OF DENDRITIC CELLS","11;9;7;6;5;5;5;4;4;4;3;3;3;2;2;2;2;2;2;2","EPILEPSY;NEURORADIOLOGY;NEUROIMAGING;MITOCHONDRIAL DISEASE;TREATMENT;CELLULAR PRION PROTEIN;CHARCOT-MARIE-TOOTH DISEASE;CLUSTER HEADACHE;ENTORHINAL CORTEX;INBORN ERRORS OF METABOLISM;MIGRAINE;MITOCHONDRIAL FUNCTION;MOVEMENT DISORDERS;NON-MOTOR SYMPTOMS;SOMATOSENSORY EVOKED POTENTIAL;CORTICOBASAL DEGENERATION;DEEP BRAIN STIMULATION;ETIOLOGY;HETEROTOPIA (MEDICINE);LEIGH DISEASE","8;8;7;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3","ITALIAN PERIPHERAL;NERVE STUDY;PERIPHERAL NERVE;MYASTHENIA GRAVIS;MULTIPLE SCLEROSIS;BRAIN STIMULATION;DEEP BRAIN;MUSCULAR DYSTROPHY;PARKINSONS DISEASE;ACHR ΑSUBUNIT;BRAIN TUMORS;CEREBRAL HETEROTOPIA;CHRONIC CLUSTER;CHRONIC INTRACTABLE;CLINICAL QUIZ;CLUSTER HEADACHE;CLUSTER HEADACHES;CONSTITUTIVE KNOCKOUT;CORTICAL DEVELOPMENT;CORTICOBASAL DEGENERATION;EMBRYONIC LETHALITY;ENTORHINAL CORTEX;EXTENDED THYMECTOMY;FOCAL CORTICAL;GABAPENTIN IMPROVED;GENETIC HETEROGENEITY;GRAVIS PATIENTS;GUINEA PIG;IMAGING FINDINGS;IMPROVED SENSORY","7;7;7;5;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;MULTIPLE SCLEROSIS;CARLO BESTA;INSTITUTE CARLO;MUSCULAR PATHOLOGY;NATIONAL NEUROLOGICAL;NEUROLOGICAL INSTITUTE;PATHOLOGY UNIT;UNIT NATIONAL;BESTA MILAN;MILAN ITALYSEARCH;PRUSINER SB;AMYLOID FIBRILS;DE GIOIA;SPANNING RESIDUES;ACAD SCI;AMINO ACID;NATL ACAD;PROC NATL;BIOL -CROSSREF;DLOUHY SR;MOL BIOL;PRION PROTEIN;FULVIO BAGGI;PRP PEPTIDES;RELAPSING REMITTING;REMITTING MULTIPLE;SWELLING RATIO;ACID SEQUENCE","41;36;17;14;14;14;14;14;14;14;12;12;10;9;9;9;8;8;8;8;7;7;7;7;6;6;6;6;6;5",25,0.19,6,4,0,1,0,1,5,0,2,4,0,0,0,0,2,0,0,0,0,0,0,63,63,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,7809660.5,247740.06,5.5,24.5,11,1,4,419481.163738871,0.32182613111095,"ISTITUTO NEUROLOGICO CARLO BESTA;ARMINES;ATOMIC ENERGY AND ALTERNATIVE ENERGIES COMMISSION;BELLVITGE UNIVERSITY HOSPITAL;CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS;DEPARTMENT FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;DIRECTORATE-GENERAL JOINT RESEARCH CENTRE;DÉLÉGATION PARIS 11;FRENCH AGENCY FOR FOOD, ENVIRONMENTAL AND OCCUPATIONAL HEALTH & SAFETY;FRENCH MUSCULAR DYSTROPHY ASSOCIATION;FRENCH NATIONAL CENTRE FOR SCIENTIFIC RESEARCH;FRIEDRICH-LOEFFLER-INSTITUT;FUNDACIÓN ESPAÑOLA PARA LA COOPERACIÓN INTERNACIONAL SALUD Y POLÍTICA SOCIAL;GENETHON (FRANCE);HADASSAH MEDICAL CENTER;HEINRICH HEINE UNIVERSITY DÜSSELDORF;INSTITUT D'INVESTIGACIÓ BIOMÉDICA DE BELLVITGE;INSTITUTO NACIONAL DE INVESTIGACIÓN Y TECNOLOGÍA AGRARIA Y ALIMENTARIA;INSTITUTO NACIONAL DE INVESTIGAÇÃO AGRÁRIA E VETERINÁRIA;ISTITUTO SUPERIORE DI SANITÀ","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","2","COALITION S;EC & ERC - EUROPEAN UNION","2;2","FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME);FP6-2002-FOOD-1 (CALL FOR PROPOSAL);FP6-FOOD - FOOD QUALITY AND SAFETY: THEMATIC PRIORITY 5 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);NOE - NETWORK OF EXCELLENCE (FUNDING SCHEME);THN - THEMATIC NETWORK CONTRACTS (FUNDING SCHEME)","1;1;1;1;1","30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;31 BIOLOGICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY","1;1;1;1","BRAIN DISORDERS;EMERGING INFECTIOUS DISEASES;FOODBORNE ILLNESS;GENETICS;INFECTIOUS DISEASES;NEURODEGENERATIVE;PREVENTION;RARE DISEASES;TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY (TSE)","1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;NEUROLOGICAL","1;1","2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)","1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A06 AGRICULTURE, VETERINARY AND FOOD SCIENCE","1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BESTA",2004,112,8.30357142857143,3.1875,0.446428571428571,0.482142857142857,0.464285714285714,1.75862068965517,1.13636363636364,1.35,1.1304347826087,0.25,2,52,28,20,8,0.46,0.25,0.18,0.07,101.21,2.15104174038584,NA,0.383928571428571,0.714285714285714,0.442,0.357,0.393,0.347,"MASSIMO ZEVIANI;GIOVANNI BROGGI;GRAZIELLA FILIPPINI;DAVIDE PAREYSON;FRANCO TARONI;V. SCAIOLI;GENNARO BUSSONE;ALBERTO ALBANESE;BIANCA POLLO;DOMENICO D’AMICO;GRAZIELLA UZIEL;MASSIMO LEONE;BARBARA GARAVAGLIA;ANGELO FRANZINI;ANNA RITA BENTIVOGLIO;FEDERICA INVERNIZZI;TIZIANA GRANATA;SUSANNA USAI;F. CORNELIO;EGILL BRIEM","13;10;7;7;7;6;6;6;5;5;4;4;4;4;4;4;4;4;4;4","GIOVANNI BROGGI;MASSIMO ZEVIANI;DARIA RIVA;FRANCO TARONI;DAVIDE PAREYSON;V. SCAIOLI;LAURA UVA;MARCO DE CURTIS;SUSANNA USAI;GRAZIELLA FILIPPINI;GENNARO BUSSONE;DOMENICO D’AMICO;M MILANI;ALBERTO ALBANESE;G. BUSSONE;MASSIMO LEONE;BIANCA POLLO;TIZIANA GRANATA;ANGELO FRANZINI;LUCIA ANGELINI","2.34;1.59;1.32;1.24;1.2;1.16;1.03;1.03;0.99;0.86;0.83;0.8;0.79;0.71;0.7;0.69;0.65;0.64;0.61;0.56","MASSIMO ZEVIANI;GIOVANNI BROGGI;GRAZIELLA FILIPPINI;DAVIDE PAREYSON;FRANCO TARONI;V. SCAIOLI;GENNARO BUSSONE;ALBERTO ALBANESE;BIANCA POLLO;DOMENICO D’AMICO;GRAZIELLA UZIEL;MASSIMO LEONE;BARBARA GARAVAGLIA;ANGELO FRANZINI;FEDERICA INVERNIZZI;TIZIANA GRANATA;SUSANNA USAI;F. CORNELIO;EGILL BRIEM;FABRIZIO TAGLIAVINI","13;10;7;7;7;6;6;6;5;5;4;4;4;4;4;4;4;4;4;3","GIOVANNI BROGGI;MASSIMO ZEVIANI;DARIA RIVA;FRANCO TARONI;DAVIDE PAREYSON;V. SCAIOLI;LAURA UVA;MARCO DE CURTIS;SUSANNA USAI;GRAZIELLA FILIPPINI;GENNARO BUSSONE;DOMENICO D’AMICO;M MILANI;ALBERTO ALBANESE;G. BUSSONE;MASSIMO LEONE;BIANCA POLLO;TIZIANA GRANATA;ANGELO FRANZINI;LUCIA ANGELINI","2.34;1.59;1.32;1.24;1.2;1.16;1.03;1.03;0.99;0.86;0.83;0.8;0.79;0.71;0.7;0.69;0.65;0.64;0.61;0.56","ALBERTO ALBANESE;ANNA RITA BENTIVOGLIO;ENZA MARIA VALENTE;BRUNO DALLAPICCOLA;SERGIO SALVI;VIVIANA CAPUTO;DANIEL G. HEALY;DAVID S. LATCHMAN;DOMENICO DEL TURCO;GEORG AUBURGER;KIRSTEN HARVEY;MIRATUL M. K. MUQIT;NICHOLAS WOOD;PATRICK M. ABOU‐SLEIMAN;PIETRO CORTELLI;RAFAEL GONZÁLEZ-MALDONADO;ROBERT NUSSBAUM;SUZANA GISPERT;THOMAS DELLER;VICTORIA L. HARVEY","5000;3807;3739;3735;3735;3735;3258;3258;3258;3258;3258;3258;3258;3258;3258;3258;3258;3258;3258;3258","ALBERTO ALBANESE;MASSIMO ZEVIANI;GIOVANNI BROGGI;EGILL BRIEM;ANGELO FRANZINI;GRAZIELLA UZIEL;LUIGI ROMITO;ELEONORA LAMANTEA;GRAZIELLA FILIPPINI;LAURA FARINA;FEDERICA INVERNIZZI;BARBARA GARAVAGLIA;GENNARO BUSSONE;BIANCA POLLO;VALERIA TIRANTI;FABRIZIO TAGLIAVINI;F. CARRARA;ISABELLA MORONI;MARIANNA BUGIANI;SIMONA ALBERIO","5000;1647;1011;927;504;479;477;450;432;417;396;330;313;298;269;264;256;256;256;256","MASSIMO ZEVIANI;GIOVANNI BROGGI;GRAZIELLA FILIPPINI;ALBERTO ALBANESE;DAVIDE PAREYSON;FRANCO TARONI;GENNARO BUSSONE;V. SCAIOLI;BIANCA POLLO;DOMENICO D’AMICO;ANGELO FRANZINI;BARBARA GARAVAGLIA;EGILL BRIEM;FEDERICA INVERNIZZI;TIZIANA GRANATA;GRAZIELLA UZIEL;ANDREA RIGAMONTI;LAURA FARINA;MASSIMO LEONE;ANNA LIMONGELLI","13;10;7;6;6;6;6;6;5;5;4;4;4;4;4;4;3;3;3;3","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;SOCIOLOGY;BUSINESS;ECONOMICS;ENGINEERING;ENVIRONMENTAL SCIENCE;GEOGRAPHY;MATHEMATICS;PHILOSOPHY;PHYSICS;POLITICAL SCIENCE","90;54;17;9;6;2;1;1;1;1;1;1;1;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;PSYCHIATRY;NEUROSCIENCE;SURGERY;BIOCHEMISTRY;ANATOMY;ENDOCRINOLOGY;IMMUNOLOGY;MOLECULAR BIOLOGY;PEDIATRICS;ANESTHESIA;RADIOLOGY;CELL BIOLOGY;ENVIRONMENTAL HEALTH;CANCER RESEARCH;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;PHARMACOLOGY","49;40;37;27;23;23;17;14;14;13;10;9;8;8;7;7;6;6;6;5","GENE;DISEASE;NEUROLOGY;EPILEPSY;MIGRAINE;MULTIPLE SCLEROSIS;RECEPTOR;PREGNANCY;ALTERNATIVE MEDICINE;POPULATION;ANTIBODY;CHEMOTHERAPY;DIABETES MELLITUS;HEADACHES;IMMUNOHISTOCHEMISTRY;MAGNETIC RESONANCE IMAGING;NEUROSURGERY;ANGIOGENESIS;ATROPHY;COGNITION;ENZYME;GLIOMA;HIPPOCAMPUS;MITOCHONDRION;RADIATION THERAPY;STIMULATION;TRIGEMINAL NERVE","34;23;9;8;8;8;8;7;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","MUTATION;MITOCHONDRIAL DNA;PHENOTYPE;NEURORADIOLOGY;PARKINSON'S DISEASE;ALLELE;CLUSTER HEADACHE;DEMENTIA;ALZHEIMER'S DISEASE;GENOTYPE;ENDOTHELIAL STEM CELL;ENTORHINAL CORTEX;EXON;GENE DUPLICATION;MICROVASCULAR DECOMPRESSION;PERIPHERAL NEUROPATHY;PLACEBO;AGE OF ONSET;AGONIST;AMYOTROPHIC LATERAL SCLEROSIS;AMYOTROPHY;ANTICONVULSANT;CARDIOMYOPATHY;CISPLATIN;CLINICAL ENDPOINT;CODING REGION;CYTOCHROME C OXIDASE;DEGENERATIVE DISEASE;FETUS;GENOME;MIGRAINE TREATMENT;MUTANT;NEURAL STEM CELL;NEUROMYELITIS OPTICA;NEUROPATHOLOGY;NEUROPSYCHOLOGY;OFFSPRING;PARKINSONISM;POSTUROGRAPHY;SODIUM CHANNEL;SPINOCEREBELLAR ATAXIA;VASCULAR ENDOTHELIAL GROWTH FACTOR;VASOSPASM;VIMENTIN","23;14;10;6;6;5;5;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MISSENSE MUTATION;MITOCHONDRIAL MYOPATHY;MITOCHONDRIAL DISEASE;COMPOUND HETEROZYGOSITY;DEEP BRAIN STIMULATION;FRAMESHIFT MUTATION;HAPLOTYPE;PROBAND;ADULT STEM CELL;DESMIN;GENE MUTATION;GENETIC HETEROGENEITY;HETEROPLASMY;IN UTERO;MITOCHONDRIAL ENCEPHALOMYOPATHY;POINT MUTATION;ACROMEGALY;ACTIVE IMMUNIZATION;ADRENOLEUKODYSTROPHY;ALLELIC HETEROGENEITY;AMYLOID PRECURSOR PROTEIN;ANAPLASTIC ASTROCYTOMA;BASIC FIBROBLAST GROWTH FACTOR;BRADYCARDIA;BUTHIDAE;CABERGOLINE;CD18;CEREBRAL AMYLOID ANGIOPATHY;CEREBRAL VASOSPASM;CLADE;CLINICAL GLOBAL IMPRESSION;COGNITIVE DECLINE;COMPLEMENTATION;COPY-NUMBER VARIATION;CROSSOVER STUDY;CXCR4;DONEPEZIL;DOPAMINE AGONIST;ENOS;EXTERNAL OPHTHALMOPLEGIA;FACTOR V LEIDEN;GENETIC RECOMBINATION;GENOTYPE-PHENOTYPE DISTINCTION;GENOTYPING;GLUTAMATERGIC;HAPLOINSUFFICIENCY;HIPPOCAMPAL SCLEROSIS;LEIGH DISEASE;LINEAGE MARKERS;LOSS OF HETEROZYGOSITY;LRRK2;METHYLENETETRAHYDROFOLATE REDUCTASE;MITOPHAGY;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;NESTIN;NEUROEPITHELIAL CELL;NON-MENDELIAN INHERITANCE;NUCLEAR DNA;NUCLEAR GENE;NUCLEOTIDE SALVAGE;PARKIN;PENETRANCE;PRESENILIN;PROLACTINOMA;PTEN;PURINE NUCLEOSIDE PHOSPHORYLASE;RNA SPLICING;SCORPION TOXIN;SCORPION VENOMS;SUBSTANTIA NIGRA;SUMATRIPTAN;TANDEM REPEAT;TESTIS DETERMINING FACTOR;TETRAHYDROBIOPTERIN;THYMIDINE KINASE;TREM2;TRINUCLEOTIDE REPEAT EXPANSION;VASCULAR ENDOTHELIAL GROWTH FACTOR A;VINCRISTINE;VITAMIN E DEFICIENCY","7;6;4;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;MIDDLE AGED;AGED;NEURONS;BRAIN NEOPLASMS;MUTATION;DNA, MITOCHONDRIAL;;MUSCLE, SKELETAL;ANIMALS;CHILD;ITALY;ADOLESCENT;CEREBRAL CORTEX;CLUSTER HEADACHE;ALZHEIMER DISEASE;MAGNETIC RESONANCE IMAGING","82;54;50;41;37;27;25;23;23;22;21;18;17;17;15;14;14;14;13;13","MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;PATHOLOGY AND MANAGEMENT OF TRIGEMINAL NEURALGIA;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;GLIOMAS;MECHANISMS OF ALZHEIMER'S DISEASE;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;OLFACTORY DYSFUNCTION IN HEALTH AND DISEASE;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;BRAIN FLUID DYNAMICS AND WASTE CLEARANCE MECHANISMS;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;GUILLAIN-BARRÉ SYNDROME AND RELATED NEUROPATHIES;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF ION CHANNELS REGULATION","10;8;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","NEURORADIOLOGY;TREATMENT;CLUSTER HEADACHE;MITOCHONDRIAL DYSFUNCTION;INBORN ERRORS OF METABOLISM;MITOCHONDRIAL DISEASE;NONSENSE MUTATION;TRIGEMINAL NERVE;TRIGEMINAL NEURALGIA;COMPOUND HETEROZYGOSITY;ENTORHINAL CORTEX;GENE EXPRESSION DYSREGULATION;MICROVASCULAR DECOMPRESSION;MIGRAINE;MITOCHONDRIA;MITOCHONDRIAL ENCEPHALOMYOPATHIES;MRNA MODIFICATION;NEURODEGENERATION;NEUROSONOGRAPHY;NEUROVASCULAR COMPRESSION","6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","MITOCHONDRIAL DNA;CHILDHOOD BRAIN;MULTIPLE SCLEROSIS;CLUSTER HEADACHE;MULTIPLE LETTERS;PARKINSONS DISEASE;ALZHEIMER DISEASE;AMYOTROPHIC LATERAL;AROMATIC HYDROCARBONS;AUTOSOMAL DOMINANT;BRAIN STIMULATION;BRAIN TUMOR;BRAIN TUMORS;BRAIN TUMOURS;CMT DISEASE;DEEP BRAIN;ENTORHINAL CORTEX;FUNCTIONAL ANALYSIS;GENE MUTATIONS;LATERAL SCLEROSIS;MUSCLE-DERIVED STEM;MYASTHENIA GRAVIS;NEUROMYELITIS OPTICA;NODULAR HETEROTOPIA;PARENTAL EXPOSURE;PATIENTS AFFECTED;POLYCYCLIC AROMATIC;SEARCH INTERNATIONAL;STEM CELLS;SUBARACHNOID HEMORRHAGE","6;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","OCCUPATIONAL EXPOSURE;BRAIN TUMORS;CHILDHOOD BRAIN;PREVIOUSLY REPORTED;MS PATIENTS;ANTI-MOG ANTIBODIES;ASTROGLIAL TUMORS;BOTULINUM NEUROTOXIN;GCH GENE;PATERNAL PRECONCEPTIONAL;PRP RES;ALZHEIMER DISEASE;BUFFY COAT;CALCIUM RESPONSIVENESS;CONFIDENCE INTERVAL;HEARING IMPAIRMENT;MITOCHONDRIAL DISORDERS;MTDNA MUTATIONS;OND PATIENTS;PLASMA DTHD;PREGNANCY REGISTRIES;RESPIRATORY CHAIN;SECONDARY PROGRESSIVE;SKELETAL MUSCLE;TP ACTIVITY;TRNA GENES;ADULT BRAIN;AGE SEX;AIR POLLUTION;ALZHEIMER KINDRED","10;9;6;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2",31,0.28,10.5,7.5,1.25,1.5,0,2,6.75,0,2,7.5,0,1,2.75,0,4.5,1,1,3,0,0,0,88.5,89,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,13,10000,0.55,1,1,137,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"31 BIOLOGICAL SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","1;1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;GENETIC TESTING;GENETICS;HUNTINGTON'S DISEASE;NEURODEGENERATIVE;NEUROSCIENCES;PREVENTION;RARE DISEASES","1;1;1;1;1;1;1;1;1;1",NA,NA,NA,NA,NA,NA,NA,NA,2,4845008.5,272685.91,5,12,6,1,7.5,392112.406318681,0.285632380396998,"ISTITUTO NEUROLOGICO CARLO BESTA;BIRKBECK, UNIVERSITY OF LONDON;DÉLÉGATION PARIS 11;FRENCH NATIONAL CENTRE FOR SCIENTIFIC RESEARCH;FRENCHAY HOSPITAL;INSTITUT D'INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL;INSTITUTE OF PSYCHIATRY AND NEUROLOGY;MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE;MEDICAL RESEARCH COUNCIL;RADBOUD UNIVERSITY NIJMEGEN MEDICAL CENTRE;RUHR UNIVERSITY BOCHUM;UNIVERSITY COLLEGE LONDON;UNIVERSITY HOSPITAL BONN;UNIVERSITY HOSPITAL FRANKFURT;UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN;UNIVERSITY OF BERN;UNIVERSITY OF CAMBRIDGE;UNIVERSITY OF DUNDEE;UNIVERSITY OF PECS;UNIVERSITY OF TÜBINGEN","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;MEDICAL RESEARCH COUNCIL","1;1","COALITION S;EC & ERC - EUROPEAN UNION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","2;1;1;1","FP6-2002-LIFESCIHEALTH (CALL FOR PROPOSAL);FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);INTRAMURAL (PROJECT CATEGORY);IP - INTEGRATED PROJECT (FUNDING SCHEME)","1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","2;1;1;1;1;1","CLINICAL RESEARCH;BIOTECHNOLOGY;BRAIN DISORDERS;COMPARATIVE EFFECTIVENESS RESEARCH;GENETICS;HEALTH SERVICES;NEURODEGENERATIVE;NEUROSCIENCES;PATIENT SAFETY;RARE DISEASES","2;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;MENTAL HEALTH","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.3 MANAGEMENT AND DECISION MAKING;8.1 ORGANISATION AND DELIVERY OF SERVICES","1;1;1;1","NOT SITE-SPECIFIC CANCER","1","6.4 COST ANALYSES AND HEALTH CARE DELIVERY","1","A02 PUBLIC HEALTH, HEALTH SERVICES AND PRIMARY CARE;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE","1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BESTA",2005,129,9.10852713178295,3.63565891472868,0.488372093023256,0.418604651162791,0.488372093023256,1.95416666666667,1.34042553191489,1.63636363636364,1.34042553191489,0.294573643410853,7,69,39,7,6,0.53,0.3,0.05,0.05,75.1,1.41850181560016,NA,0.348837209302326,0.72093023255814,0.516,0.393,0.348,0.393,"GIOVANNI BROGGI;ANGELO FRANZINI;ANTONIO SILVANI;ANDREA SALMAGGI;MASSIMO ZEVIANI;FABRIZIO TAGLIAVINI;A. BOIARDI;EUGENIO PARATI;CARLO EFISIO MARRAS;ORSO BUGIANI;SILVANA FRANCESCHETTI;MARICA EOLI;G. AVANZINI;BIANCA POLLO;DARIA RIVA;GIORGIO GIACCONE;MARCO DE CURTIS;PAOLO FERROLI;GIUSEPPE LAURIA;LUCIA MORANDI","14;9;8;8;8;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5","G. AVANZINI;ANNA RITA GIOVAGNOLI;GIOVANNI BROGGI;MARCO DE CURTIS;ANGELO FRANZINI;GIUSEPPE LAURIA;PAOLO FERROLI;ROBERTO SPREAFICO;MARIANNA BUGIANI;CARLO EFISIO MARRAS;ANTONIO SILVANI;GAETANO FINOCCHIARO;ROSETTA PEDOTTI;ANDREA SALMAGGI;GENNARO BUSSONE;GRAZIELLA FILIPPINI;ORSO BUGIANI;SILVANA FRANCESCHETTI;PAOLA SOLIVERI;A. BOIARDI","2.44;2.25;2.14;1.72;1.7;1.46;1.01;1.01;1;0.89;0.83;0.82;0.81;0.8;0.78;0.75;0.73;0.71;0.7;0.69","GIOVANNI BROGGI;ANGELO FRANZINI;ANTONIO SILVANI;ANDREA SALMAGGI;MASSIMO ZEVIANI;FABRIZIO TAGLIAVINI;A. BOIARDI;EUGENIO PARATI;CARLO EFISIO MARRAS;ORSO BUGIANI;SILVANA FRANCESCHETTI;MARICA EOLI;G. AVANZINI;BIANCA POLLO;DARIA RIVA;GIORGIO GIACCONE;MARCO DE CURTIS;PAOLO FERROLI;GIUSEPPE LAURIA;LUCIA MORANDI","14;9;8;8;8;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5","G. AVANZINI;ANNA RITA GIOVAGNOLI;GIOVANNI BROGGI;MARCO DE CURTIS;ANGELO FRANZINI;GIUSEPPE LAURIA;PAOLO FERROLI;ROBERTO SPREAFICO;MARIANNA BUGIANI;CARLO EFISIO MARRAS;ANTONIO SILVANI;GAETANO FINOCCHIARO;ROSETTA PEDOTTI;ANDREA SALMAGGI;GENNARO BUSSONE;GRAZIELLA FILIPPINI;ORSO BUGIANI;SILVANA FRANCESCHETTI;PAOLA SOLIVERI;A. BOIARDI","2.44;2.25;2.14;1.72;1.7;1.46;1.01;1.01;1;0.89;0.83;0.82;0.81;0.8;0.78;0.75;0.73;0.71;0.7;0.69","MASSIMO ZEVIANI;ALBERTO ALBANESE;GIUSEPPE LAURIA;LUIGI ROMITO;MARIA FIORELLA CONTARINO;A. M. BONNET;A.L. BENABID;ALEXANDRE GIRONELL;ANDRÉS M. LOZANO;ANTHONY E. LANG;B. PIDOUX;BERTA PASCUAL‐SEDANO;IVANA ZAMARBIDE;J. L. HOUETO;J. MOLET;J.D. SPEELMAN;JAIME KULISEVSKY;JEAN A. SAINT‐CYR;JENS VOLKMANN;JING XIE","1792;1272;1206;1164;1067;1026;1026;1026;1026;1026;1026;1026;1026;1026;1026;1026;1026;1026;1026;1026","MASSIMO ZEVIANI;ALBERTO ALBANESE;LUIGI ROMITO;GIOVANNI BROGGI;GIUSEPPE LAURIA;VALERIA TIRANTI;ANGELO FRANZINI;ELEONORA LAMANTEA;M. BORGNA;RAFFAELLA LOMBARDI;BIANCA POLLO;STEFANO DI DONATO;CARLO EFISIO MARRAS;PAOLA PENZA;CATERINA MARIOTTI;EUGENIO PARATI;ANTONIO SILVANI;A. BOIARDI;ANDREA SALMAGGI;EGILL BRIEM","1792;1231;1164;850;779;713;695;553;535;535;523;449;440;427;401;399;385;382;382;380","GIOVANNI BROGGI;ANGELO FRANZINI;ANDREA SALMAGGI;ANTONIO SILVANI;MASSIMO ZEVIANI;FABRIZIO TAGLIAVINI;G. AVANZINI;A. BOIARDI;MARICA EOLI;ORSO BUGIANI;EUGENIO PARATI;BIANCA POLLO;DARIA RIVA;GIORGIO GIACCONE;MARCO DE CURTIS;LUCIA MORANDI;SILVANA FRANCESCHETTI;CARLO EFISIO MARRAS;E. LAMPERTI;GAETANO FINOCCHIARO","13;8;8;8;8;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;PHILOSOPHY;PHYSICS;POLITICAL SCIENCE;ART;ENGINEERING;MATERIALS SCIENCE;SOCIOLOGY","108;54;32;14;7;4;3;3;3;3;2;2;2;1","INTERNAL MEDICINE;PATHOLOGY;NEUROSCIENCE;GENETICS;PSYCHIATRY;BIOCHEMISTRY;IMMUNOLOGY;SURGERY;CANCER RESEARCH;CELL BIOLOGY;ENDOCRINOLOGY;ANATOMY;ANESTHESIA;AUDIOLOGY;PEDIATRICS;RADIOLOGY;ONCOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;PHYSICAL THERAPY","54;42;36;28;27;26;20;18;16;16;15;11;11;11;10;10;8;8;6;6;6","DISEASE;GENE;EPILEPSY;GLIOMA;CENTRAL NERVOUS SYSTEM;IMMUNOHISTOCHEMISTRY;IN VITRO;NEUROLOGY;NEUROSURGERY;COGNITION;STEM CELL;CHEMOTHERAPY;INFLAMMATION;MULTIPLE SCLEROSIS;POPULATION;STIMULATION;ANTIBODY;ELECTROPHYSIOLOGY;IMMUNE SYSTEM;MAGNETIC RESONANCE IMAGING;RECEPTOR;SKELETAL MUSCLE","27;27;17;11;10;9;8;8;8;7;7;6;6;6;6;6;5;5;5;5;5;5","MUTATION;MICROGLIA;PARKINSON'S DISEASE;MITOCHONDRIAL DNA;NEURORADIOLOGY;PHENOTYPE;PRION PROTEIN;ALZHEIMER'S DISEASE;BASAL GANGLIA;DEMENTIA;NEURAL STEM CELL;ALLELE;AUTOIMMUNITY;CHROMOSOME;ELECTRORETINOGRAPHY;ERG;ICTAL;NEUROPSYCHOLOGY;PROGENITOR CELL;PROGRESSIVE SUPRANUCLEAR PALSY;TEMPORAL LOBE","9;6;6;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3","DEEP BRAIN STIMULATION;GLOBUS PALLIDUS;SCRAPIE;FRONTOTEMPORAL DEMENTIA;HAPLOTYPE;MISSENSE MUTATION;HUNTINGTIN;INCREMENTAL EXERCISE;LEVODOPA;MITOCHONDRIAL DISEASE;NERVE BIOPSY;VO2 MAX;ANAPLASTIC ASTROCYTOMA;APHIDICOLIN;AUTOIMMUNE REGULATOR;AUTOSOME;BASIC FIBROBLAST GROWTH FACTOR;BICUCULLINE;BOSTON NAMING TEST;CARMUSTINE;CHROMOSOMAL FRAGILE SITE;CHROMOSOME 9;CLADE;COMPARATIVE GENOMIC HYBRIDIZATION;CORTICOBASAL DEGENERATION;CREUTZFELDT-JAKOB SYNDROME;DECORIN;DESMOPLASIA;DONOR LYMPHOCYTE INFUSION;ELECTRON-BEAM LITHOGRAPHY;EPITOPE MAPPING;EXOME SEQUENCING;FATAL FAMILIAL INSOMNIA;FMR1;FRAMESHIFT MUTATION;GENE MUTATION;GENETICALLY MODIFIED MOUSE;GENOME INSTABILITY;GERMINAL CENTER;HAPLOINSUFFICIENCY;INTERFACE (MATTER);INTERFERON BETA-1A;ION BEAM LITHOGRAPHY;K-COMPLEX;KRABBE DISEASE;LAFORA DISEASE;LAMINOTOMY;LEIGH DISEASE;LOSS OF HETEROZYGOSITY;MDX MOUSE;METABOTROPIC GLUTAMATE RECEPTOR;METABOTROPIC RECEPTOR;MEVALONATE PATHWAY;MIGRAINE WITH AURA;MITOCHONDRIAL MYOPATHY;MONOCLONAL;MURAL CELL;MUTATION TESTING;MYELIN-ASSOCIATED GLYCOPROTEIN;NANOLITHOGRAPHY;OLIGODENDROGLIOMA;P-GLYCOPROTEIN;PARKIN;PERICYTE;PERIRHINAL CORTEX;PERLECAN;POINT MUTATION;PRENATAL DIAGNOSIS;PRIMARY MOTOR CORTEX;PTEN;RECOMBINATION-ACTIVATING GENE;SCORPION TOXIN;SCORPION VENOMS;SERUM AMYLOID P COMPONENT;SINGLE-NUCLEOTIDE POLYMORPHISM;SLEEP SPINDLE;STEROL REGULATORY ELEMENT-BINDING PROTEIN;SUBVENTRICULAR ZONE;SYNAPTIC VESICLE;TAU PROTEIN;THIOFLAVIN;THIOTEPA;THYMIC INVOLUTION;TOLL-LIKE RECEPTOR;TRANSACTIVATION;TREM2;UTROPHIN;VIGABATRIN;VINCRISTINE","6;4;4;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;BRAIN NEOPLASMS;MIDDLE AGED;BRAIN;ANIMALS;GLIOMA;AGED;EPILEPSY;IMMUNOHISTOCHEMISTRY;ADOLESCENT;CHILD;GLIOBLASTOMA;RNA, MESSENGER;;MICE;NEURONS;TREATMENT OUTCOME","92;66;63;44;42;40;33;31;28;27;27;25;24;21;21;19;17;17;15;15","MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;EPILEPSY AND SEIZURES;GLIOMAS;PRION DISEASES: CAUSES AND MOLECULAR BASIS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;MECHANISMS OF ALZHEIMER'S DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;GUILLAIN-BARRÉ SYNDROME AND RELATED NEUROPATHIES;MOLECULAR MECHANISMS OF ANGIOGENESIS AND VASCULAR FUNCTION;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE;MOLECULAR MECHANISMS OF ION CHANNELS REGULATION;OCULAR TOXICITY AND RETINAL DISORDERS FROM MEDICATIONS;PATHOPHYSIOLOGY AND MANAGEMENT OF CEREBRAL ANEURYSMS","9;8;8;7;6;6;4;4;4;3;3;3;2;2;2;2;2;2;2;2","DEEP BRAIN STIMULATION;STATUS EPILEPTICUS;TREATMENT;EPILEPSY;GLIOBLASTOMA;CELLULAR PRION PROTEIN;NEURORADIOLOGY;INBORN ERRORS OF METABOLISM;MIGRAINE;PATHOGENESIS;AMYLOID (MYCOLOGY);ANTIEPILEPTIC DRUGS;BRAIN TUMOR;ELECTRORETINOGRAPHY;ENDOTHELIAL PROGENITOR CELLS;EPILEPSY DETECTION;ERG;GRADING (ENGINEERING);MEDULLOBLASTOMA;MIGRAINE PREVENTION","7;7;7;6;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3","MULTIPLE SCLEROSIS;ALZHEIMER DISEASE;BRAIN STIMULATION;CELL LINES;DEEP BRAIN;MITOCHONDRIAL DNA;EEG PATTERN;ELECTROPHYSIOLOGICAL EVALUATION;ENDOTHELIAL CELLS;GUINEA PIG;HUNTINGTONS DISEASE;ISOLATED GUINEA;LIMB APRAXIA;MALIGNANT GLIOMAS;MENSTRUAL MIGRAINE;METABOLIC MYOPATHIES;MICROVASCULAR ENDOTHELIAL;MRP MRP;NEAR-INFRARED SPECTROSCOPY;NEURAL STEM;OPTIC NERVE;PACLITAXEL-TREATED PATIENTS;PARKINSONS DISEASE;PATIENTS AFFECTED;PIG BRAIN;PILOCARPINEINDUCED STATUS;PROGENITOR CELLS;PROGRESSIVE SUPRANUCLEAR;RECURRENT GLIOBLASTOMA;SCLEROSIS RELAPSES","5;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;GLUTAMATE RELEASE;NEUROSCI -CROSSREF;MDX MICE;PUBMED GOOGLE;MUSCULAR DYSTROPHY;NAT NEUROSCI;IMMUNOL -CROSSREF;DE CLERCQ;BIOL CHEM;IMMUNE SYSTEM;INNATE IMMUNE;MG PATIENTS;MYASTHENIA GRAVIS;SKELETAL MUSCLE;CHEM -ABSTRACT;CSA TREATMENT;PDAPP MICE;ACAD SCI;INVOLUTED THYMUS;MRNA LEVELS;NATL ACAD;NATURE -CROSSREF;PREFIBRILLAR AGGREGATES;PROC NATL;TOLL-LIKE RECEPTORS;APPLIED BIOSYSTEMS;DUCHENNE MUSCULAR;MONOCLONAL ANTIBODY","145;132;30;26;21;18;16;15;13;12;11;11;11;11;11;11;10;10;10;9;9;9;9;9;9;9;9;8;8;8",23,0.18,3.12,2.5,2,1,0,1,2.5,0,1,2.5,0,1,4.25,0,2.5,1,1,5.5,0,0,0,73,73,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,13.75,631,3.02,0,0,16.29,0,0,3,0,2,0,1,1,0,2,1,0,0,0,0,0,0,7,0,0,3,4,0,0,0,0,0,0,0,0,"Italy;Japan;Switzerland","3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3203 DENTISTRY;3209 NEUROSCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","6;3;2;2;1;1;1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;NEURODEGENERATIVE;NEUROSCIENCES;AGING;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PARKINSON'S DISEASE;PERIPHERAL NEUROPATHY;RARE DISEASES","2;2;2;2;1;1;1;1;1","NEUROLOGICAL;METABOLIC AND ENDOCRINE","3;1","6.1 PHARMACEUTICALS","5",NA,NA,NA,NA,1,1967000,327833.33,4,6,4,1,0,317268.946001221,0.406595103699508,"DÉLÉGATION PARIS 11;ISTITUTO NEUROLOGICO CARLO BESTA;MAASTRICHT UNIVERSITY;NEWCASTLE UNIVERSITY;PAMGENE (NETHERLANDS);RADBOUD UNIVERSITY NIJMEGEN MEDICAL CENTRE","1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","FP6-2003-LIFESCIHEALTH-I (CALL FOR PROPOSAL);FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);STREP - SPECIFIC TARGETED RESEARCH PROJECT (FUNDING SCHEME)","1;1;1","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES","1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;GENETICS","1;1;1",NA,NA,NA,NA,NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BESTA",2006,136,9.10294117647059,3.27205882352941,0.397058823529412,0.455882352941176,0.404411764705882,2.02272727272727,1.14893617021277,1.72222222222222,1.14583333333333,0.301470588235294,4,70,43,14,7,0.51,0.32,0.1,0.05,74.4,1.456532304682,NA,0.404411764705882,0.779411764705882,0.481,0.386,0.339,0.382,"GIOVANNI BROGGI;GIORGIO GIACCONE;G. AVANZINI;FABRIZIO TAGLIAVINI;A. BOIARDI;SILVANA FRANCESCHETTI;GAETANO FINOCCHIARO;MASSIMO ZEVIANI;MASSIMO LEONE;ANDREA SALMAGGI;MARIA GRAZIA BRUZZONE;MARCO DE CURTIS;GENNARO BUSSONE;RENATO MANTEGAZZA;CARLO EFISIO MARRAS;ORSO BUGIANI;BIANCA POLLO;ANTONIO SILVANI;ANGELO FRANZINI;EMILIO CIUSANI","11;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5","GIOVANNI BROGGI;G. AVANZINI;MARCO DE CURTIS;ORSO BUGIANI;LUDOVICO MINATI;GENNARO BUSSONE;MASSIMO LEONE;UO BIOCHIMICA;GIORGIO GIACCONE;RENATO MANTEGAZZA;FABRIZIO TAGLIAVINI;ANGELO FRANZINI;VITTORIA NAZZI;SILVANA FRANCESCHETTI;CARLO EFISIO MARRAS;MASSIMO ZEVIANI;GIUSEPPE LAURIA;A. BOIARDI;ALBERTO ALBANESE;PAOLO FERROLI","2.19;2.02;1.73;1.61;1.25;1.14;1.07;1;0.96;0.96;0.95;0.93;0.92;0.86;0.85;0.83;0.77;0.74;0.72;0.71","GIOVANNI BROGGI;GIORGIO GIACCONE;G. AVANZINI;FABRIZIO TAGLIAVINI;A. BOIARDI;SILVANA FRANCESCHETTI;GAETANO FINOCCHIARO;MASSIMO ZEVIANI;MASSIMO LEONE;ANDREA SALMAGGI;MARIA GRAZIA BRUZZONE;MARCO DE CURTIS;GENNARO BUSSONE;RENATO MANTEGAZZA;CARLO EFISIO MARRAS;ORSO BUGIANI;BIANCA POLLO;ANTONIO SILVANI;ANGELO FRANZINI;EMILIO CIUSANI","11;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5","GIOVANNI BROGGI;G. AVANZINI;MARCO DE CURTIS;ORSO BUGIANI;LUDOVICO MINATI;GENNARO BUSSONE;MASSIMO LEONE;UO BIOCHIMICA;GIORGIO GIACCONE;RENATO MANTEGAZZA;FABRIZIO TAGLIAVINI;ANGELO FRANZINI;VITTORIA NAZZI;SILVANA FRANCESCHETTI;CARLO EFISIO MARRAS;MASSIMO ZEVIANI;GIUSEPPE LAURIA;A. BOIARDI;ALBERTO ALBANESE;PAOLO FERROLI","2.19;2.02;1.73;1.61;1.25;1.14;1.07;1;0.96;0.96;0.95;0.93;0.92;0.86;0.85;0.83;0.77;0.74;0.72;0.71","BÉLA MELEGH;CATERINA MARIOTTI;ALEXANDRA DÜRR;BART P.C. VAN DE WARRENBURG;CHRISTOPH GLOBAS;LÜDGER SCHÖLS;MARIA RAKOWICZ;PAOLA GIUNTI;RAFAŁ ROLA;SANDRA SZYMANSKI;SOPHIE TÉZENAS DU MONTCEL;SYLVIA BOESCH;THOMAS KLOCKGETHER;JOSÉ BERCIANO;PASCALE RIBAÏ;B. KREMER;CHANTAL DEPONDT;J.-S. KANG;JON INFANTE;L. BALIKO","1840;1840;1835;1797;1797;1797;1797;1797;1797;1797;1797;1797;1797;1688;1682;1639;1639;1639;1639;1639","CATERINA MARIOTTI;MASSIMO ZEVIANI;GIOVANNA ZORZI;NARDO NARDOCCI;MASSIMO LEONE;GENNARO BUSSONE;GIOVANNI BROGGI;VALERIA TIRANTI;ANGELO FRANZINI;FRANCO CARRARA;GAETANO FINOCCHIARO;ANTONELLA SPINAZZOLA;CARLO EFISIO MARRAS;CARLO VISCOMI;ERIKA FERNÁNDEZ‐VIZARRA;A. BOIARDI;MATILDE LEONARDI;SILVANA FRANCESCHETTI;MARIA GRAZIA BRUZZONE;TIZIANA GRANATA","1840;861;698;698;629;628;569;565;434;426;417;402;402;402;402;396;385;373;366;360","GIOVANNI BROGGI;G. AVANZINI;GIORGIO GIACCONE;FABRIZIO TAGLIAVINI;A. BOIARDI;SILVANA FRANCESCHETTI;MARCO DE CURTIS;MASSIMO ZEVIANI;RENATO MANTEGAZZA;GAETANO FINOCCHIARO;MASSIMO LEONE;GENNARO BUSSONE;MARIA GRAZIA BRUZZONE;ORSO BUGIANI;ALBERTO ALBANESE;ANDREA SALMAGGI;ANGELO FRANZINI;ANTONIO SILVANI;BIANCA POLLO;EMILIO CIUSANI","10;8;8;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;ECONOMICS;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;GEOGRAPHY;HISTORY","111;69;28;19;10;8;3;2;2;2;2;2;1;1","INTERNAL MEDICINE;PATHOLOGY;NEUROSCIENCE;PSYCHIATRY;GENETICS;BIOCHEMISTRY;SURGERY;IMMUNOLOGY;ENDOCRINOLOGY;PEDIATRICS;CANCER RESEARCH;ANESTHESIA;CELL BIOLOGY;PHYSICAL THERAPY;RADIOLOGY;MOLECULAR BIOLOGY;ANATOMY;PHARMACOLOGY;GASTROENTEROLOGY;PHYSICAL MEDICINE AND REHABILITATION","58;37;36;36;35;28;24;21;16;16;15;14;12;12;11;10;9;8;7;7","GENE;DISEASE;EPILEPSY;RECEPTOR;CENTRAL NERVOUS SYSTEM;NEUROLOGY;DIABETES MELLITUS;ELECTROENCEPHALOGRAPHY;GLIOMA;ENZYME;MIGRAINE;MITOCHONDRION;QUALITY OF LIFE (HEALTHCARE);IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;MAGNETIC RESONANCE IMAGING;NEUROSURGERY;STIMULATION;ANGIOGENESIS;ATAXIA;COGNITION;HIPPOCAMPUS;MYOCLONUS","38;33;19;13;10;9;8;8;8;7;7;7;7;6;6;6;6;6;5;5;5;5;5","MUTATION;PHENOTYPE;MITOCHONDRIAL DNA;DEMENTIA;MUTANT;MYELIN;NEURORADIOLOGY;PERIPHERAL NEUROPATHY;PRION PROTEIN;ALLELE;ALZHEIMER'S DISEASE;CLUSTER HEADACHE;EXON;GABAA RECEPTOR;GENOTYPE;ICTAL;LOCUS (GENETICS);NEURODEGENERATION;PROGRESSIVE MYOCLONUS EPILEPSY;SPINOCEREBELLAR ATAXIA;WHITE MATTER","13;9;8;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","MISSENSE MUTATION;MITOCHONDRIAL MYOPATHY;BICUCULLINE;DEEP BRAIN STIMULATION;MDX MOUSE;MITOCHONDRIAL DISEASE;ACROMEGALY;ADULT STEM CELL;BACLOFEN;BOVINE SPONGIFORM ENCEPHALOPATHY;CAVEOLIN 3;CREUTZFELDT-JAKOB SYNDROME;CXCR4;HEREDITARY SPASTIC PARAPLEGIA;PERIPHERAL MYELIN PROTEIN 22;POINT MUTATION;SCRAPIE;AAA PROTEINS;ACTIN CYTOSKELETON;ADVANCED GLYCATION END-PRODUCT;AMPA RECEPTOR;ANGIOPOIETIN;AUTOSOME;CASPASE;CD40;CD86;CEREBRAL AMYLOID ANGIOPATHY;CHROMOSOME 9;COENZYME Q – CYTOCHROME C REDUCTASE;COGNITIVE DECLINE;COGNITIVE DISORDER;COMPLEX PARTIAL SEIZURES;COMPOUND HETEROZYGOSITY;CORONAVIRUS DISEASE 2019 (COVID-19);CORTICOBASAL DEGENERATION;FAS LIGAND;FRAMESHIFT MUTATION;FRATAXIN;GENE MUTATION;GENETIC HETEROGENEITY;GENETICALLY MODIFIED MOUSE;GLUCOSE TOLERANCE TEST;HAPLOTYPE;HUNTINGTIN;IMPAIRED GLUCOSE TOLERANCE;INCLUSION BODIES;IONOTROPIC EFFECT;KARYOTYPE;KRABBE DISEASE;LAFORA DISEASE;LEIGH DISEASE;LEUKOARAIOSIS;LMNA;LOSS OF HETEROZYGOSITY;METABOTROPIC GLUTAMATE RECEPTOR;METABOTROPIC RECEPTOR;MIGRAINE WITH AURA;MYELIN BASIC PROTEIN;NESTIN;NEUROACTIVE STEROID;OLIGODENDROCYTE;OLIGODENDROGLIOMA;P-GLYCOPROTEIN;PACHYGYRIA;PERIVENTRICULAR LEUKOMALACIA;PHOTIC STIMULATION;POLYMORPHISM (COMPUTER SCIENCE);POPULATION SPIKE;PRESENILIN;PROBAND;REMYELINATION;SENILE PLAQUES;SOLUBLE GUANYLYL CYCLASE;SUMATRIPTAN;TAU PROTEIN;TAUOPATHY;THYMIC INVOLUTION;TRANSLATION (BIOLOGY);TRANSSPHENOIDAL SURGERY;VAGUS NERVE STIMULATION;VASCULAR ENDOTHELIAL GROWTH FACTOR A;VERBAL FLUENCY TEST;VINORELBINE;VIRAL VECTOR;VO2 MAX","4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;BRAIN NEOPLASMS;BRAIN;MIDDLE AGED;ADULT;EPILEPSY;MAGNETIC RESONANCE IMAGING;AGED;ANIMALS;;MUTATION;ADOLESCENT;GLIOMA;CHILD;GLIOBLASTOMA;ANTICONVULSANTS;NERVE TISSUE PROTEINS;SEIZURES","93;67;65;48;40;38;36;27;27;26;26;24;24;20;19;17;17;16;16;16","MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;EPILEPSY AND SEIZURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;GLIOMAS;PRION DISEASES: CAUSES AND MOLECULAR BASIS;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;PRENATAL EXPOSURE TO ANTIEPILEPTIC DRUGS;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EFFECTS OF STRESS ON BRAIN FUNCTION AND HEALTH;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS","11;9;7;6;5;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2","TREATMENT;NEUROIMAGING;INBORN ERRORS OF METABOLISM;ATAXIA;NEURODEGENERATION;NEURORADIOLOGY;CLUSTER HEADACHE;EPILEPSY;ETIOLOGY;MIGRAINE;MITOCHONDRIAL DYSFUNCTION;PROGRESSIVE MYOCLONUS EPILEPSY;CELLULAR PRION PROTEIN;EPILEPSY DETECTION;MDX MOUSE;METABOLIC REGULATION;MIGRAINE PREVENTION;MITOCHONDRIA;MITOCHONDRIAL DISEASE;MITOCHONDRIAL FISSION","9;7;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3","MITOCHONDRIAL DNA;CLUSTER HEADACHE;ALZHEIMERS DISEASE;BRAIN IRON;BRAINNET EUROPE;CMT PATIENTS;CREUTZFELDTJAKOB DISEASE;DIABETIC NEUROPATHY;ENTORHINAL CORTEX;FACIAL NERVE;GUINEA PIG;HEREDITARY SPASTIC;HYPOTHALAMIC STIMULATION;MULTICENTRE STUDY;MULTIPLE SCLEROSIS;MYOCLONIC EPILEPSY;NERVE PALSY;PATIENTS ITALIAN;PROSPECTIVE STUDY;PROTEIN KINASE;SEVERE MYOCLONIC;SPASTIC PARAPLEGIA;STEM CELLS;STEMLIKE CELLS;TECHNICAL NOTE;VARIANT CREUTZFELDTJAKOB;WHITE MATTER;AC MUTATIONS;ACTIN DYNAMICS;ACUTE HYPOTHALAMIC","5;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;MITOCHONDRIAL TRANSLATION;ELONGATION FACTOR;LACTIC ACIDOSIS;AGE MO;GENET -CROSSREF;MITOCHONDRIAL ELONGATION;MOL GENET;VEGF TPA;IGF-I LEVELS;MISSENSE MUTATION;AMINO ACID;DAILY LIVING;NUCLEAR GENES;OXIDATIVE PHOSPHORYLATION;POL Γ;AMINO ACIDS;CLUSTER HEADACHE;EXPRESSION LEVELS;FACTOR TU;FNIII REPEATS;GRADE II;HIPPOCAMPAL OUTPUT;MAGNETIC RESONANCE;METABOLIC ACIDOSIS;MITOCHONDRIAL DNA;MITOCHONDRIAL PROTEIN;NCBI ACCESSION;NMDA RECEPTOR","24;21;18;10;9;7;7;7;7;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4",35,0.26,6,3,0,1,1,2.5,4,0,3.25,3,0,1,1.25,1,2,1,0,1.75,4,0,0,87.5,88,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,3.75,70.5,2.76,0,0,12.83,0,0,4,0,2,0,0,0,0,2,0,0,0,0,0,0,0,6,0,0,2,4,0,0,0,0,0,0,0,0,"Italy;United States","3;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3203 DENTISTRY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","5;2;1;1;1","CLINICAL RESEARCH;NEUROSCIENCES;ORPHAN DRUG;RARE DISEASES;AUTOIMMUNE DISEASE;BRAIN CANCER;BRAIN DISORDERS;CANCER;CARDIOVASCULAR;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;MYASTHENIA GRAVIS;PATIENT SAFETY","2;2;2;2;1;1;1;1;1;1;1;1","CANCER;NEUROLOGICAL","2;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","4;1","BRAIN TUMOR","2","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2;2",2,1013623,228831.33,3,3.5,2.5,0.5,1,414706.74160401,0.327942582929751,"ISTITUTO NEUROLOGICO CARLO BESTA;ERASMUS MC;NATIONAL RESEARCH COUNCIL;UNIVERSITY OF MILANO-BICOCCA;UNIVERSITY OF PANNONIA;UNIVERSITY OF PATRAS","2;1;1;1;1;1","EUROPEAN COMMISSION","2","COALITION S;EC & ERC - EUROPEAN UNION","2;2","EIF - MARIE CURIE ACTIONS-INTRA-EUROPEAN FELLOWSHIPS (FUNDING SCHEME);FP6-2005-MOBILITY-5 (CALL FOR PROPOSAL);FP6-IST - INFORMATION SOCIETY TECHNOLOGIES: THEMATIC PRIORITY UNDER THE SPECIFIC PROGRAMME ""INTEGRATING AND STRENGTHENING THE EUROPEAN RESEARCH AREA"" (2002-2006). (PROGRAMME);FP6-MOBILITY - HUMAN RESOURCES AND MOBILITY IN THE SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ""STRUCTURING THE EUROPEAN RESEARCH AREA"" UNDER THE SIXTH FRAMEWORK PROGRAMME 2002-2006 (PROGRAMME);STREP - SPECIFIC TARGETED RESEARCH PROJECT (FUNDING SCHEME)","1;1;1;1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;4602 ARTIFICIAL INTELLIGENCE;4605 DATA MANAGEMENT AND DATA SCIENCE;4610 LIBRARY AND INFORMATION STUDIES","1;1;1;1;1;1;1;1","BIOTECHNOLOGY;GENETICS;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);NEUROSCIENCES","1;1;1;1",NA,NA,"1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;B11 COMPUTER SCIENCE AND INFORMATICS","1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BESTA",2007,138,9.04347826086956,3.68840579710145,0.478260869565217,0.492753623188406,0.478260869565217,2.16170212765957,1.22222222222222,1.41666666666667,1.22222222222222,0.311594202898551,2,62,51,8,15,0.45,0.37,0.06,0.11,55.75,1.05628290096903,NA,0.347826086956522,0.77536231884058,0.476,0.453,0.376,0.431,"GIOVANNI BROGGI;ANGELO FRANZINI;GENNARO BUSSONE;LUDOVICO MINATI;GIORGIO GIACCONE;EUGENIO PARATI;FABRIZIO TAGLIAVINI;MASSIMO LEONE;LUCIA LIMIDO;MARIA GRAZIA BRUZZONE;CARLO EFISIO MARRAS;A. BOIARDI;MICHELA MORBIN;MARINA GRISOLI;PAOLO FERROLI;SILVANA FRANCESCHETTI;CATERINA MARIOTTI;LUCIA MORANDI;BIANCA POLLO;ANTONIO SILVANI","17;12;11;11;9;9;8;7;7;7;7;7;6;6;6;6;6;6;5;5","GIOVANNI BROGGI;A. BOIARDI;LUDOVICO MINATI;ANGELO FRANZINI;ANTONIO SILVANI;GENNARO BUSSONE;PAOLO FERROLI;FABRIZIO TAGLIAVINI;MASSIMO LEONE;DARIO CALDIROLI;MASSIMO ZEVIANI;GIORGIO GIACCONE;EUGENIO PARATI;CARLO EFISIO MARRAS;MARIA GRAZIA BRUZZONE;LUCIA LIMIDO;CHIARA FALCONE;MARINA GRISOLI;FRANCESCA INVERARDI;CAROLINA FRASSONI","2.8;1.93;1.87;1.79;1.6;1.5;1.12;1.05;1.04;1.01;1;0.99;0.98;0.83;0.76;0.72;0.69;0.69;0.67;0.67","GIOVANNI BROGGI;ANGELO FRANZINI;GENNARO BUSSONE;LUDOVICO MINATI;GIORGIO GIACCONE;EUGENIO PARATI;FABRIZIO TAGLIAVINI;MASSIMO LEONE;LUCIA LIMIDO;MARIA GRAZIA BRUZZONE;CARLO EFISIO MARRAS;A. BOIARDI;MICHELA MORBIN;MARINA GRISOLI;PAOLO FERROLI;SILVANA FRANCESCHETTI;CATERINA MARIOTTI;LUCIA MORANDI;BIANCA POLLO;ANTONIO SILVANI","17;12;11;11;9;9;8;7;7;7;7;7;6;6;6;6;6;6;5;5","GIOVANNI BROGGI;A. BOIARDI;LUDOVICO MINATI;ANGELO FRANZINI;ANTONIO SILVANI;GENNARO BUSSONE;PAOLO FERROLI;FABRIZIO TAGLIAVINI;MASSIMO LEONE;DARIO CALDIROLI;MASSIMO ZEVIANI;GIORGIO GIACCONE;EUGENIO PARATI;CARLO EFISIO MARRAS;MARIA GRAZIA BRUZZONE;LUCIA LIMIDO;CHIARA FALCONE;MARINA GRISOLI;FRANCESCA INVERARDI;CAROLINA FRASSONI","2.8;1.93;1.87;1.79;1.6;1.5;1.12;1.05;1.04;1.01;1;0.99;0.98;0.83;0.76;0.72;0.69;0.69;0.67;0.67","EUGENIO PARATI;TIZIANA GRANATA;GIULIO ALESSANDRI;GLORIA INVERNICI;ANNA BENETTI;GENNARO BUSSONE;GIORGIO GIACCONE;LUDOVICO MINATI;ALESSANDRO OLIVI;ALEX Y. LIN;ANEEKA CHAUDHRY;ANGELO L. VESCOVI;CHARLES G. EBERHART;ELI E. BAR;FRANCESCO DIMECO;KARISA C. SCHRECK;SARA PICCIRILLO;WILLIAM MATSUI;XING FAN;A. PICCININI","920;752;704;665;648;624;613;609;580;580;580;580;580;580;580;580;580;580;580;552","EUGENIO PARATI;TIZIANA GRANATA;GIULIO ALESSANDRI;GLORIA INVERNICI;GENNARO BUSSONE;GIORGIO GIACCONE;FRANCESCO DIMECO;LUDOVICO MINATI;E. CORSINI;GRAZIELLA UZIEL;MARIANNA BUGIANI;BARBARA GALLO;RENATO MANTEGAZZA;ROSETTA PEDOTTI;SILVIA MUSIO;GIOVANNI BROGGI;SILVANA FRANCESCHETTI;CATERINA MARIOTTI;MARIA GRAZIA BRUZZONE;ANGELO FRANZINI","920;752;704;665;624;613;580;557;552;519;479;478;478;478;478;435;425;407;363;337","GIOVANNI BROGGI;GENNARO BUSSONE;ANGELO FRANZINI;LUDOVICO MINATI;GIORGIO GIACCONE;EUGENIO PARATI;FABRIZIO TAGLIAVINI;MASSIMO LEONE;MARIA GRAZIA BRUZZONE;A. BOIARDI;CATERINA MARIOTTI;LUCIA MORANDI;MICHELA MORBIN;SILVANA FRANCESCHETTI;MARINA GRISOLI;FRANCO TARONI;CAROLINA FRASSONI;FRANCESCA INVERARDI;GIULIO ALESSANDRI;MARINA MORA","15;13;11;10;9;9;7;7;6;6;6;6;6;6;6;5;5;5;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;ENGINEERING;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;ECONOMICS;GEOLOGY;HISTORY","125;72;25;16;14;11;5;3;3;3;2;2;1;1","INTERNAL MEDICINE;NEUROSCIENCE;GENETICS;PATHOLOGY;PSYCHIATRY;ANESTHESIA;SURGERY;CELL BIOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;RADIOLOGY;IMMUNOLOGY;CANCER RESEARCH;PEDIATRICS;ANATOMY;PHARMACOLOGY;MOLECULAR BIOLOGY;AUDIOLOGY;BIOPHYSICS;CARDIOLOGY","63;45;42;41;34;23;22;21;18;18;18;14;13;12;11;9;8;5;5;5","GENE;DISEASE;EPILEPSY;NEUROLOGY;CENTRAL NERVOUS SYSTEM;MIGRAINE;MAGNETIC RESONANCE IMAGING;NEUROSURGERY;STEM CELL;RECEPTOR;CHEMOTHERAPY;DYSTONIA;STIMULATION;ANGIOGENESIS;ATAXIA;ALTERNATIVE MEDICINE;CORTEX (ANATOMY);GLIOMA;IN VITRO;AMYLOID (MYCOLOGY);BLOOD PRESSURE;CELL CULTURE;CEREBROSPINAL FLUID;DIABETES MELLITUS;ENZYME;GLIOBLASTOMA;HYPOTHALAMUS;IMMUNOHISTOCHEMISTRY;MUSCULAR DYSTROPHY;POPULATION;PREGNANCY;SNAP","39;33;17;14;13;11;10;9;9;8;7;7;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","MUTATION;PARKINSON'S DISEASE;NEURORADIOLOGY;PHENOTYPE;ALLELE;ALZHEIMER'S DISEASE;AURA;CLUSTER HEADACHE;DIFFUSION MRI;EXON;WHITE MATTER;MITOCHONDRIAL DNA;MYELIN;NEURAL STEM CELL;PERIPHERAL NEUROPATHY;PRION PROTEIN;PROGENITOR CELL;AGE OF ONSET;CELLULAR DIFFERENTIATION;DEGENERATIVE DISEASE;GABAERGIC;GENOTYPE;HEART RATE;HUNTINGTON'S DISEASE;ICTAL;NEUROPIL;TEMOZOLOMIDE;TEMPORAL LOBE","18;13;9;9;6;5;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","DEEP BRAIN STIMULATION;MISSENSE MUTATION;ADULT STEM CELL;MIGRAINE WITH AURA;CANNABINOID RECEPTOR;CARMUSTINE;CREUTZFELDT-JAKOB SYNDROME;DIHYDROTESTOSTERONE;FRACTIONAL ANISOTROPY;GENETICALLY MODIFIED MOUSE;GLI1;HIPPOCAMPAL SCLEROSIS;LIMB-GIRDLE MUSCULAR DYSTROPHY;LOSS OF HETEROZYGOSITY;MITOCHONDRIAL DISEASE;PARKIN;POINT MUTATION;SENILE PLAQUES;TAU PROTEIN;TAUOPATHY;TRINUCLEOTIDE REPEAT EXPANSION","9;7;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;ADULT;BRAIN;MIDDLE AGED;BRAIN NEOPLASMS;ANIMALS;AGED;MAGNETIC RESONANCE IMAGING;;MUSCLE, SKELETAL;MUTATION;DEEP BRAIN STIMULATION;NEURONS;EPILEPSY;MICE;ADOLESCENT;CHILD;DYSTONIA","103;66;65;55;50;39;28;26;25;23;21;21;21;20;18;17;17;16;16;16","MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;GLIOMAS;PRION DISEASES: CAUSES AND MOLECULAR BASIS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;EPILEPSY AND SEIZURES;CEREBROSPINAL FLUID DISORDERS AND HEMATOMAS;MANAGEMENT OF BRAIN METASTASES IN CANCER PATIENTS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;PATHOPHYSIOLOGY AND MANAGEMENT OF CEREBRAL ANEURYSMS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;DIFFUSION MAGNETIC RESONANCE IMAGING;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS;HEDGEHOG SIGNALING IN DEVELOPMENT AND CANCER;MECHANISMS OF INTRACELLULAR MEMBRANE TRAFFICKING;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR MECHANISMS OF ION CHANNELS REGULATION","11;8;8;7;5;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2","NEURORADIOLOGY;CELLULAR PRION PROTEIN;MIGRAINE;CLUSTER HEADACHE;TREATMENT;AMYLOID (MYCOLOGY);DEEP BRAIN STIMULATION;INBORN ERRORS OF METABOLISM;MIGRAINE PREVENTION;NEURODEGENERATION;SNAP;ATAXIA;DYSTONIA;GLUTAMATE RECEPTORS;NEURAL STEM CELLS;NEUROGENIC NICHES;NEUROPIL;RADIOTHERAPY;SKELETAL MUSCLE ATROPHY;TEMOZOLOMIDE","9;7;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","DEEP BRAIN;BRAIN STIMULATION;STEM CELLS;CONGENITAL CATARACT;HETEROGENEOUS EXPRESSION;HUMAN BRAIN;HUNTINGTONS DISEASE;POSTERIOR HYPOTHALAMUS;TRIGEMINAL AUTONOMIC;AMYOTROPHIC LATERAL;AUTONOMIC CEPHALALGIAS;BLOODBRAIN BARRIER;CELLS EXERT;CLUSTER HEADACHE;ENTORHINAL CORTEX;EXPERIMENTAL VARIANT;FACIAL PAIN;GENETIC FEATURES;GRADE GLIOMAS;ISCHEMIC MICROENVIRONMENT;ITALIAN PATIENTS;LATERAL SCLEROSIS;LIPOSOMAL CYTARABINE;LOCAL DELIVERY;MTDNA MUTATIONS;MUSCULAR DYSTROPHY;NEURAL STEM;NEUROPROTECTIVE ACTION;RECURRENT GLIOBLASTOMA;A-KINASE PRKA","5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","PHARMACEUTICAL INDUSTRY;DRUG COMPANIES;WHITE MATTER;ASL CAGLIARI;CELL LINE;MICROCITEMIE ASL;REGIONALE MICROCITEMIE;STEM CELLS;CELL LINES;EXECUTIVE COMMITTEE;MED GENET;ANTIEPILEPTIC DRUGS;DRUG COMPANY;MACINTOSH LARYNGOSCOPY;MRNA EXPRESSION;NEGATIVE PTP;SATELLITE SYMPOSIA;BBB PERMEABILITY;CYCLE TIME;ENDOTHELIAL CELLS;INSPIRATORY TIME;MELANOMA CELL;PTEN MUTATION;BANNAYAN-RILEY-RUVALCABA SYNDROME;CAGLIARI ITALYOSPEDALE;CAGLIARI SARDINIA;CEREBRAL ARTERY;CONGENITAL CATARACT;EMAIL PROTECTED;HUMAN MELANOMA","28;10;10;8;8;8;8;8;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4",27,0.2,6.12,3.5,2.5,1,0,1,6.25,0,1.25,3.5,0,1,1,0,1,0,1,1.25,0,0,0,85,86,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,0,0,0.9,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","2;1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;GENETICS;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;RARE DISEASES","1;1;1;1;1;1;1;1","NEUROLOGICAL","1","6.1 PHARMACEUTICALS","2",NA,NA,NA,NA,2,6293337,294578.15,4.5,20.5,9,1,1,512185.050116555,0.269433869591852,"CF CONSULTING FINANZIAMENTI UNIONE EUROPEA;ISTITUTO NEUROLOGICO CARLO BESTA;ADELANTE;AUTONOMOUS UNIVERSITY OF MADRID;BIOCODEX (FRANCE);CATHOLIC UNIVERSITY OF THE SACRED HEART;CHARITÉ - UNIVERSITY MEDICINE BERLIN;EPILEPSY IRELAND;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ;HUNGARIAN ACADEMY OF SCIENCES;INNSBRUCK MEDICAL UNIVERSITY;INSERM;ISTANBUL UNIVERSITY;ISTITUTO GIANNINA GASLINI;JOHANNES GUTENBERG UNIVERSITY OF MAINZ;LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN;LUND UNIVERSITY;MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH;MEYER CHILDREN'S HOSPITAL","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","2","COALITION S;EC & ERC - EUROPEAN UNION","2;2","FP6-2005-LIFESCIHEALTH-6 (CALL FOR PROPOSAL);FP6-2005-MOBILITY-1 (CALL FOR PROPOSAL);FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);FP6-MOBILITY - HUMAN RESOURCES AND MOBILITY IN THE SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ""STRUCTURING THE EUROPEAN RESEARCH AREA"" UNDER THE SIXTH FRAMEWORK PROGRAMME 2002-2006 (PROGRAMME);IP - INTEGRATED PROJECT (FUNDING SCHEME);RTN - MARIE CURIE ACTIONS-RESEARCH TRAINING NETWORKS (FUNDING SCHEME)","1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3209 NEUROSCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","1;1;1;1;1","BRAIN DISORDERS;EPILEPSY;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;RARE DISEASES","1;1;1;1;1;1","NEUROLOGICAL","1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1;1",NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;C17 BUSINESS AND MANAGEMENT STUDIES","1;1","4 QUALITY EDUCATION","1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BESTA",2008,142,10.1267605633803,3.90140845070423,0.52112676056338,0.492957746478873,0.591549295774648,2.09056603773585,1.23333333333333,1.66666666666667,1.23529411764706,0.323943661971831,4,69,52,11,6,0.49,0.37,0.08,0.04,55.35,1.00862372156528,NA,0.316901408450704,0.725352112676056,0.462,0.412,0.349,0.395,"GIOVANNI BROGGI;FABRIZIO TAGLIAVINI;DARIA RIVA;RENATO MANTEGAZZA;DAVIDE PAREYSON;CHIARA PANTALEONI;LUCIA MORANDI;ANTONIO SILVANI;ANDREA SALMAGGI;GIORGIO GIACCONE;V. SCAIOLI;PAOLO FERROLI;SILVANA FRANCESCHETTI;CATERINA MARIOTTI;ALESSANDRA ERBETTA;STEFANO D’ARRIGO;MARINA MORA;ALBERTO ALBANESE;SARA BULGHERONI;LUDOVICO MINATI","13;12;9;8;8;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6","GIOVANNI BROGGI;FABRIZIO TAGLIAVINI;LUDOVICO MINATI;ALBERTO ALBANESE;DARIA RIVA;PAOLO FERROLI;ALESSANDRA ERBETTA;SARA BULGHERONI;DAVIDE PAREYSON;GIUSEPPE MESSINA;ANGELO FRANZINI;MARCO DE CURTIS;LUISA CHIAPPARINI;RENATO MANTEGAZZA;CHIARA PANTALEONI;SILVANA FRANCESCHETTI;MARINA MORA;V. SCAIOLI;ANNA RITA GIOVAGNOLI;LUCIA MORANDI","3.07;1.9;1.62;1.38;1.33;1.14;1.13;1.07;1;0.96;0.93;0.92;0.91;0.9;0.84;0.76;0.75;0.72;0.65;0.65","GIOVANNI BROGGI;FABRIZIO TAGLIAVINI;DARIA RIVA;RENATO MANTEGAZZA;DAVIDE PAREYSON;CHIARA PANTALEONI;LUCIA MORANDI;ANTONIO SILVANI;ANDREA SALMAGGI;GIORGIO GIACCONE;V. SCAIOLI;PAOLO FERROLI;SILVANA FRANCESCHETTI;CATERINA MARIOTTI;ALESSANDRA ERBETTA;STEFANO D’ARRIGO;MARINA MORA;ALBERTO ALBANESE;SARA BULGHERONI;LUDOVICO MINATI","13;12;9;8;8;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6","GIOVANNI BROGGI;FABRIZIO TAGLIAVINI;LUDOVICO MINATI;ALBERTO ALBANESE;DARIA RIVA;PAOLO FERROLI;ALESSANDRA ERBETTA;SARA BULGHERONI;DAVIDE PAREYSON;GIUSEPPE MESSINA;ANGELO FRANZINI;MARCO DE CURTIS;LUISA CHIAPPARINI;RENATO MANTEGAZZA;CHIARA PANTALEONI;SILVANA FRANCESCHETTI;MARINA MORA;V. SCAIOLI;ANNA RITA GIOVAGNOLI;LUCIA MORANDI","3.07;1.9;1.62;1.38;1.33;1.14;1.13;1.07;1;0.96;0.93;0.92;0.91;0.9;0.84;0.76;0.75;0.72;0.65;0.65","FABRIZIO TAGLIAVINI;CATERINA MARIOTTI;THOMAS KLOCKGETHER;GIOVANNI BROGGI;GIORGIO GIACCONE;SYLVIA BOESCH;ISIDRÓ FERRER;PIERO PARCHI;ALBERTO BIZZI;ALESSANDRO FILLA;BART P.C. VAN DE WARRENBURG;BÉLA MELEGH;CHANTAL DEPONDT;CHRISTOPH GLOBAS;DAGMAR TIMMANN;LÜDGER SCHÖLS;MARIA RAKOWICZ;RAFAŁ ROLA;SANDRA SZYMANSKI;ANDREW KING","1056;863;744;724;617;614;557;557;536;515;515;515;515;515;515;515;515;515;515;500","FABRIZIO TAGLIAVINI;CATERINA MARIOTTI;GIOVANNI BROGGI;GIORGIO GIACCONE;RENATO MANTEGAZZA;ROBERTO FANCELLU;ALBERTO ALBANESE;PAOLO FERROLI;ORSO BUGIANI;MASSIMO ZEVIANI;DAVIDE PAREYSON;ALBERTO BIZZI;GIOVANNA ZORZI;NARDO NARDOCCI;DARIA RIVA;CARLO EFISIO MARRAS;MICHELA MANGIERI;CINZIA GELLERA;GRAZIELLA UZIEL;U. DANESI","1056;735;684;617;479;479;469;424;417;410;408;386;382;382;359;348;313;311;310;302","FABRIZIO TAGLIAVINI;GIOVANNI BROGGI;DARIA RIVA;DAVIDE PAREYSON;RENATO MANTEGAZZA;LUCIA MORANDI;CHIARA PANTALEONI;PAOLO FERROLI;LUDOVICO MINATI;MARINA MORA;SILVANA FRANCESCHETTI;ALBERTO ALBANESE;GIORGIO GIACCONE;LUISA CHIAPPARINI;ALESSANDRA ERBETTA;ANDREA SALMAGGI;ANTONIO SILVANI;V. SCAIOLI;ANGELO FRANZINI;CATERINA MARIOTTI","12;12;8;8;7;7;7;6;6;6;6;6;6;6;6;6;6;6;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;ECONOMICS;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;ART;GEOLOGY","124;64;29;12;7;5;5;3;3;3;3;2;1;1","INTERNAL MEDICINE;PATHOLOGY;GENETICS;NEUROSCIENCE;PSYCHIATRY;SURGERY;RADIOLOGY;ANATOMY;CANCER RESEARCH;CELL BIOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;PEDIATRICS;ANESTHESIA;IMMUNOLOGY;AUDIOLOGY;PHYSICAL THERAPY;PHYSICAL MEDICINE AND REHABILITATION;ONCOLOGY;DEVELOPMENTAL PSYCHOLOGY;ENVIRONMENTAL HEALTH","68;48;39;32;30;27;17;15;15;15;14;14;13;12;12;11;11;9;8;7;7","GENE;DISEASE;EPILEPSY;ATAXIA;MAGNETIC RESONANCE IMAGING;NEUROSURGERY;NEUROLOGY;RECEPTOR;CHEMOTHERAPY;POPULATION;ALTERNATIVE MEDICINE;CENTRAL NERVOUS SYSTEM;COGNITION;GLIOBLASTOMA;RADIATION THERAPY;CONTEXT (ARCHAEOLOGY);FUNCTIONAL MAGNETIC RESONANCE IMAGING;IMMUNOHISTOCHEMISTRY;LESION;STIMULATION","35;33;16;12;12;9;8;8;7;7;6;6;6;6;6;5;5;5;5;5","MUTATION;PHENOTYPE;EXON;NEURORADIOLOGY;PARKINSON'S DISEASE;AGE OF ONSET;ALLELE;CYCLOPHOSPHAMIDE;DEMENTIA;MITOCHONDRIAL DNA;NEUROPSYCHOLOGY;PRION PROTEIN;SPINOCEREBELLAR ATAXIA;TEMOZOLOMIDE;TEMPORAL LOBE;WHITE MATTER;ALZHEIMER'S DISEASE;CORTICAL DYSPLASIA;EPILEPSY SURGERY;ETOPOSIDE;GAIT ATAXIA;GENOTYPE;PARKINSONISM;PLACEBO;TOLERABILITY","17;10;8;6;6;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","COMPOUND HETEROZYGOSITY;VINCRISTINE;DEEP BRAIN STIMULATION;FRONTOTEMPORAL DEMENTIA;GREY MATTER;MACHADO–JOSEPH DISEASE;MISSENSE MUTATION;ADULT STEM CELL;CARBOPLATIN;HETEROZYGOTE ADVANTAGE;LEVODOPA;MITOCHONDRIAL DISEASE;PARKIN;PRNP;PROBAND;SCRAPIE;THIOTEPA;ALLELE FREQUENCY;ALTERNATIVE SPLICING;ANAPLASTIC ASTROCYTOMA;ANTIRETROVIRAL THERAPY;ANTIVIRAL THERAPY;BOVINE SPONGIFORM ENCEPHALOPATHY;BRAIN-DERIVED NEUROTROPHIC FACTOR;BUPRENORPHINE;CD3;CHROMATID;CHROMOSOME SEGREGATION;CILIOPATHIES;CILIOPATHY;CONGENITAL MYOPATHY;DNA METHYLATION;DOUBLECORTIN;DYSKINESIA;DYSTROGLYCAN;ENDOGLIN;ERDHEIM–CHESTER DISEASE;FOOD HYPERSENSITIVITY;FRAMESHIFT MUTATION;GABAB RECEPTOR;GENETICALLY MODIFIED MOUSE;GERMINAL CENTER;GLUTAMATERGIC;HAMILTON RATING SCALE FOR DEPRESSION;HAPLOINSUFFICIENCY;HEREDITARY SPASTIC PARAPLEGIA;HIPPOCAMPAL SCLEROSIS;HOMOCYSTINURIA;HYPERGLYCINEMIA;IFOSFAMIDE;IL-2 RECEPTOR;INSERTIONAL MUTAGENESIS;LEBER'S HEREDITARY OPTIC NEUROPATHY;LOSS FUNCTION;LRRK2;MEMORY CLINIC;METAPHASE;METHYLENETETRAHYDROFOLATE REDUCTASE;METHYLMALONIC ACIDURIA;MIGRAINE WITH AURA;MITOCHONDRIAL FUSION;MITOCHONDRIAL MYOPATHY;MITOPHAGY;MOLECULAR EPIDEMIOLOGY;MUTANT PROTEIN;NEUROPSYCHOLOGICAL ASSESSMENT;NORMAL PRESSURE HYDROCEPHALUS;OLFACTORY TUBERCLE;OPIOID PEPTIDE;OPTIC RADIATION;ORAL ALLERGY SYNDROME;PILOCYTIC ASTROCYTOMA;POINT MUTATION;PRESENILIN;RADIOIODINE THERAPY;RNA SPLICING;RYR1;SILENT PERIOD;SPERMATOCYTE;SYK;TAU PATHOLOGY;TAU PROTEIN;TREATMENT-RESISTANT DEPRESSION;TROPOMYOSIN RECEPTOR KINASE B;VAGUS NERVE STIMULATION;VASCULOGENESIS;VERBAL FLUENCY TEST;VOXEL-BASED MORPHOMETRY;WECHSLER INTELLIGENCE SCALE FOR CHILDREN","7;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;BRAIN;MIDDLE AGED;ADULT;MAGNETIC RESONANCE IMAGING;CHILD;ADOLESCENT;AGED;BRAIN NEOPLASMS;;ANIMALS;EPILEPSY;CEREBRAL CORTEX;ELECTROENCEPHALOGRAPHY;MUTATION;BRAIN DISEASES;CHILD, PRESCHOOL;MYASTHENIA GRAVIS","104;83;79;59;50;49;40;30;28;26;25;22;22;21;18;18;18;17;16;16","GLIOMAS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PRION DISEASES: CAUSES AND MOLECULAR BASIS;EPILEPSY AND SEIZURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS;MECHANISMS OF ALZHEIMER'S DISEASE;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;EFFECTS OF KETOGENIC DIET ON HEALTH;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR MECHANISMS OF ANGIOGENESIS AND VASCULAR FUNCTION;MOLECULAR MECHANISMS OF ION CHANNELS REGULATION;NEURAL MECHANISMS OF AUDITORY PROCESSING AND PERCEPTION","9;8;8;6;6;5;5;4;4;4;4;3;3;3;2;2;2;2;2;2","CELLULAR PRION PROTEIN;COMPOUND HETEROZYGOSITY;INBORN ERRORS OF METABOLISM;NEUROIMAGING;NEURORADIOLOGY;ATAXIA;CONCORDANCE;DEEP BRAIN STIMULATION;EPILEPSY;GLIOBLASTOMA;TEMOZOLOMIDE;DEPRESSION (ECONOMICS);GAIT ATAXIA;GREY MATTER;MACHADO–JOSEPH DISEASE;MEDULLOBLASTOMA;NEURODEGENERATION;PINK1;RADIOTHERAPY;TOLERABILITY","7;7;7;7;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3","GLIOBLASTOMA PATIENTS;MYASTHENIA GRAVIS;RECURRENT GLIOBLASTOMA;SPINOCEREBELLAR ATAXIA;ALZHEIMERS DISEASE;ATAXIA TYPE;AUTOSOMAL DOMINANT;BENIGN CHILDHOOD;BRAINNET EUROPE;CENTROTEMPORAL SPIKES;CHILDHOOD EPILEPSY;CHRONIC CLUSTER;CLUSTER HEADACHE;CREUTZFELDTJAKOB DISEASE;ENDOSCOPIC PERIPHERAL;ENTORHINAL CORTEX;EUROPE CONSORTIUM;FOTEMUSTINE COMBINATION;FRONTOTEMPORAL DEMENTIA;FUNCTIONAL MRI;GANGLION BLOCK;LATE ONSET;LATERAL NASAL;LATERAL TEMPORAL;MOVEMENT DISORDERS;MUSCULAR DYSTROPHY;NASAL WALL;NATURAL HISTORY;PARKINSONS DISEASE;PERIPHERAL SPHENOPALATINE","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GLIAL CELLS;RETINOIC ACID;AUTOSOMAL DOMINANT;CRYPTIC PROMOTER;GENERALIZED EPILEPSIES;GENERALIZED SEIZURES;SEIZURE ACTIVITY;GENE MUTATIONS;HD PATIENTS;ICG VIDEO;MYOCLONIC EPILEPSY;OHC LEVELS;SPINAL CORD;WHITE MATTER;AUTOSOMAL RECESSIVE;FRONTAL LOBE;GAP JUNCTION;HUMAN NEUROBLASTOMA;IDIOPATHIC EPILEPSY;IDIOPATHIC GENERALIZED;LOBE EPILEPSY;METAPHASE SPERMATOCYTES;MOUSE MODEL;PRE-HD SUBJECTS;PRION PROTEIN;PROBABLE MSA-P;PYRAMIDAL NEURONS;RED FLAGS;SPASTIC PARAPLEGIA;SPIKE-AND-WAVE DISCHARGES","8;8;7;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4",30,0.21,3.38,2,1,1,0,1.75,2,0,1,3,0,1,1,0,2,0,0,1,0,0,0,120,120,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,2.83,447,4.31,1,0.09,56.18,0,1,7,0,2,0,0,1,0,5,0,0,0,0,0,0,0,11,0,0,4,6,0,1,0,0,0,0,0,0,"Italy;United States;United Kingdom","4;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","11;5;5;4;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEURODEGENERATIVE;NEUROSCIENCES;AGING;BRAIN DISORDERS;ACQUIRED COGNITIVE IMPAIRMENT;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);DEMENTIA;PATIENT SAFETY;ALS;CARDIOVASCULAR;DIGESTIVE DISEASES;RARE DISEASES;REHABILITATION","4;4;4;4;3;3;2;2;2;2;2;1;1;1;1;1","NEUROLOGICAL;CANCER","4;3","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","9;2;2;1","BRAIN TUMOR","3","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","1;1",1,5738653,409903.79,5,14,4,1,48,582164.957259412,0.243917120447229,"BECKER & HICKL (GERMANY);CF CONSULTING FINANZIAMENTI UNIONE EUROPEA;CHARITÉ - UNIVERSITY MEDICINE BERLIN;FIANIUM (UNITED KINGDOM);INSTITUTE FOR LASER TECHNOLOGY IN MEDICINE AND MEASUREMENT TECHNIQUE;INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING;ISTITUTO NEUROLOGICO CARLO BESTA;MEDICAL UNIVERSITY OF WARSAW;MICRO PHOTON DEVICES;PHYSIKALISCH-TECHNISCHE BUNDESANSTALT;POLITECNICO DI MILANO;UNIVERSITY COLLEGE LONDON;UNIVERSITY OF BATH;UNIVERSITY OF FLORENCE","1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2007-A (CALL FOR PROPOSAL)","1;1;1","40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","1;1","BIOENGINEERING;BIOMEDICAL IMAGING;BRAIN DISORDERS;CLINICAL RESEARCH;NEUROSCIENCES","1;1;1;1;1","NEUROLOGICAL","1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1;1",NA,NA,NA,NA,"B12 ENGINEERING","1",NA,NA,3,"PUBLIC LIBRARY OF SCIENCE","3","30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;31 BIOLOGICAL SCIENCES","4;2;2","BRAIN DISORDERS;EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES;NEURODEGENERATIVE;NEUROSCIENCES;RARE DISEASES;TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY (TSE)","1;1;1;1;1;1;1","NEUROLOGICAL","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT","1;1","BIOMEDICAL","1","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"IRCCS_BESTA",2009,176,9.90909090909091,3.59090909090909,0.403409090909091,0.465909090909091,0.420454545454545,2.34944237918216,1.22413793103448,1.70833333333333,1.25423728813559,0.346590909090909,3,81,66,16,8,0.46,0.38,0.09,0.05,60.34,1.30446460448982,NA,0.392045454545455,0.823863636363636,0.486,0.413,0.368,0.412,"GIOVANNI BROGGI;ANGELO FRANZINI;FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;MASSIMO ZEVIANI;GENNARO BUSSONE;LUCIA MORANDI;GIORGIO GIACCONE;ALESSANDRA ERBETTA;ROBERTO SPREAFICO;ANDREA SALMAGGI;CINZIA GELLERA;FRANCO TARONI;MASSIMO LEONE;MICHELA MORBIN;MARIA GRAZIA BRUZZONE;LAURA FARISELLI;MARINA GRISOLI;CHIARA FALCONE;PAOLO FERROLI","17;12;11;11;10;9;9;8;8;8;7;7;7;6;6;6;6;6;6;6","GIOVANNI BROGGI;FABRIZIO TAGLIAVINI;ANGELO FRANZINI;G. AVANZINI;MASSIMO ZEVIANI;RENATO MANTEGAZZA;GIUSEPPE MESSINA;ALBERTO BIZZI;LUCIA MORANDI;GENNARO BUSSONE;ALESSANDRA ERBETTA;MASSIMO LEONE;ALBERTO ALBANESE;ROBERTO SPREAFICO;PAOLO FERROLI;DAVIDE PAREYSON;ANNA RITA GIOVAGNOLI;ANDREA SALMAGGI;MATILDE LEONARDI;GAETANO FINOCCHIARO","2.81;2.05;1.97;1.83;1.73;1.25;1.23;1.23;1.06;1.05;0.98;0.96;0.95;0.89;0.86;0.85;0.85;0.84;0.8;0.79","GIOVANNI BROGGI;ANGELO FRANZINI;FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;MASSIMO ZEVIANI;GENNARO BUSSONE;LUCIA MORANDI;GIORGIO GIACCONE;ALESSANDRA ERBETTA;ROBERTO SPREAFICO;ANDREA SALMAGGI;CINZIA GELLERA;FRANCO TARONI;MASSIMO LEONE;MICHELA MORBIN;MARIA GRAZIA BRUZZONE;LAURA FARISELLI;MARINA GRISOLI;CHIARA FALCONE;PAOLO FERROLI","17;12;11;11;10;9;9;8;8;8;7;7;7;6;6;6;6;6;6;6","GIOVANNI BROGGI;FABRIZIO TAGLIAVINI;ANGELO FRANZINI;G. AVANZINI;MASSIMO ZEVIANI;RENATO MANTEGAZZA;GIUSEPPE MESSINA;ALBERTO BIZZI;LUCIA MORANDI;GENNARO BUSSONE;ALESSANDRA ERBETTA;MASSIMO LEONE;ALBERTO ALBANESE;ROBERTO SPREAFICO;PAOLO FERROLI;DAVIDE PAREYSON;ANNA RITA GIOVAGNOLI;ANDREA SALMAGGI;MATILDE LEONARDI;GAETANO FINOCCHIARO","2.81;2.05;1.97;1.83;1.73;1.25;1.23;1.23;1.06;1.05;0.98;0.96;0.95;0.89;0.86;0.85;0.85;0.84;0.8;0.79","MASSIMO ZEVIANI;MARINA GRISOLI;GIOVANNI BROGGI;FRANCESCO DIMECO;ANGELO L. VESCOVI;CHARLES G. EBERHART;JAREK MACIACZYK;SARA PICCIRILLO;CINZIA GELLERA;MARIA GRAZIA BRUZZONE;CHIARA FALCONE;ELENA I. RUGARLI;FRANCO TARONI;ALESSANDRA ERBETTA;ANGELO FRANZINI;CAROLINE E. TALSMA;CHERYL M. KOH;GUIDO NIKKHAH;JIANGYANG ZHANG;LEILA KHAKI","910;804;768;739;709;709;709;709;695;678;673;672;661;643;634;621;621;621;621;621","MASSIMO ZEVIANI;MARINA GRISOLI;GIOVANNI BROGGI;FRANCESCO DIMECO;CINZIA GELLERA;CHIARA FALCONE;ELENA I. RUGARLI;FRANCO TARONI;MARIA GRAZIA BRUZZONE;ALESSANDRA ERBETTA;ANGELO FRANZINI;GIUSEPPE MANCUSO;ALBERTO ALBANESE;ANDREA BERNACCHIA;FABRIZIO TAGLIAVINI;GIORGIO GIACCONE;MICHELA MORBIN;LUISA CHIAPPARINI;SARA PRIONI;GENNARO BUSSONE","847;804;768;739;695;673;672;661;661;643;634;610;596;580;577;534;528;520;491;481","GIOVANNI BROGGI;ANGELO FRANZINI;FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;MASSIMO ZEVIANI;ALESSANDRA ERBETTA;GENNARO BUSSONE;GIORGIO GIACCONE;LUCIA MORANDI;ROBERTO SPREAFICO;ANDREA SALMAGGI;CINZIA GELLERA;FRANCO TARONI;CATERINA MARIOTTI;GIUSEPPE MESSINA;PAOLO FERROLI;SILVANA FRANCESCHETTI;CHIARA FALCONE;DAVIDE PAREYSON;MARINA GRISOLI","17;12;11;11;9;8;8;8;8;8;7;7;7;6;6;6;6;6;6;6","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;POLITICAL SCIENCE;MATHEMATICS;ECONOMICS;PHILOSOPHY;HISTORY;SOCIOLOGY","150;79;38;18;7;7;6;5;4;3;2;1;1","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;GENETICS;NEUROSCIENCE;SURGERY;RADIOLOGY;ANESTHESIA;CELL BIOLOGY;ENDOCRINOLOGY;IMMUNOLOGY;PHYSICAL THERAPY;BIOCHEMISTRY;PEDIATRICS;PHYSICAL MEDICINE AND REHABILITATION;CANCER RESEARCH;PHARMACOLOGY;ONCOLOGY;MOLECULAR BIOLOGY;CLINICAL PSYCHOLOGY;NUCLEAR MEDICINE","85;52;52;47;39;30;20;18;17;17;17;17;15;15;15;13;10;9;8;6;6","GENE;DISEASE;EPILEPSY;NEUROLOGY;NEUROSURGERY;CENTRAL NERVOUS SYSTEM;MAGNETIC RESONANCE IMAGING;CANCER;MIGRAINE;CHEMOTHERAPY;IMMUNOHISTOCHEMISTRY;IN VITRO;MULTIPLE SCLEROSIS;RADIATION THERAPY;ATAXIA;MUSCULAR DYSTROPHY;RECEPTOR;COGNITION;DIABETES MELLITUS;ANTIBODY;CEREBELLUM;DYSTONIA;ETIOLOGY;IMMUNE SYSTEM;MITOCHONDRION;POPULATION;QUALITY OF LIFE (HEALTHCARE);REHABILITATION;TOXICITY","47;43;23;22;17;13;10;9;9;8;8;8;8;8;7;7;7;6;6;5;5;5;5;5;5;5;5;5;5","MUTATION;PHENOTYPE;NEURORADIOLOGY;PARKINSON'S DISEASE;MITOCHONDRIAL DNA;WHITE MATTER;ALLELE;EXON;MUTANT;PERIPHERAL NEUROPATHY;ALZHEIMER'S DISEASE;AMYOTROPHIC LATERAL SCLEROSIS;BASAL GANGLIA;GENE EXPRESSION;RADIOSURGERY;CORTICAL DYSPLASIA;GENOTYPE;INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH;MOVEMENT DISORDERS;NEUROTOXICITY;TEMPORAL LOBE","22;15;14;12;9;8;7;7;7;6;5;5;5;5;5;4;4;4;4;4;4","MISSENSE MUTATION;DEEP BRAIN STIMULATION;ADULT STEM CELL;GLOBUS PALLIDUS;MITOCHONDRIAL DISEASE;AMYLOID PRECURSOR PROTEIN;HAPLOINSUFFICIENCY;MITOCHONDRIAL MYOPATHY;PENETRANCE;ALLELE FREQUENCY;BRAIN METASTASIS;COPY-NUMBER VARIATION;CYBERKNIFE;DNA METHYLATION;DYSKINESIA;DYSTROGLYCAN;GENE MUTATION;GENETICALLY MODIFIED MOUSE;HEREDITARY SPASTIC PARAPLEGIA;HETEROPLASMY;HETEROZYGOTE ADVANTAGE;HIPPOCAMPAL SCLEROSIS;METHYLTRANSFERASE;MITOCHONDRIAL FUSION;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NEUROACTIVE STEROID;PRESENILIN;PROBAND;SINGLE-NUCLEOTIDE POLYMORPHISM;WILD TYPE","6;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;BRAIN;AGED;BRAIN NEOPLASMS;ADOLESCENT;YOUNG ADULT;MAGNETIC RESONANCE IMAGING;EPILEPSY;ANIMALS;NEURONS;TREATMENT OUTCOME;;CHILD;MUTATION;MALFORMATIONS OF CORTICAL DEVELOPMENT;ELECTROENCEPHALOGRAPHY","135;111;94;67;64;51;46;41;37;35;33;32;31;30;25;24;24;24;23;22","MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;EPILEPSY AND SEIZURES;MECHANISMS OF ALZHEIMER'S DISEASE;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;GLIOMAS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT OF BRAIN METASTASES IN CANCER PATIENTS;PATHOLOGY AND MANAGEMENT OF TRIGEMINAL NEURALGIA;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;PRION DISEASES: CAUSES AND MOLECULAR BASIS","9;9;8;8;8;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3","NEURORADIOLOGY;EPILEPSY;TREATMENT;ETIOLOGY;GLIOBLASTOMA;NEURODEGENERATION;NEUROIMAGING;PROTEIN MISFOLDING;AMYLOID (MYCOLOGY);BRAIN METASTASES;CAUDATE NUCLEUS;CHARCOT-MARIE-TOOTH DISEASE;DEEP BRAIN STIMULATION;DISABILITY ASSESSMENT;INBORN ERRORS OF METABOLISM;INTERVENTIONAL RADIOLOGY;MIGRAINE;MIGRAINE PREVENTION;MITOCHONDRIAL DISEASE;MOVEMENT DISORDERS","14;12;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","MULTIPLE SCLEROSIS;AMYOTROPHIC LATERAL;LATERAL SCLEROSIS;MUSCULAR DYSTROPHY;PARKINSONS DISEASE;CENTRAL NERVOUS;CLUSTER HEADACHE;EFNS GUIDELINES;ITALIAN PATIENTS;MOLECULAR DIAGNOSIS;MYASTHENIA GRAVIS;NERVOUS SYSTEM;TRIGEMINAL NEURALGIA;ARTERY HARVESTING;BONE DENSITY;BRAIN STIMULATION;BRAIN TUMORS;BRAINNET EUROPE;CASE-CONTROL STUDY;CHARCOT-MARIE-TOOTH TYPE;CHRONIC MIGRAINE;CONSECUTIVE PATIENTS;CORTICAL DYSPLASIA;CYBERKNIFE RADIOSURGERY;DEEP BRAIN;DIFFUSION TENSOR;DUCHENNE MUSCULAR;EC-IC BYPASS;ENDOSCOPIC RADIAL;EUROPE CONSORTIUM","7;5;5;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SURVIVAL TIME;BRAIN METASTASES;FUNCTIONAL INDEPENDENCE;INTRACRANIAL PROGRESSION;SYSTEMIC DISEASE;FOCAL EPILEPSY;GENERALIZED SEIZURES;INTERNATIONAL LEAGUE;TERM BENIGN;BLOODBRAIN BARRIER;MOLECULAR DIAGNOSIS;MYOCLONIC EPILEPSY;SCIENCEGOOGLE SCHOLAR;BRAIN IRRADIATION;DOSE GY;EPILEPTIC SYNDROMES;MONTHS CI;NEUROLOGIC DEATH;OBS ARM;PARTIAL VERSUS;SOLID TUMORS;STABLE SYSTEMIC;STEM-LIKE CELLS;VERSUS GENERALIZED;VO KINETICS;WBRT ARM;ALS PATIENTS;ALZHEIMERS DISEASE;BENIGN EPILEPSY;BENIGN FAMILIAL","10;9;9;9;9;8;8;8;8;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6;5;5;5;5",46,0.26,6,3,2,1.5,1,1.5,4.25,1,1,3,0,1,1.5,2,2,2,1.75,2,1,0,0,95.25,92,2,1,0,0,0,0,0,0,2,0,0,0,3,0,0,12,3.66666666666667,1.74,1,0,0,2,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"MARTINI ALFREDO;BATTAGLIA GIORGIO STEFANO;LOCATELLI DENISE;SETOLA VERONICA;FINOCCHIARO GAETANO;PELLEGATTA SERENA","3;2;2;2;1;1","FONDAZIONE IRCCS ISTITUTO NEUROLOGICO 'CARLO BESTA';FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA","2;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;40 ENGINEERING","4;2;2;1;1;1","GENETICS;NEURODEGENERATIVE;NEUROSCIENCES;PREVENTION","2;2;2;2","5.2 CELLULAR AND GENE THERAPIES","1","A01K67/033;A01N1/00;A61K35/74;A61K38/02;A61K38/18;A61K39/00;C07H21/00;C07K14/435;C07K16/00;C07K2/00","1;1;1;1;1;1;1;1;1;1","C07K14/47;A61K2039/5154;A61K2039/5158;A61K2039/54;A61K2039/545;A61K39/0011","2;1;1;1;1;1",9,4.4,407.5,3.47,2,0.22,50,0,0,4,0,4,0,0,1,0,5,1,0,0,0,0,0,0,9,0,0,6,3,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","7;4;4;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;BRAIN DISORDERS;NEUROSCIENCES;PATIENT SAFETY;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BIOENGINEERING;BRAIN CANCER;CARDIOVASCULAR;CHRONIC PAIN;DEMENTIA;DIGESTIVE DISEASES;NEURODEGENERATIVE;PAIN RESEARCH;PREVENTION","6;5;4;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;NEUROLOGICAL;METABOLIC AND ENDOCRINE;MUSCULOSKELETAL","4;3;1;1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY","6;2;1;1;1","BRAIN TUMOR;NERVOUS SYSTEM","1;1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1",4,3957962.25,355399.77,5.75,12.25,6.5,1,45.75,628379.51032579,0.280085516965298,"ISTITUTO NEUROLOGICO CARLO BESTA;MAX PLANCK SOCIETY;OSLO UNIVERSITY HOSPITAL;UNIVERSITY COLLEGE LONDON;ASTRAZENECA (UNITED KINGDOM);ATOMIC ENERGY AND ALTERNATIVE ENERGIES COMMISSION;AUTONOMOUS UNIVERSITY OF MADRID;CARDIFF UNIVERSITY;CF CONSULTING FINANZIAMENTI UNIONE EUROPEA;COLUMBIA UNIVERSITY;COLUMBIA UNIVERSITY IRVING MEDICAL CENTER;DÉLÉGATION PARIS 11;FINNISH INSTITUTE FOR HEALTH AND WELFARE;GHENT UNIVERSITY;HADASSAH MEDICAL CENTER;HARVARD UNIVERSITY;HELMHOLTZ ZENTRUM MÜNCHEN;HVIDOVRE HOSPITAL;IMPERIAL COLLEGE LONDON;INSERM TRANSFERT","4;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;MEDICAL RESEARCH COUNCIL","3;1","COALITION S;EC & ERC - EUROPEAN UNION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","4;3;1;1","CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);CP - COLLABORATIVE PROJECT (GENERIC) (FUNDING SCHEME);FP7-HEALTH-2007-B (CALL FOR PROPOSAL);FP7-HEALTH-2009-SINGLE-STAGE (CALL FOR PROPOSAL);FP7-ICT - SPECIFIC PROGRAMME ""COOPERATION"": INFORMATION AND COMMUNICATION TECHNOLOGIES (PROGRAMME);FP7-ICT-2009-C (CALL FOR PROPOSAL);INTRAMURAL (PROJECT CATEGORY)","2;2;1;1;1;1;1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY;42 HEALTH SCIENCES;4206 PUBLIC HEALTH;44 HUMAN SOCIETY;4403 DEMOGRAPHY;51 PHYSICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","1;1;1;1;1;1;1;1;1;1;1;1","BIOTECHNOLOGY;GENETICS;NEUROSCIENCES;AUTOIMMUNE DISEASE;BIOMEDICAL IMAGING;CLINICAL RESEARCH;HUMAN GENOME;PREVENTION;RARE DISEASES;STEM CELL RESEARCH","2;2;2;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;NEUROLOGICAL;METABOLIC AND ENDOCRINE","2;2;1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES","2;2;1;1","NOT SITE-SPECIFIC CANCER","1","1.1 NORMAL FUNCTIONING","1","A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE","2;1;1",NA,NA,1,"PUBLIC LIBRARY OF SCIENCE","1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS","2;1;1","BIOTECHNOLOGY;GENETICS;HUMAN GENOME","1;1;1","GENERIC HEALTH RELEVANCE","1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","1","BIOMEDICAL","1","BASIC SCIENCE","1","NOT SITE-SPECIFIC CANCER","1",NA,NA
"IRCCS_BESTA",2010,169,10.0710059171598,3.41420118343195,0.449704142011834,0.420118343195266,0.473372781065089,2.01048951048951,1.2258064516129,1.775,1.31147540983607,0.355029585798817,5,87,39,18,13,0.51,0.23,0.11,0.08,81.6,1.80563313277336,NA,0.408284023668639,0.769230769230769,0.513,0.431,0.34,0.414,"ANGELO FRANZINI;GIOVANNI BROGGI;MASSIMO ZEVIANI;ALBERTO ALBANESE;FABRIZIO TAGLIAVINI;FERRUCCIO PANZICA;SILVANA FRANCESCHETTI;CATERINA MARIOTTI;ROBERTO SPREAFICO;FRANCESCO ACERBI;GENNARO BUSSONE;PAOLO FERROLI;CINZIA GELLERA;ELISA VISANI;FRANCO TARONI;LUDOVICO MINATI;MARCO DE CURTIS;LUIGI ROMITO;GIUSEPPE MESSINA;GIORGIO GIACCONE","13;12;12;11;9;8;8;8;8;7;7;7;7;7;7;7;6;6;6;5","GIOVANNI BROGGI;GIOVANNI TRINGALI;ROBERTO SPREAFICO;ANGELO FRANZINI;ALBERTO ALBANESE;MARCO DE CURTIS;FRANCESCO ACERBI;ANNA RITA GIOVAGNOLI;PAOLO FERROLI;MASSIMO ZEVIANI;LUDOVICO MINATI;GENNARO BUSSONE;GIUSEPPE MESSINA;MASSIMO AVOLI;ROBERTO BINI;FERRUCCIO PANZICA;SILVANA FRANCESCHETTI;FRANCO TARONI;CINZIA GELLERA;GAETANO FINOCCHIARO","2.49;2.43;2.39;2.12;1.99;1.59;1.57;1.54;1.49;1.23;1.16;1.1;1.07;1.03;1;0.98;0.98;0.97;0.81;0.81","ANGELO FRANZINI;GIOVANNI BROGGI;MASSIMO ZEVIANI;ALBERTO ALBANESE;FABRIZIO TAGLIAVINI;FERRUCCIO PANZICA;SILVANA FRANCESCHETTI;CATERINA MARIOTTI;ROBERTO SPREAFICO;FRANCESCO ACERBI;GENNARO BUSSONE;PAOLO FERROLI;CINZIA GELLERA;ELISA VISANI;FRANCO TARONI;LUDOVICO MINATI;MARCO DE CURTIS;LUIGI ROMITO;GIUSEPPE MESSINA;GIORGIO GIACCONE","13;12;12;11;9;8;8;8;8;7;7;7;7;7;7;7;6;6;6;5","GIOVANNI BROGGI;GIOVANNI TRINGALI;ROBERTO SPREAFICO;ANGELO FRANZINI;ALBERTO ALBANESE;MARCO DE CURTIS;FRANCESCO ACERBI;ANNA RITA GIOVAGNOLI;PAOLO FERROLI;MASSIMO ZEVIANI;LUDOVICO MINATI;GENNARO BUSSONE;GIUSEPPE MESSINA;FERRUCCIO PANZICA;SILVANA FRANCESCHETTI;FRANCO TARONI;CINZIA GELLERA;GAETANO FINOCCHIARO;ELISA VISANI;LUIGI ROMITO","2.49;2.43;2.39;2.12;1.99;1.59;1.57;1.54;1.49;1.23;1.16;1.1;1.07;0.98;0.98;0.97;0.81;0.81;0.78;0.77","GIORGIO BATTAGLIA;ROBERTO SPREAFICO;LAURA TASSI;N. COLOMBO;ALBERTO ALBANESE;INGMAR BLÜMCKE;G. AVANZINI;A. JAMES BARKOVICH;ALBERT J. BECKER;ALFONSO REPRESA;ANDREAS SCHULZE‐BONHAGE;ANDRÉ PALMINI;ANNAMARIA VEZZANI;CARLOS CEPEDA;CHARLES RAYBAUD;DAWNA D. ARMSTRONG;ELEONORA ARONICA;FERNANDO CENDES;FRANÇOIS DUBEAU;GARY W. MATHERN","1905;1877;1772;1714;1659;1658;1630;1588;1588;1588;1588;1588;1588;1588;1588;1588;1588;1588;1588;1588","GIORGIO BATTAGLIA;ROBERTO SPREAFICO;ALBERTO ALBANESE;G. AVANZINI;EUGENIO PARATI;GLORIA INVERNICI;GIUSEPPE LAURIA;LUIGI ROMITO;ALBERTO BIZZI;MASSIMO ZEVIANI;CATERINA MARIOTTI;FABRIZIO TAGLIAVINI;ANGELO FRANZINI;CINZIA GELLERA;PAOLA PENZA;RAFFAELLA LOMBARDI;GIOVANNI BROGGI;GIORGIO GIACCONE;NARDO NARDOCCI;FEDERICA INVERNIZZI","1905;1877;1659;1630;1394;1391;1291;947;934;819;698;565;538;492;490;490;484;467;452;442","ANGELO FRANZINI;GIOVANNI BROGGI;ALBERTO ALBANESE;MASSIMO ZEVIANI;FABRIZIO TAGLIAVINI;CATERINA MARIOTTI;ROBERTO SPREAFICO;PAOLO FERROLI;LUDOVICO MINATI;FERRUCCIO PANZICA;SILVANA FRANCESCHETTI;LUIGI ROMITO;ELISA VISANI;FRANCESCO ACERBI;GENNARO BUSSONE;MARCO DE CURTIS;FRANCO TARONI;GIUSEPPE MESSINA;CINZIA GELLERA;EUGENIO PARATI","13;12;11;10;9;8;8;7;7;7;7;6;6;6;6;6;6;6;6;5","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PHILOSOPHY;MATHEMATICS;POLITICAL SCIENCE;ECONOMICS;ENGINEERING;MATERIALS SCIENCE;GEOLOGY;ART;BUSINESS;GEOGRAPHY;HISTORY;SOCIOLOGY","139;68;45;19;17;12;11;9;6;5;3;3;2;1;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;NEUROSCIENCE;PSYCHIATRY;GENETICS;SURGERY;BIOCHEMISTRY;RADIOLOGY;CELL BIOLOGY;ANESTHESIA;CANCER RESEARCH;ANATOMY;IMMUNOLOGY;PHYSICAL THERAPY;AUDIOLOGY;ENDOCRINOLOGY;MOLECULAR BIOLOGY;PEDIATRICS;PHYSICAL MEDICINE AND REHABILITATION;CLINICAL PSYCHOLOGY","68;52;47;47;42;30;26;24;18;16;16;15;15;15;14;13;11;11;11;8","DISEASE;GENE;EPILEPSY;NEUROLOGY;RECEPTOR;MAGNETIC RESONANCE IMAGING;STEM CELL;STIMULATION;ATAXIA;CENTRAL NERVOUS SYSTEM;COGNITION;MIGRAINE;BIOPSY;CANCER;GLIOMA;IN VITRO;NEUROSURGERY;ATROPHY;POPULATION;DIABETES MELLITUS;ELECTROENCEPHALOGRAPHY;MITOCHONDRION;MYOCLONUS;REHABILITATION","40;40;24;20;16;14;11;10;9;9;9;9;8;8;8;8;8;7;7;6;6;6;6;6","PARKINSON'S DISEASE;MUTATION;NEURORADIOLOGY;PHENOTYPE;CORTICAL DYSPLASIA;GENOTYPE;AMYOTROPHIC LATERAL SCLEROSIS;DEMENTIA;INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH;MITOCHONDRIAL DNA;PERIPHERAL NEUROPATHY;SPINOCEREBELLAR ATAXIA;WHITE MATTER;AGONIST;ALZHEIMER'S DISEASE;CANCER STEM CELL;CLUSTER HEADACHE;DIFFUSION MRI;EXCITATORY POSTSYNAPTIC POTENTIAL;NEURAL STEM CELL;NEUROPSYCHOLOGY;PROGRESSIVE MYOCLONUS EPILEPSY;RADIOSURGERY;TEMPORAL LOBE","15;14;10;8;7;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","DEEP BRAIN STIMULATION;MISSENSE MUTATION;ADULT STEM CELL;CYBERKNIFE;LEVODOPA;MITOCHONDRIAL DISEASE;SENILE PLAQUES;SINGLE-NUCLEOTIDE POLYMORPHISM;SUMATRIPTAN;ALPHA (FINANCE);ALTERNATIVE SPLICING;ANDROGEN DEPRIVATION THERAPY;CEREBRAL AMYLOID ANGIOPATHY;CLINICAL PHENOTYPE;EXTERNAL BEAM RADIOTHERAPY;GENETICALLY MODIFIED MOUSE;GLOBUS PALLIDUS;HEREDITARY SPASTIC PARAPLEGIA;HIPPOCAMPAL SCLEROSIS;LAFORA DISEASE;MIGRAINE WITH AURA;NERVE BIOPSY;PRIMARY MOTOR CORTEX;PROBAND;SILENT PERIOD;VERBAL FLUENCY TEST","10;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;BRAIN;AGED;BRAIN NEOPLASMS;MAGNETIC RESONANCE IMAGING;MUTATION;ANIMALS;EPILEPSY;;PARKINSON DISEASE;CEREBRAL CORTEX;GLIOMA;YOUNG ADULT;TREATMENT OUTCOME;MALFORMATIONS OF CORTICAL DEVELOPMENT;ADOLESCENT","129;78;74;47;45;36;33;31;30;29;28;28;27;23;21;20;20;19;18;17","DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;GLIOMAS;MECHANISMS OF ALZHEIMER'S DISEASE;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;CANCER STEM CELLS AND TUMOR METASTASIS;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;EPILEPSY AND SEIZURES;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;PRION DISEASES: CAUSES AND MOLECULAR BASIS;;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;DIFFUSION MAGNETIC RESONANCE IMAGING","10;10;7;7;6;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2","NEURORADIOLOGY;TREATMENT;DEEP BRAIN STIMULATION;EPILEPSY;INBORN ERRORS OF METABOLISM;MIGRAINE;NEUROMODULATION;CLUSTER HEADACHE;DIAGNOSTIC CRITERIA;DISABILITY ASSESSMENT;GUIDELINE;NEURODEGENERATION;PROGRESSIVE MYOCLONUS EPILEPSY;TRANSCRANIAL MAGNETIC STIMULATION;ATAXIA;BRAIN ACTIVATION;CANCER EPIGENETICS;CANCER STEM CELLS;CYBERKNIFE;DEPRESSION (ECONOMICS)","10;7;6;6;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3","PARKINSONS DISEASE;FOCAL CORTICAL;AMYOTROPHIC LATERAL;LATERAL SCLEROSIS;MUSCULAR DYSTROPHY;BRAIN STIMULATION;CLUSTER HEADACHE;CORTICAL DYSPLASIA;CORTICAL DYSPLASIAS;DEEP BRAIN;EFNS GUIDELINES;NERVE SOCIETY;PERIPHERAL NERVE;STEM CELL;STEM CELLS;ALZHEIMERS DISEASE;BEAM IRRADIATION;BONE DENSITY;CANCER STEM;CELL TRANSPLANTATION;CHRONIC CLUSTER;COHERENCE ESTIMATED;CONSENSUS CLASSIFICATION;CORTICAL MALFORMATIONS;DIAGNOSTIC CHALLENGE;DOMINANT OPTIC;DUCHENNE MUSCULAR;ETHYLMALONIC ENCEPHALOPATHY;EUROPEAN FEDERATION;EXTERNAL BEAM","6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;MED GENET;AFFECTED INDIVIDUALS;INTRACRANIAL CALCIFICATION;MGL MGL;MAGNETIC RESONANCE;SIMPLIFIED GYRATION;MMOLL MMOLL;DOBYNS WB;FCD TYPE;TENSION-TYPE HEADACHE;BLOOD VESSELS;SKIN BIOPSY;TIGHT JUNCTION;ALBAND-LIKE INTRACRANIAL;DISTINCT PSEUDO-TORCH;GI CROOKS;JH RICE;LIVINGSTON JH;NEUROPATHOL -CROSSREF;NI DARRIGO;OCLN GENE;PSEUDO-TORCH PHENOTYPEAM;RICE GI;ROWLAND-HILL CA;RRMS PATIENTS;SCIATIC NERVE;TA WOLF;WB LIVINGSTON","46;44;17;16;15;12;11;11;10;9;9;9;8;8;8;7;7;7;7;7;7;7;7;7;7;7;7;7;7;7",37,0.22,6,3,1.75,2,0,1,2,1,1,3,0,1,2,1,2,1,1,1.5,1,0,0,141,141,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,3,4,0.7,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"DI FEDE GIUSEPPE;MARTINI ALFREDO;MORBIN MICHELA;TAGLIAVINI FABRIZIO","1;1;1;1","FONDAZIONE IRCCS ISTITUTO NEUROLOGICO 'CARLO BESTA'","1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY","2;1","BRAIN DISORDERS;NEURODEGENERATIVE;PREVENTION","1;1;1",NA,NA,"A01K67/027;A61K39/395;C07K14/47;C07K16/18;C12N15/11;C12N15/85;C12Q1/68;G01N33/68","1;1;1;1;1;1;1;1","A01K2207/15;A01K2217/00;A01K2217/05;A01K2217/075;A01K2217/15;A01K2227/105;A01K2267/0312;A01K67/0278;A61P25/28;C07K14/4711","1;1;1;1;1;1;1;1;1;1",4,14,1937.5,1.49,2,0.5,28.75,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"United States;Italy","32;3","31 BIOLOGICAL SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","2;2;2;1;1;1","NEUROSCIENCES;RARE DISEASES;CHARCOT-MARIE-TOOTH DISEASE;CLINICAL RESEARCH;NEURODEGENERATIVE;PERIPHERAL NEUROPATHY;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;GENETICS;PEDIATRIC;PEDIATRIC RESEARCH INITIATIVE","4;4;3;3;3;3;2;2;2;1","NEUROLOGICAL","2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","2;1",NA,NA,NA,NA,6,3054585.4,188941,4.4,12.8333333333333,7.5,0.833333333333333,19,696991.461461679,0.242470689161078,"ISTITUTO NEUROLOGICO CARLO BESTA;DÉLÉGATION PARIS 11;IMPERIAL COLLEGE LONDON;INSTITUTE OF GENETICS AND MOLECULAR AND CELLULAR BIOLOGY;UNIVERSITY COLLEGE LONDON;UNIVERSITY MEDICAL CENTER HAMBURG-EPPENDORF;UNIVERSITY OF CAMBRIDGE;UNIVERSITY OF OXFORD;ACADEMIC MEDICAL CENTER;AUTONOMOUS UNIVERSITY OF MADRID;BABEȘ-BOLYAI UNIVERSITY;BAMBINO GESÙ CHILDREN'S HOSPITAL;BRUNEL UNIVERSITY LONDON;CF CONSULTING FINANZIAMENTI UNIONE EUROPEA;DUBLIN CITY UNIVERSITY;ERASMUS MC;EUROPEAN BRAIN COUNCIL;EUROPEAN HEALTH MANAGEMENT ASSOCIATION;EUROPEAN LEUKODYSTROPHY ASSOCIATION;FINNISH INSTITUTE FOR HEALTH AND WELFARE","6;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;ALZHEIMER'S ASSOCIATION;BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL","4;1;1","COALITION S;EC & ERC - EUROPEAN UNION;HRA - HEALTH RESEARCH ALLIANCE;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","5;4;1;1;1","FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2009-SINGLE-STAGE (CALL FOR PROPOSAL);CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);CSA-CA - COORDINATION (OR NETWORKING) ACTIONS (FUNDING SCHEME);RESEARCH GRANT (PROJECT CATEGORY)","4;4;2;2;1","31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;4206 PUBLIC HEALTH;52 PSYCHOLOGY","3;3;3;2;2;1;1;1","CLINICAL RESEARCH;NEURODEGENERATIVE;NEUROSCIENCES;BRAIN DISORDERS;GENETICS;BEHAVIORAL AND SOCIAL SCIENCE;PEDIATRIC;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);AUTOIMMUNE DISEASE;DEMENTIA;MENTAL HEALTH;PREVENTION;RARE DISEASES","4;4;4;3;3;2;2;1;1;1;1;1;1;1;1;1","NEUROLOGICAL;GENERIC HEALTH RELEVANCE;MENTAL HEALTH","3;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;8.1 ORGANISATION AND DELIVERY OF SERVICES","2;1;1",NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A05 BIOLOGICAL SCIENCES;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE;C20 SOCIAL WORK AND SOCIAL POLICY","2;2;1;1",NA,NA,1,"PUBLIC LIBRARY OF SCIENCE","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3209 NEUROSCIENCES","2;1","BRAIN DISORDERS;EPILEPSY;NEURODEGENERATIVE;NEUROSCIENCES","1;1;1;1","NEUROLOGICAL","1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1;1","BIOMEDICAL","1","BASIC SCIENCE","1",NA,NA,NA,NA
"IRCCS_BESTA",2011,235,9.69787234042553,3.96170212765957,0.485106382978723,0.519148936170213,0.527659574468085,2.46031746031746,1.46153846153846,1.96774193548387,1.47619047619048,0.382978723404255,5,98,91,26,11,0.42,0.39,0.11,0.05,47.75,1.12259872122809,NA,0.446808510638298,0.817021276595745,0.526,0.394,0.351,0.385,"ANDREA SALMAGGI;GIUSEPPE LAURIA;LUCIA MORANDI;ANGELO FRANZINI;A. BOTTURI;RENATO MANTEGAZZA;MASSIMO ZEVIANI;SILVANA FRANCESCHETTI;E. LAMPERTI;LUDOVICO MINATI;ANTONIO SILVANI;EUGENIO PARATI;LAURA FARISELLI;EMILIO CIUSANI;PAOLA GAVIANI;ALBERTO ALBANESE;GRAZIELLA UZIEL;FABRIZIO TAGLIAVINI;GIOVANNI BROGGI;CATERINA MARIOTTI","15;13;13;12;12;12;12;11;11;11;10;10;10;10;10;10;9;9;8;8","GIUSEPPE LAURIA;ALBERTO ALBANESE;LUDOVICO MINATI;ANGELO FRANZINI;GENNARO BUSSONE;ANDREA SALMAGGI;MASSIMO ZEVIANI;RENATO MANTEGAZZA;A. BOTTURI;BIANCA POLLO;LUCIA MORANDI;E. LAMPERTI;GIUSEPPE MESSINA;EUGENIO PARATI;ORSO BUGIANI;ANTONIO SILVANI;PAOLA GAVIANI;ANNA RITA GIOVAGNOLI;HUGO CRITCHLEY;LAURA FARISELLI","2.62;2.54;2.27;2.05;1.94;1.85;1.65;1.56;1.55;1.52;1.49;1.4;1.37;1.34;1.3;1.28;1.28;1.24;1.23;1.16","ANDREA SALMAGGI;GIUSEPPE LAURIA;LUCIA MORANDI;ANGELO FRANZINI;A. BOTTURI;RENATO MANTEGAZZA;MASSIMO ZEVIANI;SILVANA FRANCESCHETTI;E. LAMPERTI;LUDOVICO MINATI;ANTONIO SILVANI;EUGENIO PARATI;LAURA FARISELLI;EMILIO CIUSANI;PAOLA GAVIANI;ALBERTO ALBANESE;GRAZIELLA UZIEL;FABRIZIO TAGLIAVINI;GIOVANNI BROGGI;CATERINA MARIOTTI","15;13;13;12;12;12;12;11;11;11;10;10;10;10;10;10;9;9;8;8","GIUSEPPE LAURIA;ALBERTO ALBANESE;LUDOVICO MINATI;ANGELO FRANZINI;GENNARO BUSSONE;ANDREA SALMAGGI;MASSIMO ZEVIANI;RENATO MANTEGAZZA;A. BOTTURI;BIANCA POLLO;LUCIA MORANDI;E. LAMPERTI;GIUSEPPE MESSINA;EUGENIO PARATI;ORSO BUGIANI;ANTONIO SILVANI;PAOLA GAVIANI;ANNA RITA GIOVAGNOLI;LAURA FARISELLI;MARCO DE CURTIS","2.62;2.54;2.27;2.05;1.94;1.85;1.65;1.56;1.55;1.52;1.49;1.4;1.37;1.34;1.3;1.28;1.28;1.24;1.16;1.13","DINA BATTINO;TORBJÖRN TOMSON;GIUSEPPE LAURIA;ANNE SABERS;DICK LINDHOUT;EMILIO PERUCCA;ERMINIO BONIZZONI;FRANK VAJDA;JOHN CRAIG;MASSIMO ZEVIANI;FRANCESCO DIMECO;CARLO VISCOMI;RENATO MANTEGAZZA;SILVANA FRANCESCHETTI;LUCIA MORANDI;EUGENIO PARATI;LUDOVICO MINATI;ANGELO L. VESCOVI;JASON HETH;KARIN M. MURASZKO","715;715;710;706;706;706;706;706;706;652;616;567;562;546;543;540;527;506;506;506","DINA BATTINO;GIUSEPPE LAURIA;MASSIMO ZEVIANI;FRANCESCO DIMECO;CARLO VISCOMI;RENATO MANTEGAZZA;LUCIA MORANDI;EUGENIO PARATI;EMILIO CIUSANI;CATERINA MARIOTTI;DAVIDE PAREYSON;SILVANA FRANCESCHETTI;COSTANZA LAMPERTI;GRAZIELLA UZIEL;ALESSANDRA SOLARI;LUDOVICO MINATI;LAURA FARISELLI;ANGELO L. VESCOVI;CALLIE G. FLACK;CAROLINE E. TALSMA","715;691;652;594;567;562;543;540;499;488;488;433;428;407;400;392;382;362;362;362","ANDREA SALMAGGI;LUCIA MORANDI;A. BOTTURI;GIUSEPPE LAURIA;RENATO MANTEGAZZA;MASSIMO ZEVIANI;ANGELO FRANZINI;E. LAMPERTI;EMILIO CIUSANI;SILVANA FRANCESCHETTI;ANTONIO SILVANI;EUGENIO PARATI;PAOLA GAVIANI;LAURA FARISELLI;FABRIZIO TAGLIAVINI;LUDOVICO MINATI;ALBERTO ALBANESE;GENNARO BUSSONE;GRAZIELLA UZIEL;CATERINA MARIOTTI","15;13;12;12;12;12;11;11;10;10;10;10;10;10;9;9;8;8;8;8","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;ENGINEERING;PHILOSOPHY;MATHEMATICS;ECONOMICS;POLITICAL SCIENCE;SOCIOLOGY;ART;MATERIALS SCIENCE;HISTORY;GEOGRAPHY","198;100;64;21;17;16;12;9;8;6;5;4;3;3;2;1","INTERNAL MEDICINE;NEUROSCIENCE;PATHOLOGY;PSYCHIATRY;GENETICS;SURGERY;RADIOLOGY;CELL BIOLOGY;ANESTHESIA;BIOCHEMISTRY;CANCER RESEARCH;ENDOCRINOLOGY;IMMUNOLOGY;PHYSICAL MEDICINE AND REHABILITATION;PEDIATRICS;PHYSICAL THERAPY;ANATOMY;COGNITIVE PSYCHOLOGY;AUDIOLOGY;MOLECULAR BIOLOGY","103;67;65;62;57;39;35;28;26;25;21;21;21;21;19;19;17;15;13;11","DISEASE;GENE;NEUROLOGY;MAGNETIC RESONANCE IMAGING;NEUROSURGERY;EPILEPSY;RECEPTOR;COGNITION;STEM CELL;CENTRAL NERVOUS SYSTEM;CANCER;GLIOMA;DIABETES MELLITUS;ELECTROENCEPHALOGRAPHY;SPINAL CORD;RADIATION THERAPY;STIMULATION;BLOOD PRESSURE;DYSTONIA;POPULATION","56;55;33;25;24;23;20;15;13;12;11;11;10;10;10;9;9;8;8;8","MUTATION;NEURORADIOLOGY;PHENOTYPE;DEMENTIA;PARKINSON'S DISEASE;NEUROPSYCHOLOGY;WHITE MATTER;ALZHEIMER'S DISEASE;MITOCHONDRIAL DNA;NEURAL STEM CELL;NEURODEGENERATION;ALLELE;HEART RATE;MOVEMENT DISORDERS;MYELIN;RADIOSURGERY;TEMPORAL LOBE;AMYOTROPHIC LATERAL SCLEROSIS;CANCER CELL;CANCER STEM CELL;CORTICAL DYSPLASIA;DIABETIC NEUROPATHY;DIFFUSION MRI;GENE EXPRESSION;GENOTYPE;ICTAL;MITOCHONDRIAL RESPIRATORY CHAIN;PACLITAXEL;PERIPHERAL NEUROPATHY;SPINOCEREBELLAR ATAXIA;STATUS EPILEPTICUS;STREPTOZOTOCIN;SYRINGOMYELIA;TOLERABILITY","26;19;18;12;10;7;7;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4","FRONTOTEMPORAL DEMENTIA;MISSENSE MUTATION;DEEP BRAIN STIMULATION;ADULT STEM CELL;COMPOUND HETEROZYGOSITY;HAPLOINSUFFICIENCY;MITOCHONDRIAL DISEASE;SINGLE-NUCLEOTIDE POLYMORPHISM;CEREBRAL AMYLOID ANGIOPATHY;CHIARI MALFORMATION;CYBERKNIFE;GENETIC HETEROGENEITY;HAPLOTYPE;NESTIN;POINT MUTATION;CD146;CD90;CHIARI I MALFORMATION;COGNITIVE DECLINE;DEHYDROEPIANDROSTERONE;DYSKINESIA;EPILEPSIA PARTIALIS CONTINUA;EXCESSIVE DAYTIME SLEEPINESS;EXOME SEQUENCING;FRACTIONAL ANISOTROPY;GENE MUTATION;HCN CHANNEL;HIPPOCAMPAL SCLEROSIS;IN SITU HYBRIDIZATION;LEVODOPA;MITOCHONDRIAL ENCEPHALOMYOPATHY;NEUROACTIVE STEROID;PENETRANCE;PRIMARY MOTOR CORTEX;SOD1;SUMATRIPTAN;TRACTOGRAPHY;VO2 MAX","8;8;7;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;BRAIN;BRAIN NEOPLASMS;AGED;MAGNETIC RESONANCE IMAGING;;ADOLESCENT;CHILD;GLIOMA;ANIMALS;MUTATION;YOUNG ADULT;MUSCLE, SKELETAL;CHILD, PRESCHOOL;EPILEPSY;COGNITION DISORDERS","179;124;124;82;76;68;66;51;48;38;38;37;36;35;33;32;26;22;22;21","EPILEPSY AND SEIZURES;GLIOMAS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;SPINA BIFIDA;MECHANISMS AND MANAGEMENT OF NEUROPATHIC PAIN;MECHANISMS OF ALZHEIMER'S DISEASE;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;MULTIPOTENT MESENCHYMAL STEM CELLS;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;CEREBROSPINAL FLUID DISORDERS AND HEMATOMAS","12;12;10;10;8;8;7;7;7;6;5;5;5;4;4;4;4;4;3;3","NEURORADIOLOGY;NEURODEGENERATION;EPILEPSY;DEEP BRAIN STIMULATION;NEUROMODULATION;CHARCOT-MARIE-TOOTH DISEASE;NEUROIMAGING;STROKE (ENGINE);TREATMENT;ATAXIA;CHIARI MALFORMATION;DIABETIC NEUROPATHY;ETIOLOGY;FRONTOTEMPORAL LOBAR DEGENERATION;MOVEMENT DISORDERS;NEUROIMAGING DATA ANALYSIS;PROGRANULIN;ANTIEPILEPTIC DRUGS;BRAIN TUMOR EPIDEMIOLOGY;COMPOUND HETEROZYGOSITY","19;12;10;8;7;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4","ALZHEIMERS DISEASE;BRAIN STIMULATION;DEEP BRAIN;MAGNETIC RESONANCE;MYASTHENIA GRAVIS;SPINAL CORD;AMYOTROPHIC LATERAL;CHARCOTMARIETOOTH DISEASE;LATERAL SCLEROSIS;PARKINSONS DISEASE;RESONANCE IMAGING;STEM CELL;STEM CELLS;BRAIN TUMORS;CHIARI MALFORMATION;DUCHENNE MUSCULAR;FUNCTIONING DISABILITY;INTRACRANIAL HYPOTENSION;ITALIAN FAMILY;LOBAR DEGENERATION;MOTOR TASK;MULTICENTER ITALIAN;MUSCULAR DYSTROPHY;PRECURSOR CELLS;SPINOCEREBELLAR ATAXIA;ACUTE TREATMENT;APPROACH BASED;BRAIN IRON;BRAIN NEAR-INFRARED;CANCER STEM-LIKE","5;5;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;STEM CELLS;CD CELLS;STEM CELL;CANCER STEM;RES -CROSSREF;ENDOTHELIAL CELLS;FONDAZIONE IRCCS;HIGH-GRADE GLIOMAS;VESCOVI AL;TISSUE MICROARRAYS;GRADE II;GRADE III;FLOW CYTOMETRY;STEM-LIKE CELLS;ISCHEMIC STROKE;MILANO ITALY;ASCORBIC ACID;IRCCS ISTITUTO;ISTITUTO NEUROLOGICO;LOW-GRADE GLIOMAS;NORMAL BRAINS;SURGICAL TREATMENT;AL FAN;BESTA MILANO;CELLS -CROSSREF;NODULAR HETEROTOPIA;NOTCH LIGANDS;RICH JN","57;48;41;29;29;19;19;17;15;15;15;14;13;13;12;12;11;11;10;10;10;10;10;10;9;9;9;9;9;9",65,0.28,4.5,4,1.5,1,0,2.5,3,0,1,4,0,1,2,0,2.25,1,1,2.5,1,0,0,113,116,3,1,0,2,0,0,0,0,0,0,0,0,3,0,0,4.5,2.66666666666667,0.86,2.33333333333333,0,2,2,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ALESSANDRI GIULIO;CINTHIA FARINA;DIFEDE GIUSEPPE;EMANUELA COLOMBO;MARTINI ALFREDO;MORBIN MICHELA;PESSINA AUGUSTO;TAGLIAVINI FABRIZIO","1;1;1;1;1;1;1;1","FOND I R C C S ISTITUTO NEUROLOGICO CARLO BESTA;ALESSANDRI GIULIO;CINTHIA FARINA;EMANUELA COLOMBO;FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA;PESSINA AUGUSTO","2;1;1;1;1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY","4;2;2;1","BRAIN DISORDERS;NEURODEGENERATIVE;PREVENTION;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","1;1;1;1;1;1;1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","1","A01K67/027;A01K67/033;A61K38/08;A61K47/48;A61K48/00;A61P25/28;C07H21/02;C07H21/04;C07K14/00;C07K14/71","1;1;1;1;1;1;1;1;1;1","A01K2207/15;A01K2217/00;A01K2217/05;A01K2217/075;A01K2217/15;A01K2227/105;A01K2267/0312;A01K67/0278;A61K35/12;A61K47/6901","1;1;1;1;1;1;1;1;1;1",8,7.33,248.33,2.2,1,0.12,23.88,0,0,3,0,1,0,0,4,0,4,2,0,0,0,0,0,0,8,0,0,6,2,0,0,0,0,0,0,0,0,"Italy","6","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","7;5;2;2;2","CLINICAL RESEARCH;NEUROSCIENCES;BRAIN DISORDERS;PATIENT SAFETY;REHABILITATION;ASSISTIVE TECHNOLOGY;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EYE DISEASE AND DISORDERS OF VISION;MENTAL HEALTH;NEURODEGENERATIVE;TOURETTE SYNDROME","5;4;3;2;2;1;1;1;1;1;1;1;1;1","CANCER;EYE;NEUROLOGICAL","2;1;1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","2;2","BRAIN TUMOR;NERVOUS SYSTEM","2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",3,5496610,381147.88,5,10,4.66666666666667,0.666666666666667,32.5,781865.240307833,0.300563304115523,"ISTITUTO NEUROLOGICO CARLO BESTA;ACIES BIO (SLOVENIA);APOTEX (CANADA);BAVARIAN RESEARCH ALLIANCE;CF CONSULTING FINANZIAMENTI UNIONE EUROPEA;CHILDREN'S MEMORIAL HEALTH INSTITUTE;FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;GERMAN RESEARCH CENTRE FOR ARTIFICIAL INTELLIGENCE;HOFFNUNGSBAUM;IMPERIAL COLLEGE LONDON;ITALIAN INSTITUTE OF TECHNOLOGY;KARLSRUHE INSTITUTE OF TECHNOLOGY;KUKA (GERMANY);LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN;NATIONAL RESEARCH COUNCIL;NBIA DISORDERS ASSOCIATION;NEWCASTLE UNIVERSITY;OREGON HEALTH & SCIENCE UNIVERSITY;OSPEDALE NIGUARDA CA' GRANDA;OSPEDALE SAN PAOLO","3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;ALZHEIMER'S ASSOCIATION","2;1","COALITION S;EC & ERC - EUROPEAN UNION;HRA - HEALTH RESEARCH ALLIANCE","2;2;1","CP - COLLABORATIVE PROJECT (GENERIC) (FUNDING SCHEME);CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2011-TWO-STAGE (CALL FOR PROPOSAL);FP7-ICT - SPECIFIC PROGRAMME ""COOPERATION"": INFORMATION AND COMMUNICATION TECHNOLOGIES (PROGRAMME);FP7-ICT-2009-6 (CALL FOR PROPOSAL)","1;1;1;1;1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;40 ENGINEERING;46 INFORMATION AND COMPUTING SCIENCES;4608 HUMAN-CENTRED COMPUTING;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","1;1;1;1;1;1;1;1;1","BRAIN DISORDERS;NEURODEGENERATIVE;NEUROSCIENCES;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ALZHEIMER'S DISEASE RELATED DEMENTIAS (ADRD);BIOENGINEERING;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DEMENTIA;FRONTOTEMPORAL DEMENTIA (FTD);GENETICS;ORPHAN DRUG;PEDIATRIC;RARE DISEASES","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL","2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE;B11 COMPUTER SCIENCE AND INFORMATICS","1;1;1","4 QUALITY EDUCATION","1",6,"PUBLIC LIBRARY OF SCIENCE","6","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;3206 MEDICAL BIOTECHNOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","6;4;3;2;1;1;1;1","BIOTECHNOLOGY;CANCER;GENETICS;NEURODEGENERATIVE;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ARTHRITIS;AUTOIMMUNE DISEASE;BRAIN DISORDERS;CLINICAL RESEARCH;DEMENTIA;HUMAN GENOME;NEUROSCIENCES;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;UROLOGIC DISEASES","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;NEUROLOGICAL","1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","4;1;1","BIOMEDICAL","4","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","3;1","MELANOMA;NOT SITE-SPECIFIC CANCER","2;1",NA,NA
"IRCCS_BESTA",2012,229,13.5633187772926,3.60262008733624,0.441048034934498,0.388646288209607,0.497816593886463,2.15968586387435,1.20238095238095,1.61818181818182,1.23913043478261,0.462882096069869,5,131,55,16,17,0.57,0.24,0.07,0.07,63.66,1.52421100153639,6.25173745173747,0.506550218340611,0.85589519650655,0.486,0.421,0.436,0.45,"MASSIMO ZEVIANI;FABRIZIO TAGLIAVINI;SILVANA FRANCESCHETTI;CINZIA GELLERA;ANGELO FRANZINI;GIUSEPPE LAURIA;NARDO NARDOCCI;FRANCO TARONI;FERRUCCIO PANZICA;GIOVANNI BROGGI;GIORGIO GIACCONE;DAVIDE PAREYSON;GAETANO FINOCCHIARO;MATILDE LEONARDI;GIOVANNA ZORZI;CATERINA MARIOTTI;ISABELLA MORONI;MICHELA MORBIN;GENNARO BUSSONE;VINCENZO SILANI","18;16;15;14;11;10;10;10;9;9;9;9;9;9;9;8;8;7;7;7","MATILDE LEONARDI;MASSIMO ZEVIANI;ANGELO FRANZINI;FABRIZIO TAGLIAVINI;SILVANA FRANCESCHETTI;BIANCA POLLO;CARLO ANTOZZI;GIOVANNI BROGGI;LUDOVICO MINATI;G. AVANZINI;GIUSEPPE LAURIA;ANNA RITA GIOVAGNOLI;FRANCO TARONI;NARDO NARDOCCI;CINZIA GELLERA;HUGO CRITCHLEY;MARCO DE CURTIS;FERRUCCIO PANZICA;GENNARO BUSSONE;GIOVANNA ZORZI","2.29;1.94;1.65;1.63;1.48;1.46;1.42;1.39;1.31;1.25;1.23;1.07;1.04;1.03;1;0.98;0.98;0.97;0.96;0.94","MASSIMO ZEVIANI;FABRIZIO TAGLIAVINI;SILVANA FRANCESCHETTI;CINZIA GELLERA;ANGELO FRANZINI;GIUSEPPE LAURIA;NARDO NARDOCCI;FRANCO TARONI;FERRUCCIO PANZICA;GIOVANNI BROGGI;GIORGIO GIACCONE;DAVIDE PAREYSON;GAETANO FINOCCHIARO;MATILDE LEONARDI;GIOVANNA ZORZI;CATERINA MARIOTTI;ISABELLA MORONI;MICHELA MORBIN;GENNARO BUSSONE;EUGENIO PARATI","18;16;15;14;11;10;10;10;9;9;9;9;9;9;9;8;8;7;7;7","MATILDE LEONARDI;MASSIMO ZEVIANI;ANGELO FRANZINI;FABRIZIO TAGLIAVINI;SILVANA FRANCESCHETTI;BIANCA POLLO;CARLO ANTOZZI;GIOVANNI BROGGI;LUDOVICO MINATI;G. AVANZINI;GIUSEPPE LAURIA;ANNA RITA GIOVAGNOLI;FRANCO TARONI;NARDO NARDOCCI;CINZIA GELLERA;MARCO DE CURTIS;FERRUCCIO PANZICA;GENNARO BUSSONE;GIOVANNA ZORZI;GAETANO FINOCCHIARO","2.29;1.94;1.65;1.63;1.48;1.46;1.42;1.39;1.31;1.25;1.23;1.07;1.04;1.03;1;0.98;0.97;0.96;0.94;0.92","MASSIMO ZEVIANI;TIM M. STROM;CINZIA GELLERA;SILVANA FRANCESCHETTI;HOLGER PROKISCH;TOBIAS B. HAACK;FRANCO TARONI;NICOLA TICOZZI;VINCENZO SILANI;SAMUEL F. BERKOVIC;ELISABETH GRAF;THOMAS WIELAND;GAETANO FINOCCHIARO;SERENA PELLEGATTA;MICHELA MORBIN;THOMAS MEITINGER;DAVIDE PAREYSON;JOHN E. LANDERS;ROBERT H. BROWN;ANTONIA RATTI","1372;1308;1302;1185;1067;1067;1063;1040;1040;974;936;936;917;869;868;867;847;844;802;793","MASSIMO ZEVIANI;CINZIA GELLERA;SILVANA FRANCESCHETTI;FRANCO TARONI;GAETANO FINOCCHIARO;SERENA PELLEGATTA;DAVIDE PAREYSON;PAOLA PORRATI;MICHELA MORBIN;STEFANO DI DONATO;ANDREW BOTTOMLEY;BRIGITTA G. BAUMERT;C. CARRIÉ;D. VAN DEN BERGE;DANIELE GHEZZI;EGILS VALEINIS;F. FAUCHON;GLORIA TRIDELLO;LAURA FARISELLI;LAURENCE COLLETTE","1372;1302;1185;1054;897;869;838;775;764;712;597;597;597;597;597;597;597;597;597;597","MASSIMO ZEVIANI;FABRIZIO TAGLIAVINI;SILVANA FRANCESCHETTI;CINZIA GELLERA;ANGELO FRANZINI;FERRUCCIO PANZICA;GIORGIO GIACCONE;GIUSEPPE LAURIA;MATILDE LEONARDI;FRANCO TARONI;NARDO NARDOCCI;CATERINA MARIOTTI;DAVIDE PAREYSON;GAETANO FINOCCHIARO;GIOVANNI BROGGI;DAVIDE ROSSI SEBASTIANO;ROBERTO CORDELLA;GIOVANNA ZORZI;LUDOVICO MINATI;SERENA PELLEGATTA","18;16;15;14;11;9;9;9;9;9;8;8;8;8;8;7;7;7;7;7","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;ECONOMICS;ENGINEERING;PHYSICS;POLITICAL SCIENCE;MATHEMATICS;PHILOSOPHY;MATERIALS SCIENCE;SOCIOLOGY;BUSINESS;ART;ENVIRONMENTAL SCIENCE;GEOGRAPHY;HISTORY","189;104;61;27;18;15;13;13;6;5;5;4;3;2;1;1;1;1","INTERNAL MEDICINE;GENETICS;NEUROSCIENCE;PATHOLOGY;PSYCHIATRY;SURGERY;BIOCHEMISTRY;ANESTHESIA;CELL BIOLOGY;RADIOLOGY;CANCER RESEARCH;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;AUDIOLOGY;IMMUNOLOGY;PEDIATRICS;CLINICAL PSYCHOLOGY;ENDOCRINOLOGY;ANATOMY;MACROECONOMICS","97;71;67;66;50;28;26;25;21;21;20;17;17;16;14;14;13;13;11;9","DISEASE;GENE;EPILEPSY;ELECTROENCEPHALOGRAPHY;RECEPTOR;COGNITION;MAGNETIC RESONANCE IMAGING;MIGRAINE;MITOCHONDRION;NEUROLOGY;CENTRAL NERVOUS SYSTEM;STIMULATION;DEPRESSION (ECONOMICS);ALTERNATIVE MEDICINE;CANCER;NEUROSURGERY;STEM CELL;ATAXIA;CLINICAL TRIAL;GLIOMA;TASK (PROJECT MANAGEMENT)","72;66;27;23;15;14;14;12;12;12;11;10;9;8;8;8;8;7;7;7;7","MUTATION;PHENOTYPE;ALLELE;DEMENTIA;GENOTYPE;AMYOTROPHIC LATERAL SCLEROSIS;EXON;HUNTINGTON'S DISEASE;MITOCHONDRIAL DNA;NEURODEGENERATION;ALZHEIMER'S DISEASE;NEURORADIOLOGY;PARKINSON'S DISEASE;PRION PROTEIN;WHITE MATTER;GLUTAMATE RECEPTOR;ICTAL;MOTOR CORTEX;NEUROPSYCHOLOGY;PREFRONTAL CORTEX;TEMPORAL LOBE","30;19;14;14;12;10;9;8;8;8;7;7;7;6;6;5;5;5;5;5;5","TRINUCLEOTIDE REPEAT EXPANSION;SINGLE-NUCLEOTIDE POLYMORPHISM;MISSENSE MUTATION;FRONTOTEMPORAL DEMENTIA;HAPLOTYPE;DEEP BRAIN STIMULATION;EXOME SEQUENCING;POINT MUTATION;PROBAND;SCRAPIE;CREUTZFELDT-JAKOB SYNDROME;GLUTAMATERGIC;MITOCHONDRIAL DISEASE;PENETRANCE;ADULT STEM CELL;ALLELE FREQUENCY;ALTERNATIVE SPLICING;AMPA RECEPTOR;BOVINE SPONGIFORM ENCEPHALOPATHY;CADASIL;CAREGIVER BURDEN;CEREBRAL AMYLOID ANGIOPATHY;COMPOUND HETEROZYGOSITY;FRATAXIN;GENE MUTATION;GENETIC HETEROGENEITY;GENOTYPING;HEREDITARY SPASTIC PARAPLEGIA;HUNTINGTIN;INDUCED PLURIPOTENT STEM CELL;IRINOTECAN;NEUROPSYCHOLOGICAL ASSESSMENT;SANGER SEQUENCING;SMN1;STEREOELECTROENCEPHALOGRAPHY;TAU PROTEIN;VENTROMEDIAL PREFRONTAL CORTEX","9;8;7;6;6;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;ADULT;BRAIN;MIDDLE AGED;;MUTATION;AGED;EPILEPSY;BRAIN NEOPLASMS;ANIMALS;MAGNETIC RESONANCE IMAGING;YOUNG ADULT;ADOLESCENT;CHILD;AMYOTROPHIC LATERAL SCLEROSIS;ITALY;MITOCHONDRIA;TREATMENT OUTCOME","165;110;105;70;65;60;46;43;39;38;36;35;33;31;29;28;25;23;23;23","MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;EPILEPSY AND SEIZURES;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;GLIOMAS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;PRION DISEASES: CAUSES AND MOLECULAR BASIS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MECHANISMS OF ALZHEIMER'S DISEASE;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;BIOMEDICAL OPTICAL IMAGING AND SPECTROSCOPY;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING IN SURGERY;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY","14;11;11;10;8;8;7;7;7;6;6;5;4;4;4;3;3;3;3;3","NEURODEGENERATION;EPILEPSY;DEPRESSION (ECONOMICS);NEUROIMAGING DATA ANALYSIS;NEURORADIOLOGY;EEG ANALYSIS;ATAXIA;C9ORF72;DEEP LEARNING FOR EEG;EXOME;MITOCHONDRIAL FISSION;MITOCHONDRIAL RESPIRATORY CHAIN;SEIZURES;STROKE (ENGINE);TREATMENT;AMYLOID (MYCOLOGY);BRAIN IRON ACCUMULATION;CELLULAR PRION PROTEIN;CHRONIC MIGRAINE;DEEP BRAIN STIMULATION","11;10;9;8;7;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4","AMYOTROPHIC LATERAL;LATERAL SCLEROSIS;ALZHEIMERS DISEASE;HUNTINGTONS DISEASE;MULTIPLE SCLEROSIS;CONTROLLED TRIAL;EPILEPTIC PATIENTS;EXOME SEQUENCING;HUNTINGTON DISEASE;MOVEMENT DISORDERS;TYPE II;BRIDGING KNOWLEDGE;CLINICAL STUDY;CORTICAL RESPONSE;FNIRS-EEG FMRI-EEG;ITALIAN PATIENTS;KNOWLEDGE POLICY;MINIMALLY CONSCIOUS;MITOCHONDRIAL COMPLEX;MITOCHONDRIAL DNA;MOTOR TASK;MULTIMODALITY FNIRS-EEG;PARKINSONS DISEASE;RANDOMIZED CONTROLLED;REPEAT EXPANSION;TMS CLINICAL;ADULT PATIENTS;ANTIEPILEPTIC DRUGS;BOVINE SPONGIFORM;BRAIN STIMULATION","7;7;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;GENET -CROSSREF;AFFECTED INDIVIDUALS;PGLUVAL AIF;LINEAR SKIN;MAGNETIC RESONANCE;EXOME SEQUENCING;HUM GENET;AMYOTROPHIC LATERAL;RESONANCE IMAGING;SKIN DEFECTS;GENET -ABSTRACT;MED GENET;LATERAL SCLEROSIS;RESPIRATORY CHAIN;BRAIN IRON;DE NOVO;GENE ENCODING;HYPERTROPHIC CARDIOMYOPATHY;CELL DEATH;CLINICAL FEATURES;FAMILIAL AMYOTROPHIC;MITOCHONDRIAL PROTEIN;MOTOR SYMPTOMS;NOVO MUTATIONS;OFD VI;TEMPORAL LOBE;WALKER-WARBURG SYNDROME;WHITE MATTER","188;150;33;25;23;20;20;19;18;17;16;16;15;15;14;14;13;12;12;11;10;10;10;10;10;10;10;10;10;10",102,0.45,7.04,5,1.75,2,1,1,3.5,1,1.25,5,1,1,3,1,2.25,1,1.75,2.75,1,0,0,115.5,116,4,1,0,4,0,0,0,0,0,0,0,0,5,0,0,2,2.8,1.7,3.4,0,4,2,0,0,0,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CRISTINI SILVIA;INVERNICI GLORIA;NAVONE STEFANIA ELENA;PARATI EUGENIO AGOSTINO;ALESSANDRI GIULIO;COLOMBO EMANUELA;DE CURTIS MARCO;FARINA CINTHIA;GNATKOVSKYY VADYM;PESSINA AUGUSTO","2;2;2;2;1;1;1;1;1;1","FOND I R C C S ISTITUTO NEUROLOGICO CARLO BESTA;CRISTINI SILVIA;INVERNICI GLORIA;NAVONE STEFANIA ELENA;PARATI EUGENIO AGOSTINO;ALESSANDRI GIULIO;DE CURTIS MARCO;FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA;GNATKOVSKYY VADYM;PESSINA AUGUSTO","4;2;2;2;2;1;1;1;1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;40 ENGINEERING;3208 MEDICAL PHYSIOLOGY;4006 COMMUNICATIONS ENGINEERING","6;3;2;2;1;1","STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","2;1","C12N5/00;A61B5/374;A61K47/48;A61P35/00;C07K14/705;C12N5/077;C12Q1/68;C40B30/04;G01N33/566;G01R23/16","2;1;1;1;1;1;1;1;1;1","C12N2500/25;C12N2500/34;C12N2500/46;C12N2500/84;C12N2501/11;C12N2501/115;C12N2501/39;C12N2501/392;C12N2501/91;C12N5/069","2;2;2;2;2;2;2;2;2;2",8,14,3301.71,2.3,3,0.38,54.75,0,0,2,0,1,0,2,3,0,4,3,0,0,0,0,0,0,8,0,0,6,1,0,1,0,0,0,0,0,0,"United States;Belgium;Italy","3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;31 BIOLOGICAL SCIENCES;3105 GENETICS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","7;5;2;2;1;1;1;1","CLINICAL RESEARCH;NEUROSCIENCES;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEURODEGENERATIVE;RARE DISEASES;AUTOIMMUNE DISEASE;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BEHAVIORAL AND SOCIAL SCIENCE;BRAIN CANCER;CANCER;CHRONIC PAIN;DENTAL/ORAL AND CRANIOFACIAL DISEASE;HEADACHES;HUNTINGTON'S DISEASE;MIGRAINES;MULTIPLE SCLEROSIS;PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC","7;5;4;4;4;3;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL","2","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS;2.4 SURVEILLANCE AND DISTRIBUTION;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)","4;2;2;1;1","BRAIN TUMOR;NERVOUS SYSTEM;NOT SITE-SPECIFIC CANCER;SARCOMA","1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",1,226407,37734.5,4,6,6,1,23,727535.90401751,0.314761098023402,"ANTWERP UNIVERSITY HOSPITAL;ISTITUTO NEUROLOGICO CARLO BESTA;LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN;PITIÉ-SALPÊTRIÈRE HOSPITAL;PUBLIC HEALTH AGENCY OF CANADA;UNIVERSITY OF EDINBURGH","1;1;1;1;1;1","MEDICAL RESEARCH COUNCIL","1","COALITION S;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","1;1;1","RESEARCH GRANT (PROJECT CATEGORY)","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","BRAIN DISORDERS;EMERGING INFECTIOUS DISEASES;NEURODEGENERATIVE;NEUROSCIENCES;RARE DISEASES;TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY (TSE)","1;1;1;1;1;1","INFECTION;NEUROLOGICAL","1;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1",NA,NA,NA,NA,"A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE","1",NA,NA,7,"PUBLIC LIBRARY OF SCIENCE","7","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3005 FISHERIES SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY","6;6;3;2;2;1;1;1;1","BRAIN DISORDERS;NEUROSCIENCES;RARE DISEASES;BIOTECHNOLOGY;BRAIN CANCER;CANCER;GENETICS;NEURODEGENERATIVE;AGING;IMMUNIZATION;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;VACCINE RELATED","3;3;3;2;2;2;2;2;1;1;1;1;1","CANCER;NEUROLOGICAL","2;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","3;1","BIOMEDICAL","4","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","3;1","BRAIN TUMOR;NOT SITE-SPECIFIC CANCER","3;1",NA,NA
"IRCCS_BESTA",2013,240,11.0041666666667,3.60416666666667,0.425,0.429166666666667,0.425,2.43220338983051,1.29113924050633,1.71666666666667,1.29113924050633,0.454166666666667,9,126,70,28,8,0.52,0.29,0.12,0.03,64.92,1.86059218946057,6.3582402234637,0.470833333333333,0.808333333333333,0.497,0.465,0.39,0.448,"MATILDE LEONARDI;ALBERTO RAGGI;RENATO MANTEGAZZA;LUCIA MORANDI;RUI QUINTAS;AMBRA MARA GIOVANNETTI;ANGELO FRANZINI;DAVIDE PAREYSON;MASSIMO ZEVIANI;DAVIDE SATTIN;LUDOVICO MINATI;GAETANO FINOCCHIARO;MARCO PAGANI;EUGENIO PARATI;C. ANGELINI;EMILIO CIUSANI;GIUSEPPE LAURIA;SILVANA FRANCESCHETTI;SILVIA SCHIAVOLIN;ROBERTO SPREAFICO","23;15;13;13;11;10;10;10;10;10;10;9;9;8;8;8;8;8;8;8","MATILDE LEONARDI;MARCO DE CURTIS;LUDOVICO MINATI;GIOVANNI BROGGI;ALBERTO RAGGI;ALBERTO ALBANESE;RENATO MANTEGAZZA;CARLO ANTOZZI;ANGELO FRANZINI;DAVIDE PAREYSON;AMBRA MARA GIOVANNETTI;GIUSEPPE LAURIA;DAVIDE SATTIN;SILVANA FRANCESCHETTI;RUI QUINTAS;GIUSEPPE DI FEDE;GENNARO BUSSONE;ROBERTO SPREAFICO;LICIA GRAZZI;ANTONIO SILVANI","2.79;2.72;2.44;1.82;1.82;1.77;1.58;1.49;1.24;1.23;1.22;1.18;1.18;1.17;1.15;1.14;1.11;1.11;1.1;1.08","MATILDE LEONARDI;ALBERTO RAGGI;RENATO MANTEGAZZA;LUCIA MORANDI;RUI QUINTAS;AMBRA MARA GIOVANNETTI;ANGELO FRANZINI;DAVIDE PAREYSON;MASSIMO ZEVIANI;DAVIDE SATTIN;LUDOVICO MINATI;GAETANO FINOCCHIARO;MARCO PAGANI;EUGENIO PARATI;C. ANGELINI;EMILIO CIUSANI;GIUSEPPE LAURIA;SILVANA FRANCESCHETTI;SILVIA SCHIAVOLIN;ROBERTO SPREAFICO","23;15;13;13;11;10;10;10;10;10;10;9;9;8;8;8;8;8;8;8","MATILDE LEONARDI;MARCO DE CURTIS;LUDOVICO MINATI;GIOVANNI BROGGI;ALBERTO RAGGI;ALBERTO ALBANESE;RENATO MANTEGAZZA;CARLO ANTOZZI;ANGELO FRANZINI;DAVIDE PAREYSON;AMBRA MARA GIOVANNETTI;GIUSEPPE LAURIA;DAVIDE SATTIN;SILVANA FRANCESCHETTI;RUI QUINTAS;GIUSEPPE DI FEDE;GENNARO BUSSONE;ROBERTO SPREAFICO;ANTONIO SILVANI;MARCO PAGANI","2.79;2.72;2.44;1.82;1.82;1.77;1.58;1.49;1.24;1.23;1.22;1.18;1.18;1.17;1.15;1.14;1.11;1.11;1.08;1.08","TOM MIKKELSEN;BRADY BERNARD;JILL S. BARNHOLTZ‐SLOAN;KEITH L. BLACK;MARY IACOCCA;RAJU KUCHERLAPATI;GAETANO FINOCCHIARO;DARELL D. BIGNER;RICHARD A. GIBBS;STACEY GABRIEL;AARON MCKENNA;ABHIJIT GUHA;ADITYA RAGHUNATHAN;ANDREA EAKIN;ANDREW E. SLOAN;ANGELA HADJIPANAYIS;BENITO CAMPOS;BIKASH BOSE;BRENDA RABENO;BRIAN PATRICK O’NEILL","9189;8688;8688;8688;8688;8688;5027;4845;4470;4416;4344;4344;4344;4344;4344;4344;4344;4344;4344;4344","GAETANO FINOCCHIARO;SARA BULGHERONI;DARIA RIVA;ROBERTO SPREAFICO;STEFANO D’ARRIGO;SERENA PELLEGATTA;ALBERTO ALBANESE;MASSIMO ZEVIANI;FRANCESCA DEL SORBO;PAOLA PORRATI;GIOVANNI BROGGI;GRAZIELLA UZIEL;FABRIZIO TAGLIAVINI;CATERINA MARIOTTI;GIORGIO GIACCONE;LUCIA MORANDI;LUDOVICO MINATI;EMILIO CIUSANI;GIUSEPPE LAURIA;MATILDE LEONARDI","5027;1078;1061;1056;950;667;624;610;560;527;452;398;397;386;386;376;375;351;331;325","MATILDE LEONARDI;RENATO MANTEGAZZA;ALBERTO RAGGI;LUCIA MORANDI;GAETANO FINOCCHIARO;RUI QUINTAS;GIUSEPPE LAURIA;LUDOVICO MINATI;MASSIMO ZEVIANI;ANGELO FRANZINI;DAVIDE SATTIN;EMILIO CIUSANI;EUGENIO PARATI;LORENZO MAGGI;SILVANA FRANCESCHETTI;DAVIDE PAREYSON;AMBRA MARA GIOVANNETTI;FABRIZIO TAGLIAVINI;MARCO PAGANI;ALBERTO ALBANESE","19;13;12;12;9;9;9;9;9;8;8;8;8;8;8;8;7;7;7;7","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;ENGINEERING;PHYSICS;PHILOSOPHY;MATHEMATICS;POLITICAL SCIENCE;GEOGRAPHY;BUSINESS;ECONOMICS;MATERIALS SCIENCE;HISTORY;SOCIOLOGY;GEOLOGY","201;97;73;31;24;16;12;11;10;8;6;4;4;4;3;3;1","INTERNAL MEDICINE;PATHOLOGY;NEUROSCIENCE;GENETICS;PSYCHIATRY;SURGERY;BIOCHEMISTRY;RADIOLOGY;PEDIATRICS;AUDIOLOGY;CELL BIOLOGY;IMMUNOLOGY;ANESTHESIA;ENDOCRINOLOGY;CANCER RESEARCH;PHYSICAL THERAPY;CLINICAL PSYCHOLOGY;COGNITIVE PSYCHOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH","103;69;68;63;56;29;26;24;22;20;20;20;19;18;17;16;15;15;15;13","GENE;DISEASE;EPILEPSY;COGNITION;NEUROLOGY;MAGNETIC RESONANCE IMAGING;RECEPTOR;ALTERNATIVE MEDICINE;CANCER;POPULATION;MIGRAINE;NEUROSURGERY;ATAXIA;CHEMOTHERAPY;CENTRAL NERVOUS SYSTEM;STIMULATION;ELECTROENCEPHALOGRAPHY;IMMUNE SYSTEM;ANTIBODY;BIOPSY;IN VITRO;PREGNANCY;QUALITY OF LIFE (HEALTHCARE)","55;53;26;23;17;16;13;12;12;12;11;11;10;10;9;9;8;8;7;7;7;7;7","MUTATION;PHENOTYPE;DEMENTIA;NEURODEGENERATION;PARKINSON'S DISEASE;WHITE MATTER;AMYOTROPHIC LATERAL SCLEROSIS;NEUROPSYCHOLOGY;PLACEBO;TEMPORAL LOBE;ALLELE;CELLULAR DIFFERENTIATION;CHRONIC MIGRAINE;MINIMALLY CONSCIOUS STATE;NEURORADIOLOGY;SPINOCEREBELLAR ATAXIA;AURA;AUTISM SPECTRUM DISORDER;CLINICAL ENDPOINT;CLUSTER HEADACHE;MITOCHONDRIAL DNA;MUSCLE BIOPSY;MUTANT;NEURAL STEM CELL;PAIN MEDICINE;PREFRONTAL CORTEX;PROGENITOR CELL;TOLERABILITY;VAGUS NERVE","26;20;10;10;10;9;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","DEEP BRAIN STIMULATION;MISSENSE MUTATION;PENETRANCE;PERSISTENT VEGETATIVE STATE;EXOME SEQUENCING;FRONTOTEMPORAL DEMENTIA;VAGUS NERVE STIMULATION;ADULT STEM CELL;ANEUPLOIDY;COMPOUND HETEROZYGOSITY;GENETIC HETEROGENEITY;GREY MATTER;LOSS FUNCTION;MIGRAINE WITH AURA;MITOCHONDRIAL DISEASE;POINT MUTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;SUMATRIPTAN;VERBAL FLUENCY TEST;VOXEL-BASED MORPHOMETRY","5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;FEMALE;MALE;MIDDLE AGED;;ADULT;BRAIN;AGED;ADOLESCENT;ANIMALS;YOUNG ADULT;MUTATION;BRAIN NEOPLASMS;CHILD;GLIOBLASTOMA;MAGNETIC RESONANCE IMAGING;EPILEPSY;CHILD, PRESCHOOL;SEIZURES;NEURONS","158;112;102;70;63;63;55;45;36;36;34;30;29;28;28;28;25;21;20;19","EPILEPSY AND SEIZURES;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;GLIOMAS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;MECHANISMS OF ALZHEIMER'S DISEASE;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;AUTISM SPECTRUM DISORDERS;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS","12;10;9;8;7;6;5;5;5;5;4;4;4;4;4;3;3;3;3;3","EPILEPSY;NEURODEGENERATION;TREATMENT;GLIOBLASTOMA;BRAIN DEVELOPMENT;CHARCOT-MARIE-TOOTH DISEASE;CHRONIC MIGRAINE;MIGRAINE;NEUROIMAGING;NEUROIMAGING DATA ANALYSIS;NEURORADIOLOGY;PENETRANCE;PERSISTENT VEGETATIVE STATE;STROKE (ENGINE);ATAXIA;AUTISM;BRAIN IRON ACCUMULATION;CLINICAL ENDPOINT;CLUSTER HEADACHE;EPILEPSY DETECTION","12;7;7;6;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4","LOBE EPILEPSY;TEMPORAL LOBE;AMYOTROPHIC LATERAL;BRAIN TUMOR;LATERAL SCLEROSIS;MYASTHENIA GRAVIS;PARKINSONS DISEASE;BRAIN IRON;BUILT ENVIRONMENT;FUNCTIONAL MRI;IRON ACCUMULATION;MINIMALLY CONSCIOUS;NATURAL HISTORY;NERVE STIMULATION;PRELIMINARY RESULTS;RECURRENT GLIOBLASTOMA;VAGUS NERVE;ATAXIA TYPES;AUTOLOGOUS TUMOR;AUTOSOMAL DOMINANT;BLOOD-BRAIN BARRIER;BRAIN STIMULATION;BULBAR MUSCULAR;CELL RESPONSE;CELLS LOADED;CELLS PRIMED;CEREBELLAR ATAXIA;CEREBELLAR DEGENERATION;CEREBROSPINAL FLUID;CHARCOT-MARIE-TOOTH DISEASE","5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","EPS KO;MILAN ITALY;KO MICE;ITALY SEARCH;MILANO MILAN;MEDICAL BIOTECHNOLOGY;MEDICINE UNIVERSITY;TRANSLATIONAL MEDICINE;ITALY DEPARTMENT;CNR INSTITUTE;MILANO ITALY;NEUROSCIENCE MILANO;HUMANITAS CLINICAL;RESEARCH CENTER;SPINOCEREBELLAR ATAXIA-;CENTER MILAN;MAGNETIC RESONANCE;AUTOSOMAL DOMINANT;CEREBELLAR ATAXIA;RESONANCE IMAGING;SEIZURE CONTROL;SUPPLEMENTARY FIGURE;ANKYRIN REPEATS;CHRONIC MIGRAINE;GUINEA PIG;MITOCHONDRIAL DNA;PATIENTS AFFECTED;ACCEPTANCE CRITERIA;ALS PATIENTS;BRAIN PREPARATION","46;46;33;32;24;23;23;23;16;11;11;11;10;10;10;9;9;8;8;8;8;8;7;7;7;7;7;6;6;6",104,0.43,6,5,1.75,1,2,6.5,2,1,1,5,1,1,4,0,2.25,1,1.5,3.25,2,0,0,111.5,111.5,4,0,0,3,0,0,0,0,1,0,0,0,2,0,2,0,2.5,1.16,1.5,0,1,3,0,0,1,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ABOU HAMDAN MOHAMAD;ALESSANDRI GIULIO;CRISTINI SILVIA;DE CURTIS MARCO;GNATKOVSKYY VADYM;INVERNICI GLORIA;NAVONE STEFANIA ELENA;PARATI EUGENIO AGOSTINO;PEDOTTI ROSETTA;PESSINA AUGUSTO","1;1;1;1;1;1;1;1;1;1","FOND I R C C S ISTITUTO NEUROLOGICO CARLO BESTA;ABOU HAMDAN MOHAMAD;FONDAZIONE IRCCS ISTITUTO NEUROLOGICO 'CARLO BESTA';PEDOTTI ROSETTA","3;1;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","2;2;1;1","NEUROSCIENCES","1","2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);5.1 PHARMACEUTICALS","1;1","A61B5/374;A61K31/53;A61P25/00;A61P29/00;A61P37/00;C12N5/00","1;1;1;1;1;1","A01K67/027;A61B5/374;A61B5/7253;A61B5/7257;A61K31/53;A61K35/12;A61K47/6901;A61K9/5068;A61P25/00;A61P29/00","1;1;1;1;1;1;1;1;1;1",9,3.38,240.75,2.65,5,0.56,48.11,0,0,2,0,4,0,0,3,0,7,1,0,0,0,0,0,0,7,1,1,8,1,0,0,0,0,0,0,0,0,"United States;Italy","12;3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS","8;5;2;2;2;2;1","CLINICAL RESEARCH;NEUROSCIENCES;RARE DISEASES;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BEHAVIORAL AND SOCIAL SCIENCE;CANCER;NEURODEGENERATIVE;ORPHAN DRUG;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ALZHEIMER'S DISEASE RELATED DEMENTIAS (ADRD);AUTOIMMUNE DISEASE;BIOMEDICAL IMAGING;BRAIN CANCER;BREAST CANCER;CHARCOT-MARIE-TOOTH DISEASE;DEMENTIA","6;5;5;4;4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL;NEUROLOGICAL","2;2;1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","5;1","BRAIN TUMOR;BREAST CANCER;NERVOUS SYSTEM","2;1;1","5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1;1",9,4314600.11,432636.15,5,9.66666666666667,4.88888888888889,1,87.1111111111111,1244031.78426018,0.192921115872233,"ISTITUTO NEUROLOGICO CARLO BESTA;CF CONSULTING FINANZIAMENTI UNIONE EUROPEA;UNIVERSITY COLLEGE LONDON;BAMBINO GESÙ CHILDREN'S HOSPITAL;FRENCH NATIONAL CENTRE FOR SCIENTIFIC RESEARCH;KING'S COLLEGE LONDON;MEDICAL RESEARCH COUNCIL;NEWCASTLE UNIVERSITY;UNIVERSITY OF BOLOGNA;ATOMIC ENERGY AND ALTERNATIVE ENERGIES COMMISSION;AVANTEA;BAKER IDI HEART AND DIABETES INSTITUTE;CAMELOT BIOMEDICAL SYSTEMS (ITALY);CATHOLIC UNIVERSITY OF THE SACRED HEART;CEGAT (GERMANY);CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED;CHARITÉ - UNIVERSITY MEDICINE BERLIN;DÉLÉGATION PARIS 11;ESAOTE (ITALY);GERMAN CENTER FOR NEURODEGENERATIVE DISEASES","9;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL;EUROPEAN RESEARCH COUNCIL;MEDICAL RESEARCH COUNCIL;TELETHON FOUNDATION","5;1;1;1;1","COALITION S;EC & ERC - EUROPEAN UNION;UKRI - UK RESEARCH AND INNOVATION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP","7;6;2;1","FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2013-INNOVATION-1 (CALL FOR PROPOSAL);CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-PEOPLE - SPECIFIC PROGRAMME ""PEOPLE"" IMPLEMENTING THE SEVENTH FRAMEWORK PROGRAMME OF THE EUROPEAN COMMUNITY FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ACTIVITIES (2007 TO 2013) (PROGRAMME);FP7-PEOPLE-2012-ITN (CALL FOR PROPOSAL);MC-ITN - NETWORKS FOR INITIAL TRAINING (ITN) (FUNDING SCHEME);CP-IP - LARGE-SCALE INTEGRATING PROJECT (FUNDING SCHEME);ERC-2012-ADG_20120314 (CALL FOR PROPOSAL);ERC-AG - ERC ADVANCED GRANT (FUNDING SCHEME);FP7-IDEAS-ERC - SPECIFIC PROGRAMME: ""IDEAS"" IMPLEMENTING THE SEVENTH FRAMEWORK PROGRAMME OF THE EUROPEAN COMMUNITY FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ACTIVITIES (2007 TO 2013) (PROGRAMME);INTRAMURAL (PROJECT CATEGORY);RESEARCH GRANT (PROJECT CATEGORY);TELETHON GRANT PROJECTS - 2013 (PROGRAM)","3;3;2;2;2;2;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3202 CLINICAL SCIENCES;3209 NEUROSCIENCES;3206 MEDICAL BIOTECHNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH;46 INFORMATION AND COMPUTING SCIENCES;50 PHILOSOPHY AND RELIGIOUS STUDIES;5002 HISTORY AND PHILOSOPHY OF SPECIFIC FIELDS","6;4;3;2;2;2;1;1;1;1;1;1;1;1;1;1","GENETICS;NEURODEGENERATIVE;NEUROSCIENCES;BIOTECHNOLOGY;HUMAN GENOME;RARE DISEASES;BRAIN DISORDERS;CLINICAL RESEARCH;PEDIATRIC;PREVENTION;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BIOENGINEERING;BIOMEDICAL IMAGING;CANCER;CHRONIC PAIN;DEMENTIA;EPILEPSY","5;5;4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL;GENERIC HEALTH RELEVANCE;CANCER;MENTAL HEALTH;METABOLIC AND ENDOCRINE;MUSCULOSKELETAL","4;2;1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;5.2 CELLULAR AND GENE THERAPIES;2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY);2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)","5;3;2;2;1;1","NOT SITE-SPECIFIC CANCER;BRAIN TUMOR","3;1","1.1 NORMAL FUNCTIONING;2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.2 TECHNOLOGY AND/OR MARKER EVALUATION WITH RESPECT TO FUNDAMENTAL PARAMETERS OF METHOD;5.1 LOCALIZED THERAPIES - DISCOVERY AND DEVELOPMENT","1;1;1;1;1","A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE;A05 BIOLOGICAL SCIENCES;C20 SOCIAL WORK AND SOCIAL POLICY;C21 SOCIOLOGY","4;1;1;1;1;1","3 GOOD HEALTH AND WELL BEING","1",42,"PUBLIC LIBRARY OF SCIENCE","42","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;52 PSYCHOLOGY;42 HEALTH SCIENCES;51 PHYSICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4203 HEALTH SERVICES AND SYSTEMS;3202 CLINICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3109 ZOOLOGY;3209 NEUROSCIENCES;49 MATHEMATICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3003 ANIMAL PRODUCTION;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;3107 MICROBIOLOGY;3204 IMMUNOLOGY;3208 MEDICAL PHYSIOLOGY","30;14;12;9;7;6;5;4;3;3;3;3;3;2;1;1;1;1;1;1","NEUROSCIENCES;BRAIN DISORDERS;GENETICS;MENTAL HEALTH;RARE DISEASES;BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY;CANCER;CLINICAL RESEARCH;DEPRESSION;NEURODEGENERATIVE;AUTOIMMUNE DISEASE;BRAIN CANCER;HUMAN GENOME;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MULTIPLE SCLEROSIS;MUSCULAR DYSTROPHY;PEDIATRIC;PREVENTION;SPINAL MUSCULAR ATROPHY","6;5;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","NEUROLOGICAL;CANCER;CARDIOVASCULAR;MUSCULOSKELETAL","5;4;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","3;1","BIOMEDICAL;CLINICAL","4;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","9;7","MELANOMA;BRAIN TUMOR;NOT SITE-SPECIFIC CANCER","4;2;1","4 QUALITY EDUCATION","1"
"IRCCS_BESTA",2014,299,14.4715719063545,4.1304347826087,0.397993311036789,0.424749163879599,0.494983277591973,2.70833333333333,1.23958333333333,1.73972602739726,1.25423728813559,0.581939799331104,6,184,69,18,14,0.62,0.23,0.06,0.05,45.96,1.21613647745991,6.12,0.48494983277592,0.8561872909699,0.527,0.366,0.425,0.398,"GAETANO FINOCCHIARO;MATILDE LEONARDI;LUCIA MORANDI;FABRIZIO TAGLIAVINI;DAVIDE PAREYSON;ANTONIO SILVANI;BIANCA POLLO;MARIA GRAZIA BRUZZONE;CATERINA MARIOTTI;MASSIMO ZEVIANI;MARICA EOLI;FRANCESCO DIMECO;RENATO MANTEGAZZA;GIUSEPPE LAURIA;ISABELLA MORONI;FRANCO TARONI;SILVANA FRANCESCHETTI;ALESSANDRA SOLARI;MARINA MORA;FRANCESCO PRADA","20;19;18;17;17;15;14;14;14;13;13;12;12;12;12;12;10;10;10;10","LUDOVICO MINATI;MATILDE LEONARDI;GAETANO FINOCCHIARO;ANTONIO SILVANI;FABRIZIO TAGLIAVINI;MARIA GRAZIA BRUZZONE;GRAZIELLA FILIPPINI;ALBERTO ALBANESE;BIANCA POLLO;RENATO MANTEGAZZA;ANNA RITA GIOVAGNOLI;DARIA RIVA;LUCIA MORANDI;FRANCESCO DIMECO;E. LAMPERTI;MARICA EOLI;AMBRA MARA GIOVANNETTI;DAVIDE PAREYSON;SILVANA FRANCESCHETTI;FRANCESCO PRADA","2.91;2.38;2.08;1.93;1.68;1.57;1.53;1.47;1.43;1.36;1.31;1.29;1.27;1.27;1.18;1.14;1.13;1.11;1.1;1.07","GAETANO FINOCCHIARO;MATILDE LEONARDI;LUCIA MORANDI;FABRIZIO TAGLIAVINI;DAVIDE PAREYSON;ANTONIO SILVANI;BIANCA POLLO;MARIA GRAZIA BRUZZONE;CATERINA MARIOTTI;MASSIMO ZEVIANI;MARICA EOLI;FRANCESCO DIMECO;RENATO MANTEGAZZA;GIUSEPPE LAURIA;ISABELLA MORONI;FRANCO TARONI;SILVANA FRANCESCHETTI;ALESSANDRA SOLARI;MARINA MORA;FRANCESCO PRADA","20;19;18;17;17;15;14;14;14;13;13;12;12;12;12;12;10;10;10;10","LUDOVICO MINATI;MATILDE LEONARDI;GAETANO FINOCCHIARO;ANTONIO SILVANI;FABRIZIO TAGLIAVINI;MARIA GRAZIA BRUZZONE;GRAZIELLA FILIPPINI;ALBERTO ALBANESE;BIANCA POLLO;RENATO MANTEGAZZA;ANNA RITA GIOVAGNOLI;DARIA RIVA;LUCIA MORANDI;FRANCESCO DIMECO;E. LAMPERTI;MARICA EOLI;AMBRA MARA GIOVANNETTI;DAVIDE PAREYSON;SILVANA FRANCESCHETTI;FRANCESCO PRADA","2.91;2.38;2.08;1.93;1.68;1.57;1.53;1.47;1.43;1.36;1.31;1.29;1.27;1.27;1.18;1.14;1.13;1.11;1.1;1.07","MASSIMO ZEVIANI;FABRIZIO TAGLIAVINI;GIULIO ALESSANDRI;AUGUSTO PESSINA;DAVIDE PAREYSON;EUGENIO PARATI;GIUSEPPE LAURIA;LUISA PASCUCCI;MAURIZIO MURACA;ARIANNA BONOMI;VALENTINA COCCÉ;EMILIO CIUSANI;FRANCO TARONI;ISABELLA MORONI;FRANCESCA SISTO;GIANPIETRO BONDIOLOTTI;JOHAN AUWERX;ALBERTA LOCATELLI;DILETTA AMI;LUCIA VIGANÒ","1247;1084;1027;1010;971;967;934;913;913;858;858;854;821;802;797;783;775;761;761;761","MASSIMO ZEVIANI;FABRIZIO TAGLIAVINI;GIUSEPPE LAURIA;DAVIDE PAREYSON;EMILIO CIUSANI;FRANCO TARONI;CATERINA MARIOTTI;ISABELLA MORONI;GIORGIO GIACCONE;SILVANA FRANCESCHETTI;CINZIA GELLERA;FRANCESCO DIMECO;CARLO VISCOMI;GAETANO FINOCCHIARO;LUCIA MORANDI;GIUSEPPE PISCOSQUITO;FRANCESCO PRADA;BARBARA CASTELLOTTI;LUDOVICO MINATI;VIVIANA PENSATO","1099;1070;934;884;840;802;749;708;608;596;579;577;546;537;511;509;501;486;479;475","GAETANO FINOCCHIARO;MATILDE LEONARDI;FABRIZIO TAGLIAVINI;LUCIA MORANDI;ANTONIO SILVANI;DAVIDE PAREYSON;CATERINA MARIOTTI;BIANCA POLLO;MARICA EOLI;FRANCESCO DIMECO;MARIA GRAZIA BRUZZONE;GIUSEPPE LAURIA;RENATO MANTEGAZZA;FRANCO TARONI;ISABELLA MORONI;SILVANA FRANCESCHETTI;FRANCESCO PRADA;E. LAMPERTI;MASSIMO ZEVIANI;CINZIA GELLERA","20;17;16;16;15;15;14;14;13;12;12;12;11;11;10;10;10;9;9;9","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;SOCIOLOGY;MATHEMATICS;ENGINEERING;ECONOMICS;POLITICAL SCIENCE;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;GEOGRAPHY;GEOLOGY;HISTORY","254;123;91;34;33;27;26;21;19;18;12;6;5;5;4;2;2","INTERNAL MEDICINE;PATHOLOGY;GENETICS;PSYCHIATRY;NEUROSCIENCE;CANCER RESEARCH;SURGERY;BIOCHEMISTRY;RADIOLOGY;PEDIATRICS;CELL BIOLOGY;IMMUNOLOGY;ENDOCRINOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;ANATOMY;AUDIOLOGY;DEMOGRAPHY;ONCOLOGY;PHYSICAL THERAPY","140;95;79;73;64;37;36;34;33;30;23;22;19;19;18;16;16;16;16;16","DISEASE;GENE;EPILEPSY;POPULATION;COGNITION;ELECTROENCEPHALOGRAPHY;MAGNETIC RESONANCE IMAGING;GLIOMA;CANCER;CHEMOTHERAPY;ATAXIA;NEUROLOGY;RADIATION THERAPY;ADVERSE EFFECT;RECEPTOR;ALTERNATIVE MEDICINE;CLINICAL TRIAL;IN VITRO;LESION;MIGRAINE;RANDOMIZED CONTROLLED TRIAL;ULTRASOUND","78;73;26;21;19;19;19;17;16;16;15;15;13;12;12;11;11;11;9;9;9;9","MUTATION;DEMENTIA;PHENOTYPE;PARKINSON'S DISEASE;GENOTYPE;ALLELE;CLINICAL ENDPOINT;NEUROPSYCHOLOGY;PLACEBO;AGE OF ONSET;ALZHEIMER'S DISEASE;ASTROCYTOMA;MITOCHONDRIAL DNA;LEUKOENCEPHALOPATHY;MOVEMENT DISORDERS;TEMOZOLOMIDE;BEVACIZUMAB;CONTRAST-ENHANCED ULTRASOUND;EPILEPSY SURGERY;MUTANT;PHASES OF CLINICAL RESEARCH;TOLERABILITY;WHITE MATTER","42;19;17;12;10;9;9;8;8;7;7;7;7;6;6;6;5;5;5;5;5;5;5","MISSENSE MUTATION;DEEP BRAIN STIMULATION;FRONTOTEMPORAL DEMENTIA;COMPOUND HETEROZYGOSITY;SINGLE-NUCLEOTIDE POLYMORPHISM;TRINUCLEOTIDE REPEAT EXPANSION;EXOME SEQUENCING;HEREDITARY SPASTIC PARAPLEGIA;IDH1;MITOCHONDRIAL DISEASE;WILD TYPE;ANAPLASTIC ASTROCYTOMA;FRATAXIN;GENETIC HETEROGENEITY;LIMB-GIRDLE MUSCULAR DYSTROPHY;OLIGODENDROGLIOMA;TELOMERASE REVERSE TRANSCRIPTASE;ADULT STEM CELL;ATRX;CONCURRENT VALIDITY;FRAMESHIFT MUTATION;GENE MUTATION;GENETIC ARCHITECTURE;HAPLOTYPE;MELANOCYTIC NEVUS;MITOCHONDRIAL ENCEPHALOMYOPATHY;MITOCHONDRIAL MYOPATHY;NEUROPSYCHOLOGICAL ASSESSMENT;NIMOTUZUMAB;PENETRANCE;POINT MUTATION;PROBAND;SIRTUIN;TRACTOGRAPHY;VINORELBINE","11;10;9;7;5;5;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;;ADULT;MIDDLE AGED;BRAIN;AGED;YOUNG ADULT;MUTATION;ADOLESCENT;MAGNETIC RESONANCE IMAGING;BRAIN NEOPLASMS;CHILD;ELECTROENCEPHALOGRAPHY;EPILEPSY;GLIOBLASTOMA;CHARCOT-MARIE-TOOTH DISEASE;ANIMALS;ALZHEIMER DISEASE","184;135;131;100;94;89;57;53;52;50;47;42;37;31;27;27;27;25;24;23","GLIOMAS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;EPILEPSY AND SEIZURES;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;IMPACT OF SOCIAL FACTORS ON HEALTH OUTCOMES;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;MECHANISMS OF ALZHEIMER'S DISEASE;PRION DISEASES: CAUSES AND MOLECULAR BASIS;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE","27;14;13;10;9;9;8;8;7;7;6;5;5;5;5;4;4;4;4;3","CHARCOT-MARIE-TOOTH DISEASE;CLINICAL ENDPOINT;GLIOBLASTOMA;NEURODEGENERATION;PERFUSION IMAGING;STROKE (ENGINE);COMPOUND HETEROZYGOSITY;DEEP BRAIN STIMULATION;EPILEPSY;MIGRAINE;NEUROIMAGING;AGING;AMYLOID (MYCOLOGY);ATAXIA;BRAIN TUMOR;DEEP LEARNING FOR EEG;DEPRESSION (ECONOMICS);DIAGNOSTIC CRITERIA;EEG ANALYSIS;EPILEPSY DETECTION","9;9;9;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6","ALZHEIMERS DISEASE;MULTIPLE SCLEROSIS;PHASE II;BRAIN TUMOR;FINLAND POLAND;II TRIAL;CONTRAST ENHANCED;ENHANCED ULTRASOUND;FRONTOTEMPORAL LOBAR;LOBAR DEGENERATION;MAGNETIC RESONANCE;MINIMALLY CONSCIOUS;RANDOMIZED PHASE;TUMOR SURGERY;AMYOTROPHIC LATERAL;AUTOSOMAL DOMINANT;BRAIN STIMULATION;CELL IMMUNOTHERAPY;CEREBRAL PALSY;CHRONIC MIGRAINE;CLINICAL PRACTICE;DEEP BRAIN;DENDRITIC CELL;EPILEPTOGENIC ZONE;FRONTOTEMPORAL DEMENTIA;GENE MUTATION;GLIOBLASTOMA PATIENTS;GRADE GLIOMAS;INTRAOPERATIVE CEREBRAL;LATERAL SCLEROSIS","7;6;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;SPINAL MUSCULAR;MUSCULAR ATROPHY;RESPIRATORY CHAIN;RESPIRATORY DISTRESS;DISTRESS TYPE;BRAIN MRI;BRAIN TUMOR;CELL LINES;COX DEFICIENCY;GENET -CROSSREF;CHILD HEALTH;COMPOUND HETEROZYGOUS;FAMILY HISTORY;INDIVIDUAL FAMILY;LACTIC ACIDOSIS;MITOCHONDRIAL RESPIRATORY;SURAL NERVE;BREAST CANCER;CLINICAL FEATURES;HYPERTROPHIC CARDIOMYOPATHY;MEDIAN AGE;NERVOUS SYSTEM;PATIENTS TREATED;PL BEV;TERT PROMOTER;WHITE MATTER;BEV ARM;CLINICAL MANIFESTATIONS","83;63;28;27;25;24;20;18;18;13;12;12;11;11;11;11;11;11;11;10;10;10;10;10;10;10;10;10;9;9",141,0.47,8.6,8,2,1.75,2,4.5,4,1,1,9,1,1,7,1,1,2,2,5,2,0,0,116,116,3,1,1,2,0,0,0,0,0,0,0,0,2,0,2,3,2.5,0.81,1,0,0,3,0,0,1,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ABOU HAMDAN MOHAMAD;PEDOTTI ROSETTA;COLOMBO EMANUELA;CRISTINI SILVIA;FARINA CINTHIA;INVERNICI GLORIA;NAVONE STEFANIA ELENA;PARATI EUGENIO AGOSTINO","2;2;1;1;1;1;1;1","FOND I R C C S ISTITUTO NEUROLOGICO CARLO BESTA;FONDAZIONE IRCCS ISTITUTO NEUROLOGICO 'CARLO BESTA';FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","4;2","NEUROSCIENCES","2","5.1 PHARMACEUTICALS","2","A01K67/027;A61K31/53;A61P25/00;A61P29/00;A61P37/00;C07D251/46","1;1;1;1;1;1","A01K67/027;A61K31/53;A61P25/00;A61P29/00;A61P37/00;C07D251/46;C07K14/71;C07K14/7151;C12N2500/25;C12N2500/34","2;2;2;2;2;2;1;1;1;1",6,4.83,119.83,1.49,3,0.5,26.5,1,1,0,1,3,0,0,0,0,6,0,0,0,0,0,0,0,6,0,0,4,0,0,2,0,0,0,0,0,0,"Italy;United Kingdom;United States","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;44 HUMAN SOCIETY;4409 SOCIAL WORK;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","5;3;2;1;1;1;1;1;1","CLINICAL RESEARCH;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEURODEGENERATIVE;NEUROSCIENCES;BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CANCER;CHRONIC LIVER DISEASE AND CIRRHOSIS;DIGESTIVE DISEASES;GENETICS;LIVER DISEASE;MULTIPLE SCLEROSIS;PATIENT SAFETY;PEDIATRIC;SPINAL MUSCULAR ATROPHY","5;4;3;3;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;NEUROLOGICAL","2;1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;7.2 END OF LIFE CARE;7.3 MANAGEMENT AND DECISION MAKING","4;1;1;1","BRAIN TUMOR;BREAST CANCER;LIVER CANCER;LUNG CANCER;NOT SITE-SPECIFIC CANCER;STOMACH CANCER","1;1;1;1;1;1","5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;6.6 END-OF-LIFE CARE","1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,50,"PUBLIC LIBRARY OF SCIENCE","50","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;52 PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;51 PHYSICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;34 CHEMICAL SCIENCES;40 ENGINEERING;4203 HEALTH SERVICES AND SYSTEMS;3105 GENETICS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3207 MEDICAL MICROBIOLOGY;3209 NEUROSCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;4202 EPIDEMIOLOGY;44 HUMAN SOCIETY;46 INFORMATION AND COMPUTING SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3204 IMMUNOLOGY","32;14;12;11;9;9;9;5;4;4;3;2;2;2;2;2;2;2;1;1","CLINICAL RESEARCH;NEUROSCIENCES;BRAIN DISORDERS;NEURODEGENERATIVE;GENETICS;AUTOIMMUNE DISEASE;AGING;MULTIPLE SCLEROSIS;RARE DISEASES;STROKE;ATHEROSCLEROSIS;CARDIOVASCULAR;EPILEPSY;HEMATOLOGY;BIOMEDICAL IMAGING;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EMERGING INFECTIOUS DISEASES;HUMAN GENOME;INFECTIOUS DISEASES","14;12;9;6;5;4;3;3;3;3;2;2;2;2;1;1;1;1;1;1","NEUROLOGICAL;CARDIOVASCULAR;STROKE;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;CANCER;MUSCULOSKELETAL","9;4;4;3;2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS;7.3 MANAGEMENT AND DECISION MAKING","5;2;1;1;1;1","BIOMEDICAL;CLINICAL;HEALTH SERVICES & SYSTEMS","10;2;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;HEALTH SERVICES RESEARCH","18;4;2","BRAIN TUMOR;MELANOMA;NOT SITE-SPECIFIC CANCER;PHARYNGEAL CANCER","1;1;1;1",NA,NA
"IRCCS_BESTA",2015,285,12.2245614035088,3.43157894736842,0.396491228070175,0.32280701754386,0.445614035087719,2.41831683168317,1.25555555555556,1.53333333333333,1.25742574257426,0.536842105263158,11,131,92,30,14,0.46,0.32,0.11,0.05,40.29,1.08120940446187,6.04948805460749,0.421052631578947,0.83859649122807,0.509,0.445,0.399,0.433,"MATILDE LEONARDI;GAETANO FINOCCHIARO;FABRIZIO TAGLIAVINI;LUCIA MORANDI;ENRICO BERTINI;BARBARA GARAVAGLIA;ANGELO FRANZINI;RENATO MANTEGAZZA;GIUSEPPE LAURIA;LORENZO MAGGI;LUDOVICO MINATI;MARICA EOLI;ISABELLA MORONI;SOMNATH CHATTERJI;ANTONIO SILVANI;PIA BERNASCONI;MASSIMO ZEVIANI;JOSÉ LUÍS AYUSO‐MATEOS;JOSEP MARÍA HARO;PAOLO FERROLI","19;17;15;15;14;13;13;12;12;12;12;11;11;10;10;10;10;10;9;9","LUDOVICO MINATI;ANGELO FRANZINI;MATILDE LEONARDI;LORENZO MAGGI;GAETANO FINOCCHIARO;PIA BERNASCONI;LICIA GRAZZI;GIUSEPPE MESSINA;GIORGIO GIACCONE;BARBARA GARAVAGLIA;DAVIDE BAGATTI;GIOVANNA ZORZI;NARDO NARDOCCI;G. AVANZINI;GIUSEPPE LAURIA;VALERIA TIRANTI;LUCIA MORANDI;FABRIZIO TAGLIAVINI;GIOVANNI TRINGALI;RENATO MANTEGAZZA","3.09;2.3;2.23;1.99;1.87;1.87;1.73;1.61;1.5;1.47;1.45;1.43;1.41;1.34;1.25;1.22;1.18;1.17;1.16;1.13","MATILDE LEONARDI;GAETANO FINOCCHIARO;FABRIZIO TAGLIAVINI;LUCIA MORANDI;ENRICO BERTINI;BARBARA GARAVAGLIA;ANGELO FRANZINI;RENATO MANTEGAZZA;GIUSEPPE LAURIA;LORENZO MAGGI;LUDOVICO MINATI;MARICA EOLI;ISABELLA MORONI;ANTONIO SILVANI;PIA BERNASCONI;MASSIMO ZEVIANI;PAOLO FERROLI;MARINA MORA;ALBERTO RAGGI;ADELE D’AMICO","19;17;15;15;14;13;13;12;12;12;12;11;11;10;10;10;9;9;8;8","LUDOVICO MINATI;ANGELO FRANZINI;MATILDE LEONARDI;LORENZO MAGGI;GAETANO FINOCCHIARO;PIA BERNASCONI;LICIA GRAZZI;GIUSEPPE MESSINA;GIORGIO GIACCONE;BARBARA GARAVAGLIA;DAVIDE BAGATTI;GIOVANNA ZORZI;NARDO NARDOCCI;G. AVANZINI;GIUSEPPE LAURIA;VALERIA TIRANTI;LUCIA MORANDI;FABRIZIO TAGLIAVINI;GIOVANNI TRINGALI;RENATO MANTEGAZZA","3.09;2.3;2.23;1.99;1.87;1.87;1.73;1.61;1.5;1.47;1.45;1.43;1.41;1.34;1.25;1.22;1.18;1.17;1.16;1.13","AHMED IDBAÏH;MATILDE LEONARDI;ANTONIO SILVANI;JAY‐JIGUANG ZHU;ROGER STUPP;ZVI RAM;ANDREAS F. HOTTINGER;ANDREW A. KANNER;DAVID TRAN;FRANK S. LIEBERMAN;GENE H. BARNETT;JÉRÔME HONNORAT;KAREN FINK;LYNNE P. TAYLOR;MONIKA E. HEGI;SANTOSH KESARI;SOPHIE TAILLIBERT;STEVEN A. TOMS;YORAM PALTI;EILON D. KIRSON","1282;1194;1154;1080;1080;1080;1076;1076;1076;1076;1076;1076;1076;1076;1076;1076;1076;1076;1076;1051","ANTONIO SILVANI;MATILDE LEONARDI;ISABELLA MORONI;FABRIZIO TAGLIAVINI;MASSIMO ZEVIANI;STEFANO D’ARRIGO;CARLO VISCOMI;GABRIELE CIVILETTO;SARA PRIONI;CATERINA MARIOTTI;VERONICA REDAELLI;PIETRO TIRABOSCHI;COSTANZA LAMPERTI;MARINA GRISOLI;GAETANO FINOCCHIARO;MARTA PANZERI;LORENZO NANETTI;LUCIA MORANDI;LUDOVICO MINATI;FRANCESCO DIMECO","1154;1064;1000;900;709;685;582;582;575;555;539;536;512;502;492;423;422;420;417;382","GAETANO FINOCCHIARO;FABRIZIO TAGLIAVINI;LUCIA MORANDI;MATILDE LEONARDI;BARBARA GARAVAGLIA;ANGELO FRANZINI;GIUSEPPE LAURIA;LUDOVICO MINATI;LORENZO MAGGI;RENATO MANTEGAZZA;ISABELLA MORONI;MARICA EOLI;PIA BERNASCONI;ANTONIO SILVANI;GIUSEPPE MESSINA;MARINA MORA;GIOVANNA ZORZI;CATERINA MARIOTTI;NARDO NARDOCCI;PAOLO FERROLI","15;15;15;15;13;12;12;12;12;12;11;10;10;10;10;9;8;8;8;8","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;ENGINEERING;SOCIOLOGY;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE;GEOGRAPHY;ART;BUSINESS;HISTORY","246;122;62;32;29;21;20;18;14;10;8;7;4;2;1;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;NEUROSCIENCE;PSYCHIATRY;BIOCHEMISTRY;SURGERY;CANCER RESEARCH;RADIOLOGY;IMMUNOLOGY;PEDIATRICS;CELL BIOLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;ONCOLOGY;AUDIOLOGY;NUCLEAR MEDICINE;PHYSICAL THERAPY;ANESTHESIA;DEMOGRAPHY;PHYSICAL MEDICINE AND REHABILITATION","136;76;76;64;54;41;34;32;29;28;27;26;25;20;17;15;15;15;13;13;13","GENE;DISEASE;POPULATION;MAGNETIC RESONANCE IMAGING;NEUROLOGY;COGNITION;EPILEPSY;CHEMOTHERAPY;IN VITRO;RADIATION THERAPY;COHORT;RECEPTOR;DYSTONIA;GLIOMA;NEUROSURGERY;ALTERNATIVE MEDICINE;BIOPSY;CENTRAL NERVOUS SYSTEM;MIGRAINE;MITOCHONDRION;RANDOMIZED CONTROLLED TRIAL","85;83;25;20;19;17;16;13;13;13;12;12;11;11;11;10;10;10;10;10;10","MUTATION;PHENOTYPE;PARKINSON'S DISEASE;DEMENTIA;MITOCHONDRIAL DNA;TEMOZOLOMIDE;NEURORADIOLOGY;ALLELE;AMYOTROPHIC LATERAL SCLEROSIS;GENOTYPE;MUSCLE BIOPSY;NEURODEGENERATION;CLINICAL ENDPOINT;HEART RATE;MUTANT;UNIVARIATE ANALYSIS;WHITE MATTER;ALZHEIMER'S DISEASE;BEVACIZUMAB;GENE EXPRESSION;IMMUNOTHERAPY;NEUROPSYCHOLOGY;PROGRESSION-FREE SURVIVAL;RADIOSURGERY;TEMPORAL LOBE","40;28;19;18;12;12;9;8;8;8;8;8;7;6;6;6;6;5;5;5;5;5;5;5;5","MISSENSE MUTATION;DEEP BRAIN STIMULATION;FRONTOTEMPORAL DEMENTIA;MITOCHONDRIAL DISEASE;COMPOUND HETEROZYGOSITY;GENETIC HETEROGENEITY;LOSS FUNCTION;CLINICAL PHENOTYPE;CYBERKNIFE;GENE MUTATION;HEART RATE VARIABILITY;IDH1;LIMB-GIRDLE MUSCULAR DYSTROPHY;LMNA;MITOCHONDRIAL MYOPATHY;MITOPHAGY;PROBAND;COGNITIVE DECLINE;CONGENITAL MYOPATHY;EXECUTIVE DYSFUNCTION;EXOME SEQUENCING;FATAL FAMILIAL INSOMNIA;GLOBUS PALLIDUS;GREY MATTER;HAPLOTYPE;HIPPOCAMPAL SCLEROSIS;LEVODOPA;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MICROVESICLES;MITOCHONDRIAL ENCEPHALOMYOPATHY;MITOCHONDRIAL FUSION;MYH7;MYOTONIA CONGENITA;PARKIN;PENETRANCE;RYR1;SINGLE-NUCLEOTIDE POLYMORPHISM;TAUOPATHY;UNTRANSLATED REGION;VAGUS NERVE STIMULATION","11;10;10;6;5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;;ADULT;MIDDLE AGED;AGED;BRAIN;BRAIN NEOPLASMS;YOUNG ADULT;MAGNETIC RESONANCE IMAGING;ADOLESCENT;ANIMALS;MUTATION;CHILD;AGED, 80 AND OVER;GLIOBLASTOMA;GLIOMA;ALZHEIMER DISEASE;NEURONS","166;120;116;100;76;76;61;55;46;38;34;29;29;26;23;22;21;21;20;20","GLIOMAS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;MECHANISMS OF ALZHEIMER'S DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;EPILEPSY AND SEIZURES;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;MOLECULAR MECHANISMS OF ION CHANNELS REGULATION;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;GUILLAIN-BARRÉ SYNDROME AND RELATED NEUROPATHIES;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION","22;13;11;10;8;8;8;6;6;6;6;5;5;5;5;5;4;4;4;3","GLIOBLASTOMA;TEMOZOLOMIDE;NEURODEGENERATION;NEUROIMAGING;DEEP BRAIN STIMULATION;NEURORADIOLOGY;SKELETAL MUSCLE ATROPHY;TREATMENT;CLINICAL ENDPOINT;EPILEPSY;NEUROMODULATION;SPINAL MUSCULAR ATROPHY;STROKE (ENGINE);MIGRAINE;MIGRAINE PREVENTION;MITOCHONDRIAL DISEASE;RADIOTHERAPY;UNIVARIATE ANALYSIS;AMYLOID (MYCOLOGY);C9ORF72","12;12;10;10;9;9;8;8;7;7;7;7;7;6;6;6;6;6;5;5","AMYOTROPHIC LATERAL;GLIOBLASTOMA PATIENTS;LATERAL SCLEROSIS;FRONTOTEMPORAL DEMENTIA;AINO ITALIAN;ALZHEIMERS DISEASE;ITALIAN ASSOCIATION;MURINE MODEL;PARKINSONS DISEASE;PATIENTS TREATED;GENETIC FRONTOTEMPORAL;ITALIAN PATIENTS;MAGNETIC RESONANCE;MUSCULAR DYSTROPHY;BRAIN STIMULATION;BRAIN TUMOR;CEREBROSPINAL FLUID;CHRONIC CLUSTER;CHRONIC MIGRAINE;CLUSTER HEADACHE;COGNITIVE IMPAIRMENT;DEEP BRAIN;GENE MUTATIONS;GENFI STUDY;GLIOBLASTOMA REGISTRY;MESENCHYMAL STROMAL;MUSCLE MASS;MUSCULAR ATROPHY;NEWLY DIAGNOSED;NITROSOUREA FOTEMUSTINE","8;8;8;7;6;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;ITALY SEARCH;MILAN ITALY;BESTA MILAN;MATERNAL-INFANTILE SCIENCES;NEUROSCIENCES REHABILITATION;OPHTHALMOLOGY GENETICS;REHABILITATION OPHTHALMOLOGY;SCIENCES DINOGMI;BRAIN REGIONS;CARLO BESTA;SCIENCES UNIVERSITY;GENOA ITALYSEARCH;LOS ANGELES;PATIENTS TREATED;CELL CYCLE;STEM CELL;FOUNDATION IRCCS;WHOLE-EXOME SEQUENCING;AUTOSOMAL DOMINANT;BIOSCIENCES CENTRE;CELL RESEARCH;DEGLI STUDI;DI MILANO;EMILIA MODENA;HEART RATE;IRCCS INSTITUTE;LIFE SCIENCES;MILANO MILAN","66;59;46;29;19;16;16;16;16;16;15;15;15;14;14;14;13;13;12;12;11;11;11;11;11;11;11;11;11;11",156,0.55,8.72,6,2,2,3.25,1.5,6,1,1,6.25,1,1,5,1,4,2,2,4,2,0,0,101.25,101.25,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,3,0.31,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"KROL SILKE;PELLICCIA MARIA;STELLACCI FRANCESCO","1;1;1","FONDAZIONE IRCCS ISTITUTO NEUROLOGICO 'CARLO BESTA'","1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY","1;1;1","GENE THERAPY;GENETICS","1;1","5.2 CELLULAR AND GENE THERAPIES","1","A61K35/76;A61K47/02;A61K47/20;A61K47/48;A61K48/00;C12N15/87;C12N15/88","1;1;1;1;1;1;1","A61K47/6923;A61K48/00;A61K48/0025;A61K48/0091;C12N15/87;C12N15/88;C12N2710/10343","1;1;1;1;1;1;1",16,5.08,323.92,4.35,6,0.38,46.19,0,0,9,0,3,0,0,4,0,10,3,0,0,0,0,0,0,16,0,0,13,3,0,0,0,0,0,0,0,0,"United States;Italy;Belgium;Czechia;Germany;Norway;Poland","6;5;3;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;49 MATHEMATICAL SCIENCES;51 PHYSICAL SCIENCES;5105 MEDICAL AND BIOLOGICAL PHYSICS","12;8;5;3;3;3;3;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;RARE DISEASES;BRAIN DISORDERS;BRAIN CANCER;CANCER;NEURODEGENERATIVE;PATIENT SAFETY;COMPARATIVE EFFECTIVENESS RESEARCH;PREVENTION;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BIODEFENSE;BIOMEDICAL IMAGING;CHRONIC PAIN;DEMENTIA;EMERGING INFECTIOUS DISEASES","11;9;9;7;6;5;5;3;3;2;2;1;1;1;1;1;1;1;1;1","CANCER;NEUROLOGICAL","4;3","6.1 PHARMACEUTICALS;6.4 SURGERY","10;1","BRAIN TUMOR","5","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","5;3;1;1",5,3275762.6,261555.71,5.6,17.4,9.2,1,126.8,1242344.18253859,0.229405026405512,"ISTITUTO NEUROLOGICO CARLO BESTA;UNIVERSITY COLLEGE LONDON;KAROLINSKA INSTITUTET;LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN;AUGUST PI I SUNYER BIOMEDICAL RESEARCH INSTITUTE;AUTONOMOUS UNIVERSITY OF MADRID;CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI;DONOSTIA UNIBERTSITATE OSPITALEA;ERASMUS MC;JAGIELLONIAN UNIVERSITY;MCGILL UNIVERSITY;PARC SANITARI SANT JOAN DE DÉU;PITIÉ-SALPÊTRIÈRE HOSPITAL;UNIVERSITAIR ZIEKENHUIS LEUVEN;UNIVERSITY OF BRESCIA;UNIVERSITY OF CALIFORNIA, SAN FRANCISCO;UNIVERSITY OF CAMBRIDGE;UNIVERSITY OF COIMBRA;UNIVERSITY OF FLORENCE;UNIVERSITY OF LILLE","5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","EUROPEAN COMMISSION;MEDICAL RESEARCH COUNCIL","3;2","COALITION S;EC & ERC - EUROPEAN UNION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","5;3;2;2","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-PHC-2014-TWO-STAGE (CALL FOR PROPOSAL);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME);3RD HEALTH PROGRAMME (PROGRAMME);FELLOWSHIP (PROJECT CATEGORY);RESEARCH GRANT (PROJECT CATEGORY)","2;2;2;1;1;1","42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;31 BIOLOGICAL SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY;4206 PUBLIC HEALTH","4;2;2;1;1;1;1;1;1","RARE DISEASES;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ALZHEIMER'S DISEASE RELATED DEMENTIAS (ADRD);BRAIN DISORDERS;CLINICAL RESEARCH;DEMENTIA;FRONTOTEMPORAL DEMENTIA (FTD);GENETIC TESTING;GENETICS;NEURODEGENERATIVE;NEUROSCIENCES;BIOENGINEERING;BIOMEDICAL IMAGING;BIOTECHNOLOGY;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;MENTAL HEALTH;NANOTECHNOLOGY","3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","MENTAL HEALTH;NEUROLOGICAL;GENERIC HEALTH RELEVANCE","2;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","2;2;1;1","NOT SITE-SPECIFIC CANCER","1","4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.2 TECHNOLOGY AND/OR MARKER EVALUATION WITH RESPECT TO FUNDAMENTAL PARAMETERS OF METHOD","1;1","A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE;A02 PUBLIC HEALTH, HEALTH SERVICES AND PRIMARY CARE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;C17 BUSINESS AND MANAGEMENT STUDIES","2;1;1;1","8 DECENT WORK AND ECONOMIC GROWTH","1",21,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","19;2","52 PSYCHOLOGY;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;40 ENGINEERING;4203 HEALTH SERVICES AND SYSTEMS;46 INFORMATION AND COMPUTING SCIENCES;5203 CLINICAL AND HEALTH PSYCHOLOGY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3202 CLINICAL SCIENCES;4003 BIOMEDICAL ENGINEERING;49 MATHEMATICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3001 AGRICULTURAL BIOTECHNOLOGY;34 CHEMICAL SCIENCES;3402 INORGANIC CHEMISTRY;4613 THEORY OF COMPUTATION;4905 STATISTICS","11;8;8;7;4;4;3;3;2;2;2;2;2;2;1;1;1;1;1;1","BRAIN DISORDERS;NEUROSCIENCES;NEURODEGENERATIVE;MENTAL HEALTH;CLINICAL RESEARCH;DEPRESSION;MULTIPLE SCLEROSIS;RARE DISEASES;AUTOIMMUNE DISEASE;BIOMEDICAL IMAGING;EMERGING INFECTIOUS DISEASES;GENETICS;INFECTIOUS DISEASES;TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY (TSE);BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;FOODBORNE ILLNESS;MIND AND BODY;REGENERATIVE MEDICINE","9;9;5;4;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1","NEUROLOGICAL;GENERIC HEALTH RELEVANCE","7;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;7.1 INDIVIDUAL CARE NEEDS","2;1;1;1","BIOMEDICAL;CLINICAL","4;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;HEALTH SERVICES RESEARCH","5;4;1","BRAIN TUMOR;NOT SITE-SPECIFIC CANCER","2;1","4 QUALITY EDUCATION","1"
"IRCCS_BESTA",2016,287,13.8048780487805,3.14982578397212,0.320557491289199,0.317073170731707,0.418118466898955,2.24317617866005,1.1358024691358,1.4,1.26315789473684,0.557491289198606,4,167,63,26,14,0.58,0.22,0.09,0.05,34.16,1.05163525836725,5.94453333333335,0.48780487804878,0.888501742160279,0.473,0.406,0.405,0.411,"FABRIZIO TAGLIAVINI;GAETANO FINOCCHIARO;MATILDE LEONARDI;ISABELLA MORONI;CINZIA GELLERA;ALESSANDRO PADOVANI;BIANCA POLLO;RENATO MANTEGAZZA;GIUSEPPE LAURIA;CATERINA MARIOTTI;MASSIMO ZEVIANI;MARINA MORA;ANTONIO SILVANI;GIOVANNI BARANELLO;MARIA GRAZIA BRUZZONE;BARBARA GARAVAGLIA;ANGELO FRANZINI;GIOVANNI B. FRISONI;CRISTINA MUSCIO;FRANCO TARONI","17;12;12;11;11;11;10;10;10;10;10;10;9;9;9;9;9;9;9;9","FRANCESCO PRADA;MARCO DE CURTIS;ANGELO FRANZINI;ANTONIO SILVANI;FABRIZIO TAGLIAVINI;AUGUSTO INNOCENTI;BIANCA POLLO;MATILDE LEONARDI;ISABELLA MORONI;GIUSEPPE LAURIA;GIOVANNI BARANELLO;FRANCESCO DIMECO;GIUSEPPE MESSINA;IRA SKVORTSOVA;DOSSENA MARTA;GAETANO FINOCCHIARO;A. BOTTURI;ALESSANDRO PADOVANI;MASSIMILIANO DEL BENE;MARINA BOCCARDI","1.7;1.69;1.56;1.41;1.35;1.27;1.22;1.16;1.12;1.1;1.04;1.04;1.03;1;1;0.98;0.97;0.96;0.92;0.88","FABRIZIO TAGLIAVINI;GAETANO FINOCCHIARO;MATILDE LEONARDI;ISABELLA MORONI;CINZIA GELLERA;BIANCA POLLO;RENATO MANTEGAZZA;GIUSEPPE LAURIA;CATERINA MARIOTTI;MASSIMO ZEVIANI;MARINA MORA;ANTONIO SILVANI;GIOVANNI BARANELLO;MARIA GRAZIA BRUZZONE;BARBARA GARAVAGLIA;ANGELO FRANZINI;CRISTINA MUSCIO;FRANCO TARONI;GIORGIO GIACCONE;FRANCESCO PRADA","17;12;12;11;11;10;10;10;10;10;10;9;9;9;9;9;9;9;8;8","FRANCESCO PRADA;MARCO DE CURTIS;ANGELO FRANZINI;ANTONIO SILVANI;FABRIZIO TAGLIAVINI;AUGUSTO INNOCENTI;BIANCA POLLO;MATILDE LEONARDI;ISABELLA MORONI;GIUSEPPE LAURIA;GIOVANNI BARANELLO;FRANCESCO DIMECO;GIUSEPPE MESSINA;IRA SKVORTSOVA;DOSSENA MARTA;GAETANO FINOCCHIARO;A. BOTTURI;MASSIMILIANO DEL BENE;CINZIA GELLERA;CRISTINA MUSCIO","1.7;1.69;1.56;1.41;1.35;1.27;1.22;1.16;1.12;1.1;1.04;1.04;1.03;1;1;0.98;0.97;0.92;0.86;0.86","GAETANO FINOCCHIARO;GIUSEPPE LAURIA;MASSIMO ZEVIANI;MATILDE LEONARDI;VINCENZO SILANI;MARICA EOLI;ANDREW J. BLUMBERG;ANNA LASORELLA;ANTONIO IAVARONE;DANIEL I. S. ROSENBLOOM;DO‐HYUN NAM;EMANUELA CAZZATO;ERIK LADEWIG;FRANCESCO ABATE;IN‐HEE LEE;JIGUANG WANG;JIN‐KU LEE;OLIVER ELLIOTT;RAÚL RABADÁN;SAKELLARIOS ZAIRIS","1165;805;734;670;648;639;638;638;638;638;638;638;638;638;638;638;638;638;638;638","GAETANO FINOCCHIARO;GIUSEPPE LAURIA;MARICA EOLI;EMANUELA CAZZATO;MATILDE LEONARDI;CINZIA GELLERA;FABRIZIO TAGLIAVINI;COSTANZA LAMPERTI;MASSIMO ZEVIANI;VALERIA TIRANTI;ISABELLA MORONI;IVANO DI MEO;BARBARA GARAVAGLIA;FRANCO TARONI;BIANCA POLLO;MARINA MORA;SILVIA MARCHET;DAVIDE PAREYSON;CARLO VISCOMI;GIORGIO GIACCONE","1165;770;639;638;628;603;597;590;535;456;433;419;410;391;359;293;285;279;276;274","FABRIZIO TAGLIAVINI;GAETANO FINOCCHIARO;MATILDE LEONARDI;CINZIA GELLERA;BIANCA POLLO;CATERINA MARIOTTI;MARINA MORA;CRISTINA MUSCIO;FRANCO TARONI;ANGELO FRANZINI;BARBARA GARAVAGLIA;ISABELLA MORONI;GIOVANNI BARANELLO;GIUSEPPE LAURIA;ANTONIO SILVANI;GIORGIO GIACCONE;MARIA GRAZIA BRUZZONE;MASSIMO ZEVIANI;SERENA PELLEGATTA;DAVIDE PAREYSON","17;12;11;11;10;10;10;9;9;9;9;9;9;9;8;8;8;7;7;7","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;ECONOMICS;ENGINEERING;POLITICAL SCIENCE;MATERIALS SCIENCE;SOCIOLOGY;ART;PHILOSOPHY;GEOGRAPHY;BUSINESS;GEOLOGY","243;119;74;39;35;23;18;15;13;12;8;7;5;5;3;2;1","INTERNAL MEDICINE;PATHOLOGY;GENETICS;NEUROSCIENCE;PSYCHIATRY;RADIOLOGY;BIOCHEMISTRY;SURGERY;CANCER RESEARCH;CELL BIOLOGY;PEDIATRICS;IMMUNOLOGY;ANESTHESIA;ANATOMY;ENVIRONMENTAL HEALTH;ONCOLOGY;PHYSICAL MEDICINE AND REHABILITATION;AUDIOLOGY;NUCLEAR MEDICINE;PHYSICAL THERAPY","121;84;77;68;59;49;40;38;28;27;25;24;19;18;17;17;17;16;15;15","DISEASE;GENE;MAGNETIC RESONANCE IMAGING;COGNITION;EPILEPSY;POPULATION;CANCER;COHORT;MITOCHONDRION;RADIATION THERAPY;GLIOBLASTOMA;IMMUNE SYSTEM;ELECTROENCEPHALOGRAPHY;NEUROIMAGING;GLIOMA;RECEPTOR;SPINAL CORD;STEM CELL;STIMULATION;APOPTOSIS;CHEMOTHERAPY;NEUROLOGY;PATHOGENESIS;STROKE (ENGINE)","72;72;26;22;22;16;13;13;13;13;11;11;10;10;9;9;9;9;9;8;8;8;8;8","MUTATION;DEMENTIA;PHENOTYPE;NEUROPSYCHOLOGY;AMYOTROPHIC LATERAL SCLEROSIS;GENOTYPE;WHITE MATTER;GENE EXPRESSION;ALZHEIMER'S DISEASE;MITOCHONDRIAL DNA;NEURODEGENERATION;RADIOSURGERY;ALLELE;NEURORADIOLOGY;SPINAL MUSCULAR ATROPHY;AUTOPHAGY;TEMOZOLOMIDE;AGE OF ONSET;CORTICAL DYSPLASIA;MICRORNA;MUTANT;TEMPORAL LOBE","29;26;21;13;10;9;9;8;7;7;7;7;6;6;6;5;5;4;4;4;4;4","FRONTOTEMPORAL DEMENTIA;MISSENSE MUTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;CYBERKNIFE;EXOME SEQUENCING;SOD1;TRANSCRIPTOME;GENETIC HETEROGENEITY;HAPLOINSUFFICIENCY;COGNITIVE DECLINE;COMPOUND HETEROZYGOSITY;EXTERNAL BEAM RADIOTHERAPY;FRACTIONAL ANISOTROPY;GREY MATTER;HAPLOTYPE;IDH1;LOSS FUNCTION;MITOCHONDRIAL DISEASE;TRINUCLEOTIDE REPEAT EXPANSION;VAGUS NERVE STIMULATION","11;9;8;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3","HUMANS;MALE;FEMALE;;BRAIN;MIDDLE AGED;ADULT;AGED;YOUNG ADULT;BRAIN NEOPLASMS;MAGNETIC RESONANCE IMAGING;MUTATION;ADOLESCENT;ALZHEIMER DISEASE;ANIMALS;CHILD;TREATMENT OUTCOME;CHILD, PRESCHOOL;ITALY;AMYOTROPHIC LATERAL SCLEROSIS","165;115;113;107;79;72;69;45;39;38;37;37;34;33;31;25;24;23;23;22","GLIOMAS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;PRION DISEASES: CAUSES AND MOLECULAR BASIS;EPILEPSY AND SEIZURES;MECHANISMS OF ALZHEIMER'S DISEASE;MULTIPOTENT MESENCHYMAL STEM CELLS;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;CANCER STEM CELLS AND TUMOR METASTASIS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MOLECULAR MECHANISMS OF ION CHANNELS REGULATION;CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY","16;15;12;12;10;8;6;6;6;5;5;5;4;4;4;4;4;4;4;3","NEURODEGENERATION;NEUROIMAGING;GLIOBLASTOMA;PATHOGENESIS;DEPRESSION (ECONOMICS);EPILEPSY;SPINAL MUSCULAR ATROPHY;STROKE (ENGINE);AMYLOID (MYCOLOGY);METABOLIC REGULATION;MITOCHONDRIAL DYSFUNCTION;NEURORADIOLOGY;TEMOZOLOMIDE;CANCER STEM CELLS;CYBERKNIFE;FRONTOTEMPORAL LOBAR DEGENERATION;FUNCTIONAL MRI;MESENCHYMAL STEM CELLS;MIGRAINE;MITOCHONDRIA","16;12;11;8;7;7;7;7;6;6;6;6;6;5;5;5;5;5;5;5","MULTIPLE SCLEROSIS;ALZHEIMERS DISEASE;AMYOTROPHIC LATERAL;LATERAL SCLEROSIS;FRONTOTEMPORAL DEMENTIA;GLIOBLASTOMA PATIENTS;COGNITIVE IMPAIRMENT;COHORT STUDY;MUSCULAR ATROPHY;NERVE STIMULATION;SPINAL CORD;SPINAL MUSCULAR;STROMAL CELLS;CEREBROSPINAL FLUID;CLINICAL FEATURES;CREUTZFELDT-JAKOB DISEASE;DRUG DELIVERY;FOCAL CORTICAL;GENE EXPRESSION;HUNTINGTONS DISEASE;INCREMENTAL DIAGNOSTIC;MAGNETIC RESONANCE;MESENCHYMAL STROMAL;MUSCULAR DYSTROPHY;NON-INVASIVE VAGUS;OBSERVATIONAL STUDY;PATIENTS TREATED;PHENOTYPIC VARIABILITY;PRELIMINARY RESULTS;RETROSPECTIVE STUDY","8;7;7;7;6;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ITALY SEARCH;MILAN ITALY;MA E-;CANDIOLO ITALY;PUBMED SCOPUS;ROME ITALY;SAN RAFFAELE;CROSSREF PUBMED;CANCER STEM;STEM CELL;CANCER INSTITUTE;CANDIOLO CANCER;FPO-IRCCS CANDIOLO;INSTITUTE FPO-IRCCS;INSTITUTE MILAN;RAFFAELE SCIENTIFIC;SCIENTIFIC INSTITUTE;INTELLECTUAL DISABILITY;NEUROSCIENCE SAN;UNIT DIVISION;CELL RESEARCH;RESEARCH CANDIOLO;STEM CELLS;BESTA MILAN;CNR ROME;IBPM CNR;DOWNLOAD FIGURE;DOWNLOAD POWERPOINT;FIGURE DOWNLOAD;NON-IRRADIATED CELLS","96;58;46;37;37;33;33;32;29;29;28;28;28;28;28;28;28;25;25;25;23;23;21;19;19;19;18;18;18;17",153,0.53,10.85,7,2,2,1,2,2,0,1,7,1,1,6,1,1,2,2,4,4,0,0,98,98,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,4,0.44,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"DI FEDE GIUSEPPE;MARTINI ALFREDO;MORBIN MICHELA;TAGLIAVINI FABRIZIO","1;1;1;1","FONDAZIONE IRCCS ISTITUTO NEUROLOGICO 'CARLO BESTA'","1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY","2;1",NA,NA,NA,NA,"A01K67/027;A61K39/395;C07K14/47;C07K16/18;C12N15/11;C12N15/85;C12Q1/68;G01N33/68","1;1;1;1;1;1;1;1","A01K2207/15;A01K2217/00;A01K2217/05;A01K2217/075;A01K2217/15;A01K2227/105;A01K2267/0312;A01K67/0278;A61P25/28;C07K14/4711","1;1;1;1;1;1;1;1;1;1",15,4.23,361.86,4.03,7,0.47,30.33,0,2,3,0,2,0,1,7,0,10,4,0,0,0,0,0,0,14,0,1,13,1,0,1,0,0,0,0,0,0,"United States;Italy;Belgium","19;4;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3507 STRATEGY, MANAGEMENT AND ORGANISATIONAL BEHAVIOUR;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","13;9;4;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;PEDIATRIC;BRAIN DISORDERS;RARE DISEASES;HEADACHES;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;NEURODEGENERATIVE;PAIN RESEARCH;PATIENT SAFETY;BEHAVIORAL AND SOCIAL SCIENCE;CHRONIC PAIN;MIGRAINES;MIND AND BODY;PREVENTION;CHARCOT-MARIE-TOOTH DISEASE;COMPLEMENTARY AND INTEGRATIVE HEALTH;DENTAL/ORAL AND CRANIOFACIAL DISEASE","14;11;9;7;6;5;3;3;3;3;3;3;2;2;2;2;2;1;1;1","NEUROLOGICAL;CARDIOVASCULAR;MUSCULOSKELETAL","6;1;1","6.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;6.6 PSYCHOLOGICAL AND BEHAVIOURAL","8;2;1;1;1","BLADDER CANCER;NOT SITE-SPECIFIC CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",5,2309263.5,221211.01,4.25,10.2,5.6,0.6,112,1195854.44956545,0.239995762113265,"ISTITUTO NEUROLOGICO CARLO BESTA;DÉLÉGATION PARIS 11;UNIVERSITY COLLEGE LONDON;UNIVERSITY HOSPITAL BONN;ACADEMIC MEDICAL CENTER;AMSTERDAM UMC LOCATION VUMC;ASTON UNIVERSITY;BAMBINO GESÙ CHILDREN'S HOSPITAL;CARDIFF UNIVERSITY;CARL ZEISS (GERMANY);CENTRO HOSPITALAR DO PORTO;CHILDREN'S MEMORIAL HEALTH INSTITUTE;COLLÈGE DE FRANCE;EPILEPSY ACTION;ERASMUS MC;EUROPEAN RESEARCH AND PROJECT OFFICE;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;FRENCH INSTITUTE FOR RESEARCH IN COMPUTER SCIENCE AND AUTOMATION;FRENCH NATIONAL CENTRE FOR SCIENTIFIC RESEARCH;HOSPICES CIVILS DE LYON","5;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;ALZHEIMER'S ASSOCIATION;ALZHEIMER’S RESEARCH UK;MEDICAL RESEARCH COUNCIL","2;1;1;1","COALITION S;EC & ERC - EUROPEAN UNION;AMRC - ASSOCIATION OF MEDICAL RESEARCH CHARITIES;HRA - HEALTH RESEARCH ALLIANCE;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","3;2;1;1;1;1","H2020-EU.1.3. - EXCELLENT SCIENCE - MARIE SKŁODOWSKA-CURIE ACTIONS (PROGRAMME);H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-MSCA-ITN-2016 (CALL FOR PROPOSAL);H2020-PHC-2015-TWO-STAGE (CALL FOR PROPOSAL);INTRAMURAL (PROJECT CATEGORY);MSCA-ITN-ETN - EUROPEAN TRAINING NETWORKS (FUNDING SCHEME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","1;1;1;1;1;1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3202 CLINICAL SCIENCES;3209 NEUROSCIENCES;46 INFORMATION AND COMPUTING SCIENCES","3;2;2;1;1;1;1","BRAIN DISORDERS;NEURODEGENERATIVE;NEUROSCIENCES;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);DEMENTIA;EPILEPSY;PREVENTION;RARE DISEASES;BIOENGINEERING;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;COMPLEMENTARY AND INTEGRATIVE HEALTH;HEALTH SERVICES;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);NUTRITION;PEDIATRIC","5;5;5;3;3;3;3;3;2;2;2;1;1;1;1;1;1;1;1","NEUROLOGICAL;GENERIC HEALTH RELEVANCE","5;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);5.7 PHYSICAL;6.1 PHARMACEUTICALS;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS","3;2;2;1;1;1;1;1",NA,NA,NA,NA,"A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE;A01 CLINICAL MEDICINE;B11 COMPUTER SCIENCE AND INFORMATICS;C23 EDUCATION","2;1;1;1","3 GOOD HEALTH AND WELL BEING","1",31,"PUBLIC LIBRARY OF SCIENCE;TAYLOR & FRANCIS GROUP","30;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;4206 PUBLIC HEALTH;52 PSYCHOLOGY;49 MATHEMATICAL SCIENCES;44 HUMAN SOCIETY;4905 STATISTICS;5202 BIOLOGICAL PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3210 NUTRITION AND DIETETICS;4403 DEMOGRAPHY;3103 ECOLOGY;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3206 MEDICAL BIOTECHNOLOGY;3208 MEDICAL PHYSIOLOGY;3209 NEUROSCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;33 BUILT ENVIRONMENT AND DESIGN;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES","20;16;8;7;5;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;CLINICAL RESEARCH;NUTRITION;BEHAVIORAL AND SOCIAL SCIENCE;NEUROSCIENCES;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;BRAIN CANCER;BRAIN DISORDERS;CARDIOVASCULAR;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DEPRESSION;HEART DISEASE;MENTAL HEALTH;NEURODEGENERATIVE;PREVENTION;RARE DISEASES;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","4;4;4;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;CANCER;NEUROLOGICAL;CARDIOVASCULAR","5;3;2;1","5.1 PHARMACEUTICALS","1","BIOMEDICAL;POPULATION & SOCIETY","2;2","PUBLIC HEALTH;BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE;HEALTH SERVICES RESEARCH","5;2;1;1","NOT SITE-SPECIFIC CANCER;BRAIN TUMOR;COLON AND RECTAL CANCER","3;1;1","3 GOOD HEALTH AND WELL BEING","2"
"IRCCS_BESTA",2017,267,16.1910112359551,2.90262172284644,0.288389513108614,0.299625468164794,0.363295880149813,2.32035928143713,1.13235294117647,1.33333333333333,1.18292682926829,0.546816479400749,5,140,74,21,13,0.52,0.28,0.08,0.05,53.16,1.80346919417544,5.92991783470275,0.471910112359551,0.895131086142322,0.459,0.428,0.35,0.401,"FABRIZIO TAGLIAVINI;BARBARA BORRONI;GAETANO FINOCCHIARO;DANIELA GALIMBERTI;LORENZO MAGGI;SANDRO SORBI;JAMES B. ROWE;DAVIDE PAREYSON;JONATHAN D. ROHRER;CAROLINE GRAFF;ALEXANDRE DE MENDONÇA;GIOVANNI B. FRISONI;ELIZABETH FINGER;ALESSANDRO PADOVANI;MARIA CARMELA TARTAGLIA;RENATO MANTEGAZZA;ISABELLA MORONI;ROBERT LAFORCE;JOHN C. VAN SWIETEN;MARICA EOLI","24;17;15;15;14;13;13;13;13;12;12;12;12;12;11;11;11;11;10;10","MARCO DE CURTIS;PAOLA GAVIANI;FABRIZIO TAGLIAVINI;MARINA MORA;DAVIDE SATTIN;LORENZO MAGGI;GAETANO FINOCCHIARO;VALENTINA PINZI;DINA BATTINO;RENATO MANTEGAZZA;LUISA CHIAPPARINI;LAURA GRAZIA VALENTINI;ANGELO FRANZINI;PAOLO FERROLI;FRANCESCO PRADA;FRANCESCO DIMECO;DAVIDE PAREYSON;SIMONA ZANOTTI;EUGENIO PARATI;GIOVANNI BARANELLO","1.91;1.64;1.62;1.41;1.21;1.14;1.13;1.12;1.11;1.07;0.98;0.89;0.86;0.84;0.84;0.81;0.81;0.8;0.8;0.77","FABRIZIO TAGLIAVINI;GAETANO FINOCCHIARO;LORENZO MAGGI;DAVIDE PAREYSON;RENATO MANTEGAZZA;ISABELLA MORONI;MARICA EOLI;MARINA MORA;MARY M. REILLY;LUISA CHIAPPARINI;BIANCA POLLO;GIOVANNI BARANELLO;GIACOMINA ROSSI;MICHAEL E. SHY;MARCO DE CURTIS;EUGENIO PARATI;PAOLO FERROLI;MATILDE LAURÁ;ANTONIO SILVANI;ANDREA SALMAGGI","24;15;14;13;11;11;10;10;9;9;8;8;8;8;8;8;8;8;7;7","MARCO DE CURTIS;PAOLA GAVIANI;FABRIZIO TAGLIAVINI;MARINA MORA;DAVIDE SATTIN;LORENZO MAGGI;GAETANO FINOCCHIARO;VALENTINA PINZI;DINA BATTINO;RENATO MANTEGAZZA;LUISA CHIAPPARINI;LAURA GRAZIA VALENTINI;ANGELO FRANZINI;PAOLO FERROLI;FRANCESCO PRADA;FRANCESCO DIMECO;DAVIDE PAREYSON;SIMONA ZANOTTI;EUGENIO PARATI;GIOVANNI BARANELLO","1.91;1.64;1.62;1.41;1.21;1.14;1.13;1.12;1.11;1.07;0.98;0.89;0.86;0.84;0.84;0.81;0.81;0.8;0.8;0.77","HAL W. HIRTE;GAETANO FINOCCHIARO;MICHAEL WELLER;ROGER STUPP;GARTH NICHOLAS;KAREN FINK;JAMES PERRY;JAY‐JIGUANG ZHU;ANDREW A. KANNER;ANDREAS F. HOTTINGER;AHMED IDBAÏH;BENOÎT LHERMITTE;CHAE‐YONG KIM;DAVID M. STEINBERG;EILON D. KIRSON;FRANK S. LIEBERMAN;GIUSEPPE STRAGLIOTTO;MONIKA E. HEGI;STEVEN A. TOMS;URI WEINBERG","4630;4445;3732;2832;2823;2823;2734;1971;1956;1932;1920;1920;1920;1920;1920;1920;1920;1920;1920;1920","GAETANO FINOCCHIARO;FRANCESCO DI MECO;LAURA FARISELLI;FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;VALERIA TIRANTI;DANIELE GHEZZI;SILKE KROL;MARICA EOLI;BARBARA SANAVIO;FABIO MODA;DAVIDE PAREYSON;GIORGIO GIACCONE;PAOLO FERROLI;BIANCA POLLO;FRANCESCO ACERBI;ISABELLA MORONI;CINZIA GELLERA;LORENZO MAGGI;MORGAN BROGGI","4436;1918;1009;654;636;614;577;477;434;357;355;354;316;316;299;299;267;254;250;241","FABRIZIO TAGLIAVINI;GAETANO FINOCCHIARO;DAVIDE PAREYSON;LORENZO MAGGI;RENATO MANTEGAZZA;MARICA EOLI;ISABELLA MORONI;MARINA MORA;BIANCA POLLO;GIOVANNI BARANELLO;LUISA CHIAPPARINI;PAOLO FERROLI;ANTONIO SILVANI;GIUSEPPE LAURIA;GIORGIO GIACCONE;LAURA FARISELLI;EMILIO CIUSANI;PAOLA GAVIANI;BARBARA GARAVAGLIA;EUGENIO PARATI","24;14;12;12;10;10;9;9;8;8;8;8;7;7;7;7;6;6;6;6","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;MATHEMATICS;COMPUTER SCIENCE;ENGINEERING;PHILOSOPHY;ECONOMICS;POLITICAL SCIENCE;SOCIOLOGY;MATERIALS SCIENCE;ART;BUSINESS;GEOGRAPHY;GEOLOGY;HISTORY","231;112;61;25;22;15;14;12;12;7;7;7;4;2;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;GENETICS;NEUROSCIENCE;PSYCHIATRY;SURGERY;RADIOLOGY;CANCER RESEARCH;BIOCHEMISTRY;ONCOLOGY;CELL BIOLOGY;PEDIATRICS;PHYSICAL MEDICINE AND REHABILITATION;IMMUNOLOGY;PHYSICAL THERAPY;ANESTHESIA;AUDIOLOGY;ANATOMY;ENDOCRINOLOGY;NURSING","134;82;66;66;61;52;50;38;31;29;25;21;19;17;17;15;12;11;11;11","DISEASE;GENE;MAGNETIC RESONANCE IMAGING;EPILEPSY;NEUROLOGY;CANCER;CHEMOTHERAPY;NEUROSURGERY;RECEPTOR;RADIATION THERAPY;STIMULATION;RANDOMIZED CONTROLLED TRIAL;COGNITION;COHORT;ATROPHY;CLINICAL TRIAL;GLIOMA;ADVERSE EFFECT;ELECTROENCEPHALOGRAPHY;QUALITY OF LIFE (HEALTHCARE)","64;64;30;27;23;20;19;17;16;15;15;13;12;12;11;11;11;10;10;10","MUTATION;DEMENTIA;PHENOTYPE;TEMOZOLOMIDE;NEURORADIOLOGY;WHITE MATTER;CLINICAL ENDPOINT;GENOTYPE;NEURODEGENERATION;AMYOTROPHIC LATERAL SCLEROSIS;GENE EXPRESSION;PARKINSON'S DISEASE;TEMPORAL LOBE;EXON;IMMUNOTHERAPY;MUTANT;PHASES OF CLINICAL RESEARCH;PLACEBO;TOLERABILITY;CISPLATIN;COLORECTAL CANCER;EPILEPSY SURGERY;ICTAL","27;22;16;15;13;12;10;10;9;8;8;8;8;6;6;6;6;6;6;5;5;5;5","FRONTOTEMPORAL DEMENTIA;MISSENSE MUTATION;DEEP BRAIN STIMULATION;EXOME SEQUENCING;HAPLOINSUFFICIENCY;COMPOUND HETEROZYGOSITY;VINCRISTINE;FRACTIONAL ANISOTROPY;GENETIC HETEROGENEITY;HIPPOCAMPAL SCLEROSIS;PRNP;TRANSCRIPTOME;AMPK;BRAIN METASTASIS;CETUXIMAB;DNA METHYLATION;DOUBLE BLIND;DYSTROGLYCAN;FATAL FAMILIAL INSOMNIA;FRAMESHIFT MUTATION;HEART RATE VARIABILITY;IDH1;LGR5;MICROVESICLES;MITOCHONDRIAL DISEASE;OVARIAN CARCINOMA;PERSISTENT VEGETATIVE STATE;PILOCYTIC ASTROCYTOMA;PROBAND;REGORAFENIB;RNA SPLICING;SINGLE-NUCLEOTIDE POLYMORPHISM;SOD1;TERATOLOGY;VAGUS NERVE STIMULATION;VOXEL-BASED MORPHOMETRY","19;7;6;6;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;ADULT;;MIDDLE AGED;AGED;BRAIN NEOPLASMS;BRAIN;GLIOBLASTOMA;YOUNG ADULT;ADOLESCENT;EPILEPSY;MAGNETIC RESONANCE IMAGING;CHILD;MUTATION;ANIMALS;TREATMENT OUTCOME;FRONTOTEMPORAL DEMENTIA;ITALY","176;128;123;84;77;70;54;45;43;39;37;36;36;36;35;35;33;27;23;22","GLIOMAS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;EPILEPSY AND SEIZURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;PRION DISEASES: CAUSES AND MOLECULAR BASIS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;MECHANISMS OF ALZHEIMER'S DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;IMPACT OF SOCIAL FACTORS ON HEALTH OUTCOMES;LIPID METABOLISM AND STORAGE IN ORGANISMS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT","28;14;12;9;8;8;6;6;6;5;5;5;5;5;4;3;3;3;3;3","GLIOBLASTOMA;NEURODEGENERATION;TEMOZOLOMIDE;EPILEPSY;NEURORADIOLOGY;C9ORF72;CLINICAL ENDPOINT;NEUROIMAGING;CHARCOT-MARIE-TOOTH DISEASE;CONCOMITANT;GENETICS;RADIOTHERAPY;STROKE (ENGINE);CELLULAR PRION PROTEIN;DEEP BRAIN STIMULATION;STATUS EPILEPTICUS;TOLERABILITY;TREATMENT;BRAIN TUMOR EPIDEMIOLOGY;COMPOUND HETEROZYGOSITY","18;18;16;13;13;11;11;9;8;8;7;7;7;6;6;6;6;6;5;5","FRONTOTEMPORAL DEMENTIA;GENETIC FRONTOTEMPORAL;PHASE II;MULTIPLE SCLEROSIS;AMYOTROPHIC LATERAL;LATERAL SCLEROSIS;GENFI STUDY;II STUDY;MUSCULAR DYSTROPHY;MYASTHENIA GRAVIS;NEWLY DIAGNOSED;STROMAL CELLS;WHITE MATTER;MESENCHYMAL STROMAL;CELL IMMUNOTHERAPY;DENDRITIC CELL;DUCHENNE MUSCULAR;ELDERLY PATIENTS;GENE EXPRESSION;GLIOBLASTOMA PATIENTS;LIPID STORAGE;MAGNETIC RESONANCE;NATURAL HISTORY;NEUTRAL LIPID;RANDOMIZED PHASE;RELAPSING-REMITTING MULTIPLE;SCLEROSIS PATIENTS;ACT IV;AGGREGATE MYOPATHY;ALZHEIMERS DISEASE","15;8;8;7;6;6;5;5;5;5;5;5;5;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2","FRONTOTEMPORAL DEMENTIA;MUTATION CARRIERS;MAGNETIC RESONANCE;RESONANCE IMAGING;GENETIC FRONTOTEMPORAL;DEMENTIA FTD;GENETIC FTD;MULTIPLE SCLEROSIS;SKELETAL MUSCLE;SYMPTOM ONSET;CLINICAL TRIALS;DE NOVO;GENDER-RELATED DIFFERENCES;GENE EXPRESSION;OCULAR MYOPATHY;OPTIC ATROPHY;ADVERSE EVENTS;CIDP PATIENTS;CUMULATIVE PROBABILITY;DISEASE PROGRESSION;GLIOBLASTOMA GBM;GREY MATTER;HR CI;INITIATIVE GENFI;MYASTHENIA GRAVIS;NERVOUS SYSTEM;NEWLY DIAGNOSED;PATIENTS TREATED;PRIMARY ENDPOINT;SOCIAL SUPPORT","24;20;18;13;12;11;11;11;11;11;9;9;9;9;9;9;8;8;8;8;8;8;8;8;8;8;8;8;8;8",158,0.59,7.62,8,2,3.5,2,9,4,1,1,9,1.75,1,7,2.5,2,2,2,5,3,0,0,82.75,82.75,2,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,3,0.77,1.5,0,1,2,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ABOU HAMDAN MOHAMAD;DI FEDE GIUSEPPE;MARTINI ALFREDO;MORBIN MICHELA;PEDOTTI ROSETTA;TAGLIAVINI FABRIZIO","1;1;1;1;1;1","FONDAZIONE IRCCS ISTITUTO NEUROLOGICO 'CARLO BESTA';FOND I R C C S ST NEUROLOGICO 'CARLO BESTA'","2;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3204 IMMUNOLOGY","2;2;1;1","ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BRAIN DISORDERS;DEMENTIA;GENETICS;NEURODEGENERATIVE","1;1;1;1;1;1;1;1","5.1 PHARMACEUTICALS","1","A01K67/027;A61K31/53;A61K39/395;A61P25/00;A61P29/00;A61P37/00;C07K14/47;C07K16/18;C12N15/11;C12N15/85","1;1;1;1;1;1;1;1;1;1","A01K2207/15;A01K2217/00;A01K2217/05;A01K2217/075;A01K2217/15;A01K2227/105;A01K2267/0312;A01K67/027;A01K67/0278;A61K31/53","1;1;1;1;1;1;1;1;1;1",14,4.08,746.23,4.62,11,0.79,48.57,1,0,3,1,3,0,2,4,0,9,4,0,0,0,0,0,0,12,0,2,13,1,0,0,0,0,0,0,0,0,"United States;Italy;Belgium;United Kingdom","3;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING;5204 COGNITIVE AND COMPUTATIONAL PSYCHOLOGY","12;6;6;5;3;2;2;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;NEUROSCIENCES;NEURODEGENERATIVE;PATIENT SAFETY;RARE DISEASES;AGING;CANCER;HEMATOLOGY;PEDIATRIC;PREVENTION;ACQUIRED COGNITIVE IMPAIRMENT;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BIOENGINEERING;BIOTECHNOLOGY;BRAIN CANCER;BREAST CANCER;CEREBRAL PALSY","13;10;8;7;5;4;4;2;2;2;2;2;1;1;1;1;1;1;1;1","NEUROLOGICAL;CANCER","4;2","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;4.5 RESOURCES AND INFRASTRUCTURE (DETECTION);5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT);6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION);7.1 INDIVIDUAL CARE NEEDS;7.3 MANAGEMENT AND DECISION MAKING;8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)","8;2;2;1;1;1;1;1;1;1;1","BRAIN TUMOR;NOT SITE-SPECIFIC CANCER","1;1","4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1;1;1",4,4573374,421368.88,5.25,17,9,1,35.75,1252819.18772252,0.21311934125576,"ISTITUTO NEUROLOGICO CARLO BESTA;NEWCASTLE UNIVERSITY;AGÈNCIA DE QUALITAT I AVALUACIÓ SANITÀRIES DE CATALUNYA;ARISTOTLE UNIVERSITY OF THESSALONIKI;ASTRAZENECA (UNITED KINGDOM);CAREERS RESEARCH AND ADVISORY CENTRE (UNITED KINGDOM);CATHOLIC UNIVERSITY OF THE SACRED HEART;CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS;CF CONSULTING FINANZIAMENTI UNIONE EUROPEA;COLUMBIA UNIVERSITY;COLUMBIA UNIVERSITY IRVING MEDICAL CENTER;CONSEJERÍA DE SALUD Y FAMILIAS;EUROHEALTHNET;FEDERAL AGENCY FOR FOOD CHAIN SAFETY;FINNISH INSTITUTE FOR HEALTH AND WELFARE;FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI;FRENCH NATIONAL CANCER INSTITUTE;GHENT UNIVERSITY;HADASSAH MEDICAL CENTER;HARVARD UNIVERSITY","4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;MEDICAL RESEARCH COUNCIL","3;1","COALITION S;EC & ERC - EUROPEAN UNION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","4;3;1;1","3RD HEALTH PROGRAMME (PROGRAMME);H2020-EU.1.3. - EXCELLENT SCIENCE - MARIE SKŁODOWSKA-CURIE ACTIONS (PROGRAMME);H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-MSCA-ITN-2016 (CALL FOR PROPOSAL);INTRAMURAL (PROJECT CATEGORY);MSCA-ITN-ETN - EUROPEAN TRAINING NETWORKS (FUNDING SCHEME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3202 CLINICAL SCIENCES;3209 NEUROSCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH","2;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;BIOTECHNOLOGY;CANCER;GENETICS;HUMAN GENOME;NEUROSCIENCES;BRAIN CANCER;BRAIN DISORDERS;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEALTH SERVICES;NEURODEGENERATIVE;ORPHAN DRUG;PAIN RESEARCH;PERIPHERAL NEUROPATHY;PREVENTION;RARE DISEASES","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;GENERIC HEALTH RELEVANCE;METABOLIC AND ENDOCRINE","2;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;6.1 PHARMACEUTICALS","2;1;1;1;1;1","NOT SITE-SPECIFIC CANCER;BRAIN TUMOR","2;1","1.1 NORMAL FUNCTIONING;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1;1","A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","3;1","8 DECENT WORK AND ECONOMIC GROWTH","1",19,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","11;8","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3209 NEUROSCIENCES;49 MATHEMATICAL SCIENCES;3202 CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;4905 STATISTICS;52 PSYCHOLOGY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3204 IMMUNOLOGY;38 ECONOMICS;3802 ECONOMETRICS;5202 BIOLOGICAL PSYCHOLOGY","22;5;5;5;3;2;2;2;1;1;1;1;1;1","NEUROSCIENCES;AUTOIMMUNE DISEASE;BRAIN DISORDERS;GENETICS;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ALZHEIMER'S DISEASE RELATED DEMENTIAS (ADRD);BIOTECHNOLOGY;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DEMENTIA;FRONTOTEMPORAL DEMENTIA (FTD);NEURODEGENERATIVE;PREVENTION;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL","2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS","2;1;1;1","BIOMEDICAL;CLINICAL","2;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","4;2","NOT SITE-SPECIFIC CANCER","1",NA,NA
"IRCCS_BESTA",2018,304,16.5921052631579,3.25328947368421,0.282894736842105,0.279605263157895,0.37171052631579,2.45409429280397,1.17808219178082,1.34920634920635,1.18947368421053,0.605263157894737,0,149,95,29,8,0.49,0.31,0.1,0.03,33,1.08167447736856,6.22586439155814,0.526315789473684,0.93421052631579,0.469,0.412,0.414,0.436,"FABRIZIO TAGLIAVINI;FRANCESCO DIMECO;PAOLO FERROLI;MATILDE LEONARDI;FRANCESCO PRADA;ANTONIO SILVANI;CINZIA GELLERA;GIOVANNI BARANELLO;MARIA GRAZIA BRUZZONE;MARICA EOLI;GIORGIO GIACCONE;GIUSEPPE LAURIA;BIANCA POLLO;ELENA FRERI;SILVANA FRANCESCHETTI;ANDREA PACE;MARINA MORA;BARBARA GARAVAGLIA;RENATO MANTEGAZZA;LUISA BENUSSI","19;16;15;14;14;13;13;12;12;12;11;11;10;10;9;9;9;8;8;8","MATILDE LEONARDI;FRANCESCO DIMECO;FRANCESCO PRADA;PAOLO FERROLI;ANTONIO SILVANI;FABRIZIO TAGLIAVINI;MARIA GRAZIA BRUZZONE;MARCO DE CURTIS;GIOVANNI BARANELLO;BIANCA POLLO;MORGAN BROGGI;IGNAZIO G. VETRANO;ANGELO FRANZINI;CINZIA GELLERA;GIUSEPPE LAURIA;EMANUELE LA CORTE;GIORGIO GIACCONE;BEATA TOBIASZ–ADAMCZYK;MARICA EOLI;LICIA GRAZZI","1.79;1.67;1.62;1.59;1.45;1.3;1.18;1.07;1.01;1;0.99;0.96;0.94;0.92;0.87;0.85;0.84;0.81;0.79;0.78","FABRIZIO TAGLIAVINI;FRANCESCO DIMECO;PAOLO FERROLI;MATILDE LEONARDI;FRANCESCO PRADA;ANTONIO SILVANI;CINZIA GELLERA;GIOVANNI BARANELLO;MARIA GRAZIA BRUZZONE;MARICA EOLI;GIORGIO GIACCONE;GIUSEPPE LAURIA;BIANCA POLLO;ELENA FRERI;SILVANA FRANCESCHETTI;MARINA MORA;BARBARA GARAVAGLIA;RENATO MANTEGAZZA;LICIA GRAZZI;IGNAZIO G. VETRANO","19;16;15;14;14;13;13;12;12;12;11;11;10;10;9;9;8;8;8;8","MATILDE LEONARDI;FRANCESCO DIMECO;FRANCESCO PRADA;PAOLO FERROLI;ANTONIO SILVANI;FABRIZIO TAGLIAVINI;MARIA GRAZIA BRUZZONE;MARCO DE CURTIS;GIOVANNI BARANELLO;BIANCA POLLO;MORGAN BROGGI;IGNAZIO G. VETRANO;ANGELO FRANZINI;CINZIA GELLERA;GIUSEPPE LAURIA;EMANUELE LA CORTE;GIORGIO GIACCONE;MARICA EOLI;LICIA GRAZZI;DAVIDE GUIDO","1.79;1.67;1.62;1.59;1.45;1.3;1.18;1.07;1.01;1;0.99;0.96;0.94;0.92;0.87;0.85;0.84;0.79;0.78;0.78","FRANCESCO PRADA;FABRIZIO CALLIADA;FABRIZIO TAGLIAVINI;ADRIAN SǍFTOIU;ANDREA KLAUSER;ANNAMARIA DEGANELLO;CARLOS NICOLAU;CHRISTIAN JENSSEN;CHRISTIAN NOLSØE;CHRISTOPH F. DIETRICH;CHRISTOPHER HARVEY;DAVID O. COSGROVE;DIRK‐ANDRÉ CLEVERT;EDWARD LEEN;ERNST-MICHAEL JUNG;EVA BARTELS;FABIO PISCAGLIA;FRANCESCO MARIA DRUDI;HANS-PETER WESKOTT;HELMUT PROSCH","1366;1155;1106;1105;1105;1105;1105;1105;1105;1105;1105;1105;1105;1105;1105;1105;1105;1105;1105;1105","FRANCESCO PRADA;FABRIZIO TAGLIAVINI;FRANCESCO DIMECO;GIACOMINA ROSSI;VERONICA REDAELLI;GIUSEPPE LAURIA;GIORGIO GIACCONE;DINA BATTINO;MARINA GRISOLI;GAETANO FINOCCHIARO;CINZIA GELLERA;MASSIMILIANO DEL BENE;SARA PRIONI;SILVANA FRANCESCHETTI;VERONICA SALETTI;VALERIA TIRANTI;ELENA FRERI;BARBARA CASTELLOTTI;SILKE KROL;CATERINA MARIOTTI","1366;1106;733;577;487;465;435;434;413;411;374;370;360;352;330;310;293;286;277;262","FABRIZIO TAGLIAVINI;FRANCESCO DIMECO;PAOLO FERROLI;FRANCESCO PRADA;ANTONIO SILVANI;MATILDE LEONARDI;CINZIA GELLERA;GIOVANNI BARANELLO;GIORGIO GIACCONE;GIUSEPPE LAURIA;MARIA GRAZIA BRUZZONE;MARICA EOLI;BIANCA POLLO;MARINA MORA;ELENA FRERI;SILVANA FRANCESCHETTI;GAETANO FINOCCHIARO;BARBARA CASTELLOTTI;IGNAZIO G. VETRANO;LICIA GRAZZI","19;15;14;13;13;13;12;12;11;11;11;11;10;9;9;9;8;8;8;8","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;MATHEMATICS;ENGINEERING;MATERIALS SCIENCE;PHYSICS;SOCIOLOGY;ECONOMICS;POLITICAL SCIENCE;BUSINESS;PHILOSOPHY;GEOGRAPHY;GEOLOGY;HISTORY","263;125;57;36;30;21;15;14;13;13;9;8;5;5;3;2;1","INTERNAL MEDICINE;PATHOLOGY;GENETICS;NEUROSCIENCE;PSYCHIATRY;SURGERY;RADIOLOGY;BIOCHEMISTRY;CANCER RESEARCH;PEDIATRICS;ONCOLOGY;CELL BIOLOGY;ENDOCRINOLOGY;PHYSICAL THERAPY;PHYSICAL MEDICINE AND REHABILITATION;ARTIFICIAL INTELLIGENCE;ENVIRONMENTAL HEALTH;IMMUNOLOGY;BIOINFORMATICS;MEDICAL PHYSICS","152;93;74;69;61;50;47;37;37;31;29;27;22;21;17;15;14;14;13;13","DISEASE;GENE;MAGNETIC RESONANCE IMAGING;EPILEPSY;COHORT;COGNITION;GLIOMA;NEUROLOGY;ATROPHY;CHEMOTHERAPY;RANDOMIZED CONTROLLED TRIAL;CANCER;NEUROSURGERY;RADIATION THERAPY;CENTRAL NERVOUS SYSTEM;MIGRAINE;ADVERSE EFFECT;MITOCHONDRION;POPULATION;ULTRASOUND","77;69;31;26;21;18;18;15;14;14;14;13;13;13;12;12;11;11;11;11","MUTATION;PHENOTYPE;DEMENTIA;NEURODEGENERATION;SPINAL MUSCULAR ATROPHY;PARKINSON'S DISEASE;TEMOZOLOMIDE;ALZHEIMER'S DISEASE;AMYOTROPHIC LATERAL SCLEROSIS;GENOTYPE;MITOCHONDRIAL DNA;CLINICAL ENDPOINT;NEURORADIOLOGY;ALLELE;COLORECTAL CANCER;CYCLOPHOSPHAMIDE;SPINOCEREBELLAR ATAXIA;TOLERABILITY;UNIVARIATE ANALYSIS;WHITE MATTER","24;22;21;12;11;10;10;9;9;8;8;7;7;6;6;6;6;6;6;6","FRONTOTEMPORAL DEMENTIA;MISSENSE MUTATION;EXOME SEQUENCING;VINCRISTINE;DEEP BRAIN STIMULATION;SMN1;TAU PROTEIN;TRINUCLEOTIDE REPEAT EXPANSION;FRACTIONAL ANISOTROPY;REGORAFENIB;SINGLE-NUCLEOTIDE POLYMORPHISM;TRANSCRIPTOME;VAGUS NERVE STIMULATION;COMPOUND HETEROZYGOSITY;CREUTZFELDT-JAKOB SYNDROME;DEMENTIA WITH LEWY BODIES;GENETIC HETEROGENEITY;HEREDITARY SPASTIC PARAPLEGIA;LOSS FUNCTION;MITOCHONDRIAL FUSION;PERSISTENT VEGETATIVE STATE;TAUOPATHY","15;8;6;6;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3","HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;;AGED;BRAIN;BRAIN NEOPLASMS;YOUNG ADULT;MUTATION;GLIOMA;ADOLESCENT;MAGNETIC RESONANCE IMAGING;ANIMALS;CHILD;AGED, 80 AND OVER;FRONTOTEMPORAL DEMENTIA;ITALY;MITOCHONDRIA","201;156;151;100;93;89;68;63;53;47;41;40;39;38;37;35;30;29;28;25","GLIOMAS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PRION DISEASES: CAUSES AND MOLECULAR BASIS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MECHANISMS OF ALZHEIMER'S DISEASE;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;EPILEPSY AND SEIZURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;NEURO-IMMUNE MODULATION VIA VAGUS NERVE STIMULATION;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;STANDARDS AND GUIDELINES FOR GENETIC VARIANT INTERPRETATION;ADVANCES IN ULTRASOUND ELASTOGRAPHY IMAGING TECHNIQUES","22;12;11;10;10;8;7;7;6;6;6;5;4;4;4;4;4;4;4;3","NEURODEGENERATION;NEUROIMAGING;GLIOBLASTOMA;SPINAL MUSCULAR ATROPHY;TEMOZOLOMIDE;CLINICAL ENDPOINT;C9ORF72;MIGRAINE;MIGRAINE PREVENTION;NEURORADIOLOGY;ATAXIA;CHRONIC MIGRAINE;CROSS-SECTIONAL STUDY;EPILEPSY;FRONTOTEMPORAL LOBAR DEGENERATION;LOMUSTINE;RADIOTHERAPY;SMN1;SMN2;SURVIVAL MOTOR NEURON PROTEIN","16;14;12;12;11;8;7;7;7;7;6;6;6;6;6;6;6;6;6;6","ITALIAN ASSOCIATION;MUSCULAR ATROPHY;PHASE II;SPINAL MUSCULAR;CROSS-SECTIONAL STUDY;PILOT STUDY;AMYOTROPHIC LATERAL;FRONTOTEMPORAL DEMENTIA;GLIOBLASTOMA PATIENTS;ITALIAN PATIENTS;LATERAL SCLEROSIS;MULTIPLE SCLEROSIS;ALZHEIMERS DISEASE;CHRONIC MIGRAINE;DUCHENNE MUSCULAR;EUROPEAN COUNTRIES;MUSCULAR DYSTROPHY;RELAPSED GLIOBLASTOMA;SMA THERAPIES;THERAPIES II;UPDATED RESULTS;ACUTE TREATMENT;CLINICAL TRIAL;COHORT STUDY;COMPOUND HETEROZYGOUS;CONTROLLED OPEN-LABEL;CREUTZFELDT-JAKOB DISEASE;GENFI COHORT;GLIOMA SURGERY;IDH-WILD TYPE","8;8;7;7;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","MILAN ITALY;ITALY SEARCH;APPENDIX FIG;CAMBRIDGE CAMBRIDGE;CAMBRIDGE UK;CARLO BESTA;UK SEARCH;BIOMOLECOLARI UNIVERSITÀ;DEGLI STUDI;DI MILANO;DI SCIENZE;DIPARTIMENTO DI;DISFEB DIPARTIMENTO;MILANO MILAN;SCIENZE FARMACOLOGICHE;STUDI DI;TIM COMPLEX;UNIVERSITÀ DEGLI;BIOLOGY UNIT;UNIT UNIVERSITY;MUTANT FIBROBLASTS;WESTERN BLOT;PROTEIN LEVELS;SKELETAL MUSCLE;TIMM MUTANT;ISTITUTO NEUROLOGICO;NEUROLOGICO CARLO;BESTA MILAN;FONDAZIONE IRCCS;IRCCS ISTITUTO","57;50;37;29;29;27;26;25;25;25;25;25;25;25;25;25;25;25;24;24;23;22;21;21;21;20;20;19;19;19",190,0.62,9.25,8,2,2,1,3,2.25,0,1,8,0,1,7.25,1,1,2,3,5,3,0,0,75.75,75.75,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,2,0.2,2,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ABOU HAMDAN MOHAMAD;PEDOTTI ROSETTA","1;1","FONDAZIONE I R C C S ST NEUROLOGICO CARLO BESTA;FONDAZIONE IRCCS ISTITUTO NEUROLOGICO 'CARLO BESTA'","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;34 CHEMICAL SCIENCES","1;1;1","NEUROSCIENCES","1","5.1 PHARMACEUTICALS","1","A61K31/53;A61P25/00;A61P29/00;A61P37/00","1;1;1;1","A01K67/027;A61K31/53;A61P25/00;A61P29/00;A61P37/00;C07D251/46","1;1;1;1;1;1",6,4.5,151.67,1.6,4,0.67,22.83,0,0,0,0,2,0,0,4,0,6,0,0,0,0,0,0,0,6,0,0,6,0,0,0,0,0,0,0,0,0,"Italy;United States","3;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;5203 CLINICAL AND HEALTH PSYCHOLOGY","5;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;BEHAVIORAL AND SOCIAL SCIENCE;CHRONIC PAIN;COMPLEMENTARY AND INTEGRATIVE HEALTH;HEADACHES;MENTAL HEALTH;MIGRAINES;MIND AND BODY;PAIN RESEARCH;PREVENTION;AGING;BASIC BEHAVIORAL AND SOCIAL SCIENCE;DEPRESSION;NEURODEGENERATIVE;PARKINSON'S DISEASE","5;4;4;4;2;2;2;2;2;2;2;2;2;1;1;1;1;1","NEUROLOGICAL","1","6.1 PHARMACEUTICALS;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;7.1 INDIVIDUAL CARE NEEDS","2;2;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,"PUBLIC LIBRARY OF SCIENCE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;SPRINGER NATURE;FRONTIERS;TAYLOR & FRANCIS GROUP;ZENODO;AMERICAN CHEMICAL SOCIETY","13;3;3;2;2;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;49 MATHEMATICAL SCIENCES;52 PSYCHOLOGY;3202 CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;4904 PURE MATHEMATICS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;3209 NEUROSCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4202 EPIDEMIOLOGY;4203 HEALTH SERVICES AND SYSTEMS;4605 DATA MANAGEMENT AND DATA SCIENCE;3208 MEDICAL PHYSIOLOGY;44 HUMAN SOCIETY;4608 HUMAN-CENTRED COMPUTING;4905 STATISTICS","16;13;8;7;5;5;4;3;3;2;2;2;2;2;2;2;1;1;1;1","BRAIN DISORDERS;NEUROSCIENCES;NEURODEGENERATIVE;CLINICAL RESEARCH;AGING;PREVENTION;RARE DISEASES;ACQUIRED COGNITIVE IMPAIRMENT;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DEMENTIA;GENETICS;MULTIPLE SCLEROSIS;STROKE;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;CHRONIC PAIN;HEADACHES","8;7;6;4;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1","NEUROLOGICAL;CANCER;GENERIC HEALTH RELEVANCE;STROKE","7;2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;7.1 INDIVIDUAL CARE NEEDS;7.2 END OF LIFE CARE","6;1;1","BIOMEDICAL;CLINICAL;HEALTH SERVICES & SYSTEMS;POPULATION & SOCIETY","5;3;1;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE;HEALTH SERVICES RESEARCH;PUBLIC HEALTH","4;4;1;1","NOT SITE-SPECIFIC CANCER","3",NA,NA
"IRCCS_BESTA",2019,359,17.7242339832869,3.50696378830084,0.328690807799443,0.278551532033426,0.403899721448468,2.58847736625514,1.31111111111111,1.44927536231884,1.49484536082474,0.582172701949861,2,168,105,37,10,0.47,0.29,0.1,0.03,25.86,1.06360281545836,6.18406148867312,0.534818941504178,0.919220055710306,0.558,0.426,0.394,0.406,"FABRIZIO TAGLIAVINI;MARICA EOLI;GIOVANNI BARANELLO;BIANCA POLLO;MARIA GRAZIA BRUZZONE;GAETANO FINOCCHIARO;MATILDE LEONARDI;LORENZO MAGGI;ALESSANDRO PADOVANI;CHIARA PANTALEONI;EMILIO CIUSANI;GIUSEPPE LAURIA;EUGENIO MERCURI;DAVIDE PAREYSON;ENRICO BERTINI;ANTONIO SILVANI;STEFANO F. CAPPA;FRANCESCO DIMECO;RENATO MANTEGAZZA;PAOLO FERROLI","21;21;20;16;13;13;13;13;13;12;12;12;12;12;12;11;11;11;11;11","MATILDE LEONARDI;ANNA RITA GIOVAGNOLI;BIANCA POLLO;MARICA EOLI;GIOVANNI BARANELLO;IGNAZIO G. VETRANO;VERONICA SALETTI;FABRIZIO TAGLIAVINI;GAETANO FINOCCHIARO;CHIARA PANTALEONI;MARIA GRAZIA BRUZZONE;FRANCESCO ACERBI;ANGELO FRANZINI;LUISA CHIAPPARINI;FRANCESCO DIMECO;ALESSANDRA SOLARI;PAOLO FERROLI;VINCENZO LEVI;EMILIO CIUSANI;ROBERTO ELEOPRA","2.5;2.48;1.57;1.56;1.51;1.28;1.27;1.22;1.22;1.18;1.15;1.12;1.12;1.11;1.1;1.1;1.08;1.06;1.05;1.03","FABRIZIO TAGLIAVINI;MARICA EOLI;GIOVANNI BARANELLO;BIANCA POLLO;MARIA GRAZIA BRUZZONE;GAETANO FINOCCHIARO;MATILDE LEONARDI;LORENZO MAGGI;CHIARA PANTALEONI;EMILIO CIUSANI;GIUSEPPE LAURIA;DAVIDE PAREYSON;ANTONIO SILVANI;FRANCESCO DIMECO;RENATO MANTEGAZZA;PAOLO FERROLI;SILVANA FRANCESCHETTI;NARDO NARDOCCI;GIORGIO GIACCONE;IRENE TRAMACERE","21;21;20;16;13;13;13;13;12;12;12;12;11;11;11;11;11;11;10;10","MATILDE LEONARDI;ANNA RITA GIOVAGNOLI;BIANCA POLLO;MARICA EOLI;GIOVANNI BARANELLO;IGNAZIO G. VETRANO;VERONICA SALETTI;FABRIZIO TAGLIAVINI;GAETANO FINOCCHIARO;CHIARA PANTALEONI;MARIA GRAZIA BRUZZONE;FRANCESCO ACERBI;ANGELO FRANZINI;LUISA CHIAPPARINI;FRANCESCO DIMECO;ALESSANDRA SOLARI;PAOLO FERROLI;VINCENZO LEVI;EMILIO CIUSANI;ROBERTO ELEOPRA","2.5;2.48;1.57;1.56;1.51;1.28;1.27;1.22;1.22;1.18;1.15;1.12;1.12;1.11;1.1;1.1;1.08;1.06;1.05;1.03","MICHAEL WELLER;KENNETH ALDAPE;ANZHELA D. MOSKALIK;DAVID M. ASHLEY;EMRE KOCAKAVUK;FLORIS P BARTHEL;FREDERICK S. VARN;GEORGETTE TANNER;HO‐KEUNG NG;HUI GAN;KEVIN ANDERSON;KEVIN C. JOHNSON;KRISTIN ALFARO-MUNOZ;PRATITI BANDOPADHAYAY;SAMIRKUMAR B. AMIN;GRAZIA DEVIGILI;RENATO MANTEGAZZA;PIM J. FRENCH;FABRIZIO TAGLIAVINI;GAETANO FINOCCHIARO","891;833;802;802;802;802;802;802;802;802;802;802;802;802;802;718;628;625;617;613","GRAZIA DEVIGILI;RENATO MANTEGAZZA;GAETANO FINOCCHIARO;FABRIZIO TAGLIAVINI;GIUSEPPE LAURIA;ROBERTO ELEOPRA;MARICA EOLI;GIOVANNI BARANELLO;LAURA FARISELLI;RAFFAELLA LOMBARDI;NARDO NARDOCCI;FEDERICA ZIBORDI;LORENZO MAGGI;GIOVANNA ZORZI;LUIGI ROMITO;GIORGIO B. BONCORAGLIO;VERONICA SALETTI;BIANCA POLLO;DAVIDE PAREYSON;CLAUDIO CACCIA","718;628;613;549;471;379;375;346;344;339;318;311;289;281;277;248;239;230;228;220","MARICA EOLI;FABRIZIO TAGLIAVINI;GIOVANNI BARANELLO;BIANCA POLLO;MATILDE LEONARDI;GAETANO FINOCCHIARO;MARIA GRAZIA BRUZZONE;LORENZO MAGGI;GIUSEPPE LAURIA;DAVIDE PAREYSON;FRANCESCO DIMECO;RENATO MANTEGAZZA;ANTONIO SILVANI;CHIARA PANTALEONI;NARDO NARDOCCI;PAOLO FERROLI;SILVANA FRANCESCHETTI;FRANCO TARONI;EMILIO CIUSANI;IRENE TRAMACERE","21;19;17;15;13;13;13;13;12;12;11;11;11;11;11;11;10;9;9;9","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;ENGINEERING;MATERIALS SCIENCE;ECONOMICS;SOCIOLOGY;POLITICAL SCIENCE;BUSINESS;ART;GEOGRAPHY;GEOLOGY;HISTORY","305;151;72;47;35;28;23;13;12;8;7;7;6;3;2;2;2;2","INTERNAL MEDICINE;PATHOLOGY;GENETICS;PSYCHIATRY;SURGERY;NEUROSCIENCE;RADIOLOGY;BIOCHEMISTRY;PEDIATRICS;CANCER RESEARCH;ONCOLOGY;PHYSICAL THERAPY;IMMUNOLOGY;CELL BIOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ANESTHESIA;ENDOCRINOLOGY;QUANTUM MECHANICS;DEVELOPMENTAL PSYCHOLOGY;PHARMACOLOGY","186;110;94;90;62;61;51;45;45;43;31;31;30;28;26;23;21;19;17;16","DISEASE;GENE;EPILEPSY;MAGNETIC RESONANCE IMAGING;COHORT;NEUROLOGY;CANCER;CLINICAL TRIAL;COGNITION;CHEMOTHERAPY;RANDOMIZED CONTROLLED TRIAL;GLIOMA;POPULATION;ADVERSE EFFECT;ALTERNATIVE MEDICINE;MULTIPLE SCLEROSIS;RECEPTOR;IN VITRO;MITOCHONDRION;SMA*","96;90;31;29;27;25;20;19;17;16;15;13;13;12;12;12;12;11;11;11","MUTATION;DEMENTIA;PHENOTYPE;PARKINSON'S DISEASE;NEURORADIOLOGY;WHITE MATTER;CLINICAL ENDPOINT;GENOME;MITOCHONDRIAL DNA;NEUROPSYCHOLOGY;PLACEBO;GENOTYPE;MOVEMENT DISORDERS;MUTANT;SPINAL MUSCULAR ATROPHY;TEMOZOLOMIDE;TOLERABILITY;SPINOCEREBELLAR ATAXIA;AGE OF ONSET;AMYOTROPHIC LATERAL SCLEROSIS;AUTOANTIBODY;CEREBELLAR ATAXIA;CHROMOSOME;GENE DUPLICATION;MOTOR NEURON;NEURODEGENERATION;PRION PROTEIN;RNA","35;25;25;17;12;9;8;8;8;8;8;7;7;7;7;7;7;6;5;5;5;5;5;5;5;5;5;5","FRONTOTEMPORAL DEMENTIA;DEEP BRAIN STIMULATION;MISSENSE MUTATION;MITOCHONDRIAL DISEASE;COPY-NUMBER VARIATION;EXOME SEQUENCING;DEMENTIA WITH LEWY BODIES;COMPOUND HETEROZYGOSITY;DOUBLE BLIND;GENETIC HETEROGENEITY;PROBAND;FLUORESCENCE IN SITU HYBRIDIZATION;FRAMESHIFT MUTATION;GENE MUTATION;INDUCED PLURIPOTENT STEM CELL;LEWY BODY;MITOCHONDRIAL MYOPATHY;PERSISTENT VEGETATIVE STATE;SCRAPIE;SMN1;SOD1;VINCRISTINE","15;13;10;7;6;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","HUMANS;FEMALE;MALE;;ADULT;MIDDLE AGED;AGED;MAGNETIC RESONANCE IMAGING;CHILD;BRAIN;YOUNG ADULT;ADOLESCENT;MUTATION;EPILEPSY;GLIOBLASTOMA;ANIMALS;CHILD, PRESCHOOL;ITALY;BRAIN NEOPLASMS;FRONTOTEMPORAL DEMENTIA","215;149;146;126;96;95;58;47;44;43;43;42;41;39;35;34;34;33;32;31","GLIOMAS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;EPILEPSY AND SEIZURES;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;PRION DISEASES: CAUSES AND MOLECULAR BASIS;MULTIPOTENT MESENCHYMAL STEM CELLS;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS","23;14;14;13;13;12;12;11;10;9;8;8;7;7;7;6;5;4;4;4","NEURODEGENERATION;DEEP BRAIN STIMULATION;NEURORADIOLOGY;SPINAL MUSCULAR ATROPHY;EPILEPSY;CLINICAL ENDPOINT;TREATMENT;CHARCOT-MARIE-TOOTH DISEASE;GLIOBLASTOMA;NEUROFIBROMATOSIS;MITOCHONDRIAL DISEASE;MOVEMENT DISORDERS;TEMOZOLOMIDE;TOLERABILITY;C9ORF72;EEG ANALYSIS;MENINGIOMAS;NEUROIMAGING;NEUROMODULATION;SKELETAL MUSCLE ATROPHY","16;13;12;12;11;10;10;9;9;8;7;7;7;7;6;6;6;6;6;6","BRAIN STIMULATION;DEEP BRAIN;FRONTOTEMPORAL DEMENTIA;MULTIPLE SCLEROSIS;MUSCULAR ATROPHY;SPINAL MUSCULAR;MUSCULAR DYSTROPHY;MYASTHENIA GRAVIS;PHASE II;RANDOMIZED PHASE;DUCHENNE MUSCULAR;GENETIC FRONTOTEMPORAL;AMYOTROPHIC LATERAL;CENTRAL NERVOUS;CHARCOTMARIETOOTH DISEASE;FAT TISSUE;LATERAL SCLEROSIS;LONGITUDINAL STUDY;NATURAL HISTORY;NERVOUS SYSTEM;SPINOCEREBELLAR ATAXIA;TYPE SMA;ATROPHY TYPE;BRAIN TUMOR;CANCER CHEMOTHERAPY;CELL IMMUNOTHERAPY;CHRONIC MIGRAINE;CLINICAL SPECTRUM;CLINICAL TRIAL;COHORT STUDY","11;11;11;11;9;9;8;7;7;7;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","FRONTOTEMPORAL DEMENTIA;ADVERSE EVENTS;CARLO BESTA;IRCCS ISTITUTO;ISTITUTO NEUROLOGICO;MAGNETIC RESONANCE;NEUROLOGICO CARLO;FONDAZIONE IRCCS;RESONANCE IMAGING;INTELLECTUAL DISABILITY;MUTATION CARRIERS;ISCHEMIC STROKE;ROME ITALYSEARCH;NRF EXPRESSION;NRF RED;DI SCIENZE;DIPARTIMENTO DI;FANELLI SAPIENZA;MILAN ITALYSEARCH;ROSSI FANELLI;SAPIENZA UNIVERSITY;SCIENZE BIOCHIMICHE;STEM CELL;BESTA MILAN;CELL TRANSPLANTATION;DISEASE PROGRESSION;FOCAL CORTICAL;GENETIC FRONTOTEMPORAL;MULTIPLE SCLEROSIS;OPTIC NERVE","27;23;23;21;21;21;21;19;18;17;17;16;16;15;15;14;14;14;14;14;14;14;14;13;13;13;13;13;13;13",210,0.58,9.22,7,2,1.75,0,2,1,1,1,8,1.75,1,7,1,3.5,2,2,5,3,0,0,66.5,66.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,4.26,382.74,4.56,10,0.48,53,0,1,7,1,9,0,1,2,0,17,2,0,0,0,0,0,0,21,0,0,19,2,0,0,0,0,0,0,0,0,"United States;Italy;Switzerland;United Kingdom;Germany;Norway","6;2;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3206 MEDICAL BIOTECHNOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;46 INFORMATION AND COMPUTING SCIENCES;4610 LIBRARY AND INFORMATION STUDIES;49 MATHEMATICAL SCIENCES","20;13;4;4;3;2;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;BRAIN DISORDERS;RARE DISEASES;NEURODEGENERATIVE;PATIENT SAFETY;CHRONIC PAIN;HEADACHES;MIGRAINES;PAIN RESEARCH;PEDIATRIC;PREVENTION;BRAIN CANCER;CANCER;COMPLEMENTARY AND INTEGRATIVE HEALTH;EMERGING INFECTIOUS DISEASES;HUNTINGTON'S DISEASE;NUTRITION;ORPHAN DRUG","18;15;14;11;10;8;7;5;5;5;5;5;5;3;3;2;2;2;2;2","NEUROLOGICAL;CANCER;MUSCULOSKELETAL","7;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;5.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES","17;3;2;1","BRAIN TUMOR","3","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","3;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;ZENODO;SPRINGER NATURE;TAYLOR & FRANCIS GROUP","8;5;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;3105 GENETICS;39 EDUCATION;3101 BIOCHEMISTRY AND CELL BIOLOGY;4203 HEALTH SERVICES AND SYSTEMS;49 MATHEMATICAL SCIENCES;52 PSYCHOLOGY;3202 CLINICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;3901 CURRICULUM AND PEDAGOGY;47 LANGUAGE, COMMUNICATION AND CULTURE;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;3904 SPECIALIST STUDIES IN EDUCATION;46 INFORMATION AND COMPUTING SCIENCES;4703 LANGUAGE STUDIES;4704 LINGUISTICS","15;12;6;4;4;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;NEUROSCIENCES;RARE DISEASES;AGING;BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;EYE DISEASE AND DISORDERS OF VISION;GENETICS;NEURODEGENERATIVE;ANTIMICROBIAL RESISTANCE;AUTOIMMUNE DISEASE;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY;BRAIN DISORDERS;CANCER;COMPLEMENTARY AND INTEGRATIVE HEALTH;MYASTHENIA GRAVIS;NUTRITION;PREVENTION","6;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;CANCER;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL","3;2;1;1","7.1 INDIVIDUAL CARE NEEDS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","3;2;2;1;1","BIOMEDICAL;CLINICAL;POPULATION & SOCIETY","3;2;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;HEALTH SERVICES RESEARCH;PUBLIC HEALTH","7;4;3;1","BRAIN TUMOR;NOT SITE-SPECIFIC CANCER;MYELOMA","2;2;1","4 QUALITY EDUCATION","1"
"IRCCS_BESTA",2020,425,18.1976470588235,3.19294117647059,0.296470588235294,0.251764705882353,0.362352941176471,3.11238532110092,1.41573033707865,1.48611111111111,1.46666666666667,0.670588235294118,4,198,121,36,17,0.47,0.28,0.08,0.04,23.16,0.919006524455479,6.94638359121986,0.545882352941176,0.931764705882353,0.512,0.447,0.391,0.456,"GIUSEPPE LAURIA;MATILDE LEONARDI;FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;ROBERTO ELEOPRA;BARBARA BORRONI;JAMES B. ROWE;MATTHIS SYNOFZIK;DANIELA GALIMBERTI;CINZIA GELLERA;DAVIDE PAREYSON;RAQUEL SÁNCHEZ‐VALLE;JONATHAN D. ROHRER;LORENZO MAGGI;ADRIAN DANEK;FRANCO TARONI;CAROLINE GRAFF;MARIA GRAZIA BRUZZONE;MARIA CARMELA TARTAGLIA;CHIARA PANTALEONI","25;23;22;19;19;19;17;17;17;16;15;15;15;15;15;15;14;14;14;14","MATILDE LEONARDI;GIUSEPPE LAURIA;RENATO MANTEGAZZA;LICIA GRAZZI;ROBERTO ELEOPRA;GAETANO FINOCCHIARO;IGNAZIO G. VETRANO;FRANCESCO DIMECO;FRANCESCO ACERBI;MARCO DE CURTIS;ROBERTO CILIA;CINZIA GELLERA;ANNA RITA GIOVAGNOLI;ANNA BERSANO;CHIARA PANTALEONI;PAOLO FERROLI;MARIA GRAZIA BRUZZONE;LORENZO MAGGI;ORSO BUGIANI;MORGAN BROGGI","2.52;2.28;2.05;2.05;1.47;1.45;1.42;1.37;1.36;1.33;1.3;1.23;1.2;1.19;1.19;1.18;1.09;1.08;1;0.99","GIUSEPPE LAURIA;MATILDE LEONARDI;FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;ROBERTO ELEOPRA;CINZIA GELLERA;DAVIDE PAREYSON;LORENZO MAGGI;FRANCO TARONI;MARIA GRAZIA BRUZZONE;CHIARA PANTALEONI;PAOLO FERROLI;ROBERTO CILIA;CATERINA MARIOTTI;FRANCESCO ACERBI;IRENE TRAMACERE;FRANCESCO DIMECO;LAURA CANAFOGLIA;STEFANIA MAGRI;ANNA BERSANO","25;23;22;19;19;16;15;15;15;14;14;14;14;14;12;12;12;11;11;11","MATILDE LEONARDI;GIUSEPPE LAURIA;RENATO MANTEGAZZA;LICIA GRAZZI;ROBERTO ELEOPRA;GAETANO FINOCCHIARO;IGNAZIO G. VETRANO;FRANCESCO DIMECO;FRANCESCO ACERBI;MARCO DE CURTIS;ROBERTO CILIA;CINZIA GELLERA;ANNA RITA GIOVAGNOLI;ANNA BERSANO;CHIARA PANTALEONI;PAOLO FERROLI;MARIA GRAZIA BRUZZONE;LORENZO MAGGI;ORSO BUGIANI;MORGAN BROGGI","2.52;2.28;2.05;2.05;1.47;1.45;1.42;1.37;1.36;1.33;1.3;1.23;1.2;1.19;1.19;1.18;1.09;1.08;1;0.99","RENATO MANTEGAZZA;MATTHIS SYNOFZIK;FABRIZIO TAGLIAVINI;ANNA BERSANO;GIUSEPPE LAURIA;BARBARA BORRONI;JAMES B. ROWE;FRANCO TARONI;ROBERTO ELEOPRA;DANIELA GALIMBERTI;RAQUEL SÁNCHEZ‐VALLE;ADRIAN DANEK;JONATHAN D. ROHRER;ALEXANDER GERHARD;ALEXANDRE DE MENDONÇA;CAROLINE GRAFF;CHRISTOPHER BUTLER;ELIZABETH FINGER;FERMÍN MORENO;ISABEL SANTANA","741;672;610;600;598;594;525;512;486;470;457;453;453;446;446;446;446;446;446;446","RENATO MANTEGAZZA;ANNA BERSANO;FABRIZIO TAGLIAVINI;GIUSEPPE LAURIA;FRANCO TARONI;ROBERTO ELEOPRA;DAVIDE PAREYSON;MATILDE LEONARDI;ETTORE SALSANO;IRENE TRAMACERE;GRAZIA DEVIGILI;ROBERTO CILIA;LORENZO MAGGI;CATERINA MARIOTTI;STEFANIA MAGRI;ALBERTO BIZZI;CINZIA GELLERA;LICIA GRAZZI;TIZIANA GRANATA;SALVATORE BONVEGNA","741;600;573;562;512;486;428;421;381;379;353;344;343;334;333;309;278;262;259;236","GIUSEPPE LAURIA;MATILDE LEONARDI;FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;ROBERTO ELEOPRA;CINZIA GELLERA;LORENZO MAGGI;DAVIDE PAREYSON;FRANCO TARONI;CATERINA MARIOTTI;CHIARA PANTALEONI;MARIA GRAZIA BRUZZONE;PAOLO FERROLI;ROBERTO CILIA;IRENE TRAMACERE;ANNA BERSANO;LAURA CANAFOGLIA;ISABELLA MORONI;FRANCESCO ACERBI;DAVIDE ROSSI SEBASTIANO","24;23;21;19;19;16;15;15;15;14;14;14;13;12;12;11;11;11;11;10","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;ENGINEERING;MATHEMATICS;ECONOMICS;SOCIOLOGY;POLITICAL SCIENCE;PHILOSOPHY;GEOGRAPHY;BUSINESS;MATERIALS SCIENCE;ART;HISTORY","388;162;117;45;35;31;25;24;22;22;14;11;9;8;4;2;1","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;GENETICS;NEUROSCIENCE;SURGERY;PEDIATRICS;RADIOLOGY;BIOCHEMISTRY;PHYSICAL THERAPY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;IMMUNOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ANESTHESIA;CANCER RESEARCH;ONCOLOGY;AUDIOLOGY;INTENSIVE CARE MEDICINE;BIOINFORMATICS","238;118;107;99;90;67;54;53;43;38;34;33;31;28;23;22;22;21;20;19","DISEASE;GENE;COHORT;EPILEPSY;NEUROLOGY;MAGNETIC RESONANCE IMAGING;POPULATION;COGNITION;NEUROSURGERY;RECEPTOR;ATAXIA;ALTERNATIVE MEDICINE;ADVERSE EFFECT;OUTBREAK;ATROPHY;RANDOMIZED CONTROLLED TRIAL;DYSTONIA;MULTIPLE SCLEROSIS;ANTIBODY;DIABETES MELLITUS;ELECTROENCEPHALOGRAPHY;MIGRAINE","143;96;37;37;35;32;31;24;23;19;18;16;15;15;14;14;13;13;12;12;12;12","PHENOTYPE;DEMENTIA;MUTATION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);PARKINSON'S DISEASE;NEURORADIOLOGY;ALLELE;2019-20 CORONAVIRUS OUTBREAK;GENOTYPE;PARKINSONISM;AMYOTROPHIC LATERAL SCLEROSIS;NEUROPSYCHOLOGY;CLINICAL ENDPOINT;DIFFUSION MRI;MUTANT;PLACEBO;EPILEPSY SURGERY;GENE EXPRESSION;HUNTINGTON'S DISEASE;MINIMALLY CONSCIOUS STATE;MITOCHONDRIAL DNA;NEURODEGENERATION;SPINOCEREBELLAR ATAXIA","35;32;32;29;28;20;16;13;11;11;10;8;7;7;7;7;6;6;6;6;6;6;6","CORONAVIRUS DISEASE 2019 (COVID-19);FRONTOTEMPORAL DEMENTIA;EXOME SEQUENCING;MISSENSE MUTATION;COMPOUND HETEROZYGOSITY;TRINUCLEOTIDE REPEAT EXPANSION;DEEP BRAIN STIMULATION;GENETIC HETEROGENEITY;PERSISTENT VEGETATIVE STATE;SANGER SEQUENCING;HUNTINGTIN;LEVODOPA;PENETRANCE;SINGLE-NUCLEOTIDE POLYMORPHISM;COGNITIVE DECLINE;DYSKINESIA;ECULIZUMAB;GLOBAL DEVELOPMENTAL DELAY;DEMENTIA WITH LEWY BODIES;MITOCHONDRIAL DISEASE;TAU PROTEIN;VINCRISTINE;WILD TYPE","29;22;11;11;10;8;6;6;6;6;5;5;5;5;4;4;4;4;3;3;3;3;3","HUMANS;;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;MAGNETIC RESONANCE IMAGING;MUTATION;ADOLESCENT;BRAIN;YOUNG ADULT;ITALY;CHILD;FRONTOTEMPORAL DEMENTIA;BRAIN NEOPLASMS;CHILD, PRESCHOOL;ANIMALS;PARKINSON DISEASE;CHARCOT-MARIE-TOOTH DISEASE","232;181;130;126;95;86;56;51;50;49;49;45;44;41;32;30;29;26;26;25","GLIOMAS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;EPILEPSY AND SEIZURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;GUILLAIN-BARRÉ SYNDROME AND RELATED NEUROPATHIES;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;PRION DISEASES: CAUSES AND MOLECULAR BASIS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS","20;19;15;13;12;11;11;10;9;9;9;9;8;7;7;7;7;5;5;5","NEURODEGENERATION;NEURORADIOLOGY;2019-20 CORONAVIRUS OUTBREAK;C9ORF72;EPILEPSY;PANDEMIC;DIAGNOSTIC CRITERIA;ATAXIA;COMPOUND HETEROZYGOSITY;NEUROIMAGING DATA ANALYSIS;SPINAL MUSCULAR ATROPHY;STROKE (ENGINE);TREATMENT;CHARCOT-MARIE-TOOTH DISEASE;NEUROIMAGING;SKELETAL MUSCLE ATROPHY;CLINICAL ENDPOINT;DEPRESSION (ECONOMICS);DYSTONIA;AGING","22;19;15;13;13;13;11;10;10;10;10;9;9;8;8;8;7;7;7;6","MULTIPLE SCLEROSIS;FRONTOTEMPORAL DEMENTIA;PARKINSONS DISEASE;AMYOTROPHIC LATERAL;LATERAL SCLEROSIS;MYASTHENIA GRAVIS;GENETIC FRONTOTEMPORAL;MUSCULAR DYSTROPHY;ITALIAN ASSOCIATION;MAGNETIC RESONANCE;MUSCULAR ATROPHY;SPINAL MUSCULAR;CHRONIC MIGRAINE;COVID- PANDEMIC;DE NOVO;MULTICENTER STUDY;PILOT STUDY;CLINICAL TRIAL;FRIEDREICHS ATAXIA;GENFI COHORT;HEALTHY AGEING;HUNTINGTONS DISEASE;ITALIAN PATIENTS;PROGRESSIVE MULTIPLE;RESONANCE IMAGING;ATHLOS CONSORTIUM;ATROPHY TYPE;BECKER MUSCULAR;BOTULINUM TOXIN;BRAIN FUNCTIONAL","16;14;14;9;9;9;8;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3","TYNE UK;MUTATION CARRIERS;SCIENCEGOOGLE SCHOLAR;DIJON FRANCE;MYASTHENIA GRAVIS;CARLO BESTA;FRONTOTEMPORAL DEMENTIA;NEWCASTLE UNIVERSITY;UNIVERSITY NEWCASTLE;ISTITUTO NEUROLOGICO;NEUROLOGICO CARLO;PARKINSONS DISEASE;FRANCE SEARCH;FONDAZIONE IRCCS;DE NOVO;INTELLECTUAL DISABILITY;CENTRE DE;IRCCS ISTITUTO;MAGNETIC RESONANCE;DE GÉNÉTIQUE;AUTOSOMAL DOMINANT;BOURGOGNE DIJON;CHU DIJON;DIJON BOURGOGNE;FHU-TRANSLAD CHU;MALADIES RARES;MILAN ITALY;ITALY SEARCH;PATHOGENIC VARIANTS;RESONANCE IMAGING","38;35;34;32;32;29;29;29;29;27;27;27;26;25;24;24;23;23;23;22;21;21;21;21;21;21;21;20;20;20",286,0.67,12.34,11,2,1,0,2,3,1,1,12,1,1,11,1,1.5,2,3,8,4,0,0,61.75,61.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,2.93,333.67,3.69,11,0.73,52,0,0,1,1,5,0,1,7,0,12,3,0,0,0,0,0,0,15,0,0,13,0,0,2,0,0,0,0,0,0,"Italy;United States;Belgium;Japan","7;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS","13;7;5;5;3;2;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;BRAIN DISORDERS;NEURODEGENERATIVE;RARE DISEASES;CHRONIC PAIN;PAIN RESEARCH;PREVENTION;BEHAVIORAL AND SOCIAL SCIENCE;CANCER;HEADACHES;MIGRAINES;AUTOIMMUNE DISEASE;BRAIN CANCER;COMPLEMENTARY AND INTEGRATIVE HEALTH;DENTAL/ORAL AND CRANIOFACIAL DISEASE;HEALTH SERVICES;MENTAL HEALTH;MIND AND BODY","15;11;11;8;6;6;4;4;4;3;3;3;3;2;2;2;2;2;2;2","NEUROLOGICAL;CANCER;INFECTION;MENTAL HEALTH","8;3;1;1","6.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;4.5 RESOURCES AND INFRASTRUCTURE (DETECTION);5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;7.2 END OF LIFE CARE;7.3 MANAGEMENT AND DECISION MAKING","9;3;2;1;1;1;1;1;1;1","BRAIN TUMOR;BREAST CANCER;NOT SITE-SPECIFIC CANCER","2;1;1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;6.6 END-OF-LIFE CARE","2;1;1",4,1499318.67,142206.22,4,10.25,5.25,0.5,26.75,742122.921330855,0.572681408678018,"ISTITUTO NEUROLOGICO CARLO BESTA;AUGUST PI I SUNYER BIOMEDICAL RESEARCH INSTITUTE;AUSTRALIAN NATIONAL UNIVERSITY;AUTONOMOUS UNIVERSITY OF MADRID;CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI;DONOSTIA UNIBERTSITATE OSPITALEA;ERASMUS MC;ERASMUS UNIVERSITY ROTTERDAM;KAROLINSKA INSTITUTET;LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN;MCGILL UNIVERSITY;NOFER INSTITUTE OF OCCUPATIONAL MEDICINE;PARC SANITARI SANT JOAN DE DÉU;PITIÉ-SALPÊTRIÈRE HOSPITAL;SWISS PARAPLEGIC RESEARCH;UNIVERSITAIR ZIEKENHUIS LEUVEN;UNIVERSITY COLLEGE LONDON;UNIVERSITY OF BRESCIA;UNIVERSITY OF CALIFORNIA, SAN FRANCISCO;UNIVERSITY OF CAMBRIDGE","4;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;ITALIAN ASSOCIATION FOR CANCER RESEARCH;MEDICAL RESEARCH COUNCIL;TELETHON FOUNDATION","1;1;1;1","COALITION S;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;EC & ERC - EUROPEAN UNION;UKRI - UK RESEARCH AND INNOVATION","2;2;1;1","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);RESEARCH GRANT (PROJECT CATEGORY);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","1;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH","2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;BRAIN DISORDERS;NEUROSCIENCES;RARE DISEASES;GENETICS;NEURODEGENERATIVE;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ALZHEIMER'S DISEASE RELATED DEMENTIAS (ADRD);BEHAVIORAL AND SOCIAL SCIENCE;BRAIN CANCER;CANCER;COMPARATIVE EFFECTIVENESS RESEARCH;DEMENTIA;FRONTOTEMPORAL DEMENTIA (FTD);HUMAN GENOME;IMMUNIZATION;MENTAL HEALTH;PREVENTION","4;3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL;CANCER","2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELLBEING;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS","2;1;1;1;1","BRAIN TUMOR","1","1.4 CANCER PROGRESSION AND METASTASIS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1;1","A01 CLINICAL MEDICINE;A02 PUBLIC HEALTH, HEALTH SERVICES AND PRIMARY CARE;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE","2;1;1",NA,NA,57,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;KARGER PUBLISHERS;THE CAMBRIDGE STRUCTURAL DATABASE;UNIVERSITY COLLEGE LONDON;ZENODO;TAYLOR & FRANCIS GROUP","27;16;3;2;2;2;2;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3202 CLINICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;3105 GENETICS;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;3208 MEDICAL PHYSIOLOGY;4202 EPIDEMIOLOGY;52 PSYCHOLOGY","41;32;30;17;10;7;6;5;3;3;3;2;2;2","BRAIN DISORDERS;NEUROSCIENCES;NEURODEGENERATIVE;CLINICAL RESEARCH;AGING;PARKINSON'S DISEASE;ACQUIRED COGNITIVE IMPAIRMENT;DEMENTIA;GENETICS;PEDIATRIC;RARE DISEASES;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);AUTOIMMUNE DISEASE;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EPILEPSY;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;GENETIC TESTING;MENTAL HEALTH","31;28;25;16;9;9;8;8;8;8;7;6;6;5;5;4;4;3;3;3","NEUROLOGICAL;GENERIC HEALTH RELEVANCE;MUSCULOSKELETAL","18;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;7.1 INDIVIDUAL CARE NEEDS;7.3 MANAGEMENT AND DECISION MAKING;2.4 SURVEILLANCE AND DISTRIBUTION;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;8.1 ORGANISATION AND DELIVERY OF SERVICES","14;6;3;3;2;1;1;1","CLINICAL;BIOMEDICAL;POPULATION & SOCIETY","14;13;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","15;11;1","BRAIN TUMOR","4","4 QUALITY EDUCATION;8 DECENT WORK AND ECONOMIC GROWTH","2;1"
"IRCCS_BESTA",2021,446,19.3520179372197,3.54708520179372,0.316143497757848,0.31390134529148,0.394618834080717,3.52901785714286,1.33018867924528,1.7948717948718,1.36434108527132,0.614349775784753,2,242,110,28,14,0.54,0.25,0.06,0.03,14.34,0.929825128842866,7.12010276172128,0.466367713004484,0.919282511210762,0.491,0.424,0.396,0.396,"FABRIZIO TAGLIAVINI;GIUSEPPE LAURIA;MATILDE LEONARDI;MASSIMO FILIPPI;CAROLINE GRAFF;RAQUEL SÁNCHEZ‐VALLE;ROBERTO ELEOPRA;JONATHAN D. ROHRER;DANIELA GALIMBERTI;BARBARA BORRONI;MARIA CARMELA TARTAGLIA;JAMES B. ROWE;ALEXANDER GERHARD;RENATO MANTEGAZZA;JOHANNES LEVIN;ENRICO BERTINI;MARKUS OTTO;RIK VANDENBERGHE;ELIZABETH FINGER;ADRIAN DANEK","26;24;24;23;20;20;20;20;20;20;19;19;19;19;19;19;19;19;19;19","MATILDE LEONARDI;GIUSEPPE LAURIA;LICIA GRAZZI;ANTONIO SILVANI;ROBERTO ELEOPRA;RENATO MANTEGAZZA;LORENZO MAGGI;LUISA CHIAPPARINI;FRANCESCO DIMECO;PAOLO FERROLI;ALBERTO RAGGI;FRANCESCO BONO;PAOLA GAVIANI;G. SIMONETTI;PAUL RIZZOLI;MASSIMO FILIPPI;TIZIANA GRANATA;MORGAN BROGGI;A. BOTTURI;VERONICA REDAELLI","2.66;2.05;2.03;1.97;1.94;1.55;1.53;1.49;1.38;1.34;1.33;1.27;1.26;1.25;1.2;1.14;1.13;1.11;1.08;1.08","FABRIZIO TAGLIAVINI;GIUSEPPE LAURIA;MATILDE LEONARDI;ROBERTO ELEOPRA;RENATO MANTEGAZZA;GIOVANNI BARANELLO;LICIA GRAZZI;BIANCA POLLO;ANTONIO SILVANI;MARIA GRAZIA BRUZZONE;PAOLO FERROLI;PAOLO CONFALONIERI;LUISA CHIAPPARINI;FRANCESCO DIMECO;MARICA EOLI;LORENZO MAGGI;LAURA CANAFOGLIA;COSTANZA LAMPERTI;ALESSANDRA SOLARI;GIORGIO GIACCONE","26;24;24;20;19;17;17;16;16;16;16;15;15;14;14;14;13;13;13;12","MATILDE LEONARDI;GIUSEPPE LAURIA;LICIA GRAZZI;ANTONIO SILVANI;ROBERTO ELEOPRA;RENATO MANTEGAZZA;LORENZO MAGGI;LUISA CHIAPPARINI;FRANCESCO DIMECO;PAOLO FERROLI;ALBERTO RAGGI;PAOLA GAVIANI;G. SIMONETTI;TIZIANA GRANATA;MORGAN BROGGI;A. BOTTURI;VERONICA REDAELLI;ALESSANDRA SOLARI;MARIA GRAZIA BRUZZONE;CAGNOLI GIULIA ANNA","2.66;2.05;2.03;1.97;1.94;1.55;1.53;1.49;1.38;1.34;1.33;1.26;1.25;1.13;1.11;1.08;1.08;1.03;1.03;1","ISABEL SANTANA;GIOVANNI BARANELLO;RICCARDO MASSON;LAURENT SERVAIS;KSENIJA GORNI;MARIANNE GERBER;R. SCALCO;BASIL T. DARRAS;MUNA EL-KHAIRI;H. KLETZL;KRISTY ROSE;OMAR KHWAJA;PAULO FONTOURA;FABRIZIO TAGLIAVINI;LORENZO MAGGI;RENATO MANTEGAZZA;GIOVANNI ANTONINI;MATILDE LEONARDI;EUGENIO MERCURI;GABRIELE MORA","584;570;519;488;477;477;477;472;472;469;468;465;465;463;426;406;397;375;360;358","GIOVANNI BARANELLO;RICCARDO MASSON;RENATO MANTEGAZZA;MATILDE LEONARDI;FABRIZIO TAGLIAVINI;LAURA CANAFOGLIA;ERIKA SALVI;GIUSEPPE LAURIA;SILVANA FRANCESCHETTI;DANIELE GHEZZI;FRANCESCO DIMECO;COSTANZA LAMPERTI;ALBERTO RAGGI;LICIA GRAZZI;ALESSANDRA SOLARI;ROBERTO ELEOPRA;LUISA CHIAPPARINI;DAVIDE SATTIN;ANNA BERSANO;SILVIA SCHIAVOLIN","570;494;406;375;355;320;265;264;246;244;237;236;212;203;202;192;181;175;172;167","MATILDE LEONARDI;GIUSEPPE LAURIA;FABRIZIO TAGLIAVINI;ROBERTO ELEOPRA;RENATO MANTEGAZZA;BIANCA POLLO;LICIA GRAZZI;PAOLO FERROLI;MARIA GRAZIA BRUZZONE;GIOVANNI BARANELLO;LUISA CHIAPPARINI;ANTONIO SILVANI;PAOLO CONFALONIERI;FRANCESCO DIMECO;MARICA EOLI;LAURA CANAFOGLIA;ALESSANDRA SOLARI;DAVIDE PAREYSON;COSTANZA LAMPERTI;LORENZO MAGGI","24;24;24;20;18;16;16;16;16;15;15;15;15;14;14;13;13;12;12;12","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;ECONOMICS;CHEMISTRY;PHILOSOPHY;ENGINEERING;POLITICAL SCIENCE;SOCIOLOGY;BUSINESS;GEOGRAPHY;HISTORY;MATERIALS SCIENCE;GEOLOGY","392;168;132;47;37;34;30;29;17;16;15;13;8;7;4;3;1","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;NEUROSCIENCE;GENETICS;PEDIATRICS;SURGERY;IMMUNOLOGY;PHYSICAL THERAPY;RADIOLOGY;BIOCHEMISTRY;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;CANCER RESEARCH;CELL BIOLOGY;ONCOLOGY;CLINICAL PSYCHOLOGY;COGNITIVE PSYCHOLOGY;DEVELOPMENTAL PSYCHOLOGY;NURSING","224;136;128;120;98;72;60;43;40;40;38;32;31;29;26;26;25;23;23;22","DISEASE;GENE;COGNITION;NEUROLOGY;COHORT;EPILEPSY;POPULATION;NEUROSURGERY;ATROPHY;MULTIPLE SCLEROSIS;MAGNETIC RESONANCE IMAGING;ADVERSE EFFECT;MIGRAINE;RETROSPECTIVE COHORT STUDY;ATAXIA;CLINICAL TRIAL;HEALTH CARE;CANCER;ALTERNATIVE MEDICINE;ANXIETY;RECEPTOR","164;92;44;38;33;32;31;23;22;22;21;20;20;20;18;18;18;17;15;15;15","DEMENTIA;MUTATION;PHENOTYPE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);NEURORADIOLOGY;PARKINSON'S DISEASE;NEUROPSYCHOLOGY;AMYOTROPHIC LATERAL SCLEROSIS;SPINAL MUSCULAR ATROPHY;MITOCHONDRIAL DNA;TOLERABILITY;2019-20 CORONAVIRUS OUTBREAK;AGE OF ONSET;ALLELE;HUNTINGTON'S DISEASE;MOVEMENT DISORDERS;ALZHEIMER'S DISEASE;CEREBELLAR ATAXIA;CHRONIC MIGRAINE;CLINICAL ENDPOINT;EXON;GENOTYPE;MOTOR NEURON;NEURODEGENERATION;PLACEBO;WHITE MATTER","45;32;32;31;20;18;16;15;13;12;12;11;9;8;8;8;7;7;7;7;7;7;7;7;7;7","CORONAVIRUS DISEASE 2019 (COVID-19);FRONTOTEMPORAL DEMENTIA;EXOME SEQUENCING;MISSENSE MUTATION;MITOCHONDRIAL DISEASE;DEEP BRAIN STIMULATION;GENETIC HETEROGENEITY;INDUCED PLURIPOTENT STEM CELL;LEBER'S HEREDITARY OPTIC NEUROPATHY;LEWY BODY;PROBAND;SMN1;SOD1;TRINUCLEOTIDE REPEAT EXPANSION;DEMENTIA WITH LEWY BODIES;GREY MATTER;HAPLOINSUFFICIENCY;HETEROPLASMY;LAFORA DISEASE;MIGRAINE WITH AURA;MODIFIED RANKIN SCALE;ORBITOFRONTAL CORTEX;PENETRANCE;SANGER SEQUENCING;SUBSTANTIA NIGRA;VOXEL-BASED MORPHOMETRY","31;31;10;10;8;7;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3",";HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;MUTATION;BRAIN NEOPLASMS;ITALY;CHILD;BRAIN;AGED;COVID-19;ADOLESCENT;YOUNG ADULT;ANIMALS;FRONTOTEMPORAL DEMENTIA;MAGNETIC RESONANCE IMAGING;MITOCHONDRIAL DISEASES;MIGRAINE DISORDERS","230;206;81;77;69;59;50;37;37;35;33;32;29;27;25;23;23;23;23;22","AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;GLIOMAS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;EPILEPSY AND SEIZURES;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MECHANISMS OF ALZHEIMER'S DISEASE;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;MOLECULAR MECHANISMS OF ION CHANNELS REGULATION;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS","23;20;19;18;16;16;14;11;11;10;10;8;8;7;6;6;6;6;5;5","NEURODEGENERATION;NEURORADIOLOGY;PANDEMIC;SPINAL MUSCULAR ATROPHY;C9ORF72;FRONTOTEMPORAL LOBAR DEGENERATION;TOLERABILITY;MOTOR NEURON;NEUROIMAGING;DIAGNOSTIC CRITERIA;2019-20 CORONAVIRUS OUTBREAK;CHRONIC MIGRAINE;DEEP BRAIN STIMULATION;GLIOBLASTOMA;INBORN ERRORS OF METABOLISM;MIGRAINE PREVENTION;MYASTHENIA GRAVIS;EPILEPSY;HEADACHE DISORDERS;MITOCHONDRIAL DISEASE","30;21;17;17;15;13;12;11;11;10;9;9;9;9;9;9;9;8;8;8","MULTIPLE SCLEROSIS;FRONTOTEMPORAL DEMENTIA;COVID- PANDEMIC;GENETIC FRONTOTEMPORAL;CHRONIC MIGRAINE;MUSCULAR ATROPHY;MYASTHENIA GRAVIS;PARKINSONS DISEASE;SPINAL MUSCULAR;FRONTOTEMPORAL LOBAR;LOBAR DEGENERATION;ALZHEIMERS DISEASE;AMYOTROPHIC LATERAL;BOTULINUM TOXIN;CEREBROSPINAL FLUID;DISEASE PROGRESSION;HUNTINGTONS DISEASE;LATERAL SCLEROSIS;CLINICAL FEATURES;MUSCULAR DYSTROPHY;NEUROLOGICAL DISORDERS;SCLEROSIS PATIENTS;TYPE SPINAL;COHORT STUDY;GENETICALLY MODIFIED;GENFI STUDY;BRAIN STIMULATION;CHRONIC CLUSTER;CLUSTER HEADACHE;DEEP BRAIN","25;17;11;11;9;9;9;9;9;8;8;7;7;7;7;7;7;7;6;6;6;6;6;5;5;5;4;4;4;4","MUTATION CARRIERS;ROME ITALY;ITALY SEARCH;PERSONAL FEES;BAMBINO GESÙ;CHILDRENS HOSPITAL;GESÙ CHILDRENS;HOSPITAL ROME;IRCCS BAMBINO;PQ CODELETION;GENE THERAPY;FRONTOTEMPORAL DEMENTIA;MULTIPLE SCLEROSIS;PEDIATRIC HEMATO-ONCOLOGY;THERAPY IRCCS;NUTRITIONAL STATUS;CENTRAL NERVOUS;DISEASE PROGRESSION;LATERAL SCLEROSIS;NERVOUS SYSTEM;NEXT-GENERATION SEQUENCING;PQ SNP-IDH;PUBMED SCOPUS;ADVERSE EVENTS;MITOCHONDRIAL DISEASES;AMYOTROPHIC LATERAL;COVID- PANDEMIC;CROSSREF PUBMED;SNP-IDH PANEL;HELA CELLS","43;41;40;30;26;26;26;26;26;25;24;22;21;21;21;20;19;19;19;19;19;18;18;17;17;16;16;16;16;15",241,0.54,10.5,8,1,1.75,0,2,1,1,1,9,1,1,8.75,1,2.75,1,2,7,3,0,0,41,41,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,2.84,451.84,5.29,13,0.65,42.05,0,2,4,0,5,0,1,8,0,14,5,0,0,0,0,0,0,20,0,0,19,1,0,0,0,0,0,0,0,0,"United States;Italy;Germany;Netherlands;Australia;Switzerland;Russia;Sweden","15;14;5;3;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;46 INFORMATION AND COMPUTING SCIENCES;4608 HUMAN-CENTRED COMPUTING","17;10;5;4;2;2;2;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;NEUROSCIENCES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;PREVENTION;PATIENT SAFETY;RARE DISEASES;CANCER;NEURODEGENERATIVE;AGING;BRAIN CANCER;CHRONIC PAIN;COMPLEMENTARY AND INTEGRATIVE HEALTH;DENTAL/ORAL AND CRANIOFACIAL DISEASE;HEADACHES;HEALTH SERVICES;MIGRAINES;MYASTHENIA GRAVIS;ORPHAN DRUG;PAIN RESEARCH","19;14;12;9;6;5;5;4;4;3;2;2;2;2;2;2;2;2;2;2","NEUROLOGICAL;CANCER;INFECTION;MUSCULOSKELETAL","6;3;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS;3.4 VACCINES;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;7.3 MANAGEMENT AND DECISION MAKING","10;2;2;1;1;1;1","BRAIN TUMOR;LIVER CANCER","3;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,256,"ZENODO;FRONTIERS;PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE;TAYLOR & FRANCIS GROUP","214;18;15;7;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3105 GENETICS;52 PSYCHOLOGY;42 HEALTH SCIENCES;44 HUMAN SOCIETY;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3101 BIOCHEMISTRY AND CELL BIOLOGY;38 ECONOMICS;4203 HEALTH SERVICES AND SYSTEMS;3801 APPLIED ECONOMICS;40 ENGINEERING;5203 CLINICAL AND HEALTH PSYCHOLOGY;46 INFORMATION AND COMPUTING SCIENCES;3203 DENTISTRY;3204 IMMUNOLOGY;3208 MEDICAL PHYSIOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;47 LANGUAGE, COMMUNICATION AND CULTURE","266;141;82;56;34;22;18;14;10;10;10;9;8;8;7;6;6;6;6;6","NEUROSCIENCES;CLINICAL RESEARCH;BRAIN DISORDERS;NEURODEGENERATIVE;RARE DISEASES;GENETICS;CANCER;EPILEPSY;CHRONIC PAIN;HEADACHES;PAIN RESEARCH;PATIENT SAFETY;PREVENTION;AUTOIMMUNE DISEASE;BRAIN CANCER;DENTAL/ORAL AND CRANIOFACIAL DISEASE;MIGRAINES;PEDIATRIC;PERIPHERAL NEUROPATHY;AGING","72;55;52;45;44;33;11;11;10;10;10;10;10;9;8;8;8;7;7;6","NEUROLOGICAL;CARDIOVASCULAR;MENTAL HEALTH;MUSCULOSKELETAL;CANCER;STROKE;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;GENERIC HEALTH RELEVANCE","72;5;4;4;3;3;2;2;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;7.3 MANAGEMENT AND DECISION MAKING","55;7;6;5;2;1;1;1","CLINICAL;BIOMEDICAL;POPULATION & SOCIETY;HEALTH SERVICES & SYSTEMS","51;18;4;3","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","129;19;8","BRAIN TUMOR;NOT SITE-SPECIFIC CANCER;NERVOUS SYSTEM;CERVICAL CANCER;KAPOSI'S SARCOMA;LIVER CANCER;SARCOMA;BREAST CANCER","17;6;4;2;2;2;2;1","3 GOOD HEALTH AND WELL BEING","3"
"IRCCS_BESTA",2022,403,19.3548387096774,3.59057071960298,0.320099255583127,0.300248138957816,0.349875930521092,3.08528784648188,1.40217391304348,1.59210526315789,1.46875,0.71712158808933,3,174,104,22,24,0.43,0.26,0.05,0.06,8.2,0.918970534354514,6.71223917782625,0.476426799007444,0.90818858560794,0.532,0.409,0.462,0.428,"FABRIZIO TAGLIAVINI;GIACOMINA ROSSI;GIORGIO GIACCONE;PAOLO FERROLI;BIANCA POLLO;MARIA GRAZIA BRUZZONE;RENATO MANTEGAZZA;PIETRO TIRABOSCHI;DANIELA GALIMBERTI;BARBARA BORRONI;CAROLINE GRAFF;MATILDE LEONARDI;MATTHIS SYNOFZIK;ALEXANDRE DE MENDONÇA;RAQUEL SÁNCHEZ‐VALLE;GIUSEPPE DI FEDE;SANDRO SORBI;MARIA CARMELA TARTAGLIA;JAMES B. ROWE;IRENE TRAMACERE","26;22;21;21;20;20;20;19;19;18;17;17;16;16;16;16;15;15;15;15","LICIA GRAZZI;DAVIDE PAREYSON;IGNAZIO G. VETRANO;RENATO MANTEGAZZA;MATILDE LEONARDI;FRANCESCO ACERBI;PAOLO FERROLI;IRENE TRAMACERE;BIANCA POLLO;MORGAN BROGGI;JACOPO FALCO;GIULIO BONOMO;ALBERTO RAGGI;GIACOMINA ROSSI;FABRIZIO TAGLIAVINI;MARIA GRAZIA BRUZZONE;FRANCESCO COSTA;MARCO SCHIARITI;ANNA RITA GIOVAGNOLI;GIORGIO GIACCONE","2.06;2.06;1.99;1.91;1.9;1.78;1.78;1.72;1.59;1.55;1.5;1.49;1.39;1.37;1.3;1.27;1.14;1.12;1.12;1.12","FABRIZIO TAGLIAVINI;GIACOMINA ROSSI;GIORGIO GIACCONE;PAOLO FERROLI;BIANCA POLLO;MARIA GRAZIA BRUZZONE;RENATO MANTEGAZZA;PIETRO TIRABOSCHI;MATILDE LEONARDI;GIUSEPPE DI FEDE;IRENE TRAMACERE;DAVIDE PAREYSON;FRANCESCO ACERBI;PAOLA CAROPPO;IGNAZIO G. VETRANO;MARICA EOLI;GIULIO BONOMO;MORGAN BROGGI;RICCARDO MASSON;GIOVANNI BARANELLO","26;22;21;21;20;20;20;19;17;16;15;15;13;13;13;13;13;13;12;12","LICIA GRAZZI;DAVIDE PAREYSON;IGNAZIO G. VETRANO;RENATO MANTEGAZZA;MATILDE LEONARDI;FRANCESCO ACERBI;PAOLO FERROLI;IRENE TRAMACERE;BIANCA POLLO;MORGAN BROGGI;JACOPO FALCO;GIULIO BONOMO;ALBERTO RAGGI;GIACOMINA ROSSI;FABRIZIO TAGLIAVINI;MARIA GRAZIA BRUZZONE;FRANCESCO COSTA;MARCO SCHIARITI;ANNA RITA GIOVAGNOLI;GIORGIO GIACCONE","2.06;2.06;1.99;1.91;1.9;1.78;1.78;1.72;1.59;1.55;1.5;1.49;1.39;1.37;1.3;1.27;1.14;1.12;1.12;1.12","FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;DANIELA GALIMBERTI;BARBARA BORRONI;CAROLINE GRAFF;FERMÍN MORENO;JOHN C. VAN SWIETEN;ALEXANDRE DE MENDONÇA;GIORGIO GIACCONE;GIOVANNI BARANELLO;PIETRO TIRABOSCHI;YOLANDE A.L. PIJNENBURG;MARTINA BOCCHETTA;MATTHIS SYNOFZIK;RITA GARBELLI;ALEXANDER GERHARD;CHRISTOPHER BUTLER;ELIZABETH FINGER;ISABEL SANTANA;JAMES B. ROWE","265;252;239;235;233;233;233;218;213;205;196;195;187;187;187;186;186;186;186;186","FABRIZIO TAGLIAVINI;RENATO MANTEGAZZA;GIOVANNI BARANELLO;RITA GARBELLI;RICCARDO MASSON;MATILDE LEONARDI;COSTANZA LAMPERTI;DANIELE GHEZZI;LORENZO MAGGI;PIETRO TIRABOSCHI;RICCARDO ZANIN;GIORGIO GIACCONE;PAOLO CONFALONIERI;MARIA GRAZIA BRUZZONE;FABIO MODA;GIACOMINA ROSSI;GIUSEPPE LAURIA;ROBERTO CILIA;LAURA CANAFOGLIA;CATERINA MARIOTTI","259;252;190;187;166;159;151;147;144;141;127;123;120;118;97;96;95;89;84;82","FABRIZIO TAGLIAVINI;PAOLO FERROLI;BIANCA POLLO;MARIA GRAZIA BRUZZONE;RENATO MANTEGAZZA;GIACOMINA ROSSI;MATILDE LEONARDI;PIETRO TIRABOSCHI;IRENE TRAMACERE;DAVIDE PAREYSON;GIULIO BONOMO;MARICA EOLI;FRANCESCO ACERBI;MORGAN BROGGI;IGNAZIO G. VETRANO;GIORGIO GIACCONE;ELENA ANGHILERI;LAURA CANAFOGLIA;RICCARDO MASSON;MARCO SCHIARITI","25;21;20;20;20;17;17;17;15;14;13;13;13;13;13;13;12;12;12;11","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;MATHEMATICS;PHYSICS;ECONOMICS;POLITICAL SCIENCE;PHILOSOPHY;ENGINEERING;BUSINESS;SOCIOLOGY;MATERIALS SCIENCE;GEOLOGY;HISTORY;ART;GEOGRAPHY","355;142;92;41;38;37;28;18;15;12;9;7;7;5;3;3;2;2","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;GENETICS;NEUROSCIENCE;SURGERY;RADIOLOGY;PEDIATRICS;BIOCHEMISTRY;IMMUNOLOGY;PHYSICAL THERAPY;CANCER RESEARCH;PHYSICAL MEDICINE AND REHABILITATION;CELL BIOLOGY;CLINICAL PSYCHOLOGY;ENVIRONMENTAL HEALTH;ANESTHESIA;ARTIFICIAL INTELLIGENCE;ONCOLOGY;BIOINFORMATICS","188;132;115;80;70;68;51;47;43;38;38;32;30;24;24;23;20;20;20;19","DISEASE;GENE;NEUROLOGY;COGNITION;MAGNETIC RESONANCE IMAGING;NEUROSURGERY;COHORT;POPULATION;EPILEPSY;ADVERSE EFFECT;CLINICAL TRIAL;RANDOMIZED CONTROLLED TRIAL;ANXIETY;ALTERNATIVE MEDICINE;RETROSPECTIVE COHORT STUDY;SMA*;ANTIBODY;ATROPHY;MULTIPLE SCLEROSIS;RECEPTOR","142;83;35;25;25;24;23;21;20;19;19;19;18;16;16;15;14;14;14;14","DEMENTIA;PHENOTYPE;MUTATION;NEURORADIOLOGY;PARKINSON'S DISEASE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);SPINAL MUSCULAR ATROPHY;ALLELE;NEURODEGENERATION;ALZHEIMER'S DISEASE;NEUROPSYCHOLOGY;PLACEBO;MUTANT;TUMOR MICROENVIRONMENT;WHITE MATTER;AGE OF ONSET;AMYOTROPHIC LATERAL SCLEROSIS;CHRONIC MIGRAINE;FLUORESCEIN;GENE EXPRESSION;MITOCHONDRIAL DNA;TOLERABILITY","40;31;24;18;17;16;15;12;11;10;9;9;8;8;8;7;7;7;7;7;7;7","FRONTOTEMPORAL DEMENTIA;CORONAVIRUS DISEASE 2019 (COVID-19);MISSENSE MUTATION;DEEP BRAIN STIMULATION;COGNITIVE DECLINE;COMPLEMENTATION;EXOME SEQUENCING;TRINUCLEOTIDE REPEAT EXPANSION;DEMENTIA WITH LEWY BODIES;DNA METHYLATION;HAPLOINSUFFICIENCY;HUMAN MITOCHONDRIAL GENETICS;INTRAOPERATIVE MRI;MITOCHONDRIAL DISEASE;PILOCYTIC ASTROCYTOMA;SINGLE-NUCLEOTIDE POLYMORPHISM;SODIUM FLUORESCEIN;TRANSCRIPTOME;CEREBRAL AMYLOID ANGIOPATHY;COPY-NUMBER VARIATION;CROSSOVER STUDY;GREY MATTER;HEMATOPOIETIC STEM CELL;HEREDITARY SPASTIC PARAPLEGIA;HIPPOCAMPAL SCLEROSIS;IDH1;LOSS FUNCTION;MICROVESICLES;MITOCHONDRIAL MYOPATHY;NERVE BIOPSY;NUCLEAR DNA;ORBITOFRONTAL CORTEX;PENETRANCE;PERSISTENT VEGETATIVE STATE;POINT MUTATION;PRESENILIN;PRNP;PROBAND;SCRAPIE;SMN1;SOLITARY FIBROUS TUMOR;TAUOPATHY;TELEHEALTH;TRPV1;UBIQUITIN LIGASE","30;16;14;8;7;5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;MUTATION;FRONTOTEMPORAL DEMENTIA;MAGNETIC RESONANCE IMAGING;BRAIN;BRAIN NEOPLASMS;ALZHEIMER DISEASE;MALE;MULTIPLE SCLEROSIS;FEMALE;COVID-19;PARKINSON DISEASE;RETROSPECTIVE STUDIES;TAU PROTEINS;ADULT;MUSCULAR ATROPHY, SPINAL;C9ORF72 PROTEIN;CHILD;PROGRANULINS","230;165;65;57;35;34;34;31;30;28;27;26;26;26;26;25;25;23;18;18","GLIOMAS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;EPILEPSY AND SEIZURES;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MECHANISMS OF ALZHEIMER'S DISEASE;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;PRION DISEASES: CAUSES AND MOLECULAR BASIS;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;STANDARDS AND GUIDELINES FOR GENETIC VARIANT INTERPRETATION","20;17;13;13;12;11;11;11;10;10;10;9;7;7;7;7;7;6;6;6","NEURODEGENERATION;NEURORADIOLOGY;C9ORF72;SPINAL MUSCULAR ATROPHY;FRONTOTEMPORAL LOBAR DEGENERATION;NEUROIMAGING DATA ANALYSIS;MENTAL HEALTH;NEUROIMAGING;DEEP BRAIN STIMULATION;GLIOBLASTOMA;CHARCOT-MARIE-TOOTH DISEASE;DEPRESSION (ECONOMICS);MIGRAINE;MOTOR NEURON;MYASTHENIA GRAVIS;CHRONIC MIGRAINE;COGNITIVE DECLINE;EPILEPSY;EXTRACELLULAR VESICLES;MIGRAINE PREVENTION","21;17;16;16;14;12;10;10;9;9;8;8;8;8;8;7;7;7;7;7","FRONTOTEMPORAL DEMENTIA;MULTIPLE SCLEROSIS;MUSCULAR ATROPHY;SPINAL MUSCULAR;MYASTHENIA GRAVIS;PARKINSONS DISEASE;ALZHEIMERS DISEASE;CEREBROSPINAL FLUID;FRONTOTEMPORAL LOBAR;LOBAR DEGENERATION;MUSCULAR DYSTROPHY;GENERALIZED MYASTHENIA;GENETIC FRONTOTEMPORAL;TEM-GBM STUDY;BRAIN STIMULATION;DEEP BRAIN;DUCHENNE MUSCULAR;MULTICENTER STUDY;PILOT STUDY;RETROSPECTIVE STUDY;TUMOR MICROENVIRONMENT;AMYOTROPHIC LATERAL;CHARCOTMARIETOOTH DISEASE;CLINICAL TRIAL;COVID- PANDEMIC;ITALIAN COHORT;LATERAL SCLEROSIS;MENTAL HEALTH;NATURAL HISTORY;NERVOUS SYSTEM","15;15;13;12;10;8;7;7;7;7;7;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","MUTATION CARRIERS;FRONTOTEMPORAL DEMENTIA;CLINICAL TRIALS;DISEASE PROGRESSION;MULTIPLE SCLEROSIS;ADVERSE EVENTS;NERVOUS SYSTEM;DISEASE DURATION;RISK FACTORS;CEREBROSPINAL FLUID;COGNITIVE DECLINE;COVID- PANDEMIC;MAPT MUTATION;CLINICAL TRIAL;FOCAL EPILEPSY;GRN MUTATION;ALZHEIMERS DISEASE;COMPOSITE SCORES;DNA METHYLATION;MAGNETIC RESONANCE;MENTAL HEALTH;NEURODEGENERATIVE DISEASES;CENTRAL NERVOUS;CMT PATIENTS;DEMENTIA FTD;MISSENSE VARIANTS;NATURAL HISTORY;PATHOGENIC VARIANTS;SEIZURE FREEDOM;SUSTAINED SEIZURE","42;31;27;26;23;20;19;17;16;14;14;14;14;13;13;13;12;12;12;12;12;12;11;11;11;11;11;11;11;11",224,0.56,13.69,10,1,1.75,0,2,1,1,1.75,12,1,0,9,1,1,1,4,7,4,0,0,25,25,1,0,1,0,1,0,0,0,0,0,0,0,2,0,0,0,3,0.41,1,0,0,2,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"DI FEDE GIUSEPPE;SALMONA MARIO;TAGLIAVINI FABRIZIO","2;2;2","FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA","2","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY","4;2","ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BRAIN DISORDERS;DEMENTIA;NEURODEGENERATIVE;NEUROSCIENCES","2;2;2;2;2;2;2;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","2;2","A61K38/17;A61K9/00;A61P25/28;A61P25/16","2;2;2;1","A61K38/1716;A61K9/0043;A61P25/16;A61P25/28","2;2;2;2",26,3.28,211.84,5.87,13,0.5,39.81,0,1,5,4,10,0,0,6,0,19,6,0,0,0,0,0,0,26,0,0,25,1,0,0,0,0,0,0,0,0,"Italy;United States;Switzerland;United Kingdom;Belgium;Japan","12;5;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;42 HEALTH SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4203 HEALTH SERVICES AND SYSTEMS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3105 GENETICS;3209 NEUROSCIENCES;4207 SPORTS SCIENCE AND EXERCISE","23;16;5;4;4;3;2;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;BRAIN DISORDERS;NEURODEGENERATIVE;RARE DISEASES;PEDIATRIC;PATIENT SAFETY;CANCER;AGING;BRAIN CANCER;GENETICS;PREVENTION;SPINAL MUSCULAR ATROPHY;ACQUIRED COGNITIVE IMPAIRMENT;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BIOENGINEERING;BIOMEDICAL IMAGING;CHRONIC PAIN","24;17;15;10;9;9;8;7;4;3;3;3;3;3;2;2;2;2;2;2","NEUROLOGICAL;CANCER;MENTAL HEALTH;MUSCULOSKELETAL","8;2;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.4 SURGERY","17;2;2;1;1;1;1","BRAIN TUMOR;NERVOUS SYSTEM;NOT SITE-SPECIFIC CANCER","4;1;1","4.2 TECHNOLOGY AND/OR MARKER EVALUATION WITH RESPECT TO FUNDAMENTAL PARAMETERS OF METHOD;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS","2;2;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,159,"ZENODO;FRONTIERS;PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE;TAYLOR & FRANCIS GROUP","122;18;12;6;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;52 PSYCHOLOGY;3202 CLINICAL SCIENCES;3105 GENETICS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;5202 BIOLOGICAL PSYCHOLOGY;42 HEALTH SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;44 HUMAN SOCIETY;38 ECONOMICS;51 PHYSICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3801 APPLIED ECONOMICS;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;5203 CLINICAL AND HEALTH PSYCHOLOGY;3208 MEDICAL PHYSIOLOGY;3204 IMMUNOLOGY;34 CHEMICAL SCIENCES","156;66;37;33;22;14;13;12;12;10;10;8;8;7;7;6;6;5;4;4","CLINICAL RESEARCH;NEUROSCIENCES;BRAIN DISORDERS;NEURODEGENERATIVE;RARE DISEASES;GENETICS;BIOMEDICAL IMAGING;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;HUMAN GENOME;PREVENTION;BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY;ACQUIRED COGNITIVE IMPAIRMENT;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BRAIN CANCER;DEMENTIA;MENTAL HEALTH;MULTIPLE SCLEROSIS;PEDIATRIC","26;23;20;13;11;8;6;6;5;5;5;4;4;3;3;3;3;3;3;3","NEUROLOGICAL;CANCER;MENTAL HEALTH;MUSCULOSKELETAL;CARDIOVASCULAR;REPRODUCTIVE HEALTH AND CHILDBIRTH","33;6;4;4;3;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES;3.4 VACCINES;5.1 PHARMACEUTICALS","20;5;3;3;3;3;2;1;1;1","CLINICAL;BIOMEDICAL;POPULATION & SOCIETY","20;10;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;HEALTH SERVICES RESEARCH","55;10;3","BRAIN TUMOR;NOT SITE-SPECIFIC CANCER;LUNG CANCER;MYELOMA;NON-HODGKIN'S LYMPHOMA;MELANOMA","7;4;2;2;2;1","3 GOOD HEALTH AND WELL BEING;16 PEACE, JUSTICE AND STRONG INSTITUTIONS","3;1"
"IRCCS_BESTA",2023,391,19.5294117647059,3.88746803069054,0.319693094629156,0.294117647058824,0.383631713554987,3.2409381663113,1.21359223300971,1.49350649350649,1.42857142857143,0.690537084398977,3,190,87,19,20,0.49,0.22,0.05,0.05,4.49,1.02521434001191,6.30769230769232,0.529411764705882,0.928388746803069,0.522,0.438,0.395,0.41,"RENATO MANTEGAZZA;PAOLO FERROLI;FRANCESCO ACERBI;BIANCA POLLO;LAURA CANAFOGLIA;IGNAZIO G. VETRANO;PIETRO TIRABOSCHI;MASSIMO FILIPPI;MARCO SCHIARITI;TUAN VU;MATTHIS SYNOFZIK;ROBERTO ELEOPRA;BARBARA BORRONI;ROSINA PATERRA;ANTONIO SILVANI;CAROLINE GRAFF;ALEXANDRE DE MENDONÇA;RAQUEL SÁNCHEZ‐VALLE;MARICA EOLI;DANIELA GALIMBERTI","29;25;18;17;17;17;17;16;16;16;16;16;16;15;15;15;15;15;15;15","RENATO MANTEGAZZA;PAOLO FERROLI;LAURA CANAFOGLIA;FRANCESCO ACERBI;GIULIO BONOMO;IGNAZIO G. VETRANO;SARA PALERMO;ROSINA PATERRA;MARCO SCHIARITI;ELISA CICERI;BIANCA POLLO;ALBERTO RAGGI;MARICA EOLI;TUAN VU;MORGAN BROGGI;VITTORIA NAZZI;JACOPO FALCO;ANTONIO SILVANI;DANIELE GHEZZI;NICOLÒ CASTELLI","2.39;1.94;1.65;1.64;1.51;1.49;1.44;1.36;1.3;1.27;1.25;1.18;1.18;1.18;1.17;1.14;1.13;1.12;1.1;1.08","RENATO MANTEGAZZA;PAOLO FERROLI;FRANCESCO ACERBI;BIANCA POLLO;LAURA CANAFOGLIA;IGNAZIO G. VETRANO;PIETRO TIRABOSCHI;MASSIMO FILIPPI;MARCO SCHIARITI;ROBERTO ELEOPRA;ROSINA PATERRA;ANTONIO SILVANI;MARICA EOLI;DAVIDE PAREYSON;MARIA GRAZIA BRUZZONE;CATERINA MARIOTTI;ANNA BERSANO;GIULIO BONOMO;MORGAN BROGGI;FABRIZIO TAGLIAVINI","29;25;18;17;17;17;17;16;16;16;15;15;15;14;13;13;13;13;13;12","RENATO MANTEGAZZA;PAOLO FERROLI;LAURA CANAFOGLIA;FRANCESCO ACERBI;GIULIO BONOMO;IGNAZIO G. VETRANO;SARA PALERMO;ROSINA PATERRA;MARCO SCHIARITI;ELISA CICERI;BIANCA POLLO;ALBERTO RAGGI;MARICA EOLI;MORGAN BROGGI;VITTORIA NAZZI;JACOPO FALCO;ANTONIO SILVANI;DANIELE GHEZZI;NICOLÒ CASTELLI;TORSTEIN R. MELING","2.39;1.94;1.65;1.64;1.51;1.49;1.44;1.36;1.3;1.27;1.25;1.18;1.18;1.17;1.14;1.13;1.12;1.1;1.08;1.04","RENATO MANTEGAZZA;TUAN VU;JOHN VISSING;VERA BRIL;KIMIAKI UTSUGISAWA;TANYA STOJKOVIC;SABRINA SACCONI;HENRY J. KAMINSKI;ELENA RINALDI;ALEKSANDRA NADAJ‐PAKLEZA;ANDREAS TOTZECK;ANGELA GENGE;BENJAMIN STOLTE;CHRISTINE TRANCHANT;JANA ZSCHÜNTZSCH;JEAN‐BAPTISTE CHANSON;JENS SCHMIDT;LEILA ZAIDI;LOÏC LE GUENNEC;NICOLAS WEISS","428;277;199;198;197;193;192;191;190;188;188;188;188;188;188;188;188;188;188;188","RENATO MANTEGAZZA;ROBERTO ELEOPRA;GIUSEPPE LAURIA;ANNA BERSANO;STEFANIA MAGRI;PAOLA CAVALCANTE;NICOLA IACOMINO;DANIELA DI BELLA;DAVIDE PAREYSON;SARA PALERMO;ANNA NIGRI;FRANCESCA RAGONA;GIOVANNI BARANELLO;LAURA CANAFOGLIA;RICCARDO MASSON;CATERINA MARIOTTI;ROBERTO CILIA;B. TEDESCO;FRANCESCO ACERBI;TIZIANA GRANATA","428;110;81;78;72;70;64;59;59;58;52;52;52;51;51;50;48;46;46;45","RENATO MANTEGAZZA;PAOLO FERROLI;FRANCESCO ACERBI;LAURA CANAFOGLIA;BIANCA POLLO;IGNAZIO G. VETRANO;ROBERTO ELEOPRA;MARCO SCHIARITI;MARICA EOLI;PIETRO TIRABOSCHI;ROSINA PATERRA;ANTONIO SILVANI;DAVIDE PAREYSON;ANNA BERSANO;GIULIO BONOMO;JACOPO FALCO;CATERINA MARIOTTI;FABRIZIO TAGLIAVINI;FRANCESCO RESTELLI;MORGAN BROGGI","28;24;17;17;16;16;15;15;15;15;15;14;13;13;13;12;12;12;12;12","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;MATHEMATICS;PHYSICS;ENGINEERING;ECONOMICS;POLITICAL SCIENCE;SOCIOLOGY;PHILOSOPHY;BUSINESS;HISTORY;ART;GEOGRAPHY;GEOLOGY;MATERIALS SCIENCE","359;123;98;40;32;27;21;15;14;13;9;8;7;4;3;3;2;2","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;NEUROSCIENCE;SURGERY;GENETICS;RADIOLOGY;PEDIATRICS;PHYSICAL THERAPY;BIOCHEMISTRY;ONCOLOGY;CANCER RESEARCH;IMMUNOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;ANESTHESIA;CLINICAL PSYCHOLOGY;NURSING;CELL BIOLOGY;ARTIFICIAL INTELLIGENCE;BIOINFORMATICS;CARDIOLOGY","210;121;107;86;74;72;51;47;41;38;38;29;28;27;23;22;19;18;17;15;15;15","DISEASE;GENE;NEUROLOGY;MAGNETIC RESONANCE IMAGING;EPILEPSY;ADVERSE EFFECT;ALTERNATIVE MEDICINE;COHORT;MYASTHENIA GRAVIS;CANCER;CLINICAL TRIAL;POPULATION;COGNITION;NEUROSURGERY;RANDOMIZED CONTROLLED TRIAL;ATAXIA;MULTIPLE SCLEROSIS;RECEPTOR;RETROSPECTIVE COHORT STUDY;QUALITY OF LIFE (HEALTHCARE)","106;74;39;34;33;30;26;26;25;24;24;21;19;19;17;15;15;15;15;14","DEMENTIA;PHENOTYPE;MUTATION;NEURORADIOLOGY;PLACEBO;CLINICAL ENDPOINT;PARKINSON'S DISEASE;SPINAL MUSCULAR ATROPHY;TOLERABILITY;WHITE MATTER;GENOTYPE;DIFFUSION MRI;ALLELE;AMYOTROPHIC LATERAL SCLEROSIS;TEMOZOLOMIDE;AGE OF ONSET;INTERIM ANALYSIS;MITOCHONDRIAL DNA;MOVEMENT DISORDERS;AUTOPHAGY;IMMUNOTHERAPY","31;27;19;19;18;16;16;14;13;12;11;10;9;9;8;7;7;7;7;6;6","FRONTOTEMPORAL DEMENTIA;MISSENSE MUTATION;DEEP BRAIN STIMULATION;MITOCHONDRIAL DISEASE;CEREBRAL AMYLOID ANGIOPATHY;CLINICAL DEMENTIA RATING;COMPOUND HETEROZYGOSITY;DEMENTIA WITH LEWY BODIES;EXOME SEQUENCING;FRACTIONAL ANISOTROPY;GREY MATTER;PENETRANCE;REGORAFENIB;ADRENOLEUKODYSTROPHY;ALLELE FREQUENCY;COGNITIVE DECLINE;CORONAVIRUS DISEASE 2019 (COVID-19);DYSKINESIA;FRAMESHIFT MUTATION;GENETIC HETEROGENEITY;GENETIC VARIANTS;HAPLOTYPE;IDH1;SODIUM FLUORESCEIN;TRACTOGRAPHY","19;8;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;;ADULT;FEMALE;MALE;MUTATION;MAGNETIC RESONANCE IMAGING;CHILD;MIDDLE AGED;SEIZURES;RETROSPECTIVE STUDIES;BRAIN;AMYOTROPHIC LATERAL SCLEROSIS;BRAIN NEOPLASMS;MULTIPLE SCLEROSIS;CHARCOT-MARIE-TOOTH DISEASE;EPILEPSIES, MYOCLONIC;PARKINSON DISEASE;EPILEPSY;PHENOTYPE","221;163;44;40;35;32;29;26;26;25;24;21;20;20;20;18;18;18;17;16","MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;GLIOMAS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;EPILEPSY AND SEIZURES;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIFFUSION MAGNETIC RESONANCE IMAGING;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;PRION DISEASES: CAUSES AND MOLECULAR BASIS;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;MANAGEMENT AND PATHOPHYSIOLOGY OF INTRACEREBRAL HEMORRHAGE","24;19;18;15;15;13;9;8;8;8;8;7;7;7;6;5;5;4;4;4","NEURODEGENERATION;NEURORADIOLOGY;SPINAL MUSCULAR ATROPHY;CLINICAL ENDPOINT;MYASTHENIA GRAVIS;TOLERABILITY;GLIOBLASTOMA;C9ORF72;NEUROIMAGING;ATAXIA;EPILEPSY;STROKE (ENGINE);CHARCOT-MARIE-TOOTH DISEASE;DEEP BRAIN STIMULATION;DIAGNOSTIC CRITERIA;DISCONTINUATION;TEMOZOLOMIDE;DIFFUSION MRI;INTERIM ANALYSIS;MOVEMENT DISORDERS","22;19;18;17;14;13;12;11;10;9;9;9;8;8;8;8;8;7;7;7","MYASTHENIA GRAVIS;MUSCULAR ATROPHY;MULTIPLE SCLEROSIS;SPINAL MUSCULAR;FRONTOTEMPORAL DEMENTIA;GENERALIZED MYASTHENIA;GENETIC FRONTOTEMPORAL;ATROPHY SMA;PARKINSONS DISEASE;GLIOBLASTOMA PATIENTS;PHASE STUDY;ALZHEIMERS DISEASE;AMYOTROPHIC LATERAL;CROSS-SECTIONAL STUDY;LATERAL SCLEROSIS;ONASEMNOGENE ABEPARVOVEC;OPEN-LABEL EXTENSION;RISK FACTORS;AMYLOID ANGIOPATHY;CEREBELLAR ATAXIA;CEREBRAL AMYLOID;DIFFERENTIAL DIAGNOSIS;DISEASE PROGRESSION;DOUBLE-BLIND PLACEBO-CONTROLLED;GENERALISED MYASTHENIA;LIQUID BIOPSY;NATURAL HISTORY;PATIENTS TREATED;PHASE II;RANDOMISED DOUBLE-BLIND","25;15;14;14;13;12;9;7;7;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","MUTATION CARRIERS;MYASTHENIA GRAVIS;FRONTOTEMPORAL DEMENTIA;DISEASE PROGRESSION;GENETIC FTD;WHITE MATTER;CLINICAL TRIALS;PARKINSONS DISEASE;RISK FACTORS;ADULT PATIENTS;MAGNETIC RESONANCE;MGKG MGKG;MGKG PLACEBO;MULTIPLE SCLEROSIS;RESPONSE MGKG;ADVERSE EVENTS;PATHOGENIC VARIANTS;CLINICAL PRACTICE;OUTCOME MEASURES;TOTAL SCORE;DEMENTIA FTD;HEALTHY CONTROLS;ISOLATED DYSTONIA;MOVEMENT DISORDERS;DISEASE SEVERITY;GENETIC FRONTOTEMPORAL;ISCHEMIC STROKE;RATING SCALE;RESONANCE IMAGING;UPPER LIMB","48;42;25;23;19;19;18;17;17;16;16;16;16;16;16;15;15;14;14;14;13;13;13;13;12;12;12;12;12;12",193,0.49,7,8,1.5,1.5,0,1.5,0,1,0,10,1,0,9,1,0,2,3,6,3,0,0,11,11,1,0,0,0,2,3,0,0,0,0,0,0,2,2,1,0,3,0.99,1.2,0,1,2,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"DI FEDE GIUSEPPE;SALMONA MARIO;TAGLIAVINI FABRIZIO","5;5;5","FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA;FONDAZIONE IRCCS ST NEUROLOGICO CARLO BESTA","5;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY","6;3","ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BRAIN DISORDERS;DEMENTIA;NEURODEGENERATIVE;NEUROSCIENCES","3;3;3;3;3;3;3;3","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","3;2","A61K38/17;A61K9/00;A61P25/16;A61P25/28","5;5;5;5","A61K38/1716;A61K9/0043;A61P25/16;A61P25/28","5;5;5;5",14,3.71,410.07,3.26,5,0.36,35.21,0,0,5,0,2,0,0,7,0,9,5,0,0,0,0,0,0,14,0,0,14,0,0,0,0,0,0,0,0,0,"Italy;United States;France;Germany;Netherlands","15;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4205 NURSING","10;7;3;3;2;2;1;1;1;1;1","CLINICAL RESEARCH;NEUROSCIENCES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;NEURODEGENERATIVE;PREVENTION;AGING;PEDIATRIC;RARE DISEASES;CHRONIC PAIN;HEADACHES;MIGRAINES;PAIN RESEARCH;ACQUIRED COGNITIVE IMPAIRMENT;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BEHAVIORAL AND SOCIAL SCIENCE;DEMENTIA;DENTAL/ORAL AND CRANIOFACIAL DISEASE;GENETICS","14;12;11;8;8;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2","NEUROLOGICAL;CANCER","8;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS;8.1 ORGANISATION AND DELIVERY OF SERVICES","10;1;1;1;1","BRAIN TUMOR;NOT SITE-SPECIFIC CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",1,5698475,633163.89,5,9,8,1,1,203323.130537518,1.92304731373321,"CENTRE HOSPITALIER RÉGIONAL UNIVERSITAIRE DE BREST;CHARITÉ - UNIVERSITY MEDICINE BERLIN;INSTITUT GUTTMANN;ISTITUTO NEUROLOGICO CARLO BESTA;LINKÖPING UNIVERSITY;SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST;SWISS PARAPLEGIC RESEARCH;TECHNOLOGICAL UNIVERSITY DUBLIN;UNIVERSITY OF MURCIA","1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","HORIZON-HLTH-2022-TOOL-12-TWO-STAGE (CALL FOR PROPOSAL);HORIZON-RIA - HORIZON  RESEARCH AND INNOVATION ACTIONS (FUNDING SCHEME);HORIZON.2.1 - HEALTH (PROGRAMME)","1;1;1","46 INFORMATION AND COMPUTING SCIENCES;4605 DATA MANAGEMENT AND DATA SCIENCE","1;1","CLINICAL RESEARCH;NEUROSCIENCES;STROKE","1;1;1","STROKE","1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1",NA,NA,NA,NA,"B11 COMPUTER SCIENCE AND INFORMATICS","1",NA,NA,106,"ZENODO;FRONTIERS;SAGE JOURNALS;PUBLIC LIBRARY OF SCIENCE;AMERICAN ASSOCIATION FOR CANCER RESEARCH","79;17;5;4;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;4203 HEALTH SERVICES AND SYSTEMS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;34 CHEMICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;40 ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4205 NURSING;4207 SPORTS SCIENCE AND EXERCISE;44 HUMAN SOCIETY;51 PHYSICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;3204 IMMUNOLOGY;4003 BIOMEDICAL ENGINEERING;46 INFORMATION AND COMPUTING SCIENCES","73;50;37;20;14;14;12;7;7;6;6;6;6;6;6;6;6;5;4;3","NEUROSCIENCES;BRAIN DISORDERS;CLINICAL RESEARCH;NEURODEGENERATIVE;RARE DISEASES;AGING;CANCER;GENETICS;PEDIATRIC;BIOTECHNOLOGY;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;CEREBRAL PALSY;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PHYSICAL REHABILITATION;REHABILITATION;INFECTIOUS DISEASES;ACQUIRED COGNITIVE IMPAIRMENT;DEMENTIA;EPILEPSY","23;21;18;16;8;7;7;7;7;6;5;5;5;5;5;5;4;3;3;3","NEUROLOGICAL;CANCER;MUSCULOSKELETAL;GENERIC HEALTH RELEVANCE;INFECTION","35;5;2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS;7.3 MANAGEMENT AND DECISION MAKING;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;3.4 VACCINES;6.1 PHARMACEUTICALS","24;5;5;5;3;2;2;2;1;1;1","CLINICAL;BIOMEDICAL;POPULATION & SOCIETY","19;5;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","49;15;3","NOT SITE-SPECIFIC CANCER;BRAIN TUMOR","8;2","3 GOOD HEALTH AND WELL BEING","2"
"IRCCS_BESTA",2024,331,19.9365558912387,3.70090634441088,0.29607250755287,0.280966767371601,0.335347432024169,2.68640350877193,1.24050632911392,1.40909090909091,1.20652173913043,0.667673716012085,2,166,69,14,12,0.5,0.21,0.04,0.04,0.93,0.970480329660452,5.31893984514593,0.558912386706949,0.939577039274924,0.491,0.407,0.417,0.425,"RENATO MANTEGAZZA;BIANCA POLLO;FRANCESCO DIMECO;MASSIMO FILIPPI;GIUSEPPE LAURIA;VINCENZO SILANI;MARINA GRISOLI;ANTONIO SILVANI;ROBERTO ELEOPRA;TUAN VU;NICOLA TICOZZI;PIETRO TIRABOSCHI;LORENZO MAGGI;DAVIDE ROSSI SEBASTIANO;CAROLINE GRAFF;MARIA GRAZIA BRUZZONE;ELENA ANGHILERI;ROBERTO CILIA;MATILDE LEONARDI;MARICA EOLI","20;19;19;16;16;14;14;13;13;12;12;11;11;11;10;10;10;10;10;10","RENATO MANTEGAZZA;FRANCESCO DIMECO;GIUSEPPE LAURIA;MASSIMO LEONE;BIANCA POLLO;LICIA GRAZZI;BENEDETTA STORTI;MARINA GRISOLI;DAVIDE ROSSI SEBASTIANO;MARCO DE CURTIS;LORENZO MAGGI;ANTONIO SILVANI;FABIO MARTINO DONISELLI;TUAN VU;MASSIMILIANO DEL BENE;MATILDE LEONARDI;EDOARDO PORTO;ANNA RITA GIOVAGNOLI;MASSIMO FILIPPI;FRANCESCO PRADA","1.67;1.54;1.44;1.2;1.18;1.14;1.11;1.06;1;1;0.95;0.92;0.9;0.88;0.88;0.87;0.85;0.79;0.78;0.72","RENATO MANTEGAZZA;BIANCA POLLO;FRANCESCO DIMECO;GIUSEPPE LAURIA;MARINA GRISOLI;ANTONIO SILVANI;ROBERTO ELEOPRA;PIETRO TIRABOSCHI;LORENZO MAGGI;DAVIDE ROSSI SEBASTIANO;MARIA GRAZIA BRUZZONE;ELENA ANGHILERI;ROBERTO CILIA;MATILDE LEONARDI;MARICA EOLI;LUIGI ROMITO;ANNA NIGRI;LICIA GRAZZI;COSTANZA LAMPERTI;EDOARDO PORTO","20;19;19;16;14;13;13;11;11;11;10;10;10;10;10;10;9;9;9;9","RENATO MANTEGAZZA;FRANCESCO DIMECO;GIUSEPPE LAURIA;MASSIMO LEONE;BIANCA POLLO;LICIA GRAZZI;BENEDETTA STORTI;MARINA GRISOLI;DAVIDE ROSSI SEBASTIANO;MARCO DE CURTIS;LORENZO MAGGI;ANTONIO SILVANI;FABIO MARTINO DONISELLI;MASSIMILIANO DEL BENE;MATILDE LEONARDI;EDOARDO PORTO;ANNA RITA GIOVAGNOLI;FRANCESCO PRADA;GRAZIA DEVIGILI;ALESSANDRA TELESCA","1.67;1.54;1.44;1.2;1.18;1.14;1.11;1.06;1;1;0.95;0.92;0.9;0.88;0.87;0.85;0.79;0.72;0.68;0.68","LICIA GRAZZI;ANNE SABERS;FRANK VAJDA;SANJEEV V. THOMAS;TORBJÖRN TOMSON;SILJE ALVESTAD;RENATO MANTEGAZZA;VEERLE VISSER‐VANDEWALLE;LUIGI ROMITO;ALBERTO MAZZONI;ANDREA A. KÜHN;ANDREAS HORN;BARBARA HOLLUNDER;BOMIN SUN;CARSTEN FINKE;CHENCHENG ZHANG;CLEMENS NEUDORFER;DARIN D. DOUGHERTY;EDUARDO JOAQUIM LOPES ALHO;EILEEN M. JOYCE","41;36;36;36;36;34;31;30;29;28;28;28;28;28;28;28;28;28;28;28","LICIA GRAZZI;RENATO MANTEGAZZA;LUIGI ROMITO;ALBERTO RAGGI;ARIANNA FORNARI;EMILIO CIUSANI;MATILDE LEONARDI;DINA BATTINO;COSTANZA LAMPERTI;IRENE TRAMACERE;ANNAMARIA GALLONE;FRANCESCA ANDREETTA;LORENZO MAGGI;SILVIA BONANNO;VALERIA TIRANTI;ANNA COLASUONNO;CARLO ANTOZZI;ELENA RINALDI;FIAMMETTA VANOLI;GIORGIO GIACCONE","41;31;29;24;21;21;20;19;16;14;12;12;12;12;12;11;11;11;11;11","RENATO MANTEGAZZA;BIANCA POLLO;FRANCESCO DIMECO;MARINA GRISOLI;GIUSEPPE LAURIA;ROBERTO ELEOPRA;ANTONIO SILVANI;PIETRO TIRABOSCHI;LORENZO MAGGI;DAVIDE ROSSI SEBASTIANO;ROBERTO CILIA;ALESSANDRA ERBETTA;MARIA GRAZIA BRUZZONE;MATILDE LEONARDI;ELENA ANGHILERI;LUIGI ROMITO;MARICA EOLI;LICIA GRAZZI;ANNA NIGRI;COSTANZA LAMPERTI","20;18;18;14;14;13;12;11;11;10;10;10;10;10;10;10;10;9;9;9","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;MATHEMATICS;POLITICAL SCIENCE;SOCIOLOGY;ENGINEERING;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;BUSINESS;HISTORY;ART;GEOGRAPHY","297;109;107;33;29;22;19;14;14;13;11;10;10;6;3;2;2","INTERNAL MEDICINE;NEUROSCIENCE;PATHOLOGY;PSYCHIATRY;GENETICS;SURGERY;RADIOLOGY;PHYSICAL MEDICINE AND REHABILITATION;PEDIATRICS;ONCOLOGY;CANCER RESEARCH;BIOCHEMISTRY;PHYSICAL THERAPY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;PHARMACOLOGY;BIOINFORMATICS;CELL BIOLOGY;AUDIOLOGY;CLINICAL PSYCHOLOGY;ENDOCRINOLOGY;QUANTUM MECHANICS","152;89;86;85;64;43;37;36;33;30;28;27;27;26;24;19;18;17;16;16;16;16","DISEASE;GENE;EPILEPSY;COGNITION;CLINICAL TRIAL;POPULATION;NEUROLOGY;COHORT;MYASTHENIA GRAVIS;MAGNETIC RESONANCE IMAGING;ADVERSE EFFECT;NEUROSURGERY;RECEPTOR;ANTIBODY;CANCER;OBSERVATIONAL STUDY;RADIATION THERAPY;CENTRAL NERVOUS SYSTEM;GLIOBLASTOMA;ATROPHY;ELECTROENCEPHALOGRAPHY;GLIOMA;QUALITY OF LIFE (HEALTHCARE)","91;58;25;24;22;22;21;19;17;16;14;13;13;12;12;12;12;11;11;10;10;10;10","DEMENTIA;PARKINSON'S DISEASE;MUTATION;PHENOTYPE;AMYOTROPHIC LATERAL SCLEROSIS;NEURORADIOLOGY;GENOTYPE;TOLERABILITY;INTERIM ANALYSIS;MITOCHONDRIAL DNA;NEUROPSYCHOLOGY;SPINAL MUSCULAR ATROPHY;AGE OF ONSET;CHRONIC MIGRAINE;GENOME;NEURODEGENERATION;PLACEBO;RADIOSURGERY;ALLELE;ALZHEIMER'S DISEASE;AUTISM SPECTRUM DISORDER;AUTOANTIBODY;BREAST CANCER;DOPAMINERGIC;EPILEPSY SURGERY;GENE EXPRESSION;MINIMALLY CONSCIOUS STATE;MOVEMENT DISORDERS;NEUROMUSCULAR DISEASE;SPINOCEREBELLAR ATAXIA","26;20;19;16;10;10;8;7;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","FRONTOTEMPORAL DEMENTIA;DEEP BRAIN STIMULATION;MITOCHONDRIAL DISEASE;COPY-NUMBER VARIATION;EXOME SEQUENCING;CEREBRAL AMYLOID ANGIOPATHY;LEBER'S HEREDITARY OPTIC NEUROPATHY;PERSISTENT VEGETATIVE STATE;ALPHA-SYNUCLEIN;CALCITONIN GENE-RELATED PEPTIDE;DNA METHYLATION;HAPLOINSUFFICIENCY;INDUCED PLURIPOTENT STEM CELL;MISSENSE MUTATION;PROBAND;COGNITIVE DECLINE;CORONAVIRUS DISEASE 2019 (COVID-19);CORTICOBASAL DEGENERATION;EXCESSIVE DAYTIME SLEEPINESS;LEWY BODY;MICROVESICLES;MYOTONIA CONGENITA;OCRELIZUMAB;PACHYGYRIA;POINT MUTATION;PRIMARY MOTOR CORTEX;TRINUCLEOTIDE REPEAT EXPANSION;VERBAL FLUENCY TEST","18;9;6;5;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;YOUNG ADULT;CHILD;ITALY;RETROSPECTIVE STUDIES;ADOLESCENT;MAGNETIC RESONANCE IMAGING;MUTATION;CHILD, PRESCHOOL;ANIMALS;TREATMENT OUTCOME;EPILEPSY;QUALITY OF LIFE;DISEASE PROGRESSION","195;130;77;74;56;56;37;23;21;20;20;18;17;17;15;14;14;11;11;10","GLIOMAS;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;EPILEPSY AND SEIZURES;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;MANAGEMENT AND PATHOPHYSIOLOGY OF INTRACEREBRAL HEMORRHAGE;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY","19;17;16;11;10;10;9;9;8;7;7;7;7;6;5;4;4;4;4;3","NEURODEGENERATION;EPILEPSY;NEUROMODULATION;NEURORADIOLOGY;DEEP BRAIN STIMULATION;TREATMENT;GLIOBLASTOMA;SPINAL MUSCULAR ATROPHY;MIGRAINE PREVENTION;MYASTHENIA GRAVIS;POST-HOC ANALYSIS;TOLERABILITY;CHRONIC MIGRAINE;INBORN ERRORS OF METABOLISM;INTERIM ANALYSIS;MITOCHONDRIAL DISEASE;STATUS EPILEPTICUS;C9ORF72;DYSTONIA;MENINGIOMAS","14;10;10;10;9;9;8;8;7;7;7;7;6;6;6;6;6;5;5;5","MYASTHENIA GRAVIS;GENERALIZED MYASTHENIA;FRONTOTEMPORAL DEMENTIA;PARKINSONS DISEASE;MULTIPLE SCLEROSIS;STEREOTACTIC RADIOSURGERY;MUSCULAR ATROPHY;OBSERVATIONAL STUDY;SPINAL MUSCULAR;AMYOTROPHIC LATERAL;CLINICAL TRIAL;LATERAL SCLEROSIS;OPEN-LABEL EXTENSION;RETROSPECTIVE STUDY;BRAIN STIMULATION;DEEP BRAIN;DISEASE PATIENTS;FOCUSED ULTRASOUND;GENFI STUDY;INTERNATIONAL STEREOTACTIC;LONG-TERM SAFETY;NATURAL HISTORY;RADIOSURGERY SOCIETY;ALZHEIMERS DISEASE;AMYLOID ANGIOPATHY;ANTI-CGRP MONOCLONAL;AUTISM SPECTRUM;CEREBRAL AMYLOID;CEREBRAL PALSY;CHRONIC INFLAMMATORY","17;12;11;10;9;8;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3","PARKINSONS DISEASE;ANTI-CGRP MABS;FRONTOTEMPORAL DEMENTIA;PATHOGENIC VARIANTS;MYASTHENIA GRAVIS;ABSTRACT OBJECTIVE;HEALTHY CONTROLS;PICKS DISEASE;CHRONIC PAIN;PD PATIENTS;BRAIN HEALTH;CLINICAL PRACTICE;DISEASE PROGRESSION;LATERAL SCLEROSIS;NERVOUS SYSTEM;AMYOTROPHIC LATERAL;CLINICAL DIAGNOSIS;FUNCTIONAL CONNECTIVITY;MUTATION CARRIERS;CLINICAL FEATURES;COGNITIVE IMPAIRMENT;CONCOMITANT ASMS;DISEASE ONSET;DISEASE PD;FAMILY HISTORY;MOTOR COMPENSATION;OPTIC NEUROPATHY;PLASMA SAMPLES;REPEAT SIZE;SMA PATIENTS","25;17;15;15;13;12;12;12;11;11;10;10;10;10;10;9;9;9;9;8;8;8;8;8;8;8;8;8;8;8",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,655782,81169,3.5,7.5,5,1,0,245717.976767677,1.34707278789356,"ISTITUTO NEUROLOGICO CARLO BESTA;ASTRAZENECA (SWEDEN);CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES;DON CARLO GNOCCHI FOUNDATION;INSTITUT DU CERVEAU;JAGIELLONIAN UNIVERSITY;KLINIKEN SCHMIEDER;MEDISCH SPECTRUM TWENTE;POLITECNICO DI MILANO;RADBOUD UNIVERSITY NIJMEGEN MEDICAL CENTRE;UNIVERSIDAD LOYOLA ANDALUCÍA;UNIVERSITAT POLITÈCNICA DE VALÈNCIA;UNIVERSITY OF BIRMINGHAM;UNIVERSITY OF LIÈGE","2;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","2","COALITION S;EC & ERC - EUROPEAN UNION","2;2","HORIZON.1.2 - MARIE SKŁODOWSKA-CURIE ACTIONS (MSCA) (PROGRAMME);HORIZON-MSCA-2022-PF-01 (CALL FOR PROPOSAL);HORIZON-MSCA-2022-SE-01 (CALL FOR PROPOSAL);HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA POSTDOCTORAL FELLOWSHIPS - EUROPEAN FELLOWSHIPS (FUNDING SCHEME);HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA STAFF EXCHANGES (FUNDING SCHEME)","2;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;42 HEALTH SCIENCES;4205 NURSING","2;1;1;1","BIOENGINEERING;BIOMEDICAL IMAGING;BIOTECHNOLOGY;GENE THERAPY;GENETICS;NANOTECHNOLOGY;PREVENTION","1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE","1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1;1","NOT SITE-SPECIFIC CANCER","1","4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1;1","A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;B11 COMPUTER SCIENCE AND INFORMATICS","1;1",NA,NA,7,"ZENODO;FRONTIERS","6;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","8;4;2;2;2;2;1","BASIC BEHAVIORAL AND SOCIAL SCIENCE;BEHAVIORAL AND SOCIAL SCIENCE;CLINICAL RESEARCH;MENTAL HEALTH;NEUROSCIENCES","1;1;1;1;1","NEUROLOGICAL","2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","2","CLINICAL","3","CLINICAL MEDICINE AND SCIENCE","4",NA,NA,NA,NA
